bcr_patient_uuid	patient_ID	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	pharmaceutical_therapy_drug_name	clinical_trial_drug_classification	pharmaceutical_therapy_type	days_to_drug_start	pharmaceutical_tx_ongoing_indicator	days_to_drug_end	treatment_best_response	days_to_stem_cell_transplantation	pharm_regimen	pharm_regimen_other	drug_cycles	pharma_type_other	drug_units	drug_tota_dose_units	drug_dose	regimen_number	drug_route	stem_cell_transplantation	stem_cell_transplantation_type	therapy_regimen	therapy_regimen_other	drug_total_dose	therapy_on_clinical_trial
1	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a	TCGA.04.1331	TCGA-04-1331-D23909	8248d776-145a-4301-8d69-09567aedcf3d	2009-11-10	VELCADE	NA	TARGETED MOLECULAR THERAPY	481	FALSE	498	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	4.4	NA
2	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a	TCGA.04.1331	TCGA-04-1331-D23908	0debc4f0-665e-47b4-880c-d732d3897ea2	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	36	FALSE	169	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	455	NA
3	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a	TCGA.04.1331	TCGA-04-1331-D23907	f4aaacc4-22bc-4b11-9987-42a72560fe95	2009-11-10	TAXOL	NA	CHEMOTHERAPY	36	FALSE	169	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1650	NA
4	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23916	9872734c-4308-4239-a327-badc002227f5	2009-11-30	CISPLATIN	NA	CHEMOTHERAPY	1094	FALSE	1155	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
5	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23913	eaa50f60-2e69-4f97-b316-7f7b4d6ad0e7	2009-11-30	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
6	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23917	7fb06145-71d2-4719-b919-ce42f9a236b2	2009-11-30	TAXOTERE	NA	CHEMOTHERAPY	1094	FALSE	1155	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
7	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23919	648e9735-7f2e-4d75-b997-4165f16e33f4	2009-11-30	TOPOTECAN/CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	179	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
8	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23912	a5ef9119-338a-4e6c-a55d-9898611a296a	2009-11-30	GEMCITABINE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
9	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23920	a815049a-3d7b-4507-ac73-9c01557671f5	2009-11-30	TAXOL/CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	179	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
10	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23918	45d7a0a0-7a94-413c-840e-d265aa8e32b3	2009-11-30	DOXIL	NA	CHEMOTHERAPY	1155	FALSE	1216	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
11	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23915	3cceae8f-8fbc-4d20-bc2d-aff4a747632f	2009-11-30	TAXOTERE	NA	CHEMOTHERAPY	971	FALSE	1063	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
12	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23914	66a262b2-950e-462d-a399-affebbfd0761	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	971	FALSE	1063	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
13	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23922	8ae61fa8-4a16-4bb1-aa64-344b42cfd9aa	2010-2-22	PACLITAXEL	NA	CHEMOTHERAPY	424	FALSE	606	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
14	b46263ab-c3ca-4fda-a895-74c7e6e6fe22	TCGA.04.1332	TCGA-04-1332-D23921	9938439e-42e6-45d7-b1c8-df2a25fd6afe	2010-2-22	CARBOPLATIN	NA	CHEMOTHERAPY	424	FALSE	606	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
15	538acb2a-c4ca-4656-a91c-841a42dbf15f	TCGA.04.1336	TCGA-04-1336-D23927	65f9a9bb-2580-4922-9912-38341e2c039d	2009-11-17	TAXOTERE	NA	CHEMOTHERAPY	50	FALSE	144	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
16	538acb2a-c4ca-4656-a91c-841a42dbf15f	TCGA.04.1336	TCGA-04-1336-D23929	bb1ccca2-c7cd-4696-954c-4014fc47e1fc	2009-11-17	TAXOTERE	NA	CHEMOTHERAPY	179	FALSE	542	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
17	538acb2a-c4ca-4656-a91c-841a42dbf15f	TCGA.04.1336	TCGA-04-1336-D23928	6232e1fe-6d5b-497e-bb28-aee09a3a7df5	2009-11-17	CARBOPLATIN	NA	CHEMOTHERAPY	50	FALSE	144	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
18	31872f6a-d225-4f91-b38d-4505d19e406c	TCGA.04.1338	TCGA-04-1338-D23938	7df91b7d-ebc2-4b72-9e60-d401fb168d18	2009-11-24	TAMOXIFEN	NA	CHEMOTHERAPY	627	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
19	31872f6a-d225-4f91-b38d-4505d19e406c	TCGA.04.1338	TCGA-04-1338-D23936	c40ba7f9-061d-493a-b88e-70b482fdb3be	2009-11-24	DOCETAXEL	NA	CHEMOTHERAPY	415	FALSE	510	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	812	NA
20	31872f6a-d225-4f91-b38d-4505d19e406c	TCGA.04.1338	TCGA-04-1338-D23937	303cbcd2-da20-448e-9b83-9469a2068fe8	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	597	FALSE	627	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	800	NA
21	31872f6a-d225-4f91-b38d-4505d19e406c	TCGA.04.1338	TCGA-04-1338-D23934	3852b927-d887-4d24-a04b-a490d8104764	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	0	FALSE	201	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
22	31872f6a-d225-4f91-b38d-4505d19e406c	TCGA.04.1338	TCGA-04-1338-D23935	99006d2c-78d0-433d-93c0-11361212d049	2009-11-24	TAXOL	NA	CHEMOTHERAPY	0	FALSE	201	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
23	8727855e-120a-4216-a803-8cc6cd1159be	TCGA.04.1342	TCGA-04-1342-D23944	bbc04766-0c66-4944-983f-535608ffe36d	2009-11-9	TAXOL	NA	CHEMOTHERAPY	170	FALSE	478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
24	8727855e-120a-4216-a803-8cc6cd1159be	TCGA.04.1342	TCGA-04-1342-D23946	a8f2443d-7a47-40b8-978c-2221d8a39987	2009-11-9	DOXORUBICIN	NA	CHEMOTHERAPY	170	FALSE	478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
25	8727855e-120a-4216-a803-8cc6cd1159be	TCGA.04.1342	TCGA-04-1342-D23947	5e0e55b4-42eb-4772-8dcc-a984731aacc9	2009-11-9	TOPOTECAN	NA	CHEMOTHERAPY	170	FALSE	478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
26	8727855e-120a-4216-a803-8cc6cd1159be	TCGA.04.1342	TCGA-04-1342-D23945	3d1f08e6-6295-4b2f-85b8-c9e4c70d9073	2009-11-9	TAXOTERE	NA	CHEMOTHERAPY	170	FALSE	478	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
27	8727855e-120a-4216-a803-8cc6cd1159be	TCGA.04.1342	TCGA-04-1342-D23943	d4959712-ca57-45a4-996c-550163f99420	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	32	FALSE	142	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
28	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23952	3e3aefa8-7cdc-4c16-ae47-9cce76c8de3f	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	50	FALSE	170	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	800	NA
29	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23950	4ef4a550-feb8-4a47-b61a-30e9bbcd4b3f	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	50	FALSE	170	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
30	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23951	295a9456-0793-4458-acb2-2766e579c1dd	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	50	FALSE	170	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
31	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23956	b259ff22-9552-43f2-a065-fab193830b68	2009-11-24	NAVELBINE	NA	CHEMOTHERAPY	262	FALSE	323	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
32	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23955	9334cb5b-be90-441f-b19d-9281c212dea9	2009-11-24	TOPOTECAN	NA	CHEMOTHERAPY	262	FALSE	323	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
33	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23957	981f0805-35b4-4c8d-9cf6-08473727598d	2009-11-24	TOPOTECAN	NA	CHEMOTHERAPY	323	FALSE	354	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
34	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23953	790fc301-5777-4c02-801c-688ce341e629	2009-11-24	TAXOTERE	NA	CHEMOTHERAPY	170	FALSE	262	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
35	b7715ff6-57a6-4513-9447-aa8bc93f16d4	TCGA.04.1343	TCGA-04-1343-D23954	613cb525-ddfb-4892-ab3c-647aec37b7b9	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	170	FALSE	262	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
36	f0c353fd-947c-41e2-b643-3ecc0d69796c	TCGA.04.1347	TCGA-04-1347-D23965	2f680d7c-a16e-4c02-97dc-b8735edfd538	2009-11-9	TAXOTERE	NA	CHEMOTHERAPY	19	FALSE	173	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	200	NA
37	f0c353fd-947c-41e2-b643-3ecc0d69796c	TCGA.04.1347	TCGA-04-1347-D23963	8ee7bc23-3af3-437e-a1c3-82da7ded82ba	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	173	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2400	NA
38	f0c353fd-947c-41e2-b643-3ecc0d69796c	TCGA.04.1347	TCGA-04-1347-D23962	064dd296-90e7-493a-a26b-0e9d1aa58b13	2009-11-9	TAXOL	NA	CHEMOTHERAPY	19	FALSE	173	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1764	NA
39	f0c353fd-947c-41e2-b643-3ecc0d69796c	TCGA.04.1347	TCGA-04-1347-D23964	a176cad9-0e04-4138-802e-18d4935f981f	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	173	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	750	NA
40	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23973	90f7c316-6484-466c-8ed0-6b2808bbdf32	2009-11-17	GEMZAR	NA	CHEMOTHERAPY	1006	FALSE	1157	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
41	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23969	06f08769-e9a9-463f-9dc2-feddab17d6a0	2009-11-17	CARBOPLATIN	NA	CHEMOTHERAPY	2	FALSE	184	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
42	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23971	d3abae36-f4b5-4d43-b4f8-af47f4ad136e	2009-11-17	TOPOTECAN	NA	CHEMOTHERAPY	884	FALSE	976	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
43	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23975	7e036a8c-1559-4399-885d-8a1e4d32ed53	2009-11-17	DOXIL	NA	CHEMOTHERAPY	1279	FALSE	1432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
44	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23968	98897791-90ee-47b0-a526-1c8571b319a8	2009-11-17	TAXOL	NA	CHEMOTHERAPY	2	FALSE	184	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
45	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23972	396df1c7-00b5-467a-965a-fbd8b603be40	2009-11-17	CISPLATIN/GEMZAR	NA	CHEMOTHERAPY	1006	FALSE	1157	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
46	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23974	9ae97b2d-2789-4e9c-97a4-28a084433803	2009-11-17	TAXOTERE	NA	CHEMOTHERAPY	1218	FALSE	1249	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
47	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4	TCGA.04.1348	TCGA-04-1348-D23970	bb7bed55-0fc3-4776-9cfe-59bd4adbbe7a	2009-11-17	DOXIL	NA	CHEMOTHERAPY	672	FALSE	853	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
48	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23979	dbb69d58-12bc-4b08-b033-f6445d45d0b2	2009-11-10	CISPLATIN	NA	CHEMOTHERAPY	436	FALSE	653	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	75	NA
49	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23980	e6584537-e4b7-40ac-8cd8-6e6329a6a620	2009-11-10	CISPLATIN	NA	CHEMOTHERAPY	436	FALSE	653	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	60	NA
50	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23985	657f0e7d-e78a-426c-877e-5ffe76061984	2009-11-10	PACLITAXEL	NA	CHEMOTHERAPY	1	FALSE	373	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
51	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23981	19d1b2b2-e7da-44e6-8eff-02c8438a5e16	2009-11-10	PACLITAXEL	NA	CHEMOTHERAPY	436	FALSE	653	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	60	NA
52	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23984	1d5f70a4-4277-456b-8425-78630a4842fe	2009-11-10	PACLITAXEL	NA	CHEMOTHERAPY	1	FALSE	373	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
53	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23982	eb24d9d8-a70b-43e2-af7b-199124d06a41	2009-11-10	CYTOXAN	NA	CHEMOTHERAPY	436	FALSE	653	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	750	NA
54	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23978	21e672d6-60ea-4ba5-a90a-3d8d33c0197d	2009-11-10	DOXIL	NA	CHEMOTHERAPY	436	FALSE	653	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	30	NA
55	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23983	b6b0b86f-0a20-4b17-a137-0d361563e1e3	2009-11-10	CISPLATIN	NA	CHEMOTHERAPY	1	FALSE	373	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
56	4b930a10-4b12-4428-84f9-3255b4a3bc4f	TCGA.04.1349	TCGA-04-1349-D23986	4ed4f655-53b4-4a3c-9f0d-68d03e0be4e4	2009-11-10	AVASTIN	NA	TARGETED MOLECULAR THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	5	NA
57	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23998	3f2319b5-98cf-40ee-ada2-7bd9e041c3e3	2009-11-10	FULUESTRANT	NA	TARGETED MOLECULAR THERAPY	1726	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
58	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23995	566e0b34-13c1-442d-853d-ec2a4a8b70cd	2009-11-10	AVASTIN	NA	IMMUNOTHERAPY	1389	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
59	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23993	ce73824b-a2d9-4f29-9172-453c72baefa6	2009-11-10	CISPLATIN	NA	CHEMOTHERAPY	1389	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
60	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23994	25b6f90e-7d0b-493c-8353-1e83e32684ab	2009-11-10	GEMCITIBINE	NA	CHEMOTHERAPY	1389	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
61	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23997	a5e9b1ee-6713-4f06-abd5-4450057f0ca5	2009-11-10	AROMASIN	NA	TARGETED MOLECULAR THERAPY	1622	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
62	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23990	823bb81f-7708-4a0f-b91f-02f8f375c263	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	216	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
63	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23999	cae5bb23-53c0-40bc-8bfc-d3541ebd7b2d	2009-11-10	FASLODEX	NA	TARGETED MOLECULAR THERAPY	1726	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
64	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23989	d3bc267a-90d8-490c-ac82-32383c4ca950	2009-11-10	TAXOL	NA	CHEMOTHERAPY	216	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
65	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23991	196d7307-35f0-4476-80ac-ee00c4b5a305	2009-11-10	CISPLATIN	NA	CHEMOTHERAPY	363	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
66	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23992	b7cd073a-7ba3-48ec-8172-0a230b6c0f7a	2009-11-10	GEMCITIBINE	NA	CHEMOTHERAPY	720	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
67	0f4a4ad1-e394-45c4-9aa9-aadf2bff0628	TCGA.04.1350	TCGA-04-1350-D23996	c6ca377d-35fb-4558-a98e-6a2722f37fa1	2009-11-10	TAMOXIFEN	NA	TARGETED MOLECULAR THERAPY	1580	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
68	12b032ed-ff92-4bfe-b980-eb273ae8ae17	TCGA.04.1351	TCGA-04-1351-D24002	a7c3ad1f-4d37-4b3e-9b47-d4ec008b2874	2009-12-23	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
69	12b032ed-ff92-4bfe-b980-eb273ae8ae17	TCGA.04.1351	TCGA-04-1351-D24003	b6d20430-8f48-46d9-876a-65ed5004e96e	2009-12-23	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
70	8652ddee-98f4-4584-b450-e6f2f5c9d7ec	TCGA.04.1356	TCGA-04-1356-D24007	6d03f8af-3a97-4801-bded-4dd5c67c3e8d	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	161	FALSE	312	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4531.3	NA
71	8652ddee-98f4-4584-b450-e6f2f5c9d7ec	TCGA.04.1356	TCGA-04-1356-D24006	dcc12929-7c55-426b-83cd-0f693a953cfb	2009-11-10	TAXOL	NA	CHEMOTHERAPY	161	FALSE	312	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1824.5	NA
72	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	TCGA.04.1361	TCGA-04-1361-D24014	89aeb2a5-7c9d-4496-aec9-1d616616507c	2009-11-10	TAXOL	NA	CHEMOTHERAPY	53	FALSE	844	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
73	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	TCGA.04.1361	TCGA-04-1361-D24016	a5ce32b9-e2c9-4f51-803d-168a80a2a582	2009-11-10	TAXOL	NA	CHEMOTHERAPY	53	FALSE	844	NA	NA	NA	NA	12	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
74	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	TCGA.04.1361	TCGA-04-1361-D24017	259ac9a0-8e2c-4dca-a3cc-21878c2d46e6	2009-11-10	DOXIL	NA	CHEMOTHERAPY	936	FALSE	989	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
75	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	TCGA.04.1361	TCGA-04-1361-D24018	91768e3d-6abe-4398-ace4-98c1559151ec	2009-11-10	AVASTIN	NA	IMMUNOTHERAPY	936	FALSE	989	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
76	a6aad7f9-8444-4c2f-8e4b-b19fd453544f	TCGA.04.1361	TCGA-04-1361-D24015	6e726984-aca5-4ae7-9f92-1984000dac83	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	53	FALSE	844	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
77	1d192835-524e-429d-bf74-3c4727acb446	TCGA.04.1362	TCGA-04-1362-D24021	5a583495-0c6e-4fcf-a5cb-c8bf245de3f9	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	172	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2593	NA
78	1d192835-524e-429d-bf74-3c4727acb446	TCGA.04.1362	TCGA-04-1362-D24023	3c1ece80-31b8-4d36-b4f4-d0ab005acc4b	2009-11-10	GEMCITIBINE	NA	CHEMOTHERAPY	7	FALSE	172	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	13856	NA
79	1d192835-524e-429d-bf74-3c4727acb446	TCGA.04.1362	TCGA-04-1362-D24022	3337ba21-cbbd-4aa9-a0eb-fbf135127996	2009-11-10	TAXOL	NA	CHEMOTHERAPY	7	FALSE	172	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1689	NA
80	1d192835-524e-429d-bf74-3c4727acb446	TCGA.04.1362	TCGA-04-1362-D24026	0eead925-93f1-4a66-a5cb-434ff454c034	2009-11-10	TOPOTECAN	NA	CHEMOTHERAPY	658	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
81	1d192835-524e-429d-bf74-3c4727acb446	TCGA.04.1362	TCGA-04-1362-D24024	815d5029-02f6-4c96-9417-c5b01dcde4f5	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	658	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
82	1d192835-524e-429d-bf74-3c4727acb446	TCGA.04.1362	TCGA-04-1362-D24025	af62b4e7-990c-4aad-a592-6ece7da45fd8	2009-11-10	DOXIL	NA	CHEMOTHERAPY	658	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
83	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24036	a0a50587-aad9-4b1d-8206-694d37745750	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	401	FALSE	462	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	6400	NA
84	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24041	a745b383-07f8-4eb1-a64a-7e8f7858561b	2009-11-24	DOCETAXEL	NA	CHEMOTHERAPY	919	FALSE	949	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	260	NA
85	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24030	6ec6788e-d27f-4b70-8e0d-8a863c19a3f6	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	188	NA	NA	NA	NA	7	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
86	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24033	f0840d96-e4ac-4cb5-bb8c-37f30ae5fbce	2009-11-24	TOPOTECAN	NA	CHEMOTHERAPY	279	FALSE	310	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	19.8	NA
87	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24031	82444910-d44e-4470-a279-958e2467a045	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	35	FALSE	188	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2408	NA
88	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24032	eb6c4302-3a07-4fcb-8131-2be34065fe88	2009-11-24	DOXIL	NA	CHEMOTHERAPY	35	FALSE	188	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	235	NA
89	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24039	58df2207-1cb7-402e-a01c-df9b30e13cf7	2009-11-24	AVASTIN	NA	CHEMOTHERAPY	615	FALSE	827	NA	NA	NA	NA	14	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	1860	NA
90	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24037	6c9294a5-491a-4587-95ab-ce1f11c1ae91	2009-11-24	CISPLATIN	NA	CHEMOTHERAPY	401	FALSE	462	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	240	NA
91	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24038	421f933a-52e6-42f5-b837-55b2362f589e	2009-11-24	5F4 LEUCOVORIN	NA	CHEMOTHERAPY	615	FALSE	827	NA	NA	NA	NA	14	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	7000	NA
92	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24035	ee5c2bae-8c4c-4a1d-bf59-b3c1d4357b7c	2009-11-24	HEXALEN	NA	CHEMOTHERAPY	341	FALSE	370	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	1400	NA
93	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24042	eebd6dca-fb4f-448b-8c96-5f8f94f48847	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	919	FALSE	949	NA	NA	NA	NA	2	NA	AUC	AUC	NA	NA	NA	NA	NA	RECURRENCE	NA	5	NA
94	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24040	ee3416d9-a24f-4ec5-b710-a57166eaebd4	2009-11-24	RBBX 01	NA	CHEMOTHERAPY	857	FALSE	857	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	8.5	NA
95	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24029	abbdcb69-6108-40d7-8c23-69271ce2bda5	2009-11-24	ETOPOSIDE	NA	CHEMOTHERAPY	462	FALSE	584	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	10500	NA
96	80f85c54-e12f-4afa-8fa5-5f3e083b6f95	TCGA.04.1364	TCGA-04-1364-D24034	58851b60-22dc-4a9d-85fe-338ed52e93b4	2009-11-24	NAVELBINE	NA	CHEMOTHERAPY	279	FALSE	310	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	198	NA
97	0484a929-7a7f-4926-8d25-470ddab082ec	TCGA.04.1365	TCGA-04-1365-D24050	94df838e-3175-48e9-9671-4922ad649d5f	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	2329	FALSE	2329	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
98	0484a929-7a7f-4926-8d25-470ddab082ec	TCGA.04.1365	TCGA-04-1365-D24049	c7f23742-9c3b-4bef-ad13-5888915ae592	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	2063	FALSE	2196	NA	NA	NA	NA	2	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4	NA
99	0484a929-7a7f-4926-8d25-470ddab082ec	TCGA.04.1365	TCGA-04-1365-D24046	e830225c-50d9-49db-9d48-4186bbc20fd6	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	189	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
100	0484a929-7a7f-4926-8d25-470ddab082ec	TCGA.04.1365	TCGA-04-1365-D24045	90c97127-c03c-4650-9dce-516d12af44d2	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	21	FALSE	189	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	11760	NA
101	0484a929-7a7f-4926-8d25-470ddab082ec	TCGA.04.1365	TCGA-04-1365-D24048	dd8b96a9-d738-4494-aec8-a4892eb9ba68	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	2063	FALSE	2196	NA	NA	NA	NA	4	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
102	0484a929-7a7f-4926-8d25-470ddab082ec	TCGA.04.1365	TCGA-04-1365-D24047	1d817f79-6e5a-4729-857d-41100fd09200	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	2001	FALSE	2117	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
103	30b8f4cd-9245-4496-a8a8-c3e59093bc0a	TCGA.04.1367	TCGA-04-1367-D24054	b8e70426-e545-4d98-8d53-6a6b8c355636	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	199	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	721	NA
104	30b8f4cd-9245-4496-a8a8-c3e59093bc0a	TCGA.04.1367	TCGA-04-1367-D24053	d22430b7-f915-4dfb-928c-96aea53a860c	2009-11-9	TAXOL	NA	CHEMOTHERAPY	24	FALSE	199	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1925	NA
105	6c43727d-631a-40fb-b1a1-242a12889eaa	TCGA.04.1369	TCGA-04-1369-D24058	102518d8-179f-447a-96fe-c67cccb6bdf7	2010-8-12	CARBOPLATIN	NA	CHEMOTHERAPY	56	FALSE	238	NA	NA	NA	NA	8	NA	MG	MG	464	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4539	NA
106	6c43727d-631a-40fb-b1a1-242a12889eaa	TCGA.04.1369	TCGA-04-1369-D24059	288c7d8e-3290-493e-aff8-83a7df40547a	2010-8-12	PACLITAXEL	NA	CHEMOTHERAPY	175	FALSE	238	NA	NA	NA	NA	4	NA	MG	MG	275	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1100	NA
107	6c43727d-631a-40fb-b1a1-242a12889eaa	TCGA.04.1369	TCGA-04-1369-D24060	933f5331-cf37-4d58-a9c7-5eaa2a3d234a	2010-8-12	BA4 43 9006	NA	CHEMOTHERAPY	392	FALSE	445	NA	NA	NA	NA	2	NA	MG	MG	400	NA	ORAL	NA	NA	PROGRESSION	NA	30000	NA
108	6c43727d-631a-40fb-b1a1-242a12889eaa	TCGA.04.1369	TCGA-04-1369-D24057	57014ef4-02a2-4f6f-a4ec-f63d59a47947	2010-8-12	GEMCITABINE	NA	CHEMOTHERAPY	56	FALSE	154	NA	NA	NA	NA	4	NA	MG	MG	3140	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12560	NA
109	7e6cdbc7-26a7-44f2-96fa-094738cbccae	TCGA.04.1370	TCGA-04-1370-D24063	83f67477-8b87-4f45-b848-4f793508c589	2010-8-12	PACLITAXEL	NA	CHEMOTHERAPY	8	FALSE	200	NA	NA	NA	NA	8	NA	MG	MG	315	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2520	NA
110	7e6cdbc7-26a7-44f2-96fa-094738cbccae	TCGA.04.1370	TCGA-04-1370-D24064	643a2e01-ac72-408c-b5cb-c8de74fe6c58	2010-8-12	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	200	NA	NA	NA	NA	8	NA	MG	MG	528	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5320	NA
111	bff84539-7862-45b2-b5fc-e77291fcca8b	TCGA.04.1371	TCGA-04-1371-D24068	d7136f6a-05fe-45b2-99b6-45ee4fdc1b75	2009-11-9	GEMCITIBINE	NA	CHEMOTHERAPY	7	FALSE	199	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	13200	NA
112	bff84539-7862-45b2-b5fc-e77291fcca8b	TCGA.04.1371	TCGA-04-1371-D24067	dc9acb16-b331-4c9a-8486-ceeac1cb85e1	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	199	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5120	NA
113	bff84539-7862-45b2-b5fc-e77291fcca8b	TCGA.04.1371	TCGA-04-1371-D24069	3ab89f04-e991-431d-a5de-de29b6dc3b31	2009-11-9	TAXOL	NA	CHEMOTHERAPY	7	FALSE	199	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1160	NA
114	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24078	2cb5bd71-e88f-4c88-8bfa-7fcecdd82169	2009-11-24	TAXOTERE	NA	CHEMOTHERAPY	1221	FALSE	1342	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	665	NA
115	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24085	825eb0a8-3865-4461-a42b-9822af8fabe2	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	1615	FALSE	1676	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	7792	NA
116	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24075	debdaa66-085a-4ee2-a1fb-322bc4779f60	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	126	FALSE	185	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
117	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24080	be57a53e-ba99-469a-87a4-dd76ba5de4f8	2009-11-24	DOXIL	NA	CHEMOTHERAPY	1434	FALSE	1495	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	201	NA
118	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24079	94351318-f494-4b2a-9dd7-b81d8e95c476	2009-11-24	PATUPILONE	NA	CHEMOTHERAPY	1372	FALSE	1434	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	51	NA
119	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24084	73a0fc31-688d-4661-a134-2088b85cbe37	2009-11-24	CISPLATIN	NA	CHEMOTHERAPY	1615	FALSE	1676	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	292	NA
120	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24074	d74e569d-d9e0-41af-807e-10728d5b9b7c	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	34	FALSE	126	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	494	NA
121	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24073	c3d7e061-f05f-4211-85db-5b591fbe106b	2009-11-24	CISPLATIN	NA	CHEMOTHERAPY	34	FALSE	126	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	617	NA
122	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24076	4cb85ca0-8248-46f3-8435-d03a54f46c7f	2009-11-24	TAXOTERE	NA	CHEMOTHERAPY	126	FALSE	185	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	333	NA
123	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24082	86d58252-790f-4acb-9709-e59dc68d05de	2009-11-24	NAVELBINE	NA	CHEMOTHERAPY	1525	FALSE	1587	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	336	NA
124	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24072	0734b108-d85e-4880-b4f3-5df1a9e97f32	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	34	FALSE	185	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1112	NA
125	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24083	73b76fec-4906-4c95-8a9b-c65b2072f5c3	2009-11-24	AVASTIN	NA	CHEMOTHERAPY	1464	FALSE	1587	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	1750	NA
126	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24077	25acdb52-aea6-43a1-8a86-00831b905e8d	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	1221	FALSE	1342	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	NA	NA	NA	RECURRENCE	NA	5	NA
127	e9483296-cb91-497a-b955-39a3c3289dac	TCGA.04.1514	TCGA-04-1514-D24081	fcab5840-933e-49df-8fef-a82d594a24f2	2009-11-24	TOPOTECAN	NA	CHEMOTHERAPY	1525	FALSE	1587	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	33.6	NA
128	1c86e4e5-ecc9-4f6d-a557-77bf396a653b	TCGA.04.1516	TCGA-04-1516-D24088	1cac7e12-6041-453f-bdcb-36d9023936fc	2010-6-25	TAXOTERE	NA	CHEMOTHERAPY	37	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
129	1c86e4e5-ecc9-4f6d-a557-77bf396a653b	TCGA.04.1516	TCGA-04-1516-D24089	ad51a508-de7f-4d22-b4a2-a64aebe8ebb4	2010-6-25	TAXOL	NA	CHEMOTHERAPY	56	FALSE	157	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
130	1c86e4e5-ecc9-4f6d-a557-77bf396a653b	TCGA.04.1516	TCGA-04-1516-D24090	c01ba4e5-6d06-430c-bed8-92b8566a1a2b	2010-6-25	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	157	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
131	35916942-e7aa-45db-ad27-03cba67d4d5b	TCGA.04.1517	TCGA-04-1517-D24094	c7c8f6df-41a9-4999-8081-49601b1917e2	2009-11-17	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	144	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
132	35916942-e7aa-45db-ad27-03cba67d4d5b	TCGA.04.1517	TCGA-04-1517-D24096	06f97b5a-43e9-4fe2-b385-20b3fff0cd82	2009-11-17	DOXIL	NA	CHEMOTHERAPY	352	FALSE	421	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
133	35916942-e7aa-45db-ad27-03cba67d4d5b	TCGA.04.1517	TCGA-04-1517-D24093	c2db098e-b4d0-4a08-b35a-3821b685becf	2009-11-17	TAXOTERE	NA	CHEMOTHERAPY	35	FALSE	144	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	70	NA
134	35916942-e7aa-45db-ad27-03cba67d4d5b	TCGA.04.1517	TCGA-04-1517-D24095	4e373c73-a0c8-4c20-adfc-68c098db3867	2009-11-17	GEMZAR	NA	CHEMOTHERAPY	352	FALSE	421	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
135	2bb96e1e-6992-434d-83e5-2f03713b3911	TCGA.04.1525	TCGA-04-1525-D24102	45a99f98-e53d-40d6-891d-5787134ff44e	2009-11-10	IROLFLUVIN	NA	TARGETED MOLECULAR THERAPY	436	FALSE	464	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	31	NA
136	2bb96e1e-6992-434d-83e5-2f03713b3911	TCGA.04.1525	TCGA-04-1525-D24100	5ff6409a-b31a-4c1d-9be5-cb0e87dcd044	2009-11-10	TAXOTERE	NA	CHEMOTHERAPY	16	FALSE	184	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	888	NA
137	2bb96e1e-6992-434d-83e5-2f03713b3911	TCGA.04.1525	TCGA-04-1525-D24101	17234cea-5e59-4520-bb0c-3ab4230d7138	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	184	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
138	42b3dfa3-152f-4ab7-ac9f-988c7f473bea	TCGA.04.1530	TCGA-04-1530-D24105	00ca66ba-5726-4770-97c9-3cdcb1322fe4	2009-11-9	TAXOL	NA	CHEMOTHERAPY	43	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1218	NA
139	42b3dfa3-152f-4ab7-ac9f-988c7f473bea	TCGA.04.1530	TCGA-04-1530-D24106	b92c8c57-7fe6-4ada-b32c-ec7b254b1c1c	2009-11-9	CISPLATIN	NA	CHEMOTHERAPY	43	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	678	NA
140	42b3dfa3-152f-4ab7-ac9f-988c7f473bea	TCGA.04.1530	TCGA-04-1530-D24108	e9327dc6-1775-4aff-bce4-b32ea0f465bd	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	382	FALSE	550	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2490	NA
141	42b3dfa3-152f-4ab7-ac9f-988c7f473bea	TCGA.04.1530	TCGA-04-1530-D24107	e53d3505-76db-4d22-a0e5-968e706f3e0e	2009-11-9	TAXOL	NA	CHEMOTHERAPY	382	FALSE	550	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1200	NA
142	1fe19c6b-71d0-4b07-923b-74ea32210db0	TCGA.04.1536	TCGA-04-1536-D24111	4c9cdf72-d881-4079-bec6-5453fe89239d	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	36	FALSE	232	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3360	NA
143	1fe19c6b-71d0-4b07-923b-74ea32210db0	TCGA.04.1536	TCGA-04-1536-D24116	b895268f-eb7a-4293-9f10-6dbaea5fd999	2009-11-9	TAXOTERE	NA	CHEMOTHERAPY	518	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
144	1fe19c6b-71d0-4b07-923b-74ea32210db0	TCGA.04.1536	TCGA-04-1536-D24114	feed8215-093e-4fb3-a54c-38013eb6625f	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	518	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
145	1fe19c6b-71d0-4b07-923b-74ea32210db0	TCGA.04.1536	TCGA-04-1536-D24113	57161b96-b564-4d9b-89ff-30dc8dee32c8	2009-11-9	DOXIL	NA	CHEMOTHERAPY	36	FALSE	232	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	188	NA
146	1fe19c6b-71d0-4b07-923b-74ea32210db0	TCGA.04.1536	TCGA-04-1536-D24112	049090d1-2734-4c0c-b1f1-d7fe561af4c8	2009-11-9	TAXOL	NA	CHEMOTHERAPY	36	FALSE	232	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2125	NA
147	1fe19c6b-71d0-4b07-923b-74ea32210db0	TCGA.04.1536	TCGA-04-1536-D24115	efdac1c1-cacb-45e9-8da2-5c9209fcda54	2009-11-9	DOXIL	NA	CHEMOTHERAPY	518	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
148	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24124	20d4ef39-b4e4-4099-87b4-3c1ae4e8ede7	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	1322	FALSE	1487	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	122.1	NA
149	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24133	98ae57ba-9add-4fe6-9fb3-bce9ae6a5669	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	2328	FALSE	2512	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	28756	NA
150	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24119	ba72049a-201d-41b9-8de5-836bdcfffe5d	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	2	FALSE	167	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2534	NA
151	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24134	96845b6d-fb8b-448e-a46d-fddd67417df7	2009-11-24	AVASTIN	NA	CHEMOTHERAPY	2328	FALSE	2512	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	2870	NA
152	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24125	39b4a282-57ca-433c-b064-947aee07c02b	2009-11-24	DOXIL	NA	CHEMOTHERAPY	1501	FALSE	1529	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	159	NA
153	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24126	232608ab-c0eb-4ce7-b90f-500736a7b355	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	1564	FALSE	1781	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	32496	NA
154	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24122	2bb98c0b-c301-4b4c-a529-767fd0eb9e36	2009-11-24	PACLITAXEL	NA	CHEMOTHERAPY	1051	FALSE	1294	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	4004	NA
155	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24130	1b6278b2-3735-4dbc-b72c-c3a0de8b231b	2009-11-24	AVASTIN	NA	CHEMOTHERAPY	2115	FALSE	2176	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	4875	NA
156	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24127	11a6fcf9-f217-42ef-92df-6290ee4740ac	2009-11-24	CISPLATIN	NA	CHEMOTHERAPY	1564	FALSE	1781	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	11299.9	NA
157	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24128	89467124-049b-4810-abf9-b2d8d9346378	2009-11-24	AVASTIN	NA	CHEMOTHERAPY	1993	FALSE	2106	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	7398	NA
158	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24121	957ad38f-b0eb-459a-a8d6-fe69e4ceb3ed	2009-11-24	GEMCITABINE	NA	CHEMOTHERAPY	2	FALSE	167	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	17378	NA
159	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24123	f22e4162-0e7a-4685-a9f9-f8c7c4413fb7	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	1051	FALSE	1294	NA	NA	NA	NA	12	NA	AUC	AUC	NA	NA	NA	NA	NA	RECURRENCE	NA	5	NA
160	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24120	d5500c2d-df88-43c8-bcff-c3a415ef606f	2009-11-24	CARBPLATIN	NA	CHEMOTHERAPY	2	FALSE	167	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
161	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24132	59897436-39f7-4492-9b3c-b9785fb4da51	2009-11-24	DOXORUBICIN	NA	CHEMOTHERAPY	2268	FALSE	2328	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	343	NA
162	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24131	ae31010e-271a-4578-8b6b-af308af8c194	2009-11-24	CARBOPLATIN	NA	CHEMOTHERAPY	2207	FALSE	2268	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	NA	NA	NA	RECURRENCE	NA	5	NA
163	0c1a2e7d-e7e4-481e-a012-ef214c444497	TCGA.04.1542	TCGA-04-1542-D24129	19692f61-2cbc-49a2-b4ec-8dc55dad3507	2009-11-24	DOCETAXEL	NA	CHEMOTHERAPY	2115	FALSE	2176	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	124.15	NA
164	c75c915f-ef4b-4c19-8ace-995e6c6015fd	TCGA.04.1638	TCGA-04-1638-D24142	529c5977-9ad5-40f3-89f3-4b26793a407e	2009-11-9	TAXOL	NA	CHEMOTHERAPY	346	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
165	c75c915f-ef4b-4c19-8ace-995e6c6015fd	TCGA.04.1638	TCGA-04-1638-D24141	63e4b64e-ff9e-4716-b524-46b22d2fb4de	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	346	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
166	c75c915f-ef4b-4c19-8ace-995e6c6015fd	TCGA.04.1638	TCGA-04-1638-D24139	8b200c15-6dc8-468b-b56f-e0d576fc6f0f	2009-11-9	GEMCITIBINE	NA	CHEMOTHERAPY	17	FALSE	193	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	11400	NA
167	c75c915f-ef4b-4c19-8ace-995e6c6015fd	TCGA.04.1638	TCGA-04-1638-D24137	07806476-c405-476d-9b26-904d536b25ac	2009-11-9	TAXOL	NA	CHEMOTHERAPY	17	FALSE	193	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	968	NA
168	c75c915f-ef4b-4c19-8ace-995e6c6015fd	TCGA.04.1638	TCGA-04-1638-D24140	486f4a95-24cd-4047-8ae4-2d0d1bf97c21	2009-11-9	DOXIL	NA	CHEMOTHERAPY	346	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
169	c75c915f-ef4b-4c19-8ace-995e6c6015fd	TCGA.04.1638	TCGA-04-1638-D24138	e2445899-ef2f-48ec-b6cf-24b31caa303c	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	193	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2990	NA
170	6f592f17-e00b-4d04-a45b-d9d4cf4c3075	TCGA.04.1644	TCGA-04-1644-D24148	0b27b41b-630b-4780-8962-d7d2890b1b49	2010-8-12	PACLITAXEL	NA	CHEMOTHERAPY	113	FALSE	221	NA	NA	NA	NA	4	NA	MG	MG	300	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1208	NA
171	6f592f17-e00b-4d04-a45b-d9d4cf4c3075	TCGA.04.1644	TCGA-04-1644-D24150	a5117a44-5eff-422c-a7ef-6a64aa046c04	2010-8-12	NAVELBINE	NA	CHEMOTHERAPY	661	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
172	6f592f17-e00b-4d04-a45b-d9d4cf4c3075	TCGA.04.1644	TCGA-04-1644-D24146	e34aab47-56e3-467c-b3d8-57873b04644f	2010-8-12	GEMCITABINE	NA	CHEMOTHERAPY	17	FALSE	120	NA	NA	NA	NA	4	NA	MG	MG	2704	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12432	NA
173	6f592f17-e00b-4d04-a45b-d9d4cf4c3075	TCGA.04.1644	TCGA-04-1644-D24147	394ae296-dd59-40da-afdb-8a8fd220616a	2010-8-12	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	221	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
174	6f592f17-e00b-4d04-a45b-d9d4cf4c3075	TCGA.04.1644	TCGA-04-1644-D24149	bea9d9ec-f88f-4bae-9fe3-59b8569c7439	2010-8-12	TOPOTECAN	NA	CHEMOTHERAPY	661	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
175	d38ca631-ed5c-4182-a647-625060726fa7	TCGA.04.1646	TCGA-04-1646-D24157	6d910b78-da27-4662-a1be-49ce6a177002	2009-11-9	TOPOTECAN	NA	CHEMOTHERAPY	522	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	NA
176	d38ca631-ed5c-4182-a647-625060726fa7	TCGA.04.1646	TCGA-04-1646-D24155	9e09e80f-02fb-4097-be1a-c9bfadf68c36	2009-11-9	TAXOL	NA	CHEMOTHERAPY	18	FALSE	239	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1504	NA
177	d38ca631-ed5c-4182-a647-625060726fa7	TCGA.04.1646	TCGA-04-1646-D24153	d6ee5514-3071-4e54-a301-10301dbdb0dd	2009-11-9	GEMCITIBINE	NA	CHEMOTHERAPY	18	FALSE	239	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	8188	NA
178	d38ca631-ed5c-4182-a647-625060726fa7	TCGA.04.1646	TCGA-04-1646-D24156	609ef3ee-d20e-4681-be55-2fdaa9070a04	2009-11-9	DOXIL	NA	CHEMOTHERAPY	522	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	NA
179	d38ca631-ed5c-4182-a647-625060726fa7	TCGA.04.1646	TCGA-04-1646-D24154	74086d54-72be-400c-b01d-a365f36d5674	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	239	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4709	NA
180	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24164	cd9ed497-a263-4fda-99ef-74b1f4916798	2009-11-10	TOPOTECAN	NA	CHEMOTHERAPY	247	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
181	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24165	1f937eb0-6773-48b1-925f-54a58b003fbd	2009-11-10	TAXOTERE	NA	CHEMOTHERAPY	247	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	129	NA
182	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24166	a9fefaaf-f2d3-453b-82df-f333775b8ca0	2009-11-10	AVASTIN	NA	IMMUNOTHERAPY	247	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
183	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24161	0d18b847-2e08-45dc-a2c3-d387fe57031e	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	3	FALSE	149	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5140	NA
184	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24163	d0bd5f53-352e-4300-b4c2-58609d888103	2009-11-10	DOXIL	NA	CHEMOTHERAPY	247	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	40	NA
185	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24160	1a700a0d-2529-42d5-9117-dceea252ad8a	2009-11-10	GEMCITIBINE	NA	CHEMOTHERAPY	3	FALSE	149	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	23296	NA
186	cddce77f-21e6-4124-9f03-96fb5ca7cefa	TCGA.04.1648	TCGA-04-1648-D24162	09efef17-deb9-41ff-ab69-d9567c390137	2009-11-10	TAXOL	NA	CHEMOTHERAPY	3	FALSE	149	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2544	NA
187	314e446d-3a57-4c91-ac2e-4fc211456ee6	TCGA.04.1649	TCGA-04-1649-D24170	bef99616-fb63-4a21-bb71-09f9e6a33c99	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	1704	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
188	314e446d-3a57-4c91-ac2e-4fc211456ee6	TCGA.04.1649	TCGA-04-1649-D24169	976c28f1-f941-4649-a5eb-1f8377e55c18	2009-11-9	TAXOTERE	NA	CHEMOTHERAPY	1704	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
189	55153632-1673-487a-85c0-f156377db1fc	TCGA.04.1651	TCGA-04-1651-D24177	302abefb-98a4-4ae9-b633-f083742d1dcc	2009-11-10	GEMCITIBINE	NA	CHEMOTHERAPY	994	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
190	55153632-1673-487a-85c0-f156377db1fc	TCGA.04.1651	TCGA-04-1651-D24173	2d418f76-5289-4b42-bccd-367cc6177bdd	2009-11-10	GEMCITIBINE	NA	CHEMOTHERAPY	24	FALSE	150	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4416	NA
191	55153632-1673-487a-85c0-f156377db1fc	TCGA.04.1651	TCGA-04-1651-D24174	a960436a-2466-4c72-8ef7-89b73f8a0114	2009-11-10	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	150	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3228	NA
192	55153632-1673-487a-85c0-f156377db1fc	TCGA.04.1651	TCGA-04-1651-D24175	50b984e7-efd8-4d76-9551-883eeda43257	2009-11-10	TAXOL	NA	CHEMOTHERAPY	24	FALSE	150	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1869	NA
193	55153632-1673-487a-85c0-f156377db1fc	TCGA.04.1651	TCGA-04-1651-D24176	49f8c5a0-530d-41d5-93aa-dd3accbc566d	2009-11-10	CISPLATIN	NA	CHEMOTHERAPY	638	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
194	d86adfac-56be-4a69-9315-5a90b4113e65	TCGA.04.1652	TCGA-04-1652-D24181	7c7d1c47-ed7b-411b-b974-274f7e527369	2009-11-17	PACILTAXEL	NA	CHEMOTHERAPY	60	FALSE	199	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
195	d86adfac-56be-4a69-9315-5a90b4113e65	TCGA.04.1652	TCGA-04-1652-D24183	e710f8e4-0ad9-47d6-9682-6bb5c7ec4ca1	2009-11-17	DOCETAXEL	NA	CHEMOTHERAPY	894	FALSE	955	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	30	NA
196	d86adfac-56be-4a69-9315-5a90b4113e65	TCGA.04.1652	TCGA-04-1652-D24182	bc27edb0-7d82-454f-9fcf-dfaefff83fad	2009-11-17	GEMICITABINE	NA	CHEMOTHERAPY	60	FALSE	199	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	800	NA
197	d86adfac-56be-4a69-9315-5a90b4113e65	TCGA.04.1652	TCGA-04-1652-D24180	6f994167-d0ff-4613-a3f7-193b4dc243f6	2009-11-17	CARBOPLATIN	NA	CHEMOTHERAPY	60	FALSE	199	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
198	ff33db70-91d4-4dbb-a4fc-d81a128d0f32	TCGA.04.1654	TCGA-04-1654-D24189	1247ef93-1e2d-450c-9cde-a787b06e0ab3	2009-11-9	TAXOL	NA	CHEMOTHERAPY	877	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
199	ff33db70-91d4-4dbb-a4fc-d81a128d0f32	TCGA.04.1654	TCGA-04-1654-D24186	b19aeaef-1ab3-44b8-a588-2040992cf2eb	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	877	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
200	ff33db70-91d4-4dbb-a4fc-d81a128d0f32	TCGA.04.1654	TCGA-04-1654-D24187	328766be-9ea1-4360-b816-10dd79d46bb5	2009-11-9	CISPLATIN	NA	CHEMOTHERAPY	31	FALSE	52	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	280	NA
201	ff33db70-91d4-4dbb-a4fc-d81a128d0f32	TCGA.04.1654	TCGA-04-1654-D24188	31686ad3-5c2c-4d51-aede-07dc220a29ab	2009-11-9	TAXOL	NA	CHEMOTHERAPY	31	FALSE	52	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	380	NA
202	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	TCGA.04.1655	TCGA-04-1655-D24196	6af7c96d-fd92-4419-89f8-4a3f81291128	2009-11-9	CARBOPLATIN	NA	CHEMOTHERAPY	839	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
203	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	TCGA.04.1655	TCGA-04-1655-D24195	31f9f5de-7d10-4be7-922a-486e53358208	2009-11-9	TAXOL	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
204	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	TCGA.04.1655	TCGA-04-1655-D24193	6554c537-7883-461c-a2bc-e5d5cff12e2f	2009-11-9	CISPLATIN	NA	CHEMOTHERAPY	34	FALSE	139	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	953	NA
205	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	TCGA.04.1655	TCGA-04-1655-D24194	d6ee6177-9651-4002-8886-321a006ddb09	2009-11-9	TAXOL	NA	CHEMOTHERAPY	34	FALSE	139	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	574	NA
206	f8a5547f-f1bc-4c01-8b68-25b5ee0caeab	TCGA.04.1655	TCGA-04-1655-D24192	0fc35dff-0325-4013-8faa-f9338450f776	2009-11-9	TAXOL	NA	CHEMOTHERAPY	34	FALSE	139	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1288	NA
207	6746533a-8d0b-4ebc-87ec-49c8738121a8	TCGA.09.0364	TCGA-09-0364-D24199	57b55461-64a0-45a0-baef-0650a107f9bf	2009-3-27	CARBOPLATINUM	NA	CHEMOTHERAPY	31	FALSE	188	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
208	6746533a-8d0b-4ebc-87ec-49c8738121a8	TCGA.09.0364	TCGA-09-0364-D24200	780b9212-5bfd-40ff-acef-8d60cb64bdb2	2009-3-27	TAXOL	NA	CHEMOTHERAPY	31	FALSE	188	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	125	NA
209	7621ed77-98bc-4b4e-8011-e18fcd014071	TCGA.09.0365	TCGA-09-0365-D24205	8c488ff2-8e08-47d4-ab18-b271a8d00717	2009-3-27	TAXOL	NA	CHEMOTHERAPY	15	FALSE	70	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
210	7621ed77-98bc-4b4e-8011-e18fcd014071	TCGA.09.0365	TCGA-09-0365-D24204	c742fa3b-01b4-42d8-94a9-f5909f22b5d9	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	46	FALSE	70	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	273	NA
211	23771dab-2aab-4d2b-95e2-9af7092cee6b	TCGA.09.0366	TCGA-09-0366-D24208	6c5228bf-8c8a-4919-8775-626e30a7370e	2009-3-27	CARBO	NA	CHEMOTHERAPY	5	FALSE	113	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
212	23771dab-2aab-4d2b-95e2-9af7092cee6b	TCGA.09.0366	TCGA-09-0366-D24210	b0230f3d-a6f8-4e55-a04e-d6d0d37c99e4	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	225	FALSE	288	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1.5	NA
213	23771dab-2aab-4d2b-95e2-9af7092cee6b	TCGA.09.0366	TCGA-09-0366-D24209	ac21dd09-cdc4-45dd-bf7e-3ae965e1d90b	2009-3-27	TAXOL	NA	CHEMOTHERAPY	5	FALSE	113	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
214	9bbc01b4-056c-4ddc-aca4-ff20718646d0	TCGA.09.0367	TCGA-09-0367-D24214	4e41a6a2-7536-4235-b3e2-307541a2f55e	2009-3-27	TAXOL	NA	CHEMOTHERAPY	9	FALSE	92	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
215	9bbc01b4-056c-4ddc-aca4-ff20718646d0	TCGA.09.0367	TCGA-09-0367-D24213	5947ae4d-2a9e-4e90-87e6-dca175e44cc6	2009-3-27	CARBO	NA	CHEMOTHERAPY	9	FALSE	92	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
216	9bbc01b4-056c-4ddc-aca4-ff20718646d0	TCGA.09.0367	TCGA-09-0367-D24215	c830352b-ac14-400e-a5e8-24d933b324ce	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	153	FALSE	NA	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	1145	NA
217	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24224	a3c40628-cd5c-49dd-98f3-eed3e9460b59	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	310	FALSE	446	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
218	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24222	bbdd7a4d-fef2-4c8c-861b-13a0f7078f3b	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	99	FALSE	99	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1000	NA
219	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24220	5e712ef4-3b95-4cfb-913c-1440d7767ee5	2009-3-27	TAXOTERE	NA	CHEMOTHERAPY	78	FALSE	78	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	80	NA
220	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24223	7d37f03d-f6d7-4a69-a9da-8e6830441fa9	2009-3-27	DOXIL	NA	CHEMOTHERAPY	298	FALSE	298	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	40	NA
221	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24218	aeffde3e-f5d7-46b9-98da-ec10ec9ca0ef	2009-3-27	CARBO	NA	CHEMOTHERAPY	8	FALSE	74	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
222	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24221	8f85510a-6960-4611-95c3-22de367928af	2009-3-27	CARBO	NA	CHEMOTHERAPY	99	FALSE	99	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
223	1d9893c8-0de3-4b07-b0ba-a53019b23eb4	TCGA.09.0369	TCGA-09-0369-D24219	ac05217b-40a7-4a8c-9ff0-2fb4526a9f18	2009-3-27	TAXOL	NA	CHEMOTHERAPY	8	FALSE	74	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
224	644a88a7-dc56-468a-af5c-60278aab7642	TCGA.09.1659	TCGA-09-1659-D24230	e135fb8b-9cfc-4dd4-b2c5-dea588329278	2009-8-6	TAXOL	NA	CHEMOTHERAPY	37	FALSE	137	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
225	644a88a7-dc56-468a-af5c-60278aab7642	TCGA.09.1659	TCGA-09-1659-D24229	e95461e2-9e4c-4e78-823c-562005b13fd2	2009-8-6	TAXOL	NA	CHEMOTHERAPY	16	FALSE	137	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
226	644a88a7-dc56-468a-af5c-60278aab7642	TCGA.09.1659	TCGA-09-1659-D24227	1bf3b092-4fd1-4d22-828b-a0912d5a57cb	2009-8-6	CISPLATIN	NA	CHEMOTHERAPY	16	FALSE	137	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
227	644a88a7-dc56-468a-af5c-60278aab7642	TCGA.09.1659	TCGA-09-1659-D24228	89fc6845-3c63-4c2f-ac1a-f3f53d98090f	2009-8-6	CISPLATIN	NA	CHEMOTHERAPY	16	FALSE	137	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
228	644a88a7-dc56-468a-af5c-60278aab7642	TCGA.09.1659	TCGA-09-1659-D24231	c8db72a7-72b7-4d98-a402-2e064104a929	2009-8-6	HEXAMETHYLMELAMINE	NA	CHEMOTHERAPY	176	FALSE	176	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	OTHER	NA	50	NA
229	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24237	d01e89cf-f3a7-44d6-b16c-f81b8627cf14	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	641	FALSE	709	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	6	NA
230	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24235	31c1fcf0-7c88-43b9-96db-a52d39cf4245	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	58	FALSE	165	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	192	NA
231	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24238	e2248b7d-7614-4bcd-9650-8067047dc92b	2009-8-5	GEMCITABINE	NA	CHEMOTHERAPY	758	FALSE	766	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	800	NA
232	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24236	7c35797f-19d1-480c-8bce-2040e341c6ae	2009-8-5	TAXOL	NA	CHEMOTHERAPY	58	FALSE	165	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
233	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24234	6599ea24-89a7-4494-b817-2e31333dbd26	2009-8-5	DOXIL	NA	CHEMOTHERAPY	213	FALSE	332	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	40	NA
234	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24240	d4c5014f-8791-4723-8b70-cade55f5cbde	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	1017	FALSE	1052	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	30	NA
235	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24241	360588ef-c280-4c8f-af28-5a16924646e3	2009-8-5	TAMOXIFEN	NA	HORMONE THERAPY	498	FALSE	641	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	OTHER	NA	20	NA
236	f8e9d538-7291-4fe7-b3f2-d01676a027f9	TCGA.09.1661	TCGA-09-1661-D24239	2fc710fc-85e0-4df2-af3e-6f41158143a7	2009-8-5	TAXOL	NA	CHEMOTHERAPY	828	FALSE	940	NA	NA	NA	NA	17	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	70	NA
237	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24258	f4b7d2bb-c87b-49eb-a81a-6cbe1bd786a3	2009-8-5	TOPTECAN	NA	CHEMOTHERAPY	2482	FALSE	2602	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4	NA
238	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24247	dc5a3d32-2094-4917-8a07-9bbfa17045f5	2009-8-5	GEMZAR	NA	CHEMOTHERAPY	32	FALSE	141	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	600	NA
239	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24254	fb873564-df62-4403-9335-80c56c7b00f9	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	1989	FALSE	2052	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	100	NA
240	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24259	692318d5-4cc3-48f4-8464-e4debb508e72	2009-8-5	TOPTECAN	NA	CHEMOTHERAPY	2608	FALSE	2623	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2	NA
241	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24255	7bf5f35f-f997-4287-83d2-d5da4cbd556a	2009-8-5	DOXIL	NA	CHEMOTHERAPY	2073	FALSE	2399	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	40	NA
242	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24266	4c9e6e33-7a19-48a4-85ca-dcccef13eba1	2009-8-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	2566	FALSE	2650	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
243	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24260	7631cb67-7111-4c19-8711-ccc70c4fc2c4	2009-8-5	TOPOTECAN	NA	CHEMOTHERAPY	2623	FALSE	2650	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4	NA
244	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24245	e1273eb6-bb20-46c9-9bb2-cc41b942d77c	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	15	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
245	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24248	cc5ab7ed-36cd-4a9f-ba48-c87a1b240f45	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	1128	FALSE	1233	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
246	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24253	a397d96b-fb24-4610-8181-c118d12f2166	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	1947	FALSE	1968	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	98	NA
247	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24251	1f1c006f-2912-44a7-ba4e-034e98c93d89	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	1590	FALSE	1732	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	60	NA
248	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24257	93e131ee-3380-4200-9ca5-10131c10abd1	2009-8-5	TOPOTECAN	NA	CHEMOTHERAPY	2457	FALSE	2461	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3	NA
249	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24265	de3b0446-d6ae-4fee-ad51-8c322e73ee15	2009-8-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	2503	FALSE	2517	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
250	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24250	31879e3c-bfe5-4c2f-955d-f4e7af0fbdfb	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	1590	FALSE	1732	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
251	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24262	203a528e-89f3-4e4f-bf39-ef1ad477079b	2009-8-5	CISPLATIN	NA	CHEMOTHERAPY	2684	FALSE	2697	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	47	NA
252	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24246	678644d3-1d86-43d5-828b-5ff5529a97d5	2009-8-5	TAXOL	NA	CHEMOTHERAPY	15	FALSE	15	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
253	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24249	588fd714-20ca-4600-90be-76b54f2c0ef8	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	1128	FALSE	1233	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	60	NA
254	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24252	c0a0b2df-b4d4-41ae-9463-423066932bf7	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	1947	FALSE	1968	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	390	NA
255	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24263	1b5d2909-0c97-4346-a6ad-8b64797214eb	2009-8-5	GEMZAR	NA	CHEMOTHERAPY	2684	FALSE	2697	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	954	NA
256	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24244	f41683e3-2b52-4a8f-a371-5830f1687c3a	2009-8-5	CISPLATIN	NA	CHEMOTHERAPY	32	FALSE	141	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
257	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24261	d6211b06-5b18-4f9e-851d-53c7a86bc37d	2009-8-5	GEMZAR	NA	CHEMOTHERAPY	2530	FALSE	2537	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
258	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24264	c53df0bc-2ac3-472e-9241-c6c1790d02cb	2009-8-5	ARMIDEX	NA	HORMONE THERAPY	1926	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	1	NA
259	867f9563-16c9-45a8-b519-6df61ba1b6b7	TCGA.09.1662	TCGA-09-1662-D24256	1161bec0-3bbb-49c2-88af-0a7123eb3c6a	2009-8-5	TOPOTECAN	NA	CHEMOTHERAPY	2426	FALSE	2650	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2	NA
260	3438c018-9856-4628-ae59-7d365713647f	TCGA.09.1664	TCGA-09-1664-D24270	5c586019-e92b-4f51-ad6c-5eb9366488d5	2009-9-4	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	139	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
261	3438c018-9856-4628-ae59-7d365713647f	TCGA.09.1664	TCGA-09-1664-D24269	c82effc8-6fc1-410b-8c82-5aeaf9c1a564	2009-9-4	TAXOTERE	NA	CHEMOTHERAPY	15	FALSE	139	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	70	NA
262	9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d	TCGA.09.1665	TCGA-09-1665-D24276	b1ed85a0-eac9-4666-ab39-010c1399d205	2009-8-5	TAMOXIFEN	NA	HORMONE THERAPY	400	FALSE	483	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
263	9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d	TCGA.09.1665	TCGA-09-1665-D24275	8d2d4b4c-596d-42a2-9e4b-0e7b2fee3958	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	917	FALSE	1022	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6	NA
264	9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d	TCGA.09.1665	TCGA-09-1665-D24274	37f4416a-9d1d-4c7d-877e-7871f2b85168	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	33	FALSE	208	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
265	9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d	TCGA.09.1665	TCGA-09-1665-D24273	8c2c993d-40cd-4027-9569-1b033b7edd54	2009-8-5	TAXOL	NA	CHEMOTHERAPY	33	FALSE	208	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
266	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24290	96136ebb-d42e-46e9-8ec0-5add836188f0	2009-8-5	OCA REX OREGOVOMAB	NA	IMMUNOTHERAPY	256	FALSE	480	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2	NA
267	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24280	74931445-f83f-45dc-90a1-aecb7765fa41	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	101	FALSE	173	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
268	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24289	201e8965-9390-427b-8279-89e17038f985	2009-8-5	FEMARA	NA	HORMONE THERAPY	1604	FALSE	1757	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
269	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24285	b774aba5-d495-4fcc-a1dd-0f5f06ba1d9e	2009-8-5	GEMCITABINE	NA	CHEMOTHERAPY	616	FALSE	708	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1000	NA
270	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24284	172437f0-7607-4941-bb7d-a1d174db12fa	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	616	FALSE	708	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	6	NA
271	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24281	357d4b2b-6557-43ba-865b-6991025f5471	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	73	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
272	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24286	7e32e0c6-f8ab-4cc8-944d-39c716db22fa	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
273	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24282	9ad3d880-56fd-4369-a662-6448ded41e23	2009-8-5	TAXOL	NA	CHEMOTHERAPY	27	FALSE	73	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
274	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24288	3380594f-d6ff-4fec-95a3-f50e8b444dd6	2009-8-5	DOXIL	NA	CHEMOTHERAPY	1507	FALSE	1598	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
275	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24283	722d9fc6-ae4b-4953-a962-35ffe58712ca	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	101	FALSE	173	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
276	4eac2c98-86d2-4ee6-a1d3-157d013c78dc	TCGA.09.1666	TCGA-09-1666-D24287	51c24d42-2dab-4f27-b2ba-a0bda9af9e95	2009-8-5	TAXOTERE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
277	32d4d200-1fdf-44ed-b81f-1954a9c93926	TCGA.09.1667	TCGA-09-1667-D24296	40335523-102a-49a1-b4d4-7909d043b53f	2009-8-5	DOXIL	NA	CHEMOTHERAPY	820	NA	1875	NA	NA	NA	NA	20	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
278	32d4d200-1fdf-44ed-b81f-1954a9c93926	TCGA.09.1667	TCGA-09-1667-D24294	75fe69a4-be66-4430-83bb-26c8e6fc4e3a	2009-8-5	TAXOL	NA	CHEMOTHERAPY	7	FALSE	118	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
279	32d4d200-1fdf-44ed-b81f-1954a9c93926	TCGA.09.1667	TCGA-09-1667-D24293	7128aad9-cd3e-493b-bbfd-7280aae2574f	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	118	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
280	32d4d200-1fdf-44ed-b81f-1954a9c93926	TCGA.09.1667	TCGA-09-1667-D24297	28bcdda1-2d1e-46f9-bc34-8e22d90fe9c1	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	1135	FALSE	1135	NA	NA	NA	NA	1	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6	NA
281	32d4d200-1fdf-44ed-b81f-1954a9c93926	TCGA.09.1667	TCGA-09-1667-D24295	44e0c058-2dad-42aa-a59f-80335409f7a2	2009-8-5	CARBOPLATIN	NA	CHEMOTHERAPY	559	FALSE	685	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	6	NA
282	0e475b3d-be3c-431a-ab12-5a867ea8f6cd	TCGA.09.1668	TCGA-09-1668-D24301	d03e27fc-0655-4ff0-b02f-aa7941ea73f5	2009-8-6	TAXOTERE	NA	CHEMOTHERAPY	151	FALSE	320	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	60	NA
283	0e475b3d-be3c-431a-ab12-5a867ea8f6cd	TCGA.09.1668	TCGA-09-1668-D24303	fb1e1df5-88fc-4470-8a14-b8e52cb01d91	2009-8-6	TAXOTERE	NA	CHEMOTHERAPY	31	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	120	NA
284	0e475b3d-be3c-431a-ab12-5a867ea8f6cd	TCGA.09.1668	TCGA-09-1668-D24302	e5afb655-15ff-4e6d-8a65-2427d238370e	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	480	NA
285	b1c90c69-6149-4105-8182-ab9212f196be	TCGA.09.1669	TCGA-09-1669-D24307	30c1255f-a36c-4d86-8f8e-a064143d8315	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	132	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
286	b1c90c69-6149-4105-8182-ab9212f196be	TCGA.09.1669	TCGA-09-1669-D24306	50dcc375-fa24-4050-ad1e-92cd42c75e97	2009-8-6	TAXOL	NA	CHEMOTHERAPY	27	FALSE	132	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
287	60014a6e-6a13-4f92-bbfd-eeeee9632f98	TCGA.09.1670	TCGA-09-1670-D24311	e72190f5-2626-4416-8a8c-e8435831131c	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	74	FALSE	179	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
288	60014a6e-6a13-4f92-bbfd-eeeee9632f98	TCGA.09.1670	TCGA-09-1670-D24312	a9036291-7a11-408c-bf4d-69e72c45fe65	2009-8-6	TAXOL	NA	CHEMOTHERAPY	74	FALSE	179	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
289	60014a6e-6a13-4f92-bbfd-eeeee9632f98	TCGA.09.1670	TCGA-09-1670-D24310	0425c8ba-5351-4002-8ce5-99d9f36dac5d	2009-8-6	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	OTHER	NA	NA	NA
290	66dc6379-a98b-498f-8109-e3a811d043ea	TCGA.09.1672	TCGA-09-1672-D24316	39aa2254-337c-461d-97c1-1733b934db3d	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	30	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
291	66dc6379-a98b-498f-8109-e3a811d043ea	TCGA.09.1672	TCGA-09-1672-D24315	0374f5fb-511c-41e7-a7b1-0438a5f9110a	2009-8-6	TAXOL	NA	CHEMOTHERAPY	30	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
292	4e6f88de-7624-4719-8234-4c9e5b2e2988	TCGA.09.1673	TCGA-09-1673-D24319	930899a5-34a2-46c3-9584-8203d90c4173	2009-8-6	TAXOL OR TAXOTERE	NA	CHEMOTHERAPY	25	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
293	4e6f88de-7624-4719-8234-4c9e5b2e2988	TCGA.09.1673	TCGA-09-1673-D24320	61389628-3aff-4fa0-bc4b-566c03bd0019	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	25	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
294	1ede8063-e0e9-466d-891c-ac8916f1b5fa	TCGA.09.1674	TCGA-09-1674-D24323	c829fcf0-0841-4229-adf3-10798090ed07	2009-8-6	TAXOL	NA	CHEMOTHERAPY	41	FALSE	145	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
295	1ede8063-e0e9-466d-891c-ac8916f1b5fa	TCGA.09.1674	TCGA-09-1674-D24324	a0689762-9c26-4b5d-abd0-e97287570a20	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	145	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
296	0fc8777c-8f12-472f-a0ea-085139b35d1f	TCGA.09.1675	TCGA-09-1675-D24329	c83250a3-fa1a-4fba-9d68-7656b0ae9ff0	2009-8-6	TAXOL	NA	CHEMOTHERAPY	54	FALSE	68	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
297	0fc8777c-8f12-472f-a0ea-085139b35d1f	TCGA.09.1675	TCGA-09-1675-D24328	855b5a4b-8752-46eb-ad51-3917f471d8e9	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	54	FALSE	68	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	190	NA
298	0fc8777c-8f12-472f-a0ea-085139b35d1f	TCGA.09.1675	TCGA-09-1675-D24330	6af7d774-e00a-4411-bb4b-30be83bfa4ad	2009-8-6	TAXOL	NA	CHEMOTHERAPY	75	FALSE	187	NA	NA	NA	NA	15	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	80	NA
299	0fc8777c-8f12-472f-a0ea-085139b35d1f	TCGA.09.1675	TCGA-09-1675-D24327	b14864f9-e7b2-4987-ac25-a5804bc74634	2009-8-6	CARBOPLATIN	NA	CHEMOTHERAPY	75	FALSE	187	NA	NA	NA	NA	15	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	190	NA
300	7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e	TCGA.09.2044	TCGA-09-2044-D24335	47992e98-d20a-4eaa-8d9a-e0098cf2e22a	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	32	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
301	7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e	TCGA.09.2044	TCGA-09-2044-D24336	21ab3e49-5209-4617-af8c-1c957d3616a7	2009-11-2	TAXOL	NA	CHEMOTHERAPY	32	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
302	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24343	bb92bbda-df68-4f6d-a51e-95da220fb45c	2009-11-3	CISPLATINUM	NA	CHEMOTHERAPY	121	FALSE	239	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	50	NA
303	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24346	fc471499-6c71-4641-a6a2-46d6521a837d	2009-11-3	ETOPOSIDE	NA	CHEMOTHERAPY	875	FALSE	895	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
304	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24342	7d3b6c00-c2bf-482b-bdf9-a3362a8457a0	2009-11-3	TAXOL	NA	CHEMOTHERAPY	64	FALSE	94	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
305	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24339	6c79b320-a371-4afe-a40c-af0f28090dc7	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	11	FALSE	11	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	810	NA
306	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24344	0298c721-f7a3-4b0b-836d-a7499fcfd188	2009-11-3	TAXOL	NA	CHEMOTHERAPY	121	FALSE	239	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
307	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24341	455a8a8b-4170-4478-a4a4-32a2082271d7	2009-11-3	CISPLATINUM	NA	CHEMOTHERAPY	64	FALSE	94	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	50	NA
308	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24340	868ce7a4-1bfe-46fb-a1ef-f297525b252a	2009-11-3	TAXOL	NA	CHEMOTHERAPY	11	FALSE	11	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
309	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24345	b04e60fd-6a47-4141-b49a-075c34588c7b	2009-11-3	TAXOTERE	NA	CHEMOTHERAPY	678	FALSE	808	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	RECURRENT AND PROGRESSION	70	NA
310	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24349	77d77b01-fb4c-4cf8-8f03-8ecd740b662a	2009-12-11	GEMCITIBINE	NA	CHEMOTHERAPY	933	FALSE	939	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1600	NA
311	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24348	2b57866b-5b39-4bd7-b317-a69e3f2c3143	2009-12-11	CARBOPLATINUM	NA	CHEMOTHERAPY	933	FALSE	939	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	560	NA
312	3768d34f-1527-40db-b116-cd80cee5ec3a	TCGA.09.2045	TCGA-09-2045-D24347	ae26f30d-0995-4c38-837c-9dcc29376e15	2009-12-11	TOPTECAN	NA	CHEMOTHERAPY	678	FALSE	808	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	RECURRENT AND PROGRESSION	0.665	NA
313	184aac07-44c1-47f1-8adf-50acbcc1762c	TCGA.09.2048	TCGA-09-2048-D24352	36759fad-df49-4c76-9c80-ccbd66d8d40a	2009-11-3	NA	NA	CHEMOTHERAPY	60	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
314	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24360	97c98396-8ea6-4581-95af-2fff74d5e182	2009-11-3	TAXOL	NA	CHEMOTHERAPY	995	FALSE	995	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	322	NA
315	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24355	d83a8dfc-81b1-45fe-bc71-8e50301f9067	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	172	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
316	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24358	e5d8d89d-7b09-4fa9-9f96-e01af2ad30e6	2009-11-3	TAXOL	NA	CHEMOTHERAPY	962	FALSE	981	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	92	NA
317	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24359	edad049f-fccf-495c-ad9b-e04a09872cf0	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	995	FALSE	995	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	649	NA
318	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24363	8d9c2b58-92c9-49bc-a943-f506dac97ef4	2009-11-3	GEMCITIBANE	NA	CHEMOTHERAPY	1410	FALSE	1431	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
319	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24357	8c700aae-89fb-479f-a035-ba766d117f7d	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	962	FALSE	981	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	218	NA
320	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24361	8b6d5d68-4a96-4b7f-9198-f3decc4e3817	2009-11-3	TOPOTECAN	NA	CHEMOTHERAPY	1017	FALSE	1110	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2	NA
321	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24362	bdb2cde3-1c7d-4820-a9c0-a667e68e6daf	2009-11-3	CISPLATIN	NA	CHEMOTHERAPY	1410	FALSE	1431	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
322	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24365	be355cf1-4bc6-4561-83f9-c530a6ea6e7a	2009-11-3	TAXOTERE	NA	CHEMOTHERAPY	1779	FALSE	1964	NA	NA	NA	NA	20	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	46	NA
323	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24364	41c6a131-9a0b-4745-ab82-cf90e8d54de4	2009-11-3	GEMCITIBINE	NA	CHEMOTHERAPY	1712	FALSE	1768	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1600	NA
324	05eb8bd5-d31b-4595-921a-366e53ea5a8b	TCGA.09.2049	TCGA-09-2049-D24356	806b0a19-adfb-4091-99e5-f53f85ab70c3	2009-11-3	TAXOL	NA	CHEMOTHERAPY	42	FALSE	172	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
325	3c037acf-f453-4513-a6dd-129163ddde2a	TCGA.09.2050	TCGA-09-2050-D24370	e8e55844-54ae-4eaa-870f-879d2fc1fc3c	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	47	FALSE	110	NA	NA	NA	NA	4	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
326	3c037acf-f453-4513-a6dd-129163ddde2a	TCGA.09.2050	TCGA-09-2050-D24371	1d6971b6-36e2-45af-a856-314033ffc348	2009-11-3	TAXOTERE	NA	CHEMOTHERAPY	47	FALSE	110	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
327	3c037acf-f453-4513-a6dd-129163ddde2a	TCGA.09.2050	TCGA-09-2050-D24368	8b49a093-29ac-43b2-afe1-29b764d8040c	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	5	FALSE	25	NA	NA	NA	NA	2	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
328	3c037acf-f453-4513-a6dd-129163ddde2a	TCGA.09.2050	TCGA-09-2050-D24369	a5f02758-3d64-4485-9264-696da62d12f0	2009-11-3	TAXOL	NA	CHEMOTHERAPY	5	FALSE	25	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
329	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24375	0f1610c9-8ce0-40e3-881e-0ba904f9038b	2009-11-3	TAXOL	NA	CHEMOTHERAPY	8	FALSE	155	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
330	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24377	077cc169-cf4a-4177-9f9e-8f14fa534c1c	2009-11-3	CISPLATIN	NA	CHEMOTHERAPY	913	FALSE	941	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
331	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24381	6fb5e7f5-d6cd-4b93-80cb-7f5e114b6847	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	1586	FALSE	1698	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	376	NA
332	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24376	aed478ec-3ae2-4c26-9734-8d6a57a957f5	2009-11-3	OVAREX STUDY	NA	CHEMOTHERAPY	191	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	CONSOLIDATION THERAPY	NA	NA
333	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24382	0d3f88c5-99cb-41b5-b48f-02197c8ac79f	2009-11-3	GEMZAR	NA	CHEMOTHERAPY	1586	FALSE	1698	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1380	NA
334	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24374	55db8cf8-429e-4b6e-9511-299e01d1922f	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	155	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
335	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24380	03b1566e-cda5-4842-a3f2-1fc17dfb6148	2009-11-3	TAXOL	NA	CHEMOTHERAPY	947	FALSE	1024	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
336	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24379	7857ae81-1908-47bc-93a9-072a19062d7a	2009-11-3	CARBOPLATIN	NA	CHEMOTHERAPY	947	FALSE	1024	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
337	02594e5e-8751-47c1-9245-90c66984b665	TCGA.09.2051	TCGA-09-2051-D24378	51dd5cd9-1805-42ac-bb7e-e163028eb07e	2009-11-3	TAXOL	NA	CHEMOTHERAPY	913	FALSE	941	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
338	ea605be2-6578-4e01-8ec3-bbd84c0b7f1d	TCGA.09.2053	TCGA-09-2053-D24385	d711d5ea-2290-411c-afa5-ab30773d3e11	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	138	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
339	ea605be2-6578-4e01-8ec3-bbd84c0b7f1d	TCGA.09.2053	TCGA-09-2053-D24386	e2e0c1ed-9af3-414e-b5e4-b993d4ebf97f	2009-11-2	TAXOL	NA	CHEMOTHERAPY	34	FALSE	138	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
340	cbd87697-7708-4b69-9e50-9ee474feabe1	TCGA.09.2054	TCGA-09-2054-D24393	d7d74c67-9d2c-43ce-8ccf-37ebb18b35fc	2009-11-2	GEMZAR	NA	CHEMOTHERAPY	428	FALSE	513	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
341	cbd87697-7708-4b69-9e50-9ee474feabe1	TCGA.09.2054	TCGA-09-2054-D24390	d033d1e2-585a-4515-a09c-3bb2ed9373f3	2009-11-2	TAXOL	NA	CHEMOTHERAPY	37	FALSE	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
342	cbd87697-7708-4b69-9e50-9ee474feabe1	TCGA.09.2054	TCGA-09-2054-D24391	88f8d9fd-3a90-4644-abd7-48ee8c850bdf	2009-11-2	DOXIL	NA	CHEMOTHERAPY	244	FALSE	300	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	50	NA
343	cbd87697-7708-4b69-9e50-9ee474feabe1	TCGA.09.2054	TCGA-09-2054-D24392	167ef959-4751-4101-9754-2e14e556f5d3	2009-11-2	TOPOTECAN	NA	CHEMOTHERAPY	329	FALSE	421	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
344	cbd87697-7708-4b69-9e50-9ee474feabe1	TCGA.09.2054	TCGA-09-2054-D24389	5acfc9ba-d325-4e43-b8b4-154653154ad0	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	161	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
345	838778c3-0b33-4fc5-97fc-5da163475485	TCGA.09.2055	TCGA-09-2055-D24396	71b4da94-56ba-47a7-9cbe-e33ec42f2095	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	5	FALSE	189	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
346	838778c3-0b33-4fc5-97fc-5da163475485	TCGA.09.2055	TCGA-09-2055-D24397	49441fe6-198e-43c3-ba65-b1575d1075ab	2009-11-2	TAXOL	NA	CHEMOTHERAPY	5	FALSE	189	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
347	ea6405c4-0fe4-4f37-bef2-275072f91e39	TCGA.09.2056	TCGA-09-2056-D24401	83a5aabd-3f44-4398-9fd1-09ffac14acde	2009-11-2	TAXOL	NA	CHEMOTHERAPY	25	FALSE	147	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
348	ea6405c4-0fe4-4f37-bef2-275072f91e39	TCGA.09.2056	TCGA-09-2056-D24400	4782449f-9b8d-48f6-80e7-d05021eef896	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	25	FALSE	147	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
349	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24406	10140623-084f-46ad-b207-672f4b228676	2010-2-5	CARBOPLATIN	NA	CHEMOTHERAPY	156	FALSE	293	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3000	NA
350	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24409	73fa5659-2aae-4310-9744-237bc5d74ea4	2010-2-5	TAXOL	NA	CHEMOTHERAPY	1454	FALSE	1496	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	925	NA
351	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24405	353e255d-4a5f-422b-b3ae-7f92abc7edf0	2010-2-5	TAXOL	NA	CHEMOTHERAPY	20	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1400	NA
352	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24408	f759a3d3-377f-4eab-ab14-84a4d30dba5b	2010-2-5	CARBOPLATIN	NA	CHEMOTHERAPY	1308	FALSE	1447	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2118	NA
353	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24404	4411d09e-4315-4204-aef6-ee87de442231	2010-2-5	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3380	NA
354	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24410	399884f4-0245-4df5-bad4-9c599adac869	2010-2-5	DOXIL	NA	CHEMOTHERAPY	1517	FALSE	1630	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	326	NA
355	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24407	5d6b4186-c9d2-419c-93d3-3555fc8058f7	2010-2-5	CARBOPLATIN	NA	CHEMOTHERAPY	593	FALSE	1028	NA	NA	NA	NA	15	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	7500	NA
356	869c9aae-85eb-4faa-8893-b3f487e8981c	TCGA.10.0925	TCGA-10-0925-D24411	2673b75d-e190-43f5-96f3-440828653be4	2010-2-5	TAMOXIFEN	NA	HORMONE THERAPY	321	FALSE	593	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	9600	NA
357	e641aed9-1dd8-4c30-b231-f12b20a76df0	TCGA.10.0926	TCGA-10-0926-D24417	a6419a7d-cf48-41ab-ae3c-4e1e5746e9ad	2009-3-18	INTERLEUKIN-12	NA	IMMUNOTHERAPY	232	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND PROGRESSION	NA	NA
358	e641aed9-1dd8-4c30-b231-f12b20a76df0	TCGA.10.0926	TCGA-10-0926-D24416	2ed5c38f-994f-4aae-ad6f-2be5d242946e	2009-3-18	DOXIL	NA	CHEMOTHERAPY	290	FALSE	729	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	975	NA
359	e641aed9-1dd8-4c30-b231-f12b20a76df0	TCGA.10.0926	TCGA-10-0926-D24414	7d7d38a9-711f-480d-a3f2-1c866145b0aa	2009-3-18	TAXOL	NA	CHEMOTHERAPY	8	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND PROGRESSION	860	NA
360	e641aed9-1dd8-4c30-b231-f12b20a76df0	TCGA.10.0926	TCGA-10-0926-D24415	8651d712-bb73-4b45-bbcf-1f5054c30742	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	AJUVANT AND PROGRESSION	4500	NA
361	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24425	3d37f28e-e854-4a31-a7f1-407e7c128dba	2009-3-18	TAXOL	NA	CHEMOTHERAPY	1686	NA	1910	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	PROGRESSION AND RECURRENCE	2320	NA
362	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24427	3c8fee69-6a99-4182-8581-b545e14c58a2	2009-3-18	GEMCITABINE	NA	CHEMOTHERAPY	2330	FALSE	2463	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	PROGRESSION AND RECURRENCE	9920	NA
363	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24424	f5b4eecf-392c-4dc2-b6b4-84147f8d78a8	2009-3-18	ARIMIDEX	NA	CHEMOTHERAPY	1601	NA	1686	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	PROGRESSION AND RECURRENCE	60	NA
364	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24426	5543938e-67eb-414c-a80d-dcb113ce7c6e	2009-3-18	DOXIL	NA	CHEMOTHERAPY	1938	FALSE	2302	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	PROGRESSION AND RECURRENCE	845	NA
365	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24421	8a17dc93-4b32-40e2-8134-94b2aa680461	2009-3-18	TAXOL	NA	CHEMOTHERAPY	9	NA	121	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
366	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24422	6f9c873b-a61c-4074-abaf-03124c45be22	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	9	FALSE	121	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2940	NA
367	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24428	e99dde4c-fd87-4c00-8d67-dcd6cb912a64	2009-3-18	TAMOXIFEN	NA	HORMONE THERAPY	1336	FALSE	1640	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	PROGRESSION AND RECURRENCE	12000	NA
368	933dbfbd-4697-403e-bd73-c17cb300c94b	TCGA.10.0927	TCGA-10-0927-D24423	6efe15d8-13aa-4760-8bfb-dadb529205f0	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	1017	FALSE	1301	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	PROGRESSION AND RECURRENCE	5400	NA
369	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	TCGA.10.0930	TCGA-10-0930-D24435	d0b6b8e2-d04f-4bac-9938-6ce9760f5018	2009-3-18	TAXOL	NA	CHEMOTHERAPY	694	FALSE	736	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	810	NA
370	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	TCGA.10.0930	TCGA-10-0930-D24433	5c3e10dc-5d6b-4948-ba8b-4ac663d8e8db	2009-3-18	TAXOL	NA	CHEMOTHERAPY	8	FALSE	124	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
371	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	TCGA.10.0930	TCGA-10-0930-D24436	9e40afd1-1f30-4db6-9986-40cd5b982b0f	2009-3-18	CARBO	NA	CHEMOTHERAPY	694	NA	736	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	250	NA
372	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	TCGA.10.0930	TCGA-10-0930-D24437	548ef658-969a-490c-9410-cf5e38504c2a	2009-3-18	DOXIL	NA	CHEMOTHERAPY	782	FALSE	838	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	210	NA
373	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	TCGA.10.0930	TCGA-10-0930-D24434	bfd5b64b-62d5-4c17-8783-e6dbbf799d03	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	124	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2520	NA
374	99f1ae02-86ec-4d93-8cd4-650bf6f02c10	TCGA.10.0930	TCGA-10-0930-D24438	07366f75-ef12-4507-a120-de282ff35bb7	2009-3-18	TAMOXIFEN	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2400	NA
375	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24447	6f5f2462-b8d3-41a1-a759-bd6620dbea7a	2009-3-18	TAXOTERE	NA	CHEMOTHERAPY	538	FALSE	666	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	440	NA
376	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24443	44b0875b-a102-42e4-a61f-abfce289b500	2009-3-18	HERCEPTIN	NA	CHEMOTHERAPY	19	NA	124	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2268	NA
377	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24445	9c1c5ddc-68bf-48fb-8cae-507131f94067	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	386	FALSE	509	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3240	NA
378	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24442	dfdc84f0-c615-4da5-b487-34e7f9691adc	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	19	NA	124	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
379	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24450	8bd774bd-af1c-42d9-9e7f-5b3af5ba9fab	2009-3-18	DOXIL	NA	CHEMOTHERAPY	876	FALSE	932	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	231	NA
380	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24441	9c726295-8f59-46f7-8c2b-82ffb7160c98	2009-3-18	TAXOL	NA	CHEMOTHERAPY	19	NA	124	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2430	NA
381	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24448	e771584c-41ce-4c1b-a77f-01e3c8fe3d4b	2009-3-18	TAXOTERE	NA	CHEMOTHERAPY	538	NA	666	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	420	NA
382	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24451	8e89e478-3caf-4f3c-9f7d-6beb6d51b978	2009-3-18	TAMOXIFEN	NA	HORMONE THERAPY	335	FALSE	383	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1880	NA
383	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24446	392d5262-c107-42a2-b5a5-b33725bc6c95	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	538	FALSE	666	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1840	NA
384	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24452	bffe9f9b-5c33-4340-b4d7-14f05b68f15f	2009-3-18	IRRESSA	NA	TARGETED MOLECULAR THERAPY	792	NA	848	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	14000	NA
385	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24444	fdaa015f-c778-4f16-8461-faa4255fc6c0	2009-3-18	TAXOL	NA	CHEMOTHERAPY	386	FALSE	509	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1632	NA
386	e07a61e2-bcd2-4a96-80df-97e04aafbd32	TCGA.10.0931	TCGA-10-0931-D24449	473285f6-556e-4b10-b85c-03b35b3fd7c6	2009-3-18	TOPOTECAN	NA	CHEMOTHERAPY	792	FALSE	848	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	23.78	NA
387	9446e349-71e6-455a-aa8f-53ec96597146	TCGA.10.0933	TCGA-10-0933-D24455	40b513c9-3e2c-434c-84bc-b79ca9ae8c0e	2009-3-18	TAXOL	NA	CHEMOTHERAPY	20	FALSE	132	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND RECURRENCE	1740	NA
388	9446e349-71e6-455a-aa8f-53ec96597146	TCGA.10.0933	TCGA-10-0933-D24456	89e0dd01-e64f-44ab-b287-379aa1c62a89	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	132	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND RECURRENCE	2160	NA
389	65ddccd2-70a7-48b3-88e1-9d6fd1dcd11b	TCGA.10.0934	TCGA-10-0934-D24459	369dd738-d6cc-4e91-a5bb-a317fe8f262b	2009-3-18	TAXOL	NA	CHEMOTHERAPY	40	FALSE	56	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	525	NA
390	65ddccd2-70a7-48b3-88e1-9d6fd1dcd11b	TCGA.10.0934	TCGA-10-0934-D24460	8905b636-eb21-4da2-9c21-10097b036851	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	40	FALSE	56	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
391	48f8afa8-7712-4428-b0d0-d8c3340504b6	TCGA.10.0935	TCGA-10-0935-D24463	3b5b164a-2480-499e-94a3-b17eb309ddc5	2009-3-18	TAXOL	NA	CHEMOTHERAPY	34	FALSE	34	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	240	NA
392	48f8afa8-7712-4428-b0d0-d8c3340504b6	TCGA.10.0935	TCGA-10-0935-D24464	8871014c-27c2-4cef-aeb0-58c025e2b10e	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	34	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	385	NA
393	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24467	9bd9d92a-4775-495d-9209-1475005505f4	2009-3-18	TAXOL	NA	CHEMOTHERAPY	20	FALSE	62	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1615	NA
394	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24469	84fd790c-fc01-4d6d-bd3b-c4860f0e78b4	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	89	FALSE	194	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2280	NA
395	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24474	38fab685-29ce-4fff-9179-8691a08107d1	2009-3-18	LETROZOLE	NA	HORMONE THERAPY	237	FALSE	615	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2.5	NA
396	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24470	ee4d18da-f9a9-41f5-b867-87deff293046	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	621	FALSE	678	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1035	NA
397	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24473	335550af-0cce-4f0b-bb51-d2a7c0427588	2009-3-18	GEMCITABINE	NA	CHEMOTHERAPY	939	FALSE	1007	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	11200	NA
398	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24468	3886dc45-0ac8-4881-8901-ed14880ac3c6	2009-3-18	TAXOL	NA	CHEMOTHERAPY	89	FALSE	194	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
399	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24472	f6bca061-1141-4801-8241-cd2004e60d5d	2009-3-18	TAXOTERE	NA	CHEMOTHERAPY	810	FALSE	936	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	750	NA
400	7016714b-6af8-45dd-8341-1493927e5515	TCGA.10.0936	TCGA-10-0936-D24471	edcae4f7-3cd7-420f-b9d8-a8a91be49e85	2009-3-18	DOXIL	NA	CHEMOTHERAPY	678	FALSE	800	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	225	NA
401	a5030259-cf9c-4a58-8710-b9da8ee59320	TCGA.10.0937	TCGA-10-0937-D24478	64cba306-01c8-4412-9e49-95d131594683	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	33	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3990	NA
402	a5030259-cf9c-4a58-8710-b9da8ee59320	TCGA.10.0937	TCGA-10-0937-D24477	db74055c-a84f-449b-82f1-9108f0ff89c0	2009-3-18	TAXOL	NA	CHEMOTHERAPY	33	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1980	NA
403	a5030259-cf9c-4a58-8710-b9da8ee59320	TCGA.10.0937	TCGA-10-0937-D24480	f638ea11-a654-4755-af37-e67ded7c0ca7	2009-3-18	TOPOTECAN	NA	CHEMOTHERAPY	346	FALSE	NA	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	21	NA
404	a5030259-cf9c-4a58-8710-b9da8ee59320	TCGA.10.0937	TCGA-10-0937-D24479	985bd058-ab32-48c3-b123-43ac7e98ac1a	2009-3-18	DOXIL	NA	CHEMOTHERAPY	244	FALSE	296	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	140	NA
405	a5030259-cf9c-4a58-8710-b9da8ee59320	TCGA.10.0937	TCGA-10-0937-D24481	b7a1dace-94aa-4b2e-9b21-8887a767f9b0	2009-3-18	GEMCITABINE	NA	CHEMOTHERAPY	NA	FALSE	451	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4176	NA
406	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	TCGA.10.0938	TCGA-10-0938-D24485	4ec299a4-7ca0-401b-a821-eb152b0bdb5e	2009-3-18	TAXOTERE	NA	CHEMOTHERAPY	41	FALSE	188	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND PROGRESSION	960	NA
407	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	TCGA.10.0938	TCGA-10-0938-D24486	10f1ac83-b3d8-4d46-8f20-0375c6e60795	2009-3-18	LETROZOLE	NA	HORMONE THERAPY	30	FALSE	148	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND PROGRESSION	225	NA
408	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	TCGA.10.0938	TCGA-10-0938-D24487	c66f69b0-dcca-4e31-a97d-f082c418b72e	2009-3-18	LUPRON	NA	HORMONE THERAPY	30	FALSE	153	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND PROGRESSION	3.75	NA
409	7ca97692-0bf5-4bbd-81ce-10a051d04bd5	TCGA.10.0938	TCGA-10-0938-D24484	23a9ca35-0862-46fa-a079-8d3834f1178c	2009-3-18	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	188	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	OTHER	ADJUVANT AND PROGRESSION	3150	NA
410	1e14f098-17b2-4f54-8e4f-e38088008df7	TCGA.13.0714	TCGA-13-0714-D24491	9d443d74-433e-4f6f-8591-4a482fc81098	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	12	FALSE	NA	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
411	1e14f098-17b2-4f54-8e4f-e38088008df7	TCGA.13.0714	TCGA-13-0714-D24490	8ca3dedd-47ab-4034-aab2-6050c4600c4a	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	12	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5	NA
412	1e14f098-17b2-4f54-8e4f-e38088008df7	TCGA.13.0714	TCGA-13-0714-D24492	e54432b5-99df-4c39-b995-647542102aaf	2009-4-15	GEMCITABINE	NA	CHEMOTHERAPY	12	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
413	3867e193-c82f-4693-9b32-bac76b5f4d06	TCGA.13.0717	TCGA-13-0717-D24495	01973948-9206-4968-b05a-8b19e465ef65	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	9	FALSE	182	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
414	3867e193-c82f-4693-9b32-bac76b5f4d06	TCGA.13.0717	TCGA-13-0717-D24496	3a6a17e8-3079-4667-be37-f8a1adc186e1	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	9	FALSE	182	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
415	0d23fa5b-95f8-4626-a4d2-c72ad3cc553b	TCGA.13.0720	TCGA-13-0720-D24499	aaffa8ca-1eab-4ffc-89bb-6445124f34b8	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	180	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
416	0d23fa5b-95f8-4626-a4d2-c72ad3cc553b	TCGA.13.0720	TCGA-13-0720-D24500	a2017b37-9590-4aff-83e9-ec7eca6ee91e	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	180	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
417	0d23fa5b-95f8-4626-a4d2-c72ad3cc553b	TCGA.13.0720	TCGA-13-0720-D24501	aea4d94c-bf50-4440-a9a6-8e32d97645af	2009-4-20	PACLITAXEL	NA	CHEMOTHERAPY	239	FALSE	292	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	560	NA
418	ff530f28-0ec0-4494-bb54-44bb055bae1c	TCGA.13.0723	TCGA-13-0723-D24505	2da9827e-d8d0-4341-9c31-da97c92e0d3f	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	28	NA	200	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
419	ff530f28-0ec0-4494-bb54-44bb055bae1c	TCGA.13.0723	TCGA-13-0723-D24504	bb7c2bfe-7d7b-485e-a5f7-145a5a680ef7	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	28	NA	200	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
420	a9abe7a7-4126-414b-87d2-a6d25abcf1fa	TCGA.13.0724	TCGA-13-0724-D24508	821d3091-cd9c-4958-a260-e9ea9cc10b72	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	75	NA	75	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
421	446ce2a3-d328-443c-a419-3344baad0e16	TCGA.13.0725	TCGA-13-0725-D24513	98617757-5925-4a7b-b333-b843536db376	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	190	NA	215	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
422	446ce2a3-d328-443c-a419-3344baad0e16	TCGA.13.0725	TCGA-13-0725-D24512	24e5e7f8-08b6-4217-8e45-c7a6ce7ceb03	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	15	NA	131	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
423	446ce2a3-d328-443c-a419-3344baad0e16	TCGA.13.0725	TCGA-13-0725-D24511	c01c8aa8-2ad3-4add-9c4a-56fa32923507	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	15	NA	131	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
424	32960bc7-839a-42c5-9460-3917fa578ffc	TCGA.13.0726	TCGA-13-0726-D24517	9297737f-6669-4c71-858d-095117428338	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	29	NA	169	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
425	32960bc7-839a-42c5-9460-3917fa578ffc	TCGA.13.0726	TCGA-13-0726-D24516	f8476d0c-e091-4678-a588-e33fdb388ee4	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	29	NA	169	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
426	90f4b65c-cfd4-4066-a5b9-842885c172e2	TCGA.13.0727	TCGA-13-0727-D24522	85fd0b24-2879-4b9d-af7d-b78feec02170	2009-4-16	FEMARA	NA	HORMONE THERAPY	230	NA	267	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2.5	NA
427	90f4b65c-cfd4-4066-a5b9-842885c172e2	TCGA.13.0727	TCGA-13-0727-D24521	c84669f2-ec70-49d1-b206-2db206e0976a	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	9	NA	120	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
428	90f4b65c-cfd4-4066-a5b9-842885c172e2	TCGA.13.0727	TCGA-13-0727-D24520	48326e26-e676-4b3a-a613-5f8398fa1b3a	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	9	NA	120	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
429	15c84da3-16e5-4909-aea9-cb5894b0f8af	TCGA.13.0751	TCGA-13-0751-D24527	ff901552-345c-4d2f-882f-4f90f4b6cb65	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	7	NA	126	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
430	15c84da3-16e5-4909-aea9-cb5894b0f8af	TCGA.13.0751	TCGA-13-0751-D24528	025efed8-6699-48d2-8596-788a6337a354	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	195	NA	266	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
431	15c84da3-16e5-4909-aea9-cb5894b0f8af	TCGA.13.0751	TCGA-13-0751-D24526	06eeae3a-bfc4-461d-8499-af38bf92d8ed	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	7	NA	126	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
432	15c84da3-16e5-4909-aea9-cb5894b0f8af	TCGA.13.0751	TCGA-13-0751-D24529	1e6a17fb-ccae-4774-885a-87fff00779a2	2009-4-16	GEMCITABINE	NA	CHEMOTHERAPY	195	NA	266	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	500	NA
433	2956e414-f167-438f-8747-a46fe0723622	TCGA.13.0755	TCGA-13-0755-D24532	b1fd19c5-0fce-4869-ae4b-9b46b4361b96	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	19	NA	41	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	230	NA
434	2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a	TCGA.13.0757	TCGA-13-0757-D24536	d9c850b0-6889-4a82-94f5-deeab734157d	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	36	FALSE	154	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
435	2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a	TCGA.13.0757	TCGA-13-0757-D24535	694dc262-613f-40fe-b735-58df6a8f7c5c	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	36	FALSE	153	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
436	2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a	TCGA.13.0757	TCGA-13-0757-D24537	e9908539-10a7-4295-b517-eaa029f112b2	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	211	FALSE	267	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
437	514aa64e-a58d-48c2-aff9-498604cc11d6	TCGA.13.0758	TCGA-13-0758-D24541	34cc047c-282b-4d98-b8d6-e0dcd9ab5ee9	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	14	FALSE	161	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
438	514aa64e-a58d-48c2-aff9-498604cc11d6	TCGA.13.0758	TCGA-13-0758-D24540	052c2082-e91f-4ae5-9471-90fa513e2975	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	161	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
439	00630714-7ab3-44e1-afff-186300edae44	TCGA.13.0761	TCGA-13-0761-D24546	f9983963-5c1a-496b-8282-939554cd4f52	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	53	FALSE	221	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
440	00630714-7ab3-44e1-afff-186300edae44	TCGA.13.0761	TCGA-13-0761-D24547	bcdda631-62b9-4f30-a4ed-6edd08a6dcd2	2009-4-17	DOCETAXEL	NA	CHEMOTHERAPY	53	FALSE	221	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
441	6485b68f-caa7-45cd-9bc5-78c2add8191d	TCGA.13.0762	TCGA-13-0762-D24552	93f06508-dccf-4618-83f4-c16fd7ac7e53	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	28	FALSE	141	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
442	6485b68f-caa7-45cd-9bc5-78c2add8191d	TCGA.13.0762	TCGA-13-0762-D24551	83cbff94-94d3-48a7-b33a-4271d6aef3f5	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	28	FALSE	141	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
443	6485b68f-caa7-45cd-9bc5-78c2add8191d	TCGA.13.0762	TCGA-13-0762-D24550	55ae7407-0449-4ebf-bbdb-234a9b82628c	2009-4-17	CISPLATIN	NA	CHEMOTHERAPY	28	FALSE	141	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
444	034825d0-e8b7-4ac0-be31-25f6038cb04a	TCGA.13.0764	TCGA-13-0764-D24557	443a788f-f890-4d47-bfbc-c7ff8c756087	2009-4-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	76	FALSE	160	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	ADJUVANT	NA	15	NA
445	034825d0-e8b7-4ac0-be31-25f6038cb04a	TCGA.13.0764	TCGA-13-0764-D24556	a86c31d3-6cf3-4966-8fc6-35ef8a155966	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	55	FALSE	160	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
446	034825d0-e8b7-4ac0-be31-25f6038cb04a	TCGA.13.0764	TCGA-13-0764-D24555	c5a01cb1-41c5-4db6-9fd2-771187c689da	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	55	FALSE	160	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
447	774ce281-96b2-467a-9170-079797ee10f7	TCGA.13.0765	TCGA-13-0765-D24562	e10f7682-e704-4461-99a6-bfb0f4230525	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	50	FALSE	163	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
448	774ce281-96b2-467a-9170-079797ee10f7	TCGA.13.0765	TCGA-13-0765-D24560	071ec052-a24e-4f07-98bc-11b7f907e959	2009-4-17	CISPLATIN	NA	CHEMOTHERAPY	50	FALSE	163	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
449	774ce281-96b2-467a-9170-079797ee10f7	TCGA.13.0765	TCGA-13-0765-D24564	77457f7e-2ffc-46d6-839d-6e6edfefaebc	2009-4-17	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	71	FALSE	155	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	15	NA
450	774ce281-96b2-467a-9170-079797ee10f7	TCGA.13.0765	TCGA-13-0765-D24563	58a14e2a-e159-49b3-8dcf-21e5a3d30352	2009-4-17	TAMOXIFEN	NA	HORMONE THERAPY	589	FALSE	654	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	20	NA
451	774ce281-96b2-467a-9170-079797ee10f7	TCGA.13.0765	TCGA-13-0765-D24561	ddc1fe71-a09c-4c22-8676-91f17fb10e63	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	50	FALSE	163	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
452	774ce281-96b2-467a-9170-079797ee10f7	TCGA.13.0765	TCGA-13-0765-D24565	6d3b20f2-3254-4eda-82dc-bace5d8bf3fd	2009-4-17	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	176	FALSE	519	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	ADJUVANT	NA	15	NA
453	8fe44099-b313-4bfd-a94a-27e72f2a818c	TCGA.13.0766	TCGA-13-0766-D24570	e98199f4-62f6-444e-804c-fea51774aa05	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	182	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
454	8fe44099-b313-4bfd-a94a-27e72f2a818c	TCGA.13.0766	TCGA-13-0766-D24568	3b508635-6136-468c-965e-6c9f011017c6	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
455	8fe44099-b313-4bfd-a94a-27e72f2a818c	TCGA.13.0766	TCGA-13-0766-D24569	b3b92756-81fc-4d20-8fbe-2be751f193c3	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	182	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
456	e732f81c-9b7d-44bd-a905-ff53fbed5009	TCGA.13.0768	TCGA-13-0768-D24574	419fde28-a4fc-450e-9eea-2e2bfb358bda	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	36	FALSE	57	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
457	e732f81c-9b7d-44bd-a905-ff53fbed5009	TCGA.13.0768	TCGA-13-0768-D24573	57e7d052-fdbb-4d18-85e9-c79ba8256d7b	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	36	FALSE	57	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
458	e732f81c-9b7d-44bd-a905-ff53fbed5009	TCGA.13.0768	TCGA-13-0768-D24577	17b07201-3aff-475c-b83e-6497ed980195	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	78	FALSE	148	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
459	e732f81c-9b7d-44bd-a905-ff53fbed5009	TCGA.13.0768	TCGA-13-0768-D24576	bc1188fa-1bdd-4a7b-9857-005920b5ddf7	2009-4-17	PACLITAXEL	NA	CHEMOTHERAPY	78	FALSE	148	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
460	e732f81c-9b7d-44bd-a905-ff53fbed5009	TCGA.13.0768	TCGA-13-0768-D24575	7fb6b1aa-f42a-491c-a202-18df8a0d0f5f	2009-4-17	CISPLATIN	NA	CHEMOTHERAPY	78	FALSE	148	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
461	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24581	4bbea2bf-9e76-4eb8-943a-c8261c1e3d4b	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	36	NA	141	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
462	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24580	710705ec-cf9c-48b3-ba3e-231fd550abdc	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	36	NA	141	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
463	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24582	379ea08d-75c7-4d5b-98f6-81fab2e749e8	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	213	NA	281	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
464	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24586	ae155608-caaf-401f-9b84-046e87854d2c	2010-3-8	CARBOPLATIN	NA	CHEMOTHERAPY	794	FALSE	829	NA	NA	NA	NA	2	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4	NA
465	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24583	0e93df1a-7811-43d7-ad40-d83f7e680672	2010-3-8	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	302	FALSE	449	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	40	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
466	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24584	ad968ce1-3353-45e4-a7c6-d061d40f6126	2010-3-8	TOPOTECAN	NA	CHEMOTHERAPY	479	FALSE	640	NA	NA	NA	NA	19	NA	MG/M2	MG/M2	3	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
467	90118207-8f11-4784-ac1b-0deec2e7af3a	TCGA.13.0791	TCGA-13-0791-D24585	75a48310-4c7b-4d7e-aeba-64a599ee42e4	2010-3-8	GEMCITABINE	NA	CHEMOTHERAPY	654	FALSE	780	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	800	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
468	c11cae7e-91cd-4470-a9d8-188a4f6b8fa1	TCGA.13.0792	TCGA-13-0792-D24589	4c5d66cb-f9d3-4438-944a-a84abe10f840	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	34	NA	160	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
469	c11cae7e-91cd-4470-a9d8-188a4f6b8fa1	TCGA.13.0792	TCGA-13-0792-D24590	f047d3e4-be77-443e-a63f-a9ed378a2787	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	34	NA	160	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
470	c11cae7e-91cd-4470-a9d8-188a4f6b8fa1	TCGA.13.0792	TCGA-13-0792-D24591	c684d9ec-477e-4668-af2d-69f602efaefb	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	34	NA	160	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
471	5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73	TCGA.13.0793	TCGA-13-0793-D24595	12f8b3a0-deed-409d-8434-0c0a13501dc7	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	47	FALSE	159	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
472	5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73	TCGA.13.0793	TCGA-13-0793-D24596	3a56ec6c-8b7f-482d-b6b0-4d64e56a91e4	2009-4-15	ABAGOVOMAB OR PLACEBO	NA	IMMUNOTHERAPY	200	NA	362	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2	NA
473	5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73	TCGA.13.0793	TCGA-13-0793-D24594	75b465bb-15eb-4d7f-8398-3c39d9ada2c0	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	47	NA	159	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
474	b63cad1b-b4c7-4e50-8acb-5cee4e9ce4a9	TCGA.13.0794	TCGA-13-0794-D24599	281b15dd-f21d-45da-8ba4-98a7232df8d8	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	132	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
475	b63cad1b-b4c7-4e50-8acb-5cee4e9ce4a9	TCGA.13.0794	TCGA-13-0794-D24600	3ae6ca7f-d54e-40bb-9545-a9cbe96a034e	2009-4-17	DOCETAXEL	NA	CHEMOTHERAPY	26	FALSE	132	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
476	b1e11e94-646b-4c44-9d33-1ca67d8356fb	TCGA.13.0795	TCGA-13-0795-D24604	422f22dc-5eed-420f-a1bb-c308c2a9f817	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	101	FALSE	205	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
477	b1e11e94-646b-4c44-9d33-1ca67d8356fb	TCGA.13.0795	TCGA-13-0795-D24603	a99e93f3-ba26-4014-bbbc-3504115a7f8c	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	101	FALSE	205	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
478	0de910b1-edaf-47e4-a265-727ee12ac1c3	TCGA.13.0797	TCGA-13-0797-D24608	d8ca87b3-32a4-4fad-9419-710ff00e2cb0	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	42	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
479	0de910b1-edaf-47e4-a265-727ee12ac1c3	TCGA.13.0797	TCGA-13-0797-D24607	88409662-1902-43f0-bc49-17443a879455	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	599	NA
480	b9418c6d-94f7-4db4-a1e4-f384b09d54cb	TCGA.13.0799	TCGA-13-0799-D24612	a3617379-b708-456a-9810-14b2afa80f6d	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	36	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
481	b9418c6d-94f7-4db4-a1e4-f384b09d54cb	TCGA.13.0799	TCGA-13-0799-D24613	8484fd14-0e7e-45a2-86ce-bcd6b8dfdc48	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	36	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
482	b9418c6d-94f7-4db4-a1e4-f384b09d54cb	TCGA.13.0799	TCGA-13-0799-D24611	9d2e034d-d90b-4a71-9671-3b061af0102a	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	36	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
483	390eed6b-50af-48a9-9fd6-3a68a2bbb7f9	TCGA.13.0800	TCGA-13-0800-D24618	7686a479-629f-4b7f-9af3-a7179af92576	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	30	FALSE	142	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
484	390eed6b-50af-48a9-9fd6-3a68a2bbb7f9	TCGA.13.0800	TCGA-13-0800-D24617	ff5f69d5-3de1-4738-9a02-dbe76765b393	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	30	FALSE	142	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
485	390eed6b-50af-48a9-9fd6-3a68a2bbb7f9	TCGA.13.0800	TCGA-13-0800-D24616	9a8cf2ea-d928-477e-800a-2201bdeb5b9f	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	30	FALSE	142	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
486	b8c3d99c-429b-42a3-b486-6fbcb90cc2e0	TCGA.13.0801	TCGA-13-0801-D24622	48845041-4684-4ce0-afb3-b87310cdec68	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	32	FALSE	144	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
487	b8c3d99c-429b-42a3-b486-6fbcb90cc2e0	TCGA.13.0801	TCGA-13-0801-D24623	bb31a332-a1a0-4581-9d52-56985e1e12bc	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	32	FALSE	144	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
488	b8c3d99c-429b-42a3-b486-6fbcb90cc2e0	TCGA.13.0801	TCGA-13-0801-D24621	15a73dea-bc43-4bd4-94be-918dc9428c2e	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	32	FALSE	144	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
489	3c8b5986-f9d5-4e7e-9dd4-3ad301451279	TCGA.13.0802	TCGA-13-0802-D24627	6327fc62-9594-4666-83cc-db0aed29baed	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	62	FALSE	188	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
490	3c8b5986-f9d5-4e7e-9dd4-3ad301451279	TCGA.13.0802	TCGA-13-0802-D24626	98c08254-9631-499e-b215-5c9c32eb8009	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	62	FALSE	188	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
491	54cf3bfe-51c0-4cca-9054-bf76b05a9371	TCGA.13.0803	TCGA-13-0803-D24631	4b3bed15-25df-47c4-8876-bd93ec815e04	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
492	54cf3bfe-51c0-4cca-9054-bf76b05a9371	TCGA.13.0803	TCGA-13-0803-D24630	9df60126-cad0-4536-be8b-92e6d5bc5864	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	147	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
493	7e34d3c1-1fab-4326-9a69-4260d2bac558	TCGA.13.0804	TCGA-13-0804-D24636	53652d84-be01-4719-b091-1e0c5a336931	2009-4-15	90Y-HU3S193	NA	TARGETED MOLECULAR THERAPY	270	FALSE	270	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
494	7e34d3c1-1fab-4326-9a69-4260d2bac558	TCGA.13.0804	TCGA-13-0804-D24635	9ba0bb7a-0471-4d62-a672-769e560548fd	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	26	FALSE	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
495	7e34d3c1-1fab-4326-9a69-4260d2bac558	TCGA.13.0804	TCGA-13-0804-D24634	9120000f-695e-4598-948b-393f49a35d72	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	161	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
496	2a3a6222-f477-4198-ab9e-cdf527c1a6cf	TCGA.13.0805	TCGA-13-0805-D24640	77384840-9b33-4f4c-9b08-37d02ec121b7	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	151	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
497	2a3a6222-f477-4198-ab9e-cdf527c1a6cf	TCGA.13.0805	TCGA-13-0805-D24639	bb8c4793-e6e0-4827-ba78-fcd2a9e25910	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
498	067c5c61-d147-4b08-ab8a-32c30969d564	TCGA.13.0807	TCGA-13-0807-D24644	1ecc3288-bfd8-444a-9231-b5aae9a6623d	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
499	067c5c61-d147-4b08-ab8a-32c30969d564	TCGA.13.0807	TCGA-13-0807-D24643	81a76588-bed5-4afc-b5ec-3a93daac9ead	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
500	5c159ab5-8475-4d93-89b8-b6befed4a5b3	TCGA.13.0883	TCGA-13-0883-D24648	0f78c3d5-a61e-42c2-9a2a-3d649afbcfc4	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	31	FALSE	143	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
501	5c159ab5-8475-4d93-89b8-b6befed4a5b3	TCGA.13.0883	TCGA-13-0883-D24647	d214b9d5-80dd-4328-91a0-0c5f62e7c3c2	2009-4-15	CARBOBPLATIN	NA	CHEMOTHERAPY	31	FALSE	143	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
502	5c159ab5-8475-4d93-89b8-b6befed4a5b3	TCGA.13.0883	TCGA-13-0883-D24649	10e5d0de-68b8-4480-bc66-6fb0d0544380	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	227	FALSE	350	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
503	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	TCGA.13.0884	TCGA-13-0884-D24656	f696b7ed-1114-49b6-a2a4-8d394fdcfa43	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	240	FALSE	307	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	74	NA
504	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	TCGA.13.0884	TCGA-13-0884-D24654	3eeaa9ad-d6c1-4843-8a53-d76c3243380c	2009-6-30	GEMICITABINE	NA	CHEMOTHERAPY	55	FALSE	191	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	800	NA
505	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	TCGA.13.0884	TCGA-13-0884-D24653	7cffdd63-0cfb-4c4c-98e9-ac1d35615574	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	55	FALSE	191	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
506	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	TCGA.13.0884	TCGA-13-0884-D24652	fc570206-ca8e-42f3-a1f2-a46aea37a65e	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	55	FALSE	191	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
507	63a75e0b-9241-4f0e-9236-01a2e2c05b7e	TCGA.13.0884	TCGA-13-0884-D24655	29c3e4e5-9940-499e-94ec-de4979d77ff0	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	240	FALSE	307	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	133	NA
508	2a924999-1fbf-470a-97bd-fd2276a9a366	TCGA.13.0885	TCGA-13-0885-D24659	1b109abf-497f-455d-b2cd-afb4f953f287	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	110	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
509	2a924999-1fbf-470a-97bd-fd2276a9a366	TCGA.13.0885	TCGA-13-0885-D24661	30bfb060-bc43-4205-a472-4139381c0c69	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	208	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
510	2a924999-1fbf-470a-97bd-fd2276a9a366	TCGA.13.0885	TCGA-13-0885-D24660	2786c1cb-0952-4c59-b515-77c3a5c35742	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	6	FALSE	110	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
511	91de8a74-a1e6-46b6-a06e-70aedf2c3eaf	TCGA.13.0886	TCGA-13-0886-D24664	806d8340-5dbd-4b37-be0e-0a24f1819e6e	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	12	FALSE	132	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
512	91de8a74-a1e6-46b6-a06e-70aedf2c3eaf	TCGA.13.0886	TCGA-13-0886-D24666	189a2c96-a9c3-4a56-bbdb-12b6fd50f3fa	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	221	FALSE	263	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
513	91de8a74-a1e6-46b6-a06e-70aedf2c3eaf	TCGA.13.0886	TCGA-13-0886-D24665	965956e2-03a9-4029-9a70-1be682b08540	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	12	FALSE	132	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
514	14c58def-60ee-48e0-a74b-da4eb77ef344	TCGA.13.0887	TCGA-13-0887-D24670	c463c28f-e65d-4bb2-a88a-9550f415cdd9	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	114	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
515	14c58def-60ee-48e0-a74b-da4eb77ef344	TCGA.13.0887	TCGA-13-0887-D24669	36a82010-4db9-46e7-9ff5-8fb49a5d51ff	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	114	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
516	14c58def-60ee-48e0-a74b-da4eb77ef344	TCGA.13.0887	TCGA-13-0887-D24671	f8042e57-3947-4ac3-ac85-7c47074317e3	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	184	FALSE	268	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
517	6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf	TCGA.13.0888	TCGA-13-0888-D24674	6ff16be4-ef53-4e2d-b800-e9fe11910306	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	54	FALSE	232	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
518	6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf	TCGA.13.0888	TCGA-13-0888-D24675	31c8aef7-cb07-4117-983a-0544b208f1d7	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	54	FALSE	232	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
519	6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf	TCGA.13.0888	TCGA-13-0888-D24676	e70b84ff-49ff-42fb-ae5c-18c3c1a22aa4	2009-4-16	FEMARA	NA	HORMONE THERAPY	253	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
520	e3712e5a-4575-440f-89d1-8db9498baa88	TCGA.13.0889	TCGA-13-0889-D24680	bdee55fd-304d-4731-a737-d755e3b0bb00	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	54	FALSE	159	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
521	e3712e5a-4575-440f-89d1-8db9498baa88	TCGA.13.0889	TCGA-13-0889-D24679	464ba663-795e-42ab-b946-a067761a2965	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	54	FALSE	159	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
522	ee0a4a13-613e-4c5d-96c3-8083a013702d	TCGA.13.0890	TCGA-13-0890-D24684	70389c25-6516-4dbe-96a8-657ae7a0c003	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	15	FALSE	235	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
523	ee0a4a13-613e-4c5d-96c3-8083a013702d	TCGA.13.0890	TCGA-13-0890-D24683	2116b411-beb7-44ff-a1b5-1a4a51c0c452	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	235	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
524	0740321b-f8a5-4e1d-b390-ca6187598fac	TCGA.13.0891	TCGA-13-0891-D24688	6b1c33ed-7ea9-49aa-b1ad-eaadf84463b8	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	71	FALSE	183	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1050	NA
525	0740321b-f8a5-4e1d-b390-ca6187598fac	TCGA.13.0891	TCGA-13-0891-D24687	c72e692b-29dd-4292-add3-4b3889f27442	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	71	FALSE	183	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
526	15170c7f-5880-4fb6-82ce-68d3df0dfb68	TCGA.13.0893	TCGA-13-0893-D24692	a48fb2d1-82b6-4f3b-b211-2319a0b329a7	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	80	FALSE	284	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
527	15170c7f-5880-4fb6-82ce-68d3df0dfb68	TCGA.13.0893	TCGA-13-0893-D24691	79d5303d-f605-4215-ae23-86f9e3f1e193	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	80	FALSE	284	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
528	15170c7f-5880-4fb6-82ce-68d3df0dfb68	TCGA.13.0893	TCGA-13-0893-D24693	5bdb21b9-a7f1-41eb-9eb0-ac3208afa81b	2009-6-30	FEMARA	NA	HORMONE THERAPY	340	FALSE	566	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	2.5	NA
529	e8372916-7ac7-4535-ae97-0248208224f5	TCGA.13.0894	TCGA-13-0894-D24696	cadb50a3-648a-458a-a426-dcc49348f377	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	47	FALSE	216	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
530	e8372916-7ac7-4535-ae97-0248208224f5	TCGA.13.0894	TCGA-13-0894-D24697	517b624b-f0c2-425b-a217-8e665840df42	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	47	FALSE	216	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
531	e8372916-7ac7-4535-ae97-0248208224f5	TCGA.13.0894	TCGA-13-0894-D24698	ec90a0ce-59ed-478e-9502-8bce222e6276	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	307	FALSE	330	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	600	NA
532	79e6e31c-22a1-481c-903b-ab5499cbd450	TCGA.13.0897	TCGA-13-0897-D24702	ca45bc16-c21b-49db-bf56-ee1313f059ee	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	35	FALSE	140	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1050	NA
533	79e6e31c-22a1-481c-903b-ab5499cbd450	TCGA.13.0897	TCGA-13-0897-D24701	cc1f5f91-e9e0-43f6-9e1f-688daa23a656	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	140	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
534	5c6f3cd4-19c5-418d-b1be-d3fbf63e99db	TCGA.13.0899	TCGA-13-0899-D24705	24164473-0e73-4062-bf9b-dc624f95510a	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	126	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
535	5c6f3cd4-19c5-418d-b1be-d3fbf63e99db	TCGA.13.0899	TCGA-13-0899-D24706	f1500cb6-1acc-4eba-a03d-bdf3b9327360	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	16	FALSE	126	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1050	NA
536	9e48a4b1-6917-4625-9d78-e4832eb816a5	TCGA.13.0900	TCGA-13-0900-D24710	e939513a-a319-4a7f-b724-3d9a24dbb312	2009-6-30	PACILTAXAL	NA	CHEMOTHERAPY	38	FALSE	162	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
537	9e48a4b1-6917-4625-9d78-e4832eb816a5	TCGA.13.0900	TCGA-13-0900-D24709	3dd1d8e2-9bf1-47fb-8fb4-41360012da50	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	38	FALSE	162	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
538	27920e1e-b9ab-4587-970a-0cba7025becb	TCGA.13.0901	TCGA-13-0901-D24714	6d3211ce-35d2-455e-975e-81723a31ec32	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	44	FALSE	165	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
539	27920e1e-b9ab-4587-970a-0cba7025becb	TCGA.13.0901	TCGA-13-0901-D24713	efb4d63b-68d6-452f-9457-fb4fe0c251df	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	44	FALSE	165	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
540	27920e1e-b9ab-4587-970a-0cba7025becb	TCGA.13.0901	TCGA-13-0901-D24715	87333d18-17bb-4cd5-b969-f6fdcf69dd36	2009-6-30	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	44	FALSE	88	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	250	NA
541	8783e4b0-2b62-45d5-8cd9-f5a71cc0138e	TCGA.13.0903	TCGA-13-0903-D24719	d7ddd098-94ed-4968-8ad0-9a6990826131	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	22	FALSE	127	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1050	NA
542	8783e4b0-2b62-45d5-8cd9-f5a71cc0138e	TCGA.13.0903	TCGA-13-0903-D24718	d0670488-e31a-49a9-a4ed-1015c0b39e32	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	127	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
543	8783e4b0-2b62-45d5-8cd9-f5a71cc0138e	TCGA.13.0903	TCGA-13-0903-D24720	7f98152d-4925-437d-a83a-3b9561499e78	2009-4-16	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	22	FALSE	141	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	250	NA
544	8783e4b0-2b62-45d5-8cd9-f5a71cc0138e	TCGA.13.0903	TCGA-13-0903-D24721	8a819232-2e9f-4703-9afd-2238a6314430	2009-4-16	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	169	FALSE	335	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	250	NA
545	0b519c08-9f23-4ceb-9a13-e16509ca55d7	TCGA.13.0904	TCGA-13-0904-D24725	0dfb4665-f7e4-48fa-a171-2ca620eb578c	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	63	FALSE	84	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
546	0b519c08-9f23-4ceb-9a13-e16509ca55d7	TCGA.13.0904	TCGA-13-0904-D24724	19a07949-eb4b-4ca2-a6e4-dbcaa275a295	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	63	FALSE	84	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
547	0b519c08-9f23-4ceb-9a13-e16509ca55d7	TCGA.13.0904	TCGA-13-0904-D24727	a552a880-bcd5-438e-9595-7eea9cc4ab4b	2009-4-16	DOCETAXEL	NA	CHEMOTHERAPY	105	FALSE	251	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
548	0b519c08-9f23-4ceb-9a13-e16509ca55d7	TCGA.13.0904	TCGA-13-0904-D24726	df387235-8141-4dd9-bcf3-500fb9ffaece	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	105	NA	251	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
549	2038fd65-d8f1-4b16-af90-b1c8f9a379a7	TCGA.13.0905	TCGA-13-0905-D24730	feedb04f-785c-4c0c-a091-d00618dea595	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	125	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
550	2038fd65-d8f1-4b16-af90-b1c8f9a379a7	TCGA.13.0905	TCGA-13-0905-D24732	00d12b24-ecbd-4ee0-b3c9-86d1f2051ea3	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	153	FALSE	223	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	500	NA
551	2038fd65-d8f1-4b16-af90-b1c8f9a379a7	TCGA.13.0905	TCGA-13-0905-D24731	d16052dd-7975-441f-919e-4fcf9463a163	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	20	FALSE	125	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
552	e43d3769-e25f-4fb7-9080-ea26defaf094	TCGA.13.0906	TCGA-13-0906-D24736	30150f9a-7ff8-4c97-96a5-9450f584dd84	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
553	e43d3769-e25f-4fb7-9080-ea26defaf094	TCGA.13.0906	TCGA-13-0906-D24735	0f8f7b7a-2605-4d92-89cd-029df70ea38f	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	35	NA	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
554	e43d3769-e25f-4fb7-9080-ea26defaf094	TCGA.13.0906	TCGA-13-0906-D24737	4648be54-8c2c-4fef-8fb0-fcb9d8ee65d2	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
555	0ba7b6cc-e5f5-47d7-859a-24e31aa336ab	TCGA.13.0908	TCGA-13-0908-D24740	411e47eb-8e4a-4db8-90e6-dab616f52f95	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	135	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
556	0ba7b6cc-e5f5-47d7-859a-24e31aa336ab	TCGA.13.0908	TCGA-13-0908-D24741	e0ae3a10-31dd-43b6-b2f1-bebf0fc5128b	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	24	FALSE	135	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
557	0ba7b6cc-e5f5-47d7-859a-24e31aa336ab	TCGA.13.0908	TCGA-13-0908-D24742	a715aa27-039d-4fc8-b247-fc6db02155cf	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	198	FALSE	244	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	70	NA
558	b783f33b-734a-4801-bf39-b559a2035c6f	TCGA.13.0910	TCGA-13-0910-D24747	b87c89fa-619d-4ba5-899d-e78c89e963c1	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	238	NA	289	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
559	b783f33b-734a-4801-bf39-b559a2035c6f	TCGA.13.0910	TCGA-13-0910-D24746	f8475db6-26ee-485e-ad19-8ec781617a10	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	70	NA	175	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
560	b783f33b-734a-4801-bf39-b559a2035c6f	TCGA.13.0910	TCGA-13-0910-D24745	4c9aed17-53a5-4788-8dbe-f3b825e6785e	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	70	NA	175	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
561	8cad4217-5699-4735-9be3-fc0015a8d262	TCGA.13.0911	TCGA-13-0911-D24751	e179932c-db69-4bfd-bb18-71681cf970e4	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	49	FALSE	189	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
562	8cad4217-5699-4735-9be3-fc0015a8d262	TCGA.13.0911	TCGA-13-0911-D24750	8823c209-2882-4f55-ab70-ec250593c4dc	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	49	FALSE	189	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
563	58d34254-4f5b-40a4-9e9f-7160062fb2a4	TCGA.13.0912	TCGA-13-0912-D24755	60f29631-b790-49a0-92f3-2834f89bfbc7	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
564	58d34254-4f5b-40a4-9e9f-7160062fb2a4	TCGA.13.0912	TCGA-13-0912-D24756	f039ec8f-f07a-4b69-9b57-674eb3fe8816	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
565	58d34254-4f5b-40a4-9e9f-7160062fb2a4	TCGA.13.0912	TCGA-13-0912-D24754	12cfb557-540b-425c-a068-9897165c526a	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	35	NA	147	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
566	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	TCGA.13.0913	TCGA-13-0913-D24759	0d3b6f19-f63f-41e7-9130-380e82642bb3	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	35	NA	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
567	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	TCGA.13.0913	TCGA-13-0913-D24761	e6c2ede1-ccee-463d-b028-c4eb8a176960	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	35	FALSE	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
568	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	TCGA.13.0913	TCGA-13-0913-D24760	fd329f71-cbc1-4149-9e26-3483110f7c08	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
569	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	TCGA.13.0913	TCGA-13-0913-D24763	31cc917f-186a-4e24-bd6a-6344b86f756a	2010-3-8	PACLITAXEL	NA	CHEMOTHERAPY	962	FALSE	1071	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	175	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
570	3e8a51bf-7e1f-4eab-af83-3c60d04db1bf	TCGA.13.0913	TCGA-13-0913-D24762	895b449e-1a4b-4abe-b8d2-5f86b7aba4f0	2010-3-8	CARBOPLATIN	NA	CHEMOTHERAPY	962	FALSE	1071	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
571	5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4	TCGA.13.0916	TCGA-13-0916-D24768	d5f8a386-7074-40a4-9d62-699ba2571deb	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
572	5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4	TCGA.13.0916	TCGA-13-0916-D24766	e035fe81-878f-4509-ad6e-98266495e5bd	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	35	NA	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
573	5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4	TCGA.13.0916	TCGA-13-0916-D24767	d53e97a9-93d9-46ad-9bd1-1851d1cff4a4	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	161	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
574	5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4	TCGA.13.0916	TCGA-13-0916-D24769	a5460512-89a7-41f5-9ea2-63e47680924a	2009-4-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	70	NA	182	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	15	NA
575	45957be6-e4df-4245-acf8-39dfc118ee19	TCGA.13.0919	TCGA-13-0919-D24772	943463ed-59a4-44d1-a1fe-cd706824fe1f	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	42	NA	160	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
576	45957be6-e4df-4245-acf8-39dfc118ee19	TCGA.13.0919	TCGA-13-0919-D24773	53980a2d-3250-4d22-951c-af3ecf5572e7	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	42	NA	160	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
577	85a85a11-7200-4e96-97af-6ba26d680d59	TCGA.13.0920	TCGA-13-0920-D24776	7886c638-9120-43dc-a93d-657bae62d49d	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	151	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
578	31b997dd-aaea-4003-a64d-11d3e19b0bbc	TCGA.13.0921	TCGA-13-0921-D24779	63fc0d14-1978-464b-b001-b72b7cc526f7	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	35	NA	140	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
579	31b997dd-aaea-4003-a64d-11d3e19b0bbc	TCGA.13.0921	TCGA-13-0921-D24780	fa9ca8bd-dc3a-44e7-8853-e0d8147cb914	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	35	NA	140	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
580	378f7ea2-86b4-4072-80b8-e12d67193106	TCGA.13.0923	TCGA-13-0923-D24785	b303f13f-01de-4e5a-8fe1-c7ef1b52fe06	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	39	FALSE	151	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
581	378f7ea2-86b4-4072-80b8-e12d67193106	TCGA.13.0923	TCGA-13-0923-D24783	942a1a6d-f1f2-4550-bab2-8cdbe1bcdea0	2009-4-15	CISPLATIN	NA	CHEMOTHERAPY	39	FALSE	151	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
582	378f7ea2-86b4-4072-80b8-e12d67193106	TCGA.13.0923	TCGA-13-0923-D24784	26beddad-f96d-4695-b753-f76cf0f72aeb	2009-4-15	PACLITAXEL	NA	CHEMOTHERAPY	39	FALSE	151	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
583	fbb45305-de8d-4baf-8bd0-047b29c2e9d9	TCGA.13.0924	TCGA-13-0924-D24790	1d2653d7-cad8-4cba-805f-3b87337a64ed	2009-4-16	BEVACIZUMAB OR PLACEBO	NA	TARGETED MOLECULAR THERAPY	60	NA	143	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	920	NA
584	fbb45305-de8d-4baf-8bd0-047b29c2e9d9	TCGA.13.0924	TCGA-13-0924-D24788	2b11dd9d-5b35-4573-8f46-fb5d477ef580	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	38	NA	143	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
585	fbb45305-de8d-4baf-8bd0-047b29c2e9d9	TCGA.13.0924	TCGA-13-0924-D24791	b2c02e5d-3faf-4541-9a7b-a92e1694a52e	2009-4-16	BEVACIZUMAB OR PLACEBO	NA	TARGETED MOLECULAR THERAPY	164	NA	213	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	ADJUVANT	NA	15	NA
586	fbb45305-de8d-4baf-8bd0-047b29c2e9d9	TCGA.13.0924	TCGA-13-0924-D24789	93dd4066-d984-4869-acfe-682e0aa79846	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	38	NA	143	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
587	0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8	TCGA.13.1403	TCGA-13-1403-D24794	f08d91eb-9a00-43ad-89ce-b0780a1d9bf4	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	27	FALSE	142	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
588	0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8	TCGA.13.1403	TCGA-13-1403-D24795	904c042a-d9f6-41fa-a753-91928f69b54d	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	27	FALSE	142	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
589	0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8	TCGA.13.1403	TCGA-13-1403-D24796	5e06e147-2f73-44ea-b089-fd40985fc5f4	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	27	FALSE	142	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
590	8e107f4b-1912-4d3e-814a-b863e2d65ed7	TCGA.13.1404	TCGA-13-1404-D24800	62d968f7-b34f-48cd-a123-77d8acab6661	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	232	FALSE	274	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
591	8e107f4b-1912-4d3e-814a-b863e2d65ed7	TCGA.13.1404	TCGA-13-1404-D24799	8596919f-9468-4131-9aa4-a6f21e70cebf	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	50	FALSE	156	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
592	8e107f4b-1912-4d3e-814a-b863e2d65ed7	TCGA.13.1404	TCGA-13-1404-D24801	2e7b6ee1-77d0-40f3-b598-8959537575bb	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	50	FALSE	156	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
593	29dccd25-4c4a-463b-a353-38a193337f38	TCGA.13.1405	TCGA-13-1405-D24805	036b3384-1b94-4426-af17-f314a1c6fe38	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	23	FALSE	147	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
594	29dccd25-4c4a-463b-a353-38a193337f38	TCGA.13.1405	TCGA-13-1405-D24804	e2a55a7f-4bfd-43db-bd46-3d41ad1008e8	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	147	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	599	NA
595	f2dcf4cc-609d-4532-a90d-6ae2bbb53365	TCGA.13.1407	TCGA-13-1407-D24808	4cd8eaeb-42d7-43f3-b626-83394aa6a3f9	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	184	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
596	f2dcf4cc-609d-4532-a90d-6ae2bbb53365	TCGA.13.1407	TCGA-13-1407-D24809	8ada4cc3-f455-4065-9def-1341957f353d	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	42	FALSE	184	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
597	8fac8e40-beac-4059-9d54-7ee530598cfd	TCGA.13.1408	TCGA-13-1408-D24812	11c746b9-b132-422a-b4c5-f6389fe6c53b	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	91	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
598	8fac8e40-beac-4059-9d54-7ee530598cfd	TCGA.13.1408	TCGA-13-1408-D24813	0bc7de2d-ef5a-46ab-b7cb-174b698af786	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	8	FALSE	91	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
599	8fac8e40-beac-4059-9d54-7ee530598cfd	TCGA.13.1408	TCGA-13-1408-D24814	4503cd88-2a47-4ced-af56-16b2b3a96bd3	2010-2-1	CISPLATIN	NA	CHEMOTHERAPY	152	FALSE	201	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	75	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
600	8fac8e40-beac-4059-9d54-7ee530598cfd	TCGA.13.1408	TCGA-13-1408-D24816	91bf1c84-4812-4b16-a1f7-c1cf1042de3e	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	152	FALSE	201	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	60	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
601	8fac8e40-beac-4059-9d54-7ee530598cfd	TCGA.13.1408	TCGA-13-1408-D24815	e315b96b-2868-4ae0-9096-6c62a57da9f1	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	152	FALSE	201	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	135	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
602	18e0e996-8f23-4f53-94a5-dde38b550863	TCGA.13.1409	TCGA-13-1409-D24819	fdbbf073-c52a-4972-b714-ec92cf255e88	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	94	TRUE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
603	18e0e996-8f23-4f53-94a5-dde38b550863	TCGA.13.1409	TCGA-13-1409-D24820	532deb83-2d9a-4d0c-a56a-1eeec028d682	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	94	TRUE	NA	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
604	c3f9ee36-d34f-472b-ac7f-801a0d400aa4	TCGA.13.1410	TCGA-13-1410-D24823	93edac67-ef10-41aa-afd0-fb99734e5700	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	39	FALSE	83	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
605	c3f9ee36-d34f-472b-ac7f-801a0d400aa4	TCGA.13.1410	TCGA-13-1410-D24826	5ce755e2-cf11-4bd2-a179-6f9305bb2378	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	103	FALSE	125	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
606	c3f9ee36-d34f-472b-ac7f-801a0d400aa4	TCGA.13.1410	TCGA-13-1410-D24824	d0ba7a4c-cd7a-491e-b632-d4ddef4a09e8	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	39	FALSE	83	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
607	c3f9ee36-d34f-472b-ac7f-801a0d400aa4	TCGA.13.1410	TCGA-13-1410-D24825	14439b25-7a92-4ff8-a783-68936013e4bc	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	103	FALSE	125	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
608	a9d3a7b0-faf8-4e56-8600-d9e6882a4f23	TCGA.13.1411	TCGA-13-1411-D24829	97303643-4e4a-41e8-b679-e3bfef06de2e	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	128	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
609	a9d3a7b0-faf8-4e56-8600-d9e6882a4f23	TCGA.13.1411	TCGA-13-1411-D24830	b3cf475f-ff22-4efe-a7a9-8909dff55877	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	8	FALSE	128	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
610	44493c23-82e9-4d9f-8e3c-7b3f9ae44970	TCGA.13.1412	TCGA-13-1412-D24833	0a3e9870-60d6-4529-9570-b86361452929	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	121	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
611	44493c23-82e9-4d9f-8e3c-7b3f9ae44970	TCGA.13.1412	TCGA-13-1412-D24834	8b14d588-2044-4f90-9a23-edda2259f27a	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	37	FALSE	121	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
612	44493c23-82e9-4d9f-8e3c-7b3f9ae44970	TCGA.13.1412	TCGA-13-1412-D24836	2f960c5b-fc96-4100-91d5-62689dac2d2b	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	156	FALSE	205	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	135	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
613	44493c23-82e9-4d9f-8e3c-7b3f9ae44970	TCGA.13.1412	TCGA-13-1412-D24835	65181bc8-d203-458a-9869-e6c89c79a77b	2010-2-1	CISPLATIN	NA	CHEMOTHERAPY	156	FALSE	205	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	75	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
614	44493c23-82e9-4d9f-8e3c-7b3f9ae44970	TCGA.13.1412	TCGA-13-1412-D24837	e8f007f4-1cc1-4eea-8b14-300ff06a3b8a	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	156	FALSE	205	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	60	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
615	13f5814c-1f99-4ffa-84a4-3bbd8979faae	TCGA.13.1477	TCGA-13-1477-D24841	9c33a2aa-bca5-4b74-9eae-754de2f3b26b	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	57	FALSE	206	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	360	NA
616	13f5814c-1f99-4ffa-84a4-3bbd8979faae	TCGA.13.1477	TCGA-13-1477-D24840	c4ae4f9d-4ec7-47d4-92bd-82121c761ed6	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	57	FALSE	206	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
617	c5355491-e1e8-46a4-a05e-bafcaf2e7459	TCGA.13.1481	TCGA-13-1481-D24846	f88e48af-f598-4236-bf59-a343851c2d7c	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	198	FALSE	242	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
618	c5355491-e1e8-46a4-a05e-bafcaf2e7459	TCGA.13.1481	TCGA-13-1481-D24844	82353d99-0371-47d6-90a3-c012f8fad803	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	11	FALSE	131	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
619	c5355491-e1e8-46a4-a05e-bafcaf2e7459	TCGA.13.1481	TCGA-13-1481-D24845	799031c3-47c1-4f36-a30d-e518b4c11298	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	11	FALSE	131	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
620	f3af727e-b592-4828-94f5-22008666cf8c	TCGA.13.1482	TCGA-13-1482-D24849	15515ea8-488a-4962-8719-11b9d4bda728	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	33	FALSE	152	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
621	f3af727e-b592-4828-94f5-22008666cf8c	TCGA.13.1482	TCGA-13-1482-D24850	0b9deb4b-3ed0-4350-bfc1-daadb62afa14	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	33	FALSE	152	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
622	611600a6-43ec-4029-9682-cd6d6a3312ec	TCGA.13.1483	TCGA-13-1483-D24853	2832940e-1830-4d9e-9f3e-33a1d5a213b3	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	176	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
623	611600a6-43ec-4029-9682-cd6d6a3312ec	TCGA.13.1483	TCGA-13-1483-D24855	8cb04ad5-b5e6-4d55-b79c-351194c3821d	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	219	FALSE	239	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
624	611600a6-43ec-4029-9682-cd6d6a3312ec	TCGA.13.1483	TCGA-13-1483-D24854	cb6d0c9b-51f7-4bc1-9355-880ec0fa012a	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	35	FALSE	176	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	174	NA
625	ead71c90-cc5e-42ce-8754-c3cf15a41134	TCGA.13.1484	TCGA-13-1484-D24859	28c061b0-19ec-4c30-b351-4b54731b4d8a	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	86	FALSE	191	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
626	ead71c90-cc5e-42ce-8754-c3cf15a41134	TCGA.13.1484	TCGA-13-1484-D24858	63c40a83-cb68-4b71-9d6a-b78c6e0f4bf5	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	86	FALSE	191	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
627	49bfd0fe-48ce-49db-9f76-ce2310410950	TCGA.13.1485	TCGA-13-1485-D24862	0c370900-9664-4345-ae5e-9ff4c8de205e	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	45	FALSE	149	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
628	49bfd0fe-48ce-49db-9f76-ce2310410950	TCGA.13.1485	TCGA-13-1485-D24863	9ca66b5d-b2d7-4ed3-91d7-e0a0cc34922a	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	45	FALSE	149	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
629	c9e28934-8379-4511-817c-d787f2c4ca3a	TCGA.13.1487	TCGA-13-1487-D24869	178b0653-c6f6-4a46-ac22-de69d34385c9	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	257	FALSE	412	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
630	c9e28934-8379-4511-817c-d787f2c4ca3a	TCGA.13.1487	TCGA-13-1487-D24868	9e538e9a-48e2-4dfc-8da2-35cc24c05393	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	208	FALSE	208	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
631	c9e28934-8379-4511-817c-d787f2c4ca3a	TCGA.13.1487	TCGA-13-1487-D24867	9247a4c9-3d8f-4842-9356-c21ae0c3bfd0	2009-6-30	DOCETAXEL	NA	CHEMOTHERAPY	17	FALSE	129	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
632	c9e28934-8379-4511-817c-d787f2c4ca3a	TCGA.13.1487	TCGA-13-1487-D24866	d30e9978-634d-4cb5-8263-c7e78d3a0bb7	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	129	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
633	a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61	TCGA.13.1488	TCGA-13-1488-D24872	72712026-5c3c-4b6c-9520-11796bee3a34	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	165	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
634	a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61	TCGA.13.1488	TCGA-13-1488-D24873	8b1f61bc-dd0d-42e7-818b-d437b5b7c0a6	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	8	FALSE	165	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
635	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24877	fc5425f7-3273-4bb3-838a-03543f181941	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	181	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
636	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24876	b0a011bd-04dc-4e24-b280-6c67dd5f3534	2009-6-30	CISPLATIN	NA	CHEMOTHERAPY	272	FALSE	272	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
637	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24878	4eb06fd9-31b2-459d-96a0-7315217783c1	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	41	FALSE	181	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
638	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24882	9acb3c04-7c91-484b-834b-639ead34a695	2010-3-8	TAXOTERE	NA	CHEMOTHERAPY	NA	FALSE	1012	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	60	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
639	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24879	4bdd6d3b-c2f3-458e-91ea-4e0678cc20db	2010-3-8	CARBOPLATIN	NA	CHEMOTHERAPY	867	FALSE	868	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
640	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24880	9bc5219c-8085-4ded-b99a-8444532624f6	2010-3-8	PACLITAXEL	NA	CHEMOTHERAPY	867	FALSE	868	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
641	7248cd60-be22-44bc-bc58-f644db0940a2	TCGA.13.1489	TCGA-13-1489-D24881	ee222450-84ac-4896-87a4-a7c4498c0772	2010-3-8	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	1012	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
642	c8febeef-8e7e-459e-88cb-8086692dc559	TCGA.13.1491	TCGA-13-1491-D24887	3068ce31-34ef-41d5-98e5-2a49dde8ea1d	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	245	FALSE	401	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
643	c8febeef-8e7e-459e-88cb-8086692dc559	TCGA.13.1491	TCGA-13-1491-D24886	375f90a7-f4e6-4437-95a7-823503ea757c	2009-6-30	PACILTAXEL	NA	CHEMOTHERAPY	42	FALSE	154	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
644	c8febeef-8e7e-459e-88cb-8086692dc559	TCGA.13.1491	TCGA-13-1491-D24885	c98fcc34-f54b-4813-97a9-80b88b3a26a1	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	154	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4	NA
645	63c6a89b-b28c-434a-a632-5de6545db731	TCGA.13.1492	TCGA-13-1492-D24890	6f3448eb-dbbd-49e5-9a02-7d5951b8c588	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	48	FALSE	247	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
646	63c6a89b-b28c-434a-a632-5de6545db731	TCGA.13.1492	TCGA-13-1492-D24891	c73b40ca-5b10-47a1-ac49-e4dd24db1e05	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	48	FALSE	247	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
647	f50ee039-1da9-43d9-ac01-657ec77a7f32	TCGA.13.1494	TCGA-13-1494-D24894	cd1fa5ad-5986-444a-ad95-2f307d5700c4	2009-6-30	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	182	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
648	f50ee039-1da9-43d9-ac01-657ec77a7f32	TCGA.13.1494	TCGA-13-1494-D24895	4e2bfc0a-008f-4a5d-b555-4fa7ecb07882	2009-6-30	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	182	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
649	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	TCGA.13.1495	TCGA-13-1495-D24902	ef97d8d6-aea8-42de-9b62-054e1106d2ae	2009-6-29	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	147	FALSE	224	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	250	NA
650	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	TCGA.13.1495	TCGA-13-1495-D24900	5b1848c8-8f23-471a-9171-95fd53eac209	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	231	FALSE	548	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
651	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	TCGA.13.1495	TCGA-13-1495-D24898	878063e7-b796-4aa4-aecb-55060d6028ab	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	140	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
652	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	TCGA.13.1495	TCGA-13-1495-D24901	cbd8492b-b71f-43ef-aaa8-7902407ef2a8	2009-6-29	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	21	FALSE	119	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	250	NA
653	74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7	TCGA.13.1495	TCGA-13-1495-D24899	19c672b1-5c6a-4562-80fb-a01df80b0337	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	21	FALSE	140	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
654	e5a329ec-e50e-4786-901d-b58474f8ea65	TCGA.13.1496	TCGA-13-1496-D24905	42c8232f-dc83-4025-a957-1c121f960780	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	33	FALSE	33	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
655	e5a329ec-e50e-4786-901d-b58474f8ea65	TCGA.13.1496	TCGA-13-1496-D24906	b3f86e9e-52c6-40f6-88cf-521bae342105	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	33	FALSE	33	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
656	bc4bc342-20bf-40c3-af26-2c6f942da93d	TCGA.13.1497	TCGA-13-1497-D24910	61d36d63-ca80-4df2-8f45-5b89934ca979	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	22	FALSE	127	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
657	bc4bc342-20bf-40c3-af26-2c6f942da93d	TCGA.13.1497	TCGA-13-1497-D24911	2bd40f8d-6333-4afe-a21c-f54e28cd9a14	2009-6-29	CISPLATIN	NA	CHEMOTHERAPY	185	FALSE	185	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	75	NA
658	bc4bc342-20bf-40c3-af26-2c6f942da93d	TCGA.13.1497	TCGA-13-1497-D24909	05f16e3d-5c91-4368-8769-2b40f285d9ff	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	127	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
659	bc4bc342-20bf-40c3-af26-2c6f942da93d	TCGA.13.1497	TCGA-13-1497-D24912	96fed8b4-c5f5-4ca0-95c4-183c1c2de11b	2009-6-29	CETUXIMAB	NA	TARGETED MOLECULAR THERAPY	22	FALSE	71	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	250	NA
660	56a30462-2819-4c18-95be-8e73880a4921	TCGA.13.1498	TCGA-13-1498-D24916	e3d7554b-1876-4b8c-b4e8-d94f161120b4	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	216	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
661	56a30462-2819-4c18-95be-8e73880a4921	TCGA.13.1498	TCGA-13-1498-D24915	c1a4c33c-8d2f-461f-ae07-8b782306e443	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	216	NA	NA	NA	NA	10	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
662	56a30462-2819-4c18-95be-8e73880a4921	TCGA.13.1498	TCGA-13-1498-D24917	5ec3392e-4e4f-462e-9925-77d964be0ddf	2009-6-29	FEMARA	NA	HORMONE THERAPY	250	FALSE	632	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2.5	NA
663	b25570ed-baca-4e3f-87c6-2ef18119ba49	TCGA.13.1499	TCGA-13-1499-D24920	9b87ff6d-772b-4abc-ad28-e0def040c38f	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	76	FALSE	97	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
664	b25570ed-baca-4e3f-87c6-2ef18119ba49	TCGA.13.1499	TCGA-13-1499-D24921	b836dca7-cd27-4236-9bb7-f652bd595c60	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	76	FALSE	97	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
665	b25570ed-baca-4e3f-87c6-2ef18119ba49	TCGA.13.1499	TCGA-13-1499-D24922	54dea9e5-ade7-4b1f-abfc-f3b1d49dde54	2009-6-29	CISPLATIN	NA	CHEMOTHERAPY	118	FALSE	187	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
666	b25570ed-baca-4e3f-87c6-2ef18119ba49	TCGA.13.1499	TCGA-13-1499-D24923	8c6e1a45-35e8-4195-b1e6-3ffe359242d3	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	118	FALSE	187	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	135	NA
667	b25570ed-baca-4e3f-87c6-2ef18119ba49	TCGA.13.1499	TCGA-13-1499-D24924	765962d6-30d0-4181-a602-50b728f75df8	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	118	FALSE	187	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
668	a285786d-120e-4c88-b48b-8111f4413988	TCGA.13.1500	TCGA-13-1500-D24928	15ffe254-2600-4046-bf65-1dd44c66bad5	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	136	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
669	a285786d-120e-4c88-b48b-8111f4413988	TCGA.13.1500	TCGA-13-1500-D24929	f7997b39-d17f-4df6-b167-9f763ba44acb	2009-6-29	CISPLATIN	NA	CHEMOTHERAPY	197	FALSE	225	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	40	NA
670	a285786d-120e-4c88-b48b-8111f4413988	TCGA.13.1500	TCGA-13-1500-D24927	f6462173-d369-423a-b1fc-560c5243c71d	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	136	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
671	561968ce-da9a-4d69-8bc2-bc87b9550f93	TCGA.13.1501	TCGA-13-1501-D24932	dfd6e676-24dc-4684-8f20-ad1b24c3189c	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	78	FALSE	183	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
672	561968ce-da9a-4d69-8bc2-bc87b9550f93	TCGA.13.1501	TCGA-13-1501-D24933	168cc04a-b942-44dc-906f-12795c06a1c4	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	78	FALSE	183	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
673	cd49126a-ec15-43fa-9e43-3f7460d43f2b	TCGA.13.1504	TCGA-13-1504-D24937	3bc4b2ec-79d0-491f-81ea-9d7c5eb58a96	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	283	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
674	cd49126a-ec15-43fa-9e43-3f7460d43f2b	TCGA.13.1504	TCGA-13-1504-D24936	92d2f0c8-9875-41f1-8429-6a929ec4166f	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	283	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
675	914f84bf-578b-4f4d-93cb-378228ea58f6	TCGA.13.1505	TCGA-13-1505-D24940	ca2b331b-320f-43b9-a347-0998e1b4469f	2010-2-1	CISPLATIN	NA	CHEMOTHERAPY	27	FALSE	167	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
676	914f84bf-578b-4f4d-93cb-378228ea58f6	TCGA.13.1505	TCGA-13-1505-D24941	6e83f0a3-d305-449d-82f6-7ded7579a9e0	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	27	FALSE	167	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
677	914f84bf-578b-4f4d-93cb-378228ea58f6	TCGA.13.1505	TCGA-13-1505-D24942	94940689-a0b6-4a75-8b62-bf52715197cd	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	27	FALSE	167	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
678	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	TCGA.13.1506	TCGA-13-1506-D24945	eed33a2f-1991-431e-aed9-a80e2fff5f9a	2009-6-29	CISPLATIN	NA	CHEMOTHERAPY	50	FALSE	51	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
679	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	TCGA.13.1506	TCGA-13-1506-D24948	3f0348d6-1607-4e20-9dad-1c18f02ca8e6	2009-6-29	GEMCITABINE	NA	CHEMOTHERAPY	79	FALSE	80	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	800	NA
680	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	TCGA.13.1506	TCGA-13-1506-D24946	db2514fa-f3d7-4744-aeb2-3ea6191e9513	2009-6-29	DOCETAXEL	NA	CHEMOTHERAPY	50	FALSE	51	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	65	NA
681	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	TCGA.13.1506	TCGA-13-1506-D24947	d8424615-0858-44a6-a544-4f86f99b6742	2009-6-29	CISPLATIN	NA	CHEMOTHERAPY	79	FALSE	80	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
682	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	TCGA.13.1506	TCGA-13-1506-D24950	334b7af7-5669-4098-b07a-2e3d85e88871	2010-2-1	GEMCITABINE	NA	CHEMOTHERAPY	99	FALSE	197	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	800	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
683	1cc02c64-a34e-46ae-9bc7-5d50f2fefb31	TCGA.13.1506	TCGA-13-1506-D24949	58d4d7d7-f9d6-4800-a354-11dc5d9a086e	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	99	FALSE	197	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4	NA
684	502e8d02-2953-4514-a2e1-6179dd94da73	TCGA.13.1507	TCGA-13-1507-D24954	36abb233-04b6-4ffa-be2f-1a6da2577bcf	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	54	FALSE	166	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	135	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
685	502e8d02-2953-4514-a2e1-6179dd94da73	TCGA.13.1507	TCGA-13-1507-D24953	e69faabb-e060-4871-b192-ff4af589b249	2010-2-1	CISPLATIN	NA	CHEMOTHERAPY	54	FALSE	166	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	37.5	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
686	502e8d02-2953-4514-a2e1-6179dd94da73	TCGA.13.1507	TCGA-13-1507-D24955	e313f9e5-f3b1-48ae-a9e2-eb3ff4559fb1	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	54	FALSE	166	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	60	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
687	fe402983-70da-44db-b7b1-c32702ddde26	TCGA.13.1509	TCGA-13-1509-D24959	f341bfee-7f12-4172-be59-3f8386e19360	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	21	FALSE	127	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
688	fe402983-70da-44db-b7b1-c32702ddde26	TCGA.13.1509	TCGA-13-1509-D24958	64ec67ad-a633-4554-afc3-8584cf9cf42c	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	127	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
689	dac96910-0cb2-44ea-b108-2d6d51b07112	TCGA.13.1510	TCGA-13-1510-D24963	762831bf-cafb-4024-af33-72efdf3f5222	2010-2-8	PACLITAXEL	NA	CHEMOTHERAPY	62	FALSE	174	NA	NA	NA	NA	6	NA	MG	MG	325	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
690	dac96910-0cb2-44ea-b108-2d6d51b07112	TCGA.13.1510	TCGA-13-1510-D24962	20863438-765d-4a56-a8a5-dcf76e119ac3	2010-2-8	CARBOPLATIN	NA	CHEMOTHERAPY	62	FALSE	174	NA	NA	NA	NA	6	NA	MG	MG	300	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
691	756f6768-e69a-4fe9-aa41-7c58aabe4577	TCGA.13.1511	TCGA-13-1511-D24966	4247d127-1642-4e0e-b9e0-63c1f16c4436	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	46	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
692	756f6768-e69a-4fe9-aa41-7c58aabe4577	TCGA.13.1511	TCGA-13-1511-D24967	311d0b25-b216-4f8d-a58a-b484fff48914	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	67	FALSE	186	NA	NA	NA	NA	6	NA	MG	MG	600	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
693	756f6768-e69a-4fe9-aa41-7c58aabe4577	TCGA.13.1511	TCGA-13-1511-D24968	8c238471-c7de-4922-875e-68b8c9ee6f25	2010-2-1	GEMCITABINE	NA	CHEMOTHERAPY	67	FALSE	186	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	800	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
694	82093ed9-a3c8-4e34-931f-4ec7ae745711	TCGA.13.1512	TCGA-13-1512-D24972	ff3734cb-1218-44b6-9238-000101ea4d25	2009-6-29	PACLITAXEL	NA	CHEMOTHERAPY	73	FALSE	94	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
695	82093ed9-a3c8-4e34-931f-4ec7ae745711	TCGA.13.1512	TCGA-13-1512-D24971	7bfa8188-46df-46ec-8f64-73d2c54f71b4	2009-6-29	CARBOPLATIN	NA	CHEMOTHERAPY	73	FALSE	94	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	700	NA
696	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	TCGA.13.1817	TCGA-13-1817-D24977	5f052b46-08ee-4244-9beb-91a6f49b3fe1	2010-3-1	CISPLATIN	NA	CHEMOTHERAPY	210	FALSE	318	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	75	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
697	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	TCGA.13.1817	TCGA-13-1817-D24975	46c68ad3-9918-4b43-af34-dcf1dc8b88bd	2010-3-1	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	122	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
698	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	TCGA.13.1817	TCGA-13-1817-D24976	24256629-d9d5-4c58-9dc1-ca8ccdf4f19f	2010-3-1	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	122	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	176	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
699	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	TCGA.13.1817	TCGA-13-1817-D24978	5a5172bf-f07f-4e34-980d-1413e248b8dc	2010-3-8	CARBOPLATIN	NA	CHEMOTHERAPY	552	FALSE	594	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	365	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
700	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	TCGA.13.1817	TCGA-13-1817-D24979	3166878d-db0c-4d9b-a45a-9701c30fe271	2010-3-8	PACLITAXEL	NA	CHEMOTHERAPY	552	FALSE	594	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	176	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
701	8ae56ffc-960c-46c2-bd6c-1dcff33875d0	TCGA.13.1817	TCGA-13-1817-D24980	e8666c06-5d87-4aef-a92d-637aa94392bb	2010-3-8	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	706	FALSE	902	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	39	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
702	82e96c6c-a88c-4e52-be56-7f24f6c7b835	TCGA.13.1819	TCGA-13-1819-D24983	6c86d95a-46b8-4081-b2ed-bd6dd58012e6	2010-3-1	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	149	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
703	82e96c6c-a88c-4e52-be56-7f24f6c7b835	TCGA.13.1819	TCGA-13-1819-D24984	6c54ce7d-b124-476e-8341-548977e62fd6	2010-3-1	PACLITAXEL	NA	CHEMOTHERAPY	37	FALSE	149	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	175	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
704	82e96c6c-a88c-4e52-be56-7f24f6c7b835	TCGA.13.1819	TCGA-13-1819-D24985	3100c47f-1118-4567-ab6c-dae3e00e0af2	2010-3-8	PACLITAXEL	NA	CHEMOTHERAPY	518	FALSE	518	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	135	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
705	82e96c6c-a88c-4e52-be56-7f24f6c7b835	TCGA.13.1819	TCGA-13-1819-D24986	9a7fac23-e0cf-4cfa-8f3a-9acb4fb940d9	2010-3-8	CARBOPLATIN	NA	CHEMOTHERAPY	539	FALSE	646	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
706	82e96c6c-a88c-4e52-be56-7f24f6c7b835	TCGA.13.1819	TCGA-13-1819-D24987	d0e3c1c6-6f7f-4d26-80dc-677236827dcb	2010-3-8	PACLITAXEL	NA	CHEMOTHERAPY	539	FALSE	646	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	175	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
707	56c4bd48-ab15-4b49-ae2f-968653052b50	TCGA.13.2057	TCGA-13-2057-D24990	413048b1-1b7c-4cb7-a8f3-47cc291c18a9	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	51	FALSE	159	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
708	56c4bd48-ab15-4b49-ae2f-968653052b50	TCGA.13.2057	TCGA-13-2057-D24991	37eff60b-6903-445a-b8ed-588e9df2f112	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	51	FALSE	159	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
709	f4b56568-a74a-4a2e-89d9-11722ecf5948	TCGA.13.2059	TCGA-13-2059-D24996	47648d65-c903-46b2-9f45-69f99c62c6d9	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	46	FALSE	158	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
710	f4b56568-a74a-4a2e-89d9-11722ecf5948	TCGA.13.2059	TCGA-13-2059-D24995	fcc5cdef-45eb-40d8-85c2-1b6517424003	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	46	FALSE	158	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
711	f4b56568-a74a-4a2e-89d9-11722ecf5948	TCGA.13.2059	TCGA-13-2059-D24994	ba631612-075c-4b0c-8da3-15387999edbf	2010-2-1	CISPLATIN	NA	CHEMOTHERAPY	46	FALSE	158	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
712	196f4600-b6c9-4652-9f77-65c92883f8c1	TCGA.13.2060	TCGA-13-2060-D25000	f813388d-644d-46c4-b29c-f935cfaf6bc4	2009-12-16	PACLITAXEL	NA	CHEMOTHERAPY	31	FALSE	143	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
713	196f4600-b6c9-4652-9f77-65c92883f8c1	TCGA.13.2060	TCGA-13-2060-D24999	1f942379-637b-4d34-9ebe-08a3e2d9152a	2009-12-16	CISPLATIN	NA	CHEMOTHERAPY	31	FALSE	143	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
714	196f4600-b6c9-4652-9f77-65c92883f8c1	TCGA.13.2060	TCGA-13-2060-D25001	f6f38882-1d0e-426f-af54-275027957055	2009-12-16	PACLITAXEL	NA	CHEMOTHERAPY	31	FALSE	143	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	600	NA
715	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25006	728138db-9e40-4995-af75-4b90bfd5d6a7	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	63	FALSE	112	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
716	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25008	12097149-87dd-4fa1-8f0d-5088a4c8062a	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	126	FALSE	133	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
717	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25005	df08b0fe-5176-4c16-80b1-2f2f54bbfe8e	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	63	FALSE	112	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
718	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25011	ba1d69c2-a882-4e82-b282-25f168fbcdf9	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	147	FALSE	168	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
719	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25009	24744559-e344-4016-8695-c4b55f3cd1cb	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	126	FALSE	133	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
720	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25007	ee41741e-220a-4998-a17d-e0b871f7eb88	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	126	FALSE	133	NA	NA	NA	NA	1	NA	AUC	AUC	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	4	NA
721	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25004	99777074-d6b2-4ece-ae49-81c07c9a25aa	2010-2-1	CISPLATIN	NA	CHEMOTHERAPY	63	FALSE	112	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
722	a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3	TCGA.13.2061	TCGA-13-2061-D25010	929e7c01-97cc-47d1-bcf0-6b3f02535241	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	147	FALSE	168	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
723	8d1dcf21-efd3-4fbe-ad44-f43a19239383	TCGA.13.2065	TCGA-13-2065-D25015	9d325c18-026c-4f04-80c4-bf1ce79b67ad	2010-2-2	PACLITAXEL	NA	CHEMOTHERAPY	89	FALSE	141	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
724	8d1dcf21-efd3-4fbe-ad44-f43a19239383	TCGA.13.2065	TCGA-13-2065-D25016	4cd10442-1ec3-49c9-8ec3-a564919e8276	2010-2-2	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	68	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
725	8d1dcf21-efd3-4fbe-ad44-f43a19239383	TCGA.13.2065	TCGA-13-2065-D25014	ec1c37f5-42f6-4a57-b90c-b4ffad895817	2010-2-2	CARBOPLATIN	NA	CHEMOTHERAPY	89	FALSE	141	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
726	bcb87812-94e3-4dc0-867e-d049b44a2690	TCGA.13.2066	TCGA-13-2066-D25019	1fd48297-038d-468d-a6e2-b749ef1fa449	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	61	FALSE	169	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
727	bcb87812-94e3-4dc0-867e-d049b44a2690	TCGA.13.2066	TCGA-13-2066-D25020	81c7a339-e58c-460a-82de-70cc361da73e	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	61	FALSE	169	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
728	0d15e5aa-2483-4f81-973a-ff469296c911	TCGA.13.2071	TCGA-13-2071-D25024	de33c7f9-63e7-415d-9648-7c5dc597446e	2010-2-1	PACLITAXEL	NA	CHEMOTHERAPY	41	FALSE	146	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
729	0d15e5aa-2483-4f81-973a-ff469296c911	TCGA.13.2071	TCGA-13-2071-D25023	35bbcd97-398d-453a-a49d-0e9a5d097a8b	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	41	NA	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
730	F3618472-32DC-4C90-A407-90050F68BE85	TCGA.13.A5FT	TCGA-13-A5FT-D43570	36283F3D-1E06-4D7C-A64E-DF9B07460DD9	2013-5-26	CISPLATIN	NA	CHEMOTHERAPY	49	FALSE	111	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
731	F3618472-32DC-4C90-A407-90050F68BE85	TCGA.13.A5FT	TCGA-13-A5FT-D43571	F6311109-F942-40EE-BBC7-BC3334388892	2013-5-26	PACLITAXEL	NA	CHEMOTHERAPY	48	FALSE	117	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
732	0F7AC6CA-7806-4B2A-9D37-94FF74FCD010	TCGA.13.A5FU	TCGA-13-A5FU-D43573	84B42869-00D9-41FA-BB29-C17DB74E66C9	2013-5-26	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	182	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
733	0F7AC6CA-7806-4B2A-9D37-94FF74FCD010	TCGA.13.A5FU	TCGA-13-A5FU-D43574	A3157A7F-920B-484C-A9B4-BF6C78BC2CFE	2013-5-26	PACLITAXEL	NA	CHEMOTHERAPY	35	FALSE	182	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
734	34f285ab-6c31-4865-a0a7-a57af3567df0	TCGA.20.0987	TCGA-20-0987-D25519	94d41e3c-23fc-4a1e-9848-caf6ce4d52bd	2009-3-16	TAXOL	NA	CHEMOTHERAPY	91	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
735	34f285ab-6c31-4865-a0a7-a57af3567df0	TCGA.20.0987	TCGA-20-0987-D25521	9df9ba91-1ad5-4fbb-870b-28792a4a90c0	2009-3-16	TOPOTECAN	NA	CHEMOTHERAPY	427	NA	442	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
736	34f285ab-6c31-4865-a0a7-a57af3567df0	TCGA.20.0987	TCGA-20-0987-D25520	fff65b98-a78b-436b-bef7-4a4ad0448bcd	2009-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	91	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
737	c9524775-6b50-4793-8858-24b6a6d3e4e6	TCGA.20.0990	TCGA-20-0990-D25526	b8c952b4-928b-4ceb-b655-5db68e4da13c	2009-3-16	GEMCITABINE	NA	CHEMOTHERAPY	901	NA	999	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1240	NA
738	c9524775-6b50-4793-8858-24b6a6d3e4e6	TCGA.20.0990	TCGA-20-0990-D25525	00c73916-b074-4f01-8663-a17d24d71686	2009-3-16	PACLITAXIL	NA	CHEMOTHERAPY	116	NA	236	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
739	c9524775-6b50-4793-8858-24b6a6d3e4e6	TCGA.20.0990	TCGA-20-0990-D25528	15ac365e-4f23-4eaf-aa92-f6b2dfaec21d	2009-3-16	LIPOSOMAL DOXORUBICAN	NA	CHEMOTHERAPY	1034	NA	1174	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	47	NA
740	c9524775-6b50-4793-8858-24b6a6d3e4e6	TCGA.20.0990	TCGA-20-0990-D25527	122c2ea5-7803-4149-88c4-b8601e1a2511	2009-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	1034	NA	1174	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	320	NA
741	c9524775-6b50-4793-8858-24b6a6d3e4e6	TCGA.20.0990	TCGA-20-0990-D25524	e4109126-8bb8-4994-b2c0-26b5599e62ca	2009-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	116	NA	236	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	480	NA
742	36595b52-2b5f-4e87-80eb-37c29109e92a	TCGA.20.0991	TCGA-20-0991-D25531	8a48bcf0-7943-48da-89c6-1831cbe9da03	2009-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	71	NA	NA	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	425	NA
743	d7f82e34-5b34-4e8c-a0cf-d7561bcea43c	TCGA.20.0996	TCGA-20-0996-D25534	8250f16b-1184-4fd2-8fee-602539eab355	2009-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	168	NA	224	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
744	d7f82e34-5b34-4e8c-a0cf-d7561bcea43c	TCGA.20.0996	TCGA-20-0996-D25537	dc9650af-ba57-4533-a6e1-a7f3c8462f01	2009-3-16	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	616	NA	1078	NA	NA	NA	NA	13	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	40	NA
745	d7f82e34-5b34-4e8c-a0cf-d7561bcea43c	TCGA.20.0996	TCGA-20-0996-D25538	6f44cefa-f2d9-45fb-914f-f4ce34d4ec60	2009-3-16	ETOPOSIDE	NA	CHEMOTHERAPY	1106	NA	NA	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	50	NA
746	d7f82e34-5b34-4e8c-a0cf-d7561bcea43c	TCGA.20.0996	TCGA-20-0996-D25535	0101cf7f-8bad-467b-a24b-7f0843a67403	2009-3-16	TAXOL	NA	CHEMOTHERAPY	168	NA	224	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
747	d7f82e34-5b34-4e8c-a0cf-d7561bcea43c	TCGA.20.0996	TCGA-20-0996-D25536	e552a4cc-5113-447c-b57b-c5b1e8e7d6e3	2009-3-16	TOPOTECAN	NA	CHEMOTHERAPY	443	NA	590	NA	NA	NA	NA	15	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	4	NA
748	94bd4c68-4bfc-4db3-9365-97c867747133	TCGA.20.1682	TCGA-20-1682-D25541	f9a9b49a-eefa-4274-b8b0-542674f06e3e	2009-7-27	TAXOL	NA	CHEMOTHERAPY	40	FALSE	145	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
749	94bd4c68-4bfc-4db3-9365-97c867747133	TCGA.20.1682	TCGA-20-1682-D25542	6817b450-bd86-4a72-a6f2-d2ebbc268095	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	40	FALSE	145	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
750	ac2e88ff-8b1e-4691-9a96-5a581f98d827	TCGA.20.1683	TCGA-20-1683-D25547	350300e1-643d-4b95-90bb-307cc8934f29	2009-7-27	TAMOXIFEN	NA	HORMONE THERAPY	618	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	20	NA
751	ac2e88ff-8b1e-4691-9a96-5a581f98d827	TCGA.20.1683	TCGA-20-1683-D25545	224f8ff6-5ded-405b-b206-521b0ae15315	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	135	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
752	ac2e88ff-8b1e-4691-9a96-5a581f98d827	TCGA.20.1683	TCGA-20-1683-D25546	7175a7a2-ccb7-4926-88d0-fac1af5a4ba7	2009-7-27	TAXOL	NA	CHEMOTHERAPY	17	FALSE	135	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
753	94030805-8beb-441a-af73-11a80768edb5	TCGA.20.1684	TCGA-20-1684-D25551	a6105f0f-4f35-45eb-9a4c-25692167301e	2009-7-27	TAXOL	NA	CHEMOTHERAPY	42	FALSE	120	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	60	NA
754	94030805-8beb-441a-af73-11a80768edb5	TCGA.20.1684	TCGA-20-1684-D25550	fd8ac1c7-65cb-4bca-bfa6-fab399cf7e57	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	120	NA	NA	NA	NA	4	NA	AUC	AUC	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	6	NA
755	94030805-8beb-441a-af73-11a80768edb5	TCGA.20.1684	TCGA-20-1684-D25552	67c20b40-f5e3-4937-a3fc-41ae888dc1a7	2009-7-27	BEVACIZUMAB	NA	CHEMOTHERAPY	42	FALSE	120	NA	NA	NA	NA	4	NA	MG/KG	MG/KG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	15	NA
756	cbc5b936-ead5-4858-ab90-e639402789b0	TCGA.20.1685	TCGA-20-1685-D25556	61e2a648-eede-4da8-98d8-b59dd2b3d85a	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	39	FALSE	144	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
757	cbc5b936-ead5-4858-ab90-e639402789b0	TCGA.20.1685	TCGA-20-1685-D25555	480d3ba4-151c-424e-ac1c-bbfeb855e517	2009-7-27	BEVACIZUMAB	NA	CHEMOTHERAPY	39	FALSE	144	NA	NA	NA	NA	6	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	15	NA
758	cbc5b936-ead5-4858-ab90-e639402789b0	TCGA.20.1685	TCGA-20-1685-D25557	431a1b7d-0bb3-4262-bf04-9b427b1764d9	2009-7-27	TAXOL	NA	CHEMOTHERAPY	39	FALSE	144	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
759	f007fa7a-7da9-4cb0-8aea-623af1a122c5	TCGA.20.1686	TCGA-20-1686-D25561	d4a19506-867a-4ff5-914f-9656355a77dc	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	131	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
760	f007fa7a-7da9-4cb0-8aea-623af1a122c5	TCGA.20.1686	TCGA-20-1686-D25560	a175f848-af9d-492d-8e22-cb3522f495a7	2009-7-27	TAXOL	NA	CHEMOTHERAPY	26	FALSE	131	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
761	9bf16a89-2fc7-4c08-93bc-3105eec5c3cc	TCGA.20.1687	TCGA-20-1687-D25564	c94c5c61-aaa1-4029-bcb9-34b31ebc25d2	2009-10-26	TAXOL	NA	CHEMOTHERAPY	42	FALSE	172	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
762	9bf16a89-2fc7-4c08-93bc-3105eec5c3cc	TCGA.20.1687	TCGA-20-1687-D25565	345ae7fa-8baa-4247-bcbb-f86a0ab0aa37	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	172	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
763	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25571	9ade7aa5-18d8-4919-ae99-2a73732ba30e	2009-4-1	TOPOTECAN	NA	CHEMOTHERAPY	722	FALSE	861	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	60	NA
764	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25574	9c425509-cbf7-43a5-8830-f4f4f75459f7	2009-4-1	DOXORUBICIN	NA	CHEMOTHERAPY	1408	FALSE	1408	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	25	NA
765	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25568	ade37eb4-02de-42c7-8d26-fad6a3398a00	2009-4-1	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	119	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2880	NA
766	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25573	3fd43153-5bdf-45ff-8eef-1bdc764b40ba	2009-4-1	VINORELBINE	NA	CHEMOTHERAPY	1352	FALSE	1380	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	50	NA
767	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25570	f3d78a9b-08ea-4aa8-9cb5-677b67207783	2009-4-1	GEMCITABINE	NA	CHEMOTHERAPY	526	FALSE	693	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENCE	6061	NA
768	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25572	c20a16f7-cfb8-421e-8951-fbc938aaa1b2	2009-4-1	PACLITAXEL	NA	CHEMOTHERAPY	1226	FALSE	1331	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2540	NA
769	b923ac70-70ea-4a82-8466-46350c5803bf	TCGA.23.1021	TCGA-23-1021-D25569	ba314cd4-e2a6-4f5a-9104-137cd1e29ba7	2009-4-1	PACLITAXEL	NA	CHEMOTHERAPY	14	FALSE	119	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2100	NA
770	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25577	74e65174-6f54-47f9-bf5b-d0f1391cb0dc	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	162	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2730	NA
771	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25584	b1b96f3b-7fe8-4b7b-838b-327f628319fb	2009-3-27	CYCLOPHOSPHAMIDE	NA	CHEMOTHERAPY	1274	FALSE	1357	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	8120	NA
772	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25581	abf39c56-803d-4f80-a5df-e3b2694ada67	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	762	FALSE	818	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	27.5	NA
773	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25578	331fc9fd-da0f-4cac-99d7-e00038d4bd7c	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	29	FALSE	162	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2170	NA
774	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25580	f1fa07d1-a044-41de-8df7-59d7e43dd7d0	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	614	FALSE	741	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	820	NA
775	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25583	02f03126-9559-4f48-b898-b7f5637a68b3	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	1056	FALSE	1252	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2500	NA
776	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25585	d09f3ba6-475f-44a0-a551-0ce2cf7fc770	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	1378	FALSE	1378	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1560	NA
777	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25582	0a90f6a3-ec5d-4d6a-9b2f-7faa331d8147	2009-3-27	DOCETAXEL	NA	CHEMOTHERAPY	853	FALSE	937	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	640	NA
778	d0673efd-3315-4dd5-8ab6-912bfa07dceb	TCGA.23.1022	TCGA-23-1022-D25579	fb478bd8-7b3a-4ac6-8819-9d01950ecfe0	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	614	FALSE	741	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	17200	NA
779	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25590	adcca623-3353-4ce2-9458-70cf557d250f	2009-12-14	DOXIL	NA	CHEMOTHERAPY	1272	FALSE	1364	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	300	NA
780	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25588	719d9c8c-f6ea-48b1-8f10-6c8c8931e44d	2009-12-14	CISPLATIN	NA	CHEMOTHERAPY	1427	FALSE	1455	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	120	NA
781	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25589	de887de7-b839-47a9-8ed7-e5edd06adf99	2009-12-14	CISPLATIN	NA	CHEMOTHERAPY	1582	FALSE	1603	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	198	NA
782	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25591	4c3c5329-14f8-452b-a67e-9fee4792426e	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	1386	FALSE	1407	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	1100	NA
783	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25598	5caf6ccc-58cf-4133-8594-9687bcbe0cac	2010-4-26	CISPLATIN	NA	CHEMOTHERAPY	509	FALSE	509	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	195	NA
784	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25600	45e660fe-4782-4a00-b0f5-2ff47a27a7b2	2010-4-26	CARBOPLATIN	NA	CHEMOTHERAPY	539	FALSE	560	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	640	NA
785	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25594	401feab7-c57d-45b1-97e3-c8c0809643b4	2010-4-26	CISPLATIN	NA	CHEMOTHERAPY	1427	FALSE	1455	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTANT	120	NA
786	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25599	1038377c-956a-4017-bf37-e559748251c8	2010-4-26	GEMCITABINE	NA	CHEMOTHERAPY	539	FALSE	560	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4860	NA
787	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25601	b43cacae-9796-4b39-aa27-28671ff77f47	2010-4-26	OVAREX/PLACEBO	NA	CHEMOTHERAPY	155	FALSE	468	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12	NA
788	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25602	011de666-fcd8-42fc-9990-b3f6da3c087f	2010-4-26	TOPOTECAN	NA	CHEMOTHERAPY	1616	FALSE	1665	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTANT	23.6	NA
789	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25596	1245e6b4-623f-4373-837a-30b186dd53e6	2010-4-26	CISPLATIN	NA	CHEMOTHERAPY	557	FALSE	609	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	369	NA
790	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25592	2ff9ec4a-25a5-4e13-855b-28beb08405c6	2010-4-26	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	120	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2021	NA
791	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25597	5005f67e-ca1d-4c05-baf1-36cff1fd4a1d	2010-4-26	GEMCITABINE	NA	CHEMOTHERAPY	509	FALSE	509	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1560	NA
792	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25593	5f56f9d2-2a3c-4f5e-a512-7e633a7f29e7	2010-4-26	PACLITAXEL	NA	CHEMOTHERAPY	29	FALSE	120	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1492	NA
793	9e18238f-ae85-4b75-ae87-d92da9731a40	TCGA.23.1023	TCGA-23-1023-D25595	324ff779-6c57-4e1f-adf7-34b7d3bd72e8	2010-4-26	GEMCITABINE	NA	CHEMOTHERAPY	557	FALSE	609	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	7800	NA
794	8ac6ce06-ab50-4ab4-a469-9f8bf01be963	TCGA.23.1024	TCGA-23-1024-D25608	4aa79340-215b-4e20-98be-676cd4c8f2e8	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	13	FALSE	304	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	541	NA
795	8ac6ce06-ab50-4ab4-a469-9f8bf01be963	TCGA.23.1024	TCGA-23-1024-D25607	39c2c36e-c470-48f1-82a2-9f358d3e5957	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	13	FALSE	304	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	776	NA
796	8ac6ce06-ab50-4ab4-a469-9f8bf01be963	TCGA.23.1024	TCGA-23-1024-D25606	0a45720d-954b-4382-b052-f73401d543ce	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	13	FALSE	304	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	1608	NA
797	8ac6ce06-ab50-4ab4-a469-9f8bf01be963	TCGA.23.1024	TCGA-23-1024-D25605	ad2ca791-17ad-4489-b546-ffff653fff09	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	224	FALSE	529	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	CONSOLIDATION	2556	NA
798	c6ede8ae-881c-47a0-a0ef-745ed4b7764a	TCGA.23.1026	TCGA-23-1026-D25613	98eca7c8-8f45-43b4-806f-193aba7901b6	2009-4-1	GEMCITABINE	NA	CHEMOTHERAPY	866	FALSE	936	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5648	NA
799	c6ede8ae-881c-47a0-a0ef-745ed4b7764a	TCGA.23.1026	TCGA-23-1026-D25614	3b5456ab-a33b-4cbf-b0e9-6958219b0063	2009-4-1	CISPLATIN	NA	CHEMOTHERAPY	866	FALSE	936	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	520	NA
800	c6ede8ae-881c-47a0-a0ef-745ed4b7764a	TCGA.23.1026	TCGA-23-1026-D25612	8eb2970b-6005-448d-b3aa-a1ebcc49df1f	2009-4-1	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	108	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1560	NA
801	c6ede8ae-881c-47a0-a0ef-745ed4b7764a	TCGA.23.1026	TCGA-23-1026-D25611	5e32312e-6a0d-4e28-a91e-b186be5f1c1c	2009-4-1	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	108	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3420	NA
802	c9e58844-9d61-44a2-aee6-1760bc19711b	TCGA.23.1027	TCGA-23-1027-D25619	9aacdc7c-5ecf-49a8-9521-4decc19f0433	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	166	FALSE	250	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	748	NA
803	c9e58844-9d61-44a2-aee6-1760bc19711b	TCGA.23.1027	TCGA-23-1027-D25622	4c2c89ca-d46c-4f42-9b08-c66459b8189d	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	769	FALSE	867	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	450	NA
804	c9e58844-9d61-44a2-aee6-1760bc19711b	TCGA.23.1027	TCGA-23-1027-D25621	bae3a196-ad8b-4c6e-baf3-cc6c49029a2f	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	769	FALSE	867	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10932	NA
805	c9e58844-9d61-44a2-aee6-1760bc19711b	TCGA.23.1027	TCGA-23-1027-D25618	979a32c9-ef1b-4990-9f45-caaa8d702ca3	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	26	FALSE	129	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1281	NA
806	c9e58844-9d61-44a2-aee6-1760bc19711b	TCGA.23.1027	TCGA-23-1027-D25620	a3e4c26f-59b6-4dfb-858b-dae3a7810a29	2009-3-27	DOCETAXEL	NA	CHEMOTHERAPY	166	FALSE	250	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	360	NA
807	c9e58844-9d61-44a2-aee6-1760bc19711b	TCGA.23.1027	TCGA-23-1027-D25617	541ac876-abe8-4dfb-9330-f95da504b531	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	129	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2088	NA
808	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25635	f26754f2-8f61-4593-9928-59d785330f4e	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	1461	FALSE	1461	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	525	NA
809	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25626	7891f1ae-b0a9-448d-b9c0-c4f15de2e582	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	110	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2900	NA
810	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25636	be0eed66-9759-46f5-861d-85d2b3c7dcd4	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	1468	FALSE	1489	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3100	NA
811	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25634	02d68082-acf3-4467-b42a-da9e8cd5c130	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	1461	FALSE	1461	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1552	NA
812	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25637	7f691d4d-5047-4632-9a47-8b0354586a4e	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	1468	FALSE	1489	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	100	NA
813	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25627	850beb81-2d13-437e-ae2a-8d4377df3ef9	2009-3-27	DOXORUBICIN	NA	CHEMOTHERAPY	173	FALSE	229	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	201	NA
814	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25625	dc8137b1-aa0c-46f3-b4bb-fb1b22ed2913	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	26	FALSE	110	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1600	NA
815	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25629	b09d45b1-238e-42ff-be29-a0aa4024010a	2009-3-27	DOCETAXEL	NA	CHEMOTHERAPY	749	FALSE	859	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	846	NA
816	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25633	9d1e5abe-9d8b-4399-930e-7a32f508b7ff	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	1363	FALSE	1461	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2667	NA
817	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25628	04a1186c-fbac-46cc-9511-f3410889dfca	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	749	FALSE	859	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2802	NA
818	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25631	987f46e8-6c27-4d5a-b765-c5125640486e	2009-3-27	DOXORUBICIN	NA	CHEMOTHERAPY	1112	FALSE	1335	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	417.5	NA
819	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25630	266bdf06-86e9-4dde-a5f7-5f96cc3c6eca	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	908	FALSE	1006	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40.89	NA
820	df53c3c0-3605-4d2b-bdc7-96d9beab27ea	TCGA.23.1028	TCGA-23-1028-D25632	b5320a45-929d-4b52-b0d4-d3a67e2a6e60	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	1140	FALSE	1153	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10.3	NA
821	4d71dd15-cd01-4dae-ad70-6dc325140207	TCGA.23.1029	TCGA-23-1029-D25640	eb833ce3-8f8b-4694-b538-a8d573f473d0	2009-8-12	CISPLATIN	NA	CHEMOTHERAPY	30	FALSE	78	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	375	NA
822	4d71dd15-cd01-4dae-ad70-6dc325140207	TCGA.23.1029	TCGA-23-1029-D25641	5f098756-c714-43d6-b097-9d2dae9f2152	2009-8-12	PACILTAXEL	NA	CHEMOTHERAPY	30	FALSE	78	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1212	NA
823	cbcf6922-a3c0-43a1-826e-642918b0a635	TCGA.23.1030	TCGA-23-1030-D25645	d696489a-0cbd-49c2-a070-3d4161baecc2	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	62	FALSE	165	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5010	NA
824	cbcf6922-a3c0-43a1-826e-642918b0a635	TCGA.23.1030	TCGA-23-1030-D25644	0545b759-fc20-4f2e-bdc1-95a8e3b09d84	2009-12-14	DOXIL	NA	CHEMOTHERAPY	622	FALSE	767	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	540	NA
825	cbcf6922-a3c0-43a1-826e-642918b0a635	TCGA.23.1030	TCGA-23-1030-D25646	790576ff-0101-4585-a311-1b60c28a5ea8	2009-12-14	PACLITAXEL	NA	CHEMOTHERAPY	62	FALSE	165	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2130	NA
826	cbcf6922-a3c0-43a1-826e-642918b0a635	TCGA.23.1030	TCGA-23-1030-D25647	a30cd254-7973-4765-883d-f4a89c773a88	2009-12-14	XYOTAX	NA	CHEMOTHERAPY	243	FALSE	438	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	CONSOLIDATION	2160	NA
827	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25651	9be966b3-0747-412f-a979-39238e9d9e22	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	26	FALSE	166	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2305	NA
828	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25654	285fafde-48f2-415b-bf55-b7e7ef4e6253	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	341	FALSE	446	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	715	NA
829	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25657	a876fbfc-b6f9-425c-9f99-8581d9c760ab	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	541	FALSE	555	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	11.4	NA
830	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25650	6c520881-7f90-4327-848b-639e34dda8b9	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	166	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
831	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25655	57796331-d5b0-4b3d-9544-405b027f6373	2009-3-27	DOCETAXEL	NA	CHEMOTHERAPY	460	FALSE	485	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	280	NA
832	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25653	d9844a5a-51b3-43da-b153-53e40564a073	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	341	FALSE	446	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	16500	NA
833	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25656	7ac6d001-2bdb-4e6a-863d-a72c506dfd1c	2009-3-27	XELODA	NA	CHEMOTHERAPY	460	FALSE	477	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	1000	NA
834	c7c3fe4a-327a-4b7e-a259-989b72971209	TCGA.23.1031	TCGA-23-1031-D25652	ae37b6fb-a4cb-4003-b9e4-6cbc3d5ef1b2	2009-3-27	DOXORUBICIN	NA	CHEMOTHERAPY	265	FALSE	321	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	225	NA
835	9fb1ba57-2007-4477-b000-2d36f163efd2	TCGA.23.1110	TCGA-23-1110-D25669	58fe9851-57be-4df2-bd75-5e5dcbc2a094	2009-12-14	PACLITAXEL	NA	CHEMOTHERAPY	6	FALSE	110	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3960	NA
836	9fb1ba57-2007-4477-b000-2d36f163efd2	TCGA.23.1110	TCGA-23-1110-D25667	05f0a85e-8428-42e9-b8c6-79bf2d0eceed	2009-12-14	XELODA	NA	CHEMOTHERAPY	333	FALSE	375	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	RECURRENCE	NA	16800	NA
837	9fb1ba57-2007-4477-b000-2d36f163efd2	TCGA.23.1110	TCGA-23-1110-D25668	b7078743-ae46-40f4-87e4-3e5d1e8873c7	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	110	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
838	9fb1ba57-2007-4477-b000-2d36f163efd2	TCGA.23.1110	TCGA-23-1110-D25670	b9882c4e-8bcd-42a7-baa4-a91102a3853a	2009-12-14	OVAREX/IND	NA	IMMUNOTHERAPY	179	FALSE	235	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	CONSOLIDATION	6	NA
839	6b2a9f9a-fe96-4311-a330-925c4ad36fe7	TCGA.23.1111	TCGA-23-1111-D25675	5b8a8e00-e4be-4a14-a676-a1e13668a596	2009-8-12	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	129	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3389	NA
840	6b2a9f9a-fe96-4311-a330-925c4ad36fe7	TCGA.23.1111	TCGA-23-1111-D25673	47ac4877-04ba-4b1e-8cd0-abbe3e23f2e2	2009-8-12	TAXOL	NA	CHEMOTHERAPY	24	FALSE	129	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1860	NA
841	6b2a9f9a-fe96-4311-a330-925c4ad36fe7	TCGA.23.1111	TCGA-23-1111-D25674	23d2be25-9d1f-4e0d-a2cd-ce35c16e2cd9	2009-8-12	INVESTIGAL DRUG AVASTIN	NA	CHEMOTHERAPY	45	FALSE	129	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5850	NA
842	6209e80d-a115-4f8e-bf0d-18461401a1c6	TCGA.23.1113	TCGA-23-1113-D25678	a3b52bce-08d8-456b-8f1e-d68fb5b21ef7	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	74	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1650	NA
843	6209e80d-a115-4f8e-bf0d-18461401a1c6	TCGA.23.1113	TCGA-23-1113-D25679	ad1b6d9d-88c5-4a21-a3d5-485738b49d45	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	27	FALSE	74	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	870	NA
844	6209e80d-a115-4f8e-bf0d-18461401a1c6	TCGA.23.1113	TCGA-23-1113-D25680	26c1331d-7f91-47a7-996d-d19bdc7a1244	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	102	FALSE	187	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	11282	NA
845	6209e80d-a115-4f8e-bf0d-18461401a1c6	TCGA.23.1113	TCGA-23-1113-D25682	d6010400-23c3-4365-a990-0aa37395b0fa	2009-3-27	DOXORUBICIN	NA	CHEMOTHERAPY	225	FALSE	253	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	816	NA
846	6209e80d-a115-4f8e-bf0d-18461401a1c6	TCGA.23.1113	TCGA-23-1113-D25681	8c3b8e3e-b95c-467c-acdf-7734757cc2e3	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	102	FALSE	187	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	528	NA
847	6209e80d-a115-4f8e-bf0d-18461401a1c6	TCGA.23.1113	TCGA-23-1113-D25683	0e6ed55a-1671-4de0-92bb-1f511b80c3d6	2009-3-27	DOCETAXEL	NA	CHEMOTHERAPY	253	FALSE	873	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	910	NA
848	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25688	e6c36e8f-5244-49fd-b850-7b811204f0e4	2009-12-14	DOCETAXEL	NA	CHEMOTHERAPY	1159	FALSE	1222	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	520	NA
849	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25686	28862da8-6071-4b65-a284-73b03b98866e	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	43	FALSE	182	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
850	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25689	5369784c-c259-4b05-979b-d85b3da36f4d	2009-12-14	GEMZAR	NA	CHEMOTHERAPY	1324	FALSE	1350	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	5500	NA
851	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25696	665be94d-c439-4e5c-9f31-6d83d62a544a	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	663	FALSE	747	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2100	NA
852	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25687	2594811e-287f-418e-bf86-1e968be8111e	2009-12-14	PACLITAXEL	NA	CHEMOTHERAPY	43	FALSE	182	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
853	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25693	380c38b7-6850-4e82-8f9f-71a6f23b2d41	2009-12-14	DOXIL	NA	CHEMOTHERAPY	1741	FALSE	1918	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	475	NA
854	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25691	2a752af9-ba01-4375-96ee-7f936b87f0be	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	1357	FALSE	1425	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	1190	NA
855	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25694	a1d5312d-e9dc-4357-a3a8-a122efc3e0a4	2009-12-14	TOPOTECAN	NA	CHEMOTHERAPY	1985	FALSE	2026	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	20.4	NA
856	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25697	2875ceab-afed-41fe-bc04-f6b7729cd8c1	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	865	FALSE	907	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	CONSOLIDATION	1305	NA
857	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25692	93752a4e-b8b2-48e8-a5d1-519882e4cd05	2009-12-14	GEMZAR	NA	CHEMOTHERAPY	1348	FALSE	1425	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	9625	NA
858	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25690	073ba0a0-4d7b-42fa-807f-7bac715d4b88	2009-12-14	CISPLATIN	NA	CHEMOTHERAPY	1324	FALSE	1350	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	260	NA
859	c0c3caab-9277-4a31-a96c-c607e38d5ccc	TCGA.23.1114	TCGA-23-1114-D25695	114cca0b-8220-4673-b571-a6a051f4e930	2009-12-14	PACLITAXEL	NA	CHEMOTHERAPY	663	FALSE	747	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1400	NA
860	70fe08bd-a0b4-4a88-b82e-813b176f8e40	TCGA.23.1116	TCGA-23-1116-D25749	fdcbd10e-6a29-44af-a6d3-0ae779462f28	2009-4-1	PACLITAXEL	NA	CHEMOTHERAPY	19	NA	187	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1746	NA
861	70fe08bd-a0b4-4a88-b82e-813b176f8e40	TCGA.23.1116	TCGA-23-1116-D25748	cebb3b12-fd0f-4d3d-836e-9a2f550a8a89	2009-4-1	CARBOPLATIN	NA	CHEMOTHERAPY	19	NA	187	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2100	NA
862	70fe08bd-a0b4-4a88-b82e-813b176f8e40	TCGA.23.1116	TCGA-23-1116-D25750	ca70e5a7-b898-44a8-a40a-56f5788f613d	2009-12-14	CARBOPLATIN	NA	CHEMOTHERAPY	306	FALSE	418	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1530	NA
863	70fe08bd-a0b4-4a88-b82e-813b176f8e40	TCGA.23.1116	TCGA-23-1116-D25751	aadd8f4f-1254-476b-ae3f-6c120a36477e	2009-12-14	GEMZAR	NA	CHEMOTHERAPY	306	FALSE	418	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	11028	NA
864	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25700	ae227383-099e-44a2-8398-ba4aa5c804eb	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	294	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6470	NA
865	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25702	bffb1d3e-6bc8-472c-b3b6-2b072e107ea2	2009-3-27	CYCLOPHOSPHAMIDE	NA	CHEMOTHERAPY	712	FALSE	757	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3450	NA
866	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25703	647f8f33-378a-47c3-8cda-37dbc04a7c54	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	781	FALSE	863	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	600	NA
867	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25701	df44bbcd-995d-4b79-9bee-e364bb571dcd	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	459	FALSE	624	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	92	NA
868	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25704	d5b2da86-8889-4e99-b890-64d403e5e8d3	2009-3-27	DOCETAXEL	NA	CHEMOTHERAPY	890	FALSE	928	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	280	NA
869	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25705	53b2ce95-0ac5-4e1b-af64-9a769cdc3df6	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	951	FALSE	993	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3960	NA
870	a88b7e66-5f12-4023-a7e2-fcfbd1f25977	TCGA.23.1117	TCGA-23-1117-D25706	044d289f-4ad5-4e9f-9e5a-373407bd5892	2010-1-11	HERCEPTIN	NA	IMMUNOTHERAPY	890	FALSE	928	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	600	NA
871	700e91bb-d675-41b2-bbbd-935767c7b447	TCGA.23.1118	TCGA-23-1118-D25709	553ae8b5-bba0-4760-bc39-007b45663eba	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	56	FALSE	196	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	300	NA
872	2dfd8a0e-e642-49b3-abd7-f0334927eebb	TCGA.23.1119	TCGA-23-1119-D25712	f137b469-6105-4631-9476-7318dfa0df61	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	3389	FALSE	3494	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2230	NA
873	2dfd8a0e-e642-49b3-abd7-f0334927eebb	TCGA.23.1119	TCGA-23-1119-D25713	d66ab420-e93b-4d8a-9414-c8439da9c270	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2700	NA
874	fdf83fdf-dfbb-4306-9a1b-b4487d18b402	TCGA.23.1120	TCGA-23-1120-D25716	706a2a1b-ec67-4c1e-9588-9ad9b8a629ef	2009-4-1	CISPLATIN	NA	CHEMOTHERAPY	63	NA	146	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	700	NA
875	fdf83fdf-dfbb-4306-9a1b-b4487d18b402	TCGA.23.1120	TCGA-23-1120-D25717	14e5fa9c-6598-4755-8dcf-a2ad8f0253c2	2009-4-1	PACLITAXEL	NA	CHEMOTHERAPY	63	NA	146	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	2090	NA
876	81005bae-686a-4598-8994-49d90ebac56f	TCGA.23.1121	TCGA-23-1121-D25721	a4055b6b-966f-49eb-b54e-58851bea490d	2009-7-7	TAXOL	NA	CHEMOTHERAPY	31	FALSE	194	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1362	NA
877	81005bae-686a-4598-8994-49d90ebac56f	TCGA.23.1121	TCGA-23-1121-D25722	41650c19-fb75-4a26-81cf-84c3d503fbf8	2009-7-7	AVASTIN	NA	CHEMOTHERAPY	53	FALSE	152	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2400	NA
878	81005bae-686a-4598-8994-49d90ebac56f	TCGA.23.1121	TCGA-23-1121-D25720	6533e40b-a0cb-48bf-96f6-65d01afb4d7f	2009-7-7	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	194	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3135	NA
879	d2c0d320-d1c5-4eed-af4f-15540e60db0b	TCGA.23.1122	TCGA-23-1122-D25726	9be1fb51-4bb5-4ad9-8bdd-d26152e731aa	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	501	FALSE	686	NA	NA	NA	NA	20	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	15900	NA
880	d2c0d320-d1c5-4eed-af4f-15540e60db0b	TCGA.23.1122	TCGA-23-1122-D25729	75bcf34f-515a-4ada-aca8-b0e8548a4a67	2009-3-27	IFOSFAMIDE	NA	CHEMOTHERAPY	921	FALSE	1031	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENCE	72	NA
881	d2c0d320-d1c5-4eed-af4f-15540e60db0b	TCGA.23.1122	TCGA-23-1122-D25730	5b6a82d6-b750-44e9-b52f-c8ce5cd84a75	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	1054	FALSE	1089	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENCE	240	NA
882	d2c0d320-d1c5-4eed-af4f-15540e60db0b	TCGA.23.1122	TCGA-23-1122-D25728	d4bbd55b-fc97-42f6-bb91-518b51ae30d0	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	775	FALSE	859	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENCE	5900	NA
883	d2c0d320-d1c5-4eed-af4f-15540e60db0b	TCGA.23.1122	TCGA-23-1122-D25727	5490f2a7-3eb4-4529-b556-001c0b298aaf	2009-3-27	GEMZAR	NA	CHEMOTHERAPY	707	FALSE	754	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3500	NA
884	d2c0d320-d1c5-4eed-af4f-15540e60db0b	TCGA.23.1122	TCGA-23-1122-D25725	948c7d43-3dbd-4e69-b81b-ba635e818523	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	244	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4200	NA
885	60cce7ac-d27d-44a6-9873-ecf91da5e906	TCGA.23.1123	TCGA-23-1123-D25735	ca5ac43f-2f1e-4180-9c04-2d70675ebbda	2009-4-1	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	250	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	2000	NA
886	60cce7ac-d27d-44a6-9873-ecf91da5e906	TCGA.23.1123	TCGA-23-1123-D25736	3348bc4e-bbef-480d-81d3-aa751f366dd9	2009-4-1	DOXORUBICIN	NA	CHEMOTHERAPY	452	FALSE	599	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	NA	NA	NA	OTHER	PERSISTENCE	456	NA
887	60cce7ac-d27d-44a6-9873-ecf91da5e906	TCGA.23.1123	TCGA-23-1123-D25737	800b81f9-0925-43c9-b017-0e9c8fa28a33	2009-4-1	TOPOTECAN	NA	CHEMOTHERAPY	812	FALSE	894	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	OTHER	NA	NA	OTHER	PERSISTENCE	39.9	NA
888	60cce7ac-d27d-44a6-9873-ecf91da5e906	TCGA.23.1123	TCGA-23-1123-D25734	d80cf2a4-4284-404d-a4d6-72fc39b01dff	2009-4-1	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	250	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	4800	NA
889	8a6d2ce3-cc57-451b-9b07-8263782aa23f	TCGA.23.1124	TCGA-23-1124-D25744	ac2cb5f8-306a-4e7e-b2cf-e9e8e84ea8fd	2009-3-27	DOXORUBICIN	NA	CHEMOTHERAPY	1363	FALSE	1510	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	390	NA
890	8a6d2ce3-cc57-451b-9b07-8263782aa23f	TCGA.23.1124	TCGA-23-1124-D25741	df58a615-2cd0-4768-855e-d920caff4cbe	2009-3-27	GEMCITABINE	NA	CHEMOTHERAPY	676	FALSE	872	NA	NA	NA	NA	18	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	18000	NA
891	8a6d2ce3-cc57-451b-9b07-8263782aa23f	TCGA.23.1124	TCGA-23-1124-D25740	4285dc70-1dda-45e9-b520-d7704bfb61ba	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	197	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4950	NA
892	8a6d2ce3-cc57-451b-9b07-8263782aa23f	TCGA.23.1124	TCGA-23-1124-D25743	4575fc46-e77a-4c7e-b1bc-351538c08b00	2009-3-27	VINORELBINE	NA	CHEMOTHERAPY	1307	FALSE	1342	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	180	NA
893	8a6d2ce3-cc57-451b-9b07-8263782aa23f	TCGA.23.1124	TCGA-23-1124-D25742	d72e12a2-1524-4f1e-ab4e-108fffef106a	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	1070	FALSE	1286	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3080	NA
894	8a6d2ce3-cc57-451b-9b07-8263782aa23f	TCGA.23.1124	TCGA-23-1124-D25745	d94c08b1-d8f5-480f-bae4-b7239957cdf4	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	1538	FALSE	1566	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	12	NA
895	bc3e0b74-ea09-46a5-9f61-16bd15ffd883	TCGA.23.1809	TCGA-23-1809-D25755	6dab45bd-9189-4f7a-a844-85635ed7cbf7	2009-12-9	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	107	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1898	NA
896	bc3e0b74-ea09-46a5-9f61-16bd15ffd883	TCGA.23.1809	TCGA-23-1809-D25754	548a5293-e55f-4f0d-aea8-880f79908766	2009-12-9	PACLITAXEL	NA	CHEMOTHERAPY	24	FALSE	107	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1495	NA
897	1592af8e-8d11-4325-8a2b-e0c690b15b58	TCGA.23.2072	TCGA-23-2072-D25758	0eb5afce-60e8-4797-9672-a84ced84dbdb	2009-11-18	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	151	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3325	NA
898	1592af8e-8d11-4325-8a2b-e0c690b15b58	TCGA.23.2072	TCGA-23-2072-D25760	f58539f9-5158-4d42-8b4c-701c651a0c41	2009-11-18	GEMZAR	NA	CHEMOTHERAPY	579	FALSE	620	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6280	NA
899	1592af8e-8d11-4325-8a2b-e0c690b15b58	TCGA.23.2072	TCGA-23-2072-D25759	7fde5afb-c211-4558-a45f-0bfc5aeb3791	2009-11-18	TAXOL	NA	CHEMOTHERAPY	26	FALSE	151	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1890	NA
900	1592af8e-8d11-4325-8a2b-e0c690b15b58	TCGA.23.2072	TCGA-23-2072-D25761	ac71f616-6349-4cdd-aee1-9e7df89acd4a	2009-11-18	DOXIL	NA	CHEMOTHERAPY	571	FALSE	571	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	64	NA
901	ef57bc45-858f-4d4e-8407-b7eadfa43be5	TCGA.23.2077	TCGA-23-2077-D25766	5521e637-59d8-4ddf-87cb-146a5266b295	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	1622	FALSE	1622	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	460	NA
902	ef57bc45-858f-4d4e-8407-b7eadfa43be5	TCGA.23.2077	TCGA-23-2077-D25769	1fa345ea-b957-4961-9564-ba4fc0bbc1fc	2009-11-20	TAXOTERE	NA	CHEMOTHERAPY	1653	FALSE	1758	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	600	NA
903	ef57bc45-858f-4d4e-8407-b7eadfa43be5	TCGA.23.2077	TCGA-23-2077-D25764	5880f08c-91d2-4a3a-b546-c5f38ad84b21	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	155	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3300	NA
904	ef57bc45-858f-4d4e-8407-b7eadfa43be5	TCGA.23.2077	TCGA-23-2077-D25765	55580b30-aed7-4821-a5e6-3c6723d59d3b	2009-11-20	TAXOL	NA	CHEMOTHERAPY	22	FALSE	155	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	751	NA
905	ef57bc45-858f-4d4e-8407-b7eadfa43be5	TCGA.23.2077	TCGA-23-2077-D25767	0963b087-b1d1-46a8-ac6f-a9fca75b64a8	2009-11-20	TAXOL	NA	CHEMOTHERAPY	1622	FALSE	1622	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	275	NA
906	ef57bc45-858f-4d4e-8407-b7eadfa43be5	TCGA.23.2077	TCGA-23-2077-D25768	9c985cb2-5676-4ad4-ae8f-cfd416c28bbb	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	1653	FALSE	1758	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2206	NA
907	ebe677e6-94b6-45be-a58d-eaae4cf63d12	TCGA.23.2078	TCGA-23-2078-D25773	3bbb5d6b-af79-42f3-a412-3ae01a8b6bb0	2009-11-20	TAXOL	NA	CHEMOTHERAPY	35	FALSE	149	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1980	NA
908	ebe677e6-94b6-45be-a58d-eaae4cf63d12	TCGA.23.2078	TCGA-23-2078-D25772	e275dc2a-fe10-41d0-9a98-fe92de858ab9	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	149	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3240	NA
909	e3ea5137-76b8-4afc-9b80-ed74714e7172	TCGA.23.2079	TCGA-23-2079-D25778	366f4c76-78f8-4c6e-afa5-375494d96d7e	2009-11-20	DOXIL	NA	CHEMOTHERAPY	296	FALSE	489	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	663	NA
910	e3ea5137-76b8-4afc-9b80-ed74714e7172	TCGA.23.2079	TCGA-23-2079-D25777	04a0cf5a-70ec-4199-bbaa-75569a40bec1	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	4	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3420	NA
911	e3ea5137-76b8-4afc-9b80-ed74714e7172	TCGA.23.2079	TCGA-23-2079-D25779	fb19a65d-7489-4347-8ea4-b6d265cdcaf6	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	2102	FALSE	2147	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1651	NA
912	e3ea5137-76b8-4afc-9b80-ed74714e7172	TCGA.23.2079	TCGA-23-2079-D25776	8b9712e1-d798-4f32-b9a7-1087b0a93e16	2009-11-20	PACLITAXEL	NA	CHEMOTHERAPY	4	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
913	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25783	c9566413-8e08-47c1-8a4f-527b3da46ef9	2009-11-20	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	300	NA
914	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25782	9ac0d608-4f98-4a24-a71d-73e2428d160c	2009-11-20	AVASTIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT	1750	NA
915	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25787	498bccb4-7600-48cd-b1dd-3c8c80fb6b6b	2009-11-20	TAXOTERE	NA	CHEMOTHERAPY	939	FALSE	960	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	290	NA
916	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25793	903e47f3-51cb-44cf-8d4b-104edf2dd63e	2009-11-20	AMG 706	NA	CHEMOTHERAPY	2070	FALSE	2173	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	ORAL	NA	NA	RECURRENCE	NA	1325	NA
917	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25788	3274a846-11f3-4a57-a950-f5115fa188a2	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	939	FALSE	960	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1400	NA
918	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25785	6b335083-5754-47d9-8591-2910cb2ad861	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	173	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4400	NA
919	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25786	0c4ca03d-0418-47da-bbaf-216d3a8d39cb	2009-11-20	DOXIL	NA	CHEMOTHERAPY	331	FALSE	418	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	280	NA
920	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25789	87be1e88-31e9-48b0-aa2f-4159d6917c71	2009-11-20	CISPLATIN	NA	CHEMOTHERAPY	988	FALSE	1154	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1020	NA
921	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25790	98483a68-d8fc-4b86-a0e5-51e3715b1bcf	2009-11-20	GEMZAR	NA	CHEMOTHERAPY	988	FALSE	1154	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	20400	NA
922	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25792	03beed10-8066-4b0d-9003-4ba326eb7011	2009-11-20	CISPLATIN	NA	CHEMOTHERAPY	1790	FALSE	1948	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	660	NA
923	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25784	a9f3cb5e-4bf8-4810-9a1e-f310588bff21	2009-11-20	PACLITAXEL	NA	CHEMOTHERAPY	16	FALSE	173	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2480	NA
924	41178cbc-db73-4007-b5d8-febebf7f578d	TCGA.23.2081	TCGA-23-2081-D25791	fe9683d7-e2d6-4136-92ea-1d6d51fd5023	2009-11-20	GEMZAR	NA	CHEMOTHERAPY	1790	FALSE	1948	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	13200	NA
925	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25798	18d6f8ad-a8f1-49e1-bb97-9234ae71d25e	2009-11-18	CISPLATIN	NA	CHEMOTHERAPY	631	FALSE	701	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	700	NA
926	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25802	11a3ce02-a4a6-4448-bc5b-d75b5e18eea8	2009-11-18	TAXOTERE	NA	CHEMOTHERAPY	1261	FALSE	1302	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	360	NA
927	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25808	63edb1bd-5389-42c8-9cb6-56f0558c4a86	2009-11-18	ETOPOSIDE (VP16)	NA	CHEMOTHERAPY	1457	FALSE	1485	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
928	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25805	0cb1799a-62c8-4961-a97c-6a3042a78457	2009-11-18	CARBOPLATIN	NA	CHEMOTHERAPY	1381	FALSE	1401	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	920	NA
929	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25803	938c58a6-fd84-45a0-b087-8f3fb48c7b86	2009-11-18	TOPOTECAN	NA	CHEMOTHERAPY	1324	FALSE	1359	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	14	NA
930	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25804	78eeb3f1-4910-4452-adf8-b5bb45819a16	2009-11-18	IFOSFAMIDE	NA	CHEMOTHERAPY	1381	FALSE	1401	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1615	NA
931	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25807	087ed361-e202-4f43-ad80-7548e4afddcc	2009-11-18	CISPLATIN	NA	CHEMOTHERAPY	1425	FALSE	1425	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	100	NA
932	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25800	a695bdf7-521c-40a8-bfdb-7b26c2f2b383	2009-11-18	RHUMAB/IND	NA	IMMUNOTHERAPY	1127	FALSE	1169	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1680	NA
933	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25797	eb6393b4-8b07-467d-9140-7edec56177f7	2009-11-18	PACLITAXEL	NA	CHEMOTHERAPY	6	FALSE	155	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2200	NA
934	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25806	7bd3a692-65be-4684-9346-157cc286a6aa	2009-11-18	IFOSFAMIDE	NA	CHEMOTHERAPY	1425	FALSE	1425	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	730	NA
935	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25796	3e7107e7-5d80-4ac1-9a79-d3bcc79ef6dc	2009-11-18	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	155	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4240	NA
936	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25799	6e3564f4-d965-41f4-8f26-06c247e46d23	2009-11-18	GEMZAR	NA	CHEMOTHERAPY	631	FALSE	701	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	12600	NA
937	2cb82948-7cbe-4b6c-8414-c02f662de2d0	TCGA.23.2084	TCGA-23-2084-D25801	cf73ecb9-0c9c-4f5a-a6ef-a0c18c63995e	2009-11-18	DOXIL	NA	CHEMOTHERAPY	1183	FALSE	1240	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	195	NA
938	5554a003-da6f-4ddf-9f05-6785987ac46c	TCGA.23.2643	TCGA-23-2643-D25816	b22c0d76-80d5-40aa-bb10-9ddc9571a9fa	2009-12-9	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	24	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	373	NA
939	5554a003-da6f-4ddf-9f05-6785987ac46c	TCGA.23.2643	TCGA-23-2643-D25814	25aaccf8-7a6f-441b-9938-b771bec4e3e8	2009-12-9	CISPLATIN	NA	CHEMOTHERAPY	45	FALSE	129	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	610	NA
940	5554a003-da6f-4ddf-9f05-6785987ac46c	TCGA.23.2643	TCGA-23-2643-D25815	37da2899-93db-4757-9940-479746754dac	2009-12-9	TAXOL	NA	CHEMOTHERAPY	24	FALSE	24	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	294	NA
941	5554a003-da6f-4ddf-9f05-6785987ac46c	TCGA.23.2643	TCGA-23-2643-D25813	25e8bdc4-321f-4b54-993e-cb26be058f73	2009-12-9	TAXOL	NA	CHEMOTHERAPY	45	FALSE	129	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1295	NA
942	fef1696c-a8f4-4db6-8615-e486522baaaa	TCGA.24.0966	TCGA-24-0966-D25877	d59ae257-aaed-4b32-b2ee-4819c0c1f330	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	21	NA	120	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2456	NA
943	fef1696c-a8f4-4db6-8615-e486522baaaa	TCGA.24.0966	TCGA-24-0966-D25876	6e46e95c-59bd-4b05-aa53-4d4ab9726c05	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	21	NA	120	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1390	NA
944	fef1696c-a8f4-4db6-8615-e486522baaaa	TCGA.24.0966	TCGA-24-0966-D25878	b56ccf47-30cb-49bc-a45b-5d2c2d1617f1	2009-3-30	AVASTIN/BEVACIZUMAB/PLACEBO	NA	TARGETED MOLECULAR THERAPY	71	NA	120	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2457	NA
945	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25884	e3ed5ab9-5714-4914-8344-71cafcd55745	2009-3-10	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSITANT DISEASE; GIVEN WITH GEMZAR	NA	NA
946	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25888	44789b67-0fe7-4ee7-9461-8adc8b68a710	2009-3-10	CYTOXAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
947	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25886	98a1282c-fc9a-4ae4-a806-3cd66d04a656	2009-3-10	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
948	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25883	46c69a64-5995-4736-b17c-f77e8e340301	2009-3-10	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSITANT DISEASE; GIVEN WITH GEMZAR	NA	NA
949	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25881	33f57318-3e28-48d4-b198-23a2ab37b5ea	2009-3-10	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	119	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2790	NA
950	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25882	80e7d102-6aab-4e2b-a2f5-5e98667313d4	2009-3-10	PACLITAXEL	NA	CHEMOTHERAPY	35	FALSE	119	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1378	NA
951	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25887	3b897a94-6154-4608-9a7b-720eb376d971	2009-3-10	NAVELBINE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
952	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25885	4bd719b9-d64e-4581-85e3-5806c52eecc0	2009-3-10	GEMZAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSITANT DISEASE; GIVEN 1X WITH DOXIL	NA	NA
953	619b14f3-b8cc-4c0a-8304-6719853d592a	TCGA.24.0968	TCGA-24-0968-D25889	c04896d2-d54b-40dc-a0dd-6dae1fccadd8	2010-2-25	GEMZAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTANT DISEASE; GIVEN 1X WITH CISPLATIN	NA	NA
954	95e58015-a7c0-4bdc-bf64-7617d24d0784	TCGA.24.0970	TCGA-24-0970-D25873	426b35b9-eeab-4015-898d-f5a50d3c5f6e	2009-3-9	DOXIL	NA	CHEMOTHERAPY	25	NA	314	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	152	NA
955	95e58015-a7c0-4bdc-bf64-7617d24d0784	TCGA.24.0970	TCGA-24-0970-D25871	e1f3db9f-1bfe-4fca-8fb6-d17d4ae824fa	2009-3-9	TAXOL	NA	CHEMOTHERAPY	25	FALSE	314	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1980	NA
956	95e58015-a7c0-4bdc-bf64-7617d24d0784	TCGA.24.0970	TCGA-24-0970-D25872	3d5f98c0-fb1e-4647-aa0f-4e9ab61b6d8b	2009-3-9	CARBOPLATIN	NA	CHEMOTHERAPY	25	NA	314	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3840	NA
957	6a57948c-0dc5-4ea2-8043-380f26763752	TCGA.24.0975	TCGA-24-0975-D25864	441ae864-4ce1-43eb-8f2c-3783269ca89b	2009-3-9	GEMCITABINE	NA	CHEMOTHERAPY	22	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
958	6a57948c-0dc5-4ea2-8043-380f26763752	TCGA.24.0975	TCGA-24-0975-D25867	e255c05a-03e0-47a8-a3bc-064fe0d4449b	2009-3-9	NAVELBINE	NA	CHEMOTHERAPY	NA	FALSE	611	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
959	6a57948c-0dc5-4ea2-8043-380f26763752	TCGA.24.0975	TCGA-24-0975-D25862	b6206599-e812-43db-8625-fdd6a2142a9c	2009-3-9	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
960	6a57948c-0dc5-4ea2-8043-380f26763752	TCGA.24.0975	TCGA-24-0975-D25865	fbde8509-b99c-4069-86ea-638a3eff0d8d	2009-3-9	DOXIL	NA	CHEMOTHERAPY	22	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
961	6a57948c-0dc5-4ea2-8043-380f26763752	TCGA.24.0975	TCGA-24-0975-D25866	afafd8b8-0b8c-4e45-944e-df82466920bf	2009-3-9	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	611	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
962	6a57948c-0dc5-4ea2-8043-380f26763752	TCGA.24.0975	TCGA-24-0975-D25863	f67062fb-a896-4c7b-adab-2bfedbaf34cf	2009-3-9	PACLITAXEL	NA	CHEMOTHERAPY	22	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
963	9a30dee8-962a-49db-a85a-c39515c91b68	TCGA.24.0979	TCGA-24-0979-D25893	8942e664-0aaa-4893-ab7d-027ca7215144	2009-5-11	TAXOL	NA	CHEMOTHERAPY	15	FALSE	187	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
964	9a30dee8-962a-49db-a85a-c39515c91b68	TCGA.24.0979	TCGA-24-0979-D25892	95fa449a-d622-4c36-a4d4-fe256899666f	2009-5-11	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	187	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
965	d1eeaca3-52c0-4a0c-916a-fd64cec911d9	TCGA.24.0980	TCGA-24-0980-D25897	15cde1b3-b643-4d88-b4e5-6a05bfb9ab64	2009-3-27	PACLITAXEL	NA	CHEMOTHERAPY	77	NA	178	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1265.5	NA
966	d1eeaca3-52c0-4a0c-916a-fd64cec911d9	TCGA.24.0980	TCGA-24-0980-D25898	2f798bfb-2136-4d59-81f1-297bc7fbf831	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	77	NA	178	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2012	NA
967	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25901	09307e85-1a95-410e-96db-c9761556f6fb	2009-3-10	CARBOPLATIN	NA	CHEMOTHERAPY	13	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4090	NA
968	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25903	ef503cec-e161-41bd-85a3-8bb01f6b1328	2009-3-10	TOPOTECAN	NA	CHEMOTHERAPY	251	FALSE	321	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	39	NA
969	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25902	86c8e150-07cf-4e9e-83d9-e57f33818e05	2009-3-10	PACLITAXEL	NA	CHEMOTHERAPY	13	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1966	NA
970	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25906	52092e56-744b-43f4-8bda-609e63790207	2009-3-10	DOXIL	NA	CHEMOTHERAPY	341	FALSE	474	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	388	NA
971	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25905	912d8e00-f08e-482d-bb62-634b415019cc	2009-3-10	GEMZAR	NA	CHEMOTHERAPY	341	FALSE	474	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	24798	NA
972	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25904	8070fa1e-6749-46b8-af00-245149e18154	2009-3-10	NAVELBINE	NA	CHEMOTHERAPY	251	FALSE	321	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	390	NA
973	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25907	ce37916d-d891-424a-bc45-12e3cb0755f6	2010-1-29	TAXOL	NA	CHEMOTHERAPY	488	FALSE	615	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2276	NA
974	206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18	TCGA.24.0982	TCGA-24-0982-D25908	8e3d7162-d3b2-4f32-b3a8-948be3ee41ab	2010-1-29	CARBOPLATIN	NA	CHEMOTHERAPY	488	FALSE	615	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3800	NA
975	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25825	f44476cf-cc04-42d3-bb41-71b9b94dd313	2009-3-9	TAXOL	NA	CHEMOTHERAPY	19	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1920	NA
976	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25826	5c3acf57-141b-4ce6-91fe-581490c243ba	2009-3-9	TOPOTECAN	NA	CHEMOTHERAPY	694	FALSE	910	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	43.2	NA
977	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25828	31b255dd-31d7-4ed8-933f-d460bb56c52e	2009-3-9	TAXOTERE	NA	CHEMOTHERAPY	1016	FALSE	1127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	756	NA
978	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25827	22f59aba-f17a-4a62-99f6-f823663235f8	2009-3-9	NAVELBINE	NA	CHEMOTHERAPY	694	FALSE	910	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	816	NA
979	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25829	ded5f911-f2be-4407-8843-973d988ec6b2	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2210	NA
980	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25831	ba9a1f08-8120-426b-8d9e-75de1729a6ff	2010-2-1	TAXOTERE	NA	CHEMOTHERAPY	1625	FALSE	NA	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	RECURRENCE	NA	130	NA
981	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25830	23789e95-afa2-45e4-863c-265228e4944c	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	1016	FALSE	1127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2322	NA
982	f34aa3b6-e966-49c6-bc55-130545772c53	TCGA.24.1103	TCGA-24-1103-D25832	e6d71b0b-52f3-46bb-9928-e8313c172b61	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	1625	FALSE	NA	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	RECURRENCE	NA	347	NA
983	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25835	49a7aa0b-ee9a-451f-bbc4-1b6de517ec0e	2009-3-9	PACLITAXEL	NA	CHEMOTHERAPY	30	FALSE	175	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1518	NA
984	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25836	e9de231f-ab26-4ed6-af61-fa3e6e1173f7	2009-3-9	DOXIL	NA	CHEMOTHERAPY	1526	FALSE	1589	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	190	NA
985	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25837	b446a898-1eae-4f20-88d0-55fafab04fa8	2009-3-9	CISPLATIN	NA	CHEMOTHERAPY	30	FALSE	175	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	250	NA
986	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25838	d48553ab-2f2b-4708-8d43-fdd995fa330c	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	30	FALSE	175	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2007	NA
987	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25839	3bcc4b9b-c529-4706-845d-5c82f0e81e9a	2010-2-1	TAXOL	NA	CHEMOTHERAPY	1001	FALSE	1113	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1800	NA
988	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25841	8d708e6e-b456-4878-9446-dad3734222aa	2010-2-1	TAXOL	NA	CHEMOTHERAPY	1858	FALSE	1876	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	438	NA
989	f9f44f86-10c7-4473-b156-5afbfa9a2ad0	TCGA.24.1104	TCGA-24-1104-D25840	3a12c164-e3cd-4312-ba87-6320222e0dbc	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	1001	FALSE	1113	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	402	NA
990	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25846	ecff3707-6213-40e7-bfba-a2b87b1ac780	2009-3-9	TAXOL	NA	CHEMOTHERAPY	25	FALSE	178	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1400	NA
991	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25850	19208898-549c-4bec-9587-862255401569	2009-3-9	DOXIL	NA	CHEMOTHERAPY	1004	FALSE	1116	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	258	NA
992	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25849	b0de8465-4152-4b3c-88e6-fc2adbdc54ed	2009-3-9	GEMZAR	NA	CHEMOTHERAPY	1004	FALSE	1116	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	19320	NA
993	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25852	666da692-65f8-4bad-ab2d-32179231bdbf	2009-3-9	CISPLATIN	NA	CHEMOTHERAPY	1368	FALSE	1375	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	92	NA
994	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25847	f2b55619-c372-4f75-83ac-52dd647bcbf0	2009-3-9	TOPOTECAN	NA	CHEMOTHERAPY	724	FALSE	860	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	48.2	NA
995	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25851	ddb1bcf5-8150-4936-9f35-65b161732d58	2009-3-9	CYTOXAN	NA	CHEMOTHERAPY	1228	FALSE	1298	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	4500	NA
996	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25858	42d6f1c9-fe2e-40a1-8017-3c7fcbb35bb9	2009-3-9	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1228	FALSE	1298	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	2001	NA
997	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25845	a5c72ec2-4288-4610-a12d-5a88be4834ee	2009-3-9	CARBOPLATIN	NA	CHEMOTHERAPY	25	FALSE	178	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3410	NA
998	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25848	6b4fe1cc-975c-40fb-8ba2-24ceed6eb1f4	2009-3-9	NAVELBINE	NA	CHEMOTHERAPY	724	FALSE	860	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	486	NA
999	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25853	b73fda29-b8ca-47ae-9cb2-74fcbfeaa2b7	2010-2-1	CARBOPLATIN	NA	CHEMOTHERAPY	1130	FALSE	1200	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	2275	NA
1000	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25855	df0b4051-0453-488c-abe4-2edaeb0ec8c0	2010-2-1	GEMZAR	NA	CHEMOTHERAPY	1368	FALSE	1375	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1826	NA
1001	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25854	1e77ffe6-2c69-45a6-8102-044a2aa42a6f	2010-2-1	TAXOL	NA	CHEMOTHERAPY	1313	FALSE	1340	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	975	NA
1002	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25857	46f8c3f9-d453-4187-9a47-96a473ca8e76	2010-3-10	TAXOL	NA	CHEMOTHERAPY	486	FALSE	584	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1725	NA
1003	7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2	TCGA.24.1105	TCGA-24-1105-D25856	b73f86c1-9dc1-4f86-b095-649ed53d41e2	2010-3-10	CARBOPLATIN	NA	CHEMOTHERAPY	486	FALSE	584	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3360	NA
1004	3fc8f799-5bd3-4f48-baf0-c458ce86ab7e	TCGA.24.1413	TCGA-24-1413-D25911	2c6dac55-044c-46d6-a296-897bda1add73	2009-3-9	PACLITAXEL	NA	CHEMOTHERAPY	34	NA	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1340	NA
1005	3fc8f799-5bd3-4f48-baf0-c458ce86ab7e	TCGA.24.1413	TCGA-24-1413-D25912	86d3680c-7af1-4bcf-9466-ac5d0d032144	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	34	NA	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3864	NA
1006	f9793a4b-c0e7-4475-bf80-69543b7ee2f6	TCGA.24.1416	TCGA-24-1416-D25916	97a17aa1-374b-4024-b74c-8329f9811fc9	2009-4-1	CISPLATIN	NA	CHEMOTHERAPY	16	FALSE	170	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	946	NA
1007	f9793a4b-c0e7-4475-bf80-69543b7ee2f6	TCGA.24.1416	TCGA-24-1416-D25917	d5c511d8-151f-4705-9bc4-f38116984562	2009-4-1	TAXOL	NA	CHEMOTHERAPY	16	FALSE	170	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	647	NA
1008	f9793a4b-c0e7-4475-bf80-69543b7ee2f6	TCGA.24.1416	TCGA-24-1416-D25915	c1f341c3-2bb0-4ba5-be48-5a13a54fc492	2009-4-1	TAXOTERE	NA	CHEMOTHERAPY	16	FALSE	170	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	934	NA
1009	f9793a4b-c0e7-4475-bf80-69543b7ee2f6	TCGA.24.1416	TCGA-24-1416-D25918	9b15719a-2356-4fa2-9a7f-42274bbac4a7	2009-4-1	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	170	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	422	NA
1010	48f831b0-5d91-44ae-bc4e-db57ca84fe46	TCGA.24.1417	TCGA-24-1417-D25921	df82d543-c4f6-4f73-8dfa-b8a5c33a8cce	2009-4-1	TAXOL	NA	CHEMOTHERAPY	25	FALSE	156	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2538	NA
1011	48f831b0-5d91-44ae-bc4e-db57ca84fe46	TCGA.24.1417	TCGA-24-1417-D25922	f6dfbc3c-363e-4bc3-8873-82cbcf734bfa	2009-4-1	CARBOPLATIN	NA	CHEMOTHERAPY	25	FALSE	156	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5500	NA
1012	195ecf43-06bd-4ffe-8d8b-a766f3f7179b	TCGA.24.1418	TCGA-24-1418-D25927	2e35c3fb-6a4e-42c0-bb5d-928456c65618	2009-4-16	BEVACIZAMAB/PLACEBO	NA	TARGETED MOLECULAR THERAPY	43	FALSE	231	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	8459	NA
1013	195ecf43-06bd-4ffe-8d8b-a766f3f7179b	TCGA.24.1418	TCGA-24-1418-D25925	cbfa21bd-902b-45ff-9d92-67b836fa99b9	2009-4-16	TAXOL	NA	CHEMOTHERAPY	23	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1510	NA
1014	195ecf43-06bd-4ffe-8d8b-a766f3f7179b	TCGA.24.1418	TCGA-24-1418-D25926	9911f81a-48c0-47f9-aa6e-343694b85003	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2554	NA
1015	5e18b17d-4626-4b6d-8ac6-e560cee0376c	TCGA.24.1419	TCGA-24-1419-D25930	91f667fe-afb5-471d-af76-66b09ed65858	2009-4-15	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	121	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3882	NA
1016	5e18b17d-4626-4b6d-8ac6-e560cee0376c	TCGA.24.1419	TCGA-24-1419-D25931	fb686b35-70cb-45e0-991c-0169f28f0115	2009-4-15	PACITAXEL	NA	CHEMOTHERAPY	197	TRUE	NA	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	CONSOLIDATION CHEMOTHERAPY	478	NA
1017	5e18b17d-4626-4b6d-8ac6-e560cee0376c	TCGA.24.1419	TCGA-24-1419-D25932	248762ea-e200-4742-b0f3-bcd821f96cf3	2009-4-24	DOCETAXEL	NA	CHEMOTHERAPY	17	FALSE	131	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	806	NA
1018	f64ebc7f-0e5a-42b4-af57-6cdb90d24f90	TCGA.24.1423	TCGA-24-1423-D25939	69287a5a-8ebe-4dbd-b3aa-2c81832c098b	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	21	FALSE	151	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1703	NA
1019	f64ebc7f-0e5a-42b4-af57-6cdb90d24f90	TCGA.24.1423	TCGA-24-1423-D25938	cf137e40-7f33-415e-834a-da9dfb583a3c	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	21	FALSE	151	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	532	NA
1020	f64ebc7f-0e5a-42b4-af57-6cdb90d24f90	TCGA.24.1423	TCGA-24-1423-D25937	dfa0c377-ef42-4909-977c-58d6c1d64fe9	2009-4-16	DOXORUBICIN	NA	CHEMOTHERAPY	21	FALSE	151	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	477	NA
1021	c3e443b9-5dc5-4793-91e3-534f21485268	TCGA.24.1424	TCGA-24-1424-D25942	763af0d0-0624-41b1-bd45-20ace6a3e7c8	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	120	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1441	NA
1022	c3e443b9-5dc5-4793-91e3-534f21485268	TCGA.24.1424	TCGA-24-1424-D25944	2d84d139-9b11-4149-96e4-346b15bfdf3e	2009-4-16	DOCETAXEL	NA	CHEMOTHERAPY	8	FALSE	120	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	429	NA
1023	c3e443b9-5dc5-4793-91e3-534f21485268	TCGA.24.1424	TCGA-24-1424-D25943	528aaae9-7fb0-4b0e-a7c6-1492c1d7808f	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	8	FALSE	120	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	972	NA
1024	b120b701-c194-43d7-a491-3206fac38ec1	TCGA.24.1425	TCGA-24-1425-D25948	4e000e93-7c9c-430e-803d-b235fa58d076	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5065	NA
1025	b120b701-c194-43d7-a491-3206fac38ec1	TCGA.24.1425	TCGA-24-1425-D25949	96ca010b-3b93-4206-8972-2599cf9895cd	2009-5-12	TAXOL	NA	CHEMOTHERAPY	27	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	553	NA
1026	b120b701-c194-43d7-a491-3206fac38ec1	TCGA.24.1425	TCGA-24-1425-D25947	def339b3-1e0a-4329-aaae-7a397dcd76a1	2009-5-12	TAXOTERE	NA	CHEMOTHERAPY	27	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	832	NA
1027	c8acee1b-6854-409b-86ab-bf69dbe22ab6	TCGA.24.1426	TCGA-24-1426-D25954	b9d51cf6-9d92-4497-97a8-30a39aea0f11	2009-4-16	TAXOL	NA	CHEMOTHERAPY	-8	FALSE	142	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	720	NA
1028	c8acee1b-6854-409b-86ab-bf69dbe22ab6	TCGA.24.1426	TCGA-24-1426-D25952	15275f97-b04f-43e1-822e-15c46ca9b9b8	2009-4-16	TAXOTERECIN	NA	CHEMOTHERAPY	-8	FALSE	142	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	780	NA
1029	c8acee1b-6854-409b-86ab-bf69dbe22ab6	TCGA.24.1426	TCGA-24-1426-D25953	ccad2740-e09b-4453-8196-ca0bba953c68	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	-8	FALSE	142	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	900	NA
1030	02d9aa2e-b16a-48ea-a420-5daed9fd51a6	TCGA.24.1427	TCGA-24-1427-D25958	f0961ad4-f0c1-406c-ae2d-9d44d6118237	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3848	NA
1031	02d9aa2e-b16a-48ea-a420-5daed9fd51a6	TCGA.24.1427	TCGA-24-1427-D25957	c30b8039-7ef8-495e-954e-b0985c302c10	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	14	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1996	NA
1032	9c744ff8-1cde-4176-b6d7-0ab62bf42620	TCGA.24.1428	TCGA-24-1428-D25961	d43e79be-c0cc-4f9b-9631-fbaebe20de3a	2009-4-16	DOCETAXEL	NA	CHEMOTHERAPY	46	FALSE	130	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	780	NA
1033	9c744ff8-1cde-4176-b6d7-0ab62bf42620	TCGA.24.1428	TCGA-24-1428-D25962	b79259a9-f490-4eb8-b109-250dc9b3e2bb	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	46	FALSE	130	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	900	NA
1034	9c744ff8-1cde-4176-b6d7-0ab62bf42620	TCGA.24.1428	TCGA-24-1428-D25963	5548e7d7-b1dd-43fa-8ccc-db41342a5281	2009-4-16	PACLITAXEL	NA	CHEMOTHERAPY	46	FALSE	130	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	600	NA
1035	9c744ff8-1cde-4176-b6d7-0ab62bf42620	TCGA.24.1428	TCGA-24-1428-D25964	acd19c02-f634-4947-b1d5-33ce6ddcd4f5	2010-6-11	CARBPLATIN	NA	CHEMOTHERAPY	466	FALSE	508	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1519	NA
1036	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25968	4630dd23-dba3-4101-8d84-62b9fd51dfa3	2009-5-12	TAXOL	NA	CHEMOTHERAPY	22	FALSE	106	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1252	NA
1037	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25971	bafc8e9f-3310-409a-9129-50f29f23b38d	2009-5-12	DOXIL	NA	CHEMOTHERAPY	568	FALSE	624	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	177	NA
1038	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25973	26fd89d8-c384-4c27-8f76-e8fa42667511	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	652	FALSE	769	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1960	NA
1039	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25969	ada775a9-b4ec-43c5-bf11-7533cd8667cd	2009-5-12	AMITOSTINE	NA	CHEMOTHERAPY	22	FALSE	106	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5301	NA
1040	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25972	3194f6fd-af01-4f55-ba85-50eb0bd7af8e	2009-5-12	TAXOL	NA	CHEMOTHERAPY	652	FALSE	769	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	128	NA
1041	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25967	574ea0f6-0c98-43ed-a8c7-3bf90f81ae70	2009-5-12	CISPLATIN	NA	CHEMOTHERAPY	22	FALSE	106	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	539	NA
1042	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25975	2a8e83d3-0e03-4a92-ac3d-9db1c4104de4	2009-5-12	GOMZAR	NA	CHEMOTHERAPY	804	FALSE	841	NA	NA	NA	NA	1.5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5150	NA
1043	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25974	a3db39b6-eb97-47a8-8e64-cb0d8de8ffab	2009-5-12	DOXIL	NA	CHEMOTHERAPY	804	FALSE	841	NA	NA	NA	NA	1.5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	81	NA
1044	3018efe7-13a1-47ae-a726-8fc967c73841	TCGA.24.1430	TCGA-24-1430-D25970	cbaf76a6-ae77-42d5-8ff7-fdc31b7a31bb	2009-5-12	TOPOTECAN	NA	CHEMOTHERAPY	463	FALSE	547	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	44.88	NA
1045	384170fc-e8be-426a-a54e-bf1ca61f2986	TCGA.24.1431	TCGA-24-1431-D25982	db569566-3e65-423b-89ee-f96f8dd2ae9d	2009-5-12	DOXIL	NA	CHEMOTHERAPY	329	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1046	384170fc-e8be-426a-a54e-bf1ca61f2986	TCGA.24.1431	TCGA-24-1431-D25978	f75d63b3-e5e9-4e08-a119-43aa095dec60	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	147	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1047	384170fc-e8be-426a-a54e-bf1ca61f2986	TCGA.24.1431	TCGA-24-1431-D25979	e647deaf-bd3a-46ee-929f-aec2930b59d4	2009-5-12	TAXOL	NA	CHEMOTHERAPY	42	FALSE	147	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1048	384170fc-e8be-426a-a54e-bf1ca61f2986	TCGA.24.1431	TCGA-24-1431-D25980	bb8a8867-a1b4-46fb-8c6d-fb1b8f31fcfe	2009-5-12	TOPOTECAN	NA	CHEMOTHERAPY	262	FALSE	308	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1049	384170fc-e8be-426a-a54e-bf1ca61f2986	TCGA.24.1431	TCGA-24-1431-D25981	e6f0b81a-42c2-40cb-b3a4-e2fa19737f34	2009-5-12	TAXOTERE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1050	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25985	e6cc7a45-81ef-4091-9c90-12614add799c	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	45	FALSE	228	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	284	NA
1051	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25988	dd5e3e6f-08f9-4449-8085-6d08ee8f8737	2009-5-12	TOPOTECAN	NA	CHEMOTHERAPY	281	FALSE	314	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	24	NA
1052	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25986	7daf51fd-b9e9-40ab-8923-3827104240b3	2009-5-12	TAXOL	NA	CHEMOTHERAPY	45	FALSE	228	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1890	NA
1053	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25987	6114e4ae-ce79-42ec-a860-ff6e8be5c913	2009-5-12	GEMZET	NA	CHEMOTHERAPY	45	FALSE	228	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	16000	NA
1054	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25991	d5d87b8c-f2a7-4933-952a-d6d64697e9b0	2009-5-12	TAXOL	NA	CHEMOTHERAPY	496	FALSE	535	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	756	NA
1055	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25990	5335c47b-38e3-47d8-ba92-73a859a8d43b	2009-5-12	ETOPOSIDE	NA	CHEMOTHERAPY	395	FALSE	426	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	4200	NA
1056	5503b3a1-7d03-41b2-9ec8-e478c5414d67	TCGA.24.1434	TCGA-24-1434-D25989	d46e3ac3-da2a-4655-b0e8-04190ea91652	2009-5-12	DOXIL	NA	CHEMOTHERAPY	343	FALSE	371	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	160	NA
1057	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D26000	2833bed6-7480-43d9-b6d1-4528bb4bc1ac	2009-5-12	GEMAR	NA	CHEMOTHERAPY	1140	FALSE	1189	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6952	NA
1058	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D25995	a4a2e768-8d66-4eef-9a7e-e24397ed1287	2009-5-12	TOPOTECAN	NA	CHEMOTHERAPY	511	FALSE	771	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	135.9	NA
1059	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D25999	ceab1fa5-5738-4e60-9100-6e0a1b677193	2009-5-12	CISPLATIN	NA	CHEMOTHERAPY	1140	FALSE	1189	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	263	NA
1060	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D26001	11036e12-450c-404f-99fd-492656d8bc80	2009-5-12	TOPOTECAN	NA	CHEMOTHERAPY	1259	FALSE	1266	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	9.63	NA
1061	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D25996	6094c2cf-43ec-43b8-a9ec-8e21041440e4	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	814	FALSE	912	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2350	NA
1062	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D25998	cf7b733e-4265-4eab-9822-3974d73a0a34	2009-5-12	TAXOL	NA	CHEMOTHERAPY	1058	FALSE	1126	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4500	NA
1063	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D25994	b65aacb1-c5bb-431b-b422-9d3a5053f383	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	149	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3590	NA
1064	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D25997	ceaae508-8082-4f39-b5d5-356e4dba9b75	2009-5-12	DOXIL	NA	CHEMOTHERAPY	944	FALSE	1028	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	286	NA
1065	49d2c0cf-a3f3-4519-a755-0a5f769df2ea	TCGA.24.1435	TCGA-24-1435-D26002	4308a2a0-1e10-4c84-bc45-6ecfc1e7729b	2009-5-15	TAXOL	NA	CHEMOTHERAPY	27	FALSE	149	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1848	NA
1066	6e84e89d-4f35-43b8-b47d-b1343b8c1ab9	TCGA.24.1436	TCGA-24-1436-D26006	af7ffeda-3c58-4d51-a79b-eb8aac840cf2	2009-5-12	TAXOL	NA	CHEMOTHERAPY	24	FALSE	135	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1282	NA
1067	6e84e89d-4f35-43b8-b47d-b1343b8c1ab9	TCGA.24.1436	TCGA-24-1436-D26007	82fcfea2-5e77-496f-9bc7-3f26570982f2	2009-5-12	TOPOTECAN	NA	CHEMOTHERAPY	157	FALSE	223	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	28.25	NA
1068	6e84e89d-4f35-43b8-b47d-b1343b8c1ab9	TCGA.24.1436	TCGA-24-1436-D26005	075db38d-494a-43d6-87ac-701eef1c15bb	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	135	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2730	NA
1069	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26020	ed822373-fdf3-4ff0-b016-89d6d3a79706	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	1742	FALSE	1791	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	168	NA
1070	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26019	f8497cc1-74f7-4707-81d7-cd60360edb9b	2009-4-16	TAXOL	NA	CHEMOTHERAPY	1600	FALSE	1733	NA	NA	NA	NA	17	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2275	NA
1071	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26012	c98d3bb2-e60e-4279-b057-73e950818533	2009-4-16	TAXOL	NA	CHEMOTHERAPY	976	FALSE	1084	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1660	NA
1072	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26015	3b745d08-afcc-48eb-8a61-35314bdb9ee8	2009-4-16	TOPOTECAN	NA	CHEMOTHERAPY	1270	FALSE	1383	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	49.4	NA
1073	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26014	a858e299-ace2-4e04-928c-9a5938100d07	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	976	FALSE	1084	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	172	NA
1074	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26017	6510eb77-3a5d-419f-980b-ca3687eb0f83	2009-4-16	GEMCITABINE	NA	CHEMOTHERAPY	1465	FALSE	1558	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	20684	NA
1075	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26018	1d34f8bd-3209-421a-a381-503783bec76d	2009-4-16	DOXIL	NA	CHEMOTHERAPY	1465	FALSE	1558	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	277	NA
1076	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26011	e6da954d-4e2e-4695-8f5e-e641e746c8e5	2009-4-16	TAXOL	NA	CHEMOTHERAPY	18	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1712	NA
1077	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26010	cfa3c675-5453-420f-81dd-b11485a4d8de	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3310	NA
1078	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26013	9a2292f5-c1c1-4c34-baa7-75659a6b31a0	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	976	FALSE	1084	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1895	NA
1079	171f7917-69eb-4a3f-9cc0-0e1dffd412c1	TCGA.24.1463	TCGA-24-1463-D26016	094334ef-5942-45f8-ab0a-d1b1ef328303	2009-4-16	NAVELBINE	NA	CHEMOTHERAPY	1270	FALSE	1383	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	508	NA
1080	4160e048-f0b0-40f5-805b-e277a5893a3b	TCGA.24.1464	TCGA-24-1464-D26023	00cf7ce9-c07f-4dad-9bb6-c753b989cc0a	2009-4-24	TAXOL	NA	CHEMOTHERAPY	28	FALSE	163	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1937	NA
1081	4160e048-f0b0-40f5-805b-e277a5893a3b	TCGA.24.1464	TCGA-24-1464-D26024	b1703138-84c6-4bae-8a50-718ca2ebde6f	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	163	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5555	NA
1082	4160e048-f0b0-40f5-805b-e277a5893a3b	TCGA.24.1464	TCGA-24-1464-D26025	5610bcd5-4bfb-40ee-bdd7-15c71555094a	2009-5-12	TOPTECAN	NA	CHEMOTHERAPY	342	FALSE	343	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	8.44	NA
1083	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26033	f173fa84-796d-4b1c-a328-63bc667ded63	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	880	FALSE	1020	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3110	NA
1084	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26037	60fd442d-0cea-4420-beb7-74230f801921	2009-4-17	TAMOXIFEN	NA	HORMONE THERAPY	1227	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1085	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26030	c6e44e2b-090b-4e55-bdde-6b44e3a1f501	2009-4-17	TAXOL	NA	CHEMOTHERAPY	12	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1715	NA
1086	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26032	95c8c713-2e46-4b1f-ba01-0327f5df424f	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	483	FALSE	680	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3820	NA
1087	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26035	7a193f01-5589-49f8-affe-87258ba73206	2009-4-17	TOPETECAN	NA	CHEMOTHERAPY	1081	FALSE	1216	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	57.6	NA
1088	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26036	d560fa78-e2e9-4912-a9de-fefea60898f4	2009-4-17	TAMOXIFEN	NA	HORMONE THERAPY	670	FALSE	852	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	RECURRENCE	NA	20	NA
1089	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26031	565fb3ee-a4c7-4150-a80f-4b2abfcc9bc0	2009-4-17	TAXOL	NA	CHEMOTHERAPY	483	FALSE	680	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1904	NA
1090	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26029	e6de86e0-4434-4398-93ab-507903ddf2e5	2009-4-17	CARBOPLATIN	NA	CHEMOTHERAPY	12	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3502	NA
1091	098acb76-0bf5-44e5-bcae-f919cf5fa5e5	TCGA.24.1466	TCGA-24-1466-D26034	da59a6a9-6e33-407b-aaca-6d930603d936	2009-4-17	TAXOL	NA	CHEMOTHERAPY	880	FALSE	1020	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1564	NA
1092	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26046	b48c9b58-4f39-41a9-9475-781a87ef06c1	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	1804	TRUE	1909	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	600	NA
1093	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26049	27368d0d-fbd6-44f4-b65c-ac5ae2b8380a	2009-4-16	DOXIL	NA	CHEMOTHERAPY	2476	TRUE	2531	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	240	NA
1094	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26057	7e70652e-a5d0-4f50-9fc4-8343dabac54a	2009-4-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	2819	FALSE	2889	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3610	NA
1095	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26041	79b8d114-bedd-4c6e-b9af-333a85dc5a85	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	6	TRUE	110	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4565	NA
1096	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26050	4599a840-cb0a-43d2-9461-c29b7c3f9a0b	2009-4-16	DOXETAXEL	NA	CHEMOTHERAPY	2561	TRUE	2737	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1350	NA
1097	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26042	fb26dbaa-2ce9-4a77-94dd-c1e3a03fd281	2009-4-16	TAXOL	NA	CHEMOTHERAPY	1277	TRUE	1391	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1780	NA
1098	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26044	46af543c-9421-4864-823d-c9ad5d81850d	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	1277	TRUE	1391	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	400	NA
1099	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26048	2789fe54-3b24-476b-bbaa-b6003d617c4d	2009-4-16	NAVELBINE	NA	CHEMOTHERAPY	2170	TRUE	2296	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	600	NA
1100	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26045	825e30c9-5a77-4cd9-8b02-62cb9cb2000f	2009-4-16	TAXOL	NA	CHEMOTHERAPY	1804	TRUE	1909	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1620	NA
1101	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26052	0deb02e0-1be4-4b66-9b33-f2ab838a750e	2009-4-16	CYTOXEN	NA	CHEMOTHERAPY	2819	TRUE	2889	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	50	NA
1102	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26054	a4acf824-ec0d-4ff6-a1e2-2e4dbe449d6a	2009-4-16	TOPOTECAN	NA	CHEMOTHERAPY	3073	TRUE	3101	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	21	NA
1103	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26055	7f1be972-6b5d-41cc-8707-73ef55706f5a	2009-4-16	TAMOXIFEN	NA	HORMONE THERAPY	2363	TRUE	2458	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	20	NA
1104	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26043	ed7b02b2-b81a-44b4-a476-72c61e8c5558	2009-4-16	CARBOPLATIN	NA	CHEMOTHERAPY	1277	TRUE	1391	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1275	NA
1105	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26051	f10bb298-cef0-480a-a2aa-c2cfba674c88	2009-4-16	CISPLATIN	NA	CHEMOTHERAPY	2561	TRUE	2737	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	115	NA
1106	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26058	faac15d8-07b9-42b6-908d-b0fbc92e4927	2009-4-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	2989	FALSE	3059	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	8871	NA
1107	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26053	ec830e30-41a6-4b9d-bcf9-ab281700ff79	2009-4-16	DOXIL	NA	CHEMOTHERAPY	2989	TRUE	3059	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	240	NA
1108	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26056	d9d6017a-251c-4150-b37a-91c584273b99	2009-4-16	TAMOXIFEN	NA	HORMONE THERAPY	2758	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	20	NA
1109	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26040	03fc29d1-6abc-40fe-ace3-74f6a4214538	2009-4-16	TAXOL	NA	CHEMOTHERAPY	6	FALSE	110	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2650	NA
1110	34f545ab-d420-4dd2-8db4-3159896efd23	TCGA.24.1467	TCGA-24-1467-D26047	2b31a6de-3753-4ca2-91a0-03eb6c130d67	2009-4-16	TOPOTECAN	NA	CHEMOTHERAPY	2170	TRUE	2296	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	60	NA
1111	cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56	TCGA.24.1469	TCGA-24-1469-D26061	0669881e-ea31-48f5-a8fb-5f91b62e6e9c	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	135	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1112	cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56	TCGA.24.1469	TCGA-24-1469-D26062	8b7e3c93-43ce-4a4c-88e0-eebfe8e5373a	2009-5-13	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	135	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1113	a3898640-0d85-441d-a000-b5b8ff857399	TCGA.24.1470	TCGA-24-1470-D26066	c67a8709-2f8f-4d07-b3d0-548234c86b68	2009-5-12	CISPLATIN	NA	CHEMOTHERAPY	17	FALSE	83	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	593	NA
1114	a3898640-0d85-441d-a000-b5b8ff857399	TCGA.24.1470	TCGA-24-1470-D26065	521e955c-b121-4399-9a5b-4e665a6d8c53	2009-5-12	DOCETAXEL	NA	CHEMOTHERAPY	17	FALSE	83	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	475	NA
1115	a3898640-0d85-441d-a000-b5b8ff857399	TCGA.24.1470	TCGA-24-1470-D26067	3285d027-0f38-45a6-807c-92ef0d27504d	2009-5-12	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	83	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
1116	ceb19678-b453-4529-b6cb-d02f9cb101b4	TCGA.24.1471	TCGA-24-1471-D26070	9214c29b-a67f-4762-9ca0-9297a0bad8ac	2010-5-24	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1117	ceb19678-b453-4529-b6cb-d02f9cb101b4	TCGA.24.1471	TCGA-24-1471-D26071	789f5290-ddbc-4a16-8398-ab5cb498b563	2010-5-24	GOG 218	NA	TARGETED MOLECULAR THERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1118	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	TCGA.24.1474	TCGA-24-1474-D26075	bfeee902-a018-4e6e-bb1d-38e6dfa8586a	2009-5-13	TAXOL	NA	CHEMOTHERAPY	18	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1962	NA
1119	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	TCGA.24.1474	TCGA-24-1474-D26077	2a00f718-f1e2-4eff-bc7f-5b77b5f35bc2	2009-5-13	GEMZAR	NA	CHEMOTHERAPY	454	FALSE	635	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2365	NA
1120	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	TCGA.24.1474	TCGA-24-1474-D26074	df02a6f7-9b82-42f2-acf8-938d8e6af6f3	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4050	NA
1121	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	TCGA.24.1474	TCGA-24-1474-D26078	a604ab2b-1244-4582-aeb7-42765d3a9923	2009-5-13	DOXIL	NA	CHEMOTHERAPY	454	FALSE	635	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	302	NA
1122	d7b3156d-672a-4a55-868d-9ca6a09fcb0f	TCGA.24.1474	TCGA-24-1474-D26076	eecac960-1b19-4854-beb4-ab67384cee3a	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	350	FALSE	431	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	57	NA
1123	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	TCGA.24.1544	TCGA-24-1544-D26085	b0f731bc-150c-4aa5-a5e0-66f092fb26cd	2009-7-28	TAXOL	NA	CHEMOTHERAPY	533	FALSE	638	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2500	NA
1124	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	TCGA.24.1544	TCGA-24-1544-D26086	0270a543-8f1d-42a0-a604-ddd1749bb8cd	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	777	FALSE	799	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	595	NA
1125	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	TCGA.24.1544	TCGA-24-1544-D26083	accbdf55-0909-4132-b4d5-18989608b05f	2009-7-28	TAXOL	NA	CHEMOTHERAPY	18	FALSE	203	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1356	NA
1126	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	TCGA.24.1544	TCGA-24-1544-D26081	6cf2832e-8a89-462e-8fea-dd6919a4d1a1	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	203	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3080	NA
1127	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	TCGA.24.1544	TCGA-24-1544-D26084	20b56992-e730-4408-b8ea-3e27d43407b5	2009-7-28	DOXIL	NA	CHEMOTHERAPY	243	FALSE	470	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT STABEL DISEASE	2100	NA
1128	21f6bf91-dfc6-4a59-8b76-88a0f95c7b47	TCGA.24.1544	TCGA-24-1544-D26082	10643fbe-cd7a-449d-97de-e788fcb322c4	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	18	FALSE	203	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12.6	NA
1129	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26092	47004f32-ba26-4d9c-be14-611ebf3f5dd9	2009-7-27	DOXIL	NA	CHEMOTHERAPY	973	FALSE	1028	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	165	NA
1130	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26095	f2c12ae2-10b5-4066-b8c4-2538743a8fff	2009-7-27	NAVELBINE	NA	CHEMOTHERAPY	1203	FALSE	1238	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	215	NA
1131	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26091	bca3bc2d-ed36-41e0-afc3-d899ba451903	2009-7-27	TOPOTECAN	NA	CHEMOTHERAPY	867	FALSE	951	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	42	NA
1132	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26094	7eae83cf-f8b8-4002-aaa2-c10132f7fdf4	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	1056	FALSE	1169	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3068	NA
1133	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26089	55f6d8ae-116b-4664-9b7c-dbdb2cccac10	2009-7-27	TAXOL	NA	CHEMOTHERAPY	14	FALSE	285	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2520	NA
1134	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26093	e4f6dcef-e36c-4d69-973e-66292bb6d9c3	2009-7-27	TAXOL	NA	CHEMOTHERAPY	1056	FALSE	1169	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1476	NA
1135	f2ec64f5-a414-4c34-99c7-d59bc4e831e0	TCGA.24.1545	TCGA-24-1545-D26090	63fb1c9b-e07e-4a55-a88e-be3534fd87fc	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	285	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5750	NA
1136	9e7d3dea-5d81-4f10-819c-1c2a68ddd150	TCGA.24.1546	TCGA-24-1546-D26099	2c1b2afb-5dba-4ecc-b390-b8169b0edfdb	2009-7-24	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1137	9e7d3dea-5d81-4f10-819c-1c2a68ddd150	TCGA.24.1546	TCGA-24-1546-D26098	16c5f27e-162a-4104-9911-29d227cfd46c	2009-7-24	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1138	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26105	b8403ea4-d3d0-4ac1-982d-8b6fc8f73f25	2009-7-28	CISPLATIN	NA	CHEMOTHERAPY	221	FALSE	242	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	250	NA
1139	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26102	82b896d7-b3b2-420c-b7aa-bb20459cf97c	2009-7-28	TAXOL	NA	CHEMOTHERAPY	6	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1750	NA
1140	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26106	6839976c-7816-4663-8ed7-41c9acf7ae7a	2009-7-28	DOXIL	NA	CHEMOTHERAPY	272	FALSE	327	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	197	NA
1141	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26104	73e950cc-b96f-4ae2-8983-c7c368a066b6	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	221	FALSE	242	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	10	NA
1142	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26103	aeccb39c-034f-423f-ae71-332c7ac802aa	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4790	NA
1143	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26108	f51b5aad-7380-4d3e-894d-a8addb1a7404	2009-7-28	NAVELBINE	NA	CHEMOTHERAPY	351	FALSE	443	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1144	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26107	89cd8691-38f2-4991-86dd-3e97bde5b0a1	2009-7-28	GEMCITABINE	NA	CHEMOTHERAPY	351	FALSE	443	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1145	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26109	4530176e-75d6-434b-8d76-b4de9496cde5	2009-7-28	TAXOL	NA	CHEMOTHERAPY	475	FALSE	488	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	360	NA
1146	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26110	e6eb5a6a-9561-4c32-9425-50299638e15e	2009-7-29	TAXOL	NA	CHEMOTHERAPY	6	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1750	NA
1147	66c92b9e-de3c-4d1a-bb69-46ffbc6caf33	TCGA.24.1548	TCGA-24-1548-D26111	1d635a63-88f6-4118-aede-37e239476d22	2009-7-29	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4790	NA
1148	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26122	48e4085b-04cf-45c7-aa48-96f5b687e896	2009-5-12	VP16	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1149	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26127	eb07e660-7282-4a69-af97-edc6838f09b4	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1150	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26115	9b813b03-b91a-4d45-a2b3-3fb971350e7c	2009-5-12	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1151	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26119	58e05d89-9a97-460f-ad0e-e15e4bfc2277	2009-5-12	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1152	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26120	f0686f43-a6af-4c6c-8a21-ba3f086ff822	2009-5-12	GEMZAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1153	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26126	1896232b-3242-4294-a28e-cb7b347ad760	2009-5-12	XELODA	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1154	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26114	678cf3de-c647-4e78-b3d1-7540322bb15b	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1155	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26118	d80cf401-7c03-46d9-811a-35f6ca35de19	2009-5-12	TOPTECAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1156	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26121	91dafd17-6ac1-41ec-a1fa-16d7af1f1a24	2009-5-12	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1157	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26124	b98c19e8-a11c-4161-9d42-53caa322ca87	2009-5-12	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1158	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26125	dd2a3437-2db9-4766-a79d-c31bbbc85e04	2009-5-12	TAXOTERE	NA	CHEMOTHERAPY	1518	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1159	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26117	e6e97277-54e1-4889-9cfd-2defde4c7f2f	2009-5-12	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1160	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26123	50c23ce7-dc88-463e-b3d3-46f14ecb21d9	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1161	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26128	c6fa6de4-b848-4745-9dd7-3f0fdad55379	2009-5-12	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1162	3b81ec7c-0934-4649-9231-9919dd26dd15	TCGA.24.1549	TCGA-24-1549-D26116	924adb2e-a095-4a4f-8783-fc6f490f2f3c	2009-5-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1163	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26134	57b1a47e-8ee1-430f-947c-2aa9308fe0a5	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	986	FALSE	1107	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4200	NA
1164	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26131	216cba1d-50e3-40b2-83a8-1c94cf9b2c59	2009-5-13	TAXOL	NA	CHEMOTHERAPY	8	FALSE	174	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2070	NA
1165	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26136	4a1b352e-113a-4b57-8c5d-a68cd3a08e2e	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1164	FALSE	1211	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1950	NA
1166	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26133	816567f8-959f-4ac6-881e-af02c374aea7	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	902	FALSE	965	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	405	NA
1167	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26132	4ab59025-4c19-46a1-8a2f-10774327df1b	2009-5-13	CISPLATIN	NA	CHEMOTHERAPY	8	FALSE	174	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	165	NA
1168	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26135	06c0b8ce-5bc9-4141-b182-d5e9235ad517	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1164	FALSE	1211	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	837	NA
1169	1858b58f-fdf4-413c-9c29-96ae85b88a74	TCGA.24.1550	TCGA-24-1550-D26137	c32b99a6-9f34-4281-9364-de59a8a6f66c	2009-5-13	DOXIL	NA	CHEMOTHERAPY	1233	FALSE	1233	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	64	NA
1170	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26140	b10b8c3a-9710-41f3-bd63-884d87cc52a3	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	10	FALSE	135	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4140	NA
1171	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26143	9df28b30-f8dc-426a-865e-15ce20302858	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	842	FALSE	975	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3600	NA
1172	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26146	a38abeb3-1386-434d-b0b9-71f5beff97c4	2009-5-13	DOXIL	NA	CHEMOTHERAPY	1549	FALSE	1549	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
1173	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26142	ec427308-ea67-43e0-9b4e-a4c9e2db1d3e	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	790	FALSE	790	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	12.5	NA
1174	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26145	7960a8b0-06e3-44a3-886f-bfae511a0a3d	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1289	FALSE	1437	NA	NA	NA	NA	19	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3020	NA
1175	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26144	cb2ba36d-6d1b-4a6a-b054-158386921e0c	2009-5-13	DOXIL	NA	CHEMOTHERAPY	1227	FALSE	1254	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	160	NA
1176	499a9b57-ee1a-4012-bbab-c6ad955b5e0a	TCGA.24.1551	TCGA-24-1551-D26141	76c2ecc7-ea48-46b9-8b1f-e4f6186921fc	2009-5-13	TAXOL	NA	CHEMOTHERAPY	10	FALSE	135	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2080	NA
1177	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26150	ecf05a0e-1a8f-4c2b-9370-808c3f91f4ba	2009-5-13	TAXOL	NA	CHEMOTHERAPY	53	FALSE	265	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1178	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26152	2c4df149-3420-49af-ac83-0c6141b6cb6e	2009-5-13	DOXIL	NA	CHEMOTHERAPY	728	FALSE	851	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	350	NA
1179	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26155	8712ebf0-ac5c-4247-9ef9-0182dfcbe756	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1044	FALSE	1170	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1925	NA
1180	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26151	c1aee209-7e03-4455-8b8d-d94c99b25758	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	479	FALSE	587	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1181	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26149	98b74f89-c75a-4ca7-93bf-6870cf515821	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	53	FALSE	265	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1182	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26154	f3e0bfc1-9550-4386-a99e-ea615344961c	2009-5-13	AMITOSTINE	NA	CHEMOTHERAPY	876	FALSE	1030	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4325	NA
1183	62379be5-13f0-474b-94d3-6f944ec4ee96	TCGA.24.1552	TCGA-24-1552-D26153	b0251e28-66c8-4d66-8438-ae12f29c7ff0	2009-5-13	TAXOL	NA	CHEMOTHERAPY	876	FALSE	1030	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	822	NA
1184	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26161	802977b2-5136-4d4c-b3fe-39420081c9ba	2009-5-13	TAXOL	NA	CHEMOTHERAPY	566	FALSE	735	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1740	NA
1185	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26169	4ab24572-b866-4291-91b9-130da20b76d5	2009-5-13	TAMOXIFEN	NA	HORMONE THERAPY	1243	FALSE	1293	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	20	NA
1186	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26166	97353178-8b14-4304-83e8-5d36dbcc9d0d	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1309	FALSE	1623	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3800	NA
1187	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26164	3aadf80a-15eb-4f7c-a794-8d20c2571504	2009-5-13	GEMZAR	NA	CHEMOTHERAPY	944	FALSE	1224	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	29746	NA
1188	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26159	f6cf4869-e5f8-4d25-80ea-1d2edb7be439	2009-5-13	TAXOL	NA	CHEMOTHERAPY	17	FALSE	154	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1732	NA
1189	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26158	2022d5b4-4eb4-4828-a336-9b0339315ee4	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	154	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2715	NA
1190	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26167	0786542b-f7dd-4a39-96a6-561bf1c5f560	2009-5-13	XELODA	NA	CHEMOTHERAPY	1659	FALSE	1691	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	6000	NA
1191	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26162	e9f1ebec-2d11-4a31-9f6b-8611497ee60d	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	864	FALSE	1283	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	70.2	NA
1192	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26165	bad48395-48e1-49eb-ae95-8f224ae67640	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1309	FALSE	1623	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3360	NA
1193	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26160	2c52a49d-a429-4fc4-b3a6-b0a71736b176	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	566	FALSE	735	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3360	NA
1194	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26163	5c874880-be44-4e11-b790-426708bd6e46	2009-5-13	DOXIL	NA	CHEMOTHERAPY	944	FALSE	1224	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	448	NA
1195	08c64000-d320-4e4d-974b-da503d48890c	TCGA.24.1553	TCGA-24-1553-D26168	ab504577-5032-4dd4-a101-1013de5f8513	2009-5-13	DOXIL	NA	CHEMOTHERAPY	1735	FALSE	1735	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	63	NA
1196	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26175	5cae58de-79d6-40a8-84e3-4d5435b373f1	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1959	FALSE	2050	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1197	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26180	91c2f17b-0c3a-45d7-b649-490b80802943	2009-5-13	DOXIL	NA	CHEMOTHERAPY	2506	FALSE	2628	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1198	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26182	117ed049-353f-465d-82bb-1ff4b61c6dec	2009-5-13	TAXOL	NA	CHEMOTHERAPY	2635	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1199	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26173	63def26d-2198-4012-9d2a-e17538649b95	2009-5-13	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1200	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26178	79c1118b-b324-4d35-bca4-9e7825ae7d64	2009-5-13	TAXOL	NA	CHEMOTHERAPY	2262	FALSE	2415	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1201	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26174	5bbe4103-b205-4f8a-88e4-ff87713c9481	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	1563	FALSE	1928	NA	NA	NA	NA	16	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1202	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26177	9ad7092e-7bb7-47d4-87d0-49c8ac554e44	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	2262	FALSE	2415	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1203	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26172	b0e7bfa1-aa6f-4875-a333-1d37969df73a	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1204	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26176	bc8f5f9c-8a23-44d0-a253-3a6cc0100be1	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1959	FALSE	2050	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1205	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26179	ffd29f9d-1824-4e15-b2b2-aea9b65e04e0	2009-5-13	GEMZAR	NA	CHEMOTHERAPY	2506	FALSE	2628	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1206	5d36676e-4140-44b5-aa0e-b2af092b7dc0	TCGA.24.1555	TCGA-24-1555-D26181	50740da7-ca0d-45d3-b7ca-7fe04e0bfc2d	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	2635	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1207	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26185	7e3fdad5-f18b-4551-8eac-a51ba6bf4320	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1208	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26190	d5ae144a-c41e-497b-9f77-a10744c020b8	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	1724	FALSE	1832	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1209	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26186	5525035e-275d-4663-86b4-e8498b97943e	2009-7-28	CYTOXAN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1210	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26189	9c0ce3f1-7ff4-48b3-81d4-8462c10b43b4	2009-7-28	CISPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1211	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26187	ce8d232a-8763-494e-a177-a4bc0bd01733	2009-7-28	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1212	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26191	3384e1f5-7a6b-474c-bcbb-ea510df68def	2009-7-28	TAXOTERE	NA	CHEMOTHERAPY	1724	FALSE	1832	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1213	7592a659-7175-486f-a16e-24a4b4365a36	TCGA.24.1556	TCGA-24-1556-D26188	b8d6bbad-95c7-45ab-a561-b962d3d39d4f	2009-7-28	TOPTECAN	NA	CHEMOTHERAPY	539	FALSE	628	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1214	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26197	c496b3e4-ce90-4e94-9a46-55bb27442fe7	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	27	FALSE	281	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	14.7	NA
1215	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26195	386a4c8c-a9a8-45a8-b364-458ce1968c66	2009-7-28	TAXOL	NA	CHEMOTHERAPY	27	FALSE	281	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3392	NA
1216	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26202	df63e12d-81ee-4689-a57a-d0e15aac56bc	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	462	FALSE	623	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5350	NA
1217	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26205	c9831383-8169-4c19-a7ad-fc3cc27c0a65	2009-7-28	CISPLATIN	NA	CHEMOTHERAPY	875	FALSE	1008	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	670	NA
1218	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26199	52dafb0c-43cf-4792-8ac6-5c637bc5b87d	2009-7-28	GEMZAR	NA	CHEMOTHERAPY	368	FALSE	445	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10980	NA
1219	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26200	e57199e1-666f-4ecf-bb4b-4ea3ddd7b2f1	2009-7-28	DOXIL	NA	CHEMOTHERAPY	368	FALSE	445	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	175	NA
1220	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26203	baf86572-a1d7-42d3-aeaf-8d2fa5a4b4ee	2009-7-28	TAXOL	NA	CHEMOTHERAPY	644	FALSE	727	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1300	NA
1221	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26206	7dbeeb29-0d9a-4b2f-91ea-d8d37e26e1f0	2009-7-28	GEMZAR	NA	CHEMOTHERAPY	875	FALSE	1008	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	12240	NA
1222	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26198	debe84cc-e3d6-4000-a882-d98d3c8a6ba4	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	300	FALSE	347	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	32.4	NA
1223	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26207	ba3ef76c-2125-4d51-9389-53fbe45038ce	2009-7-28	TAXOTERE	NA	CHEMOTHERAPY	1027	FALSE	1069	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	424	NA
1224	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26210	a3727227-4be8-4f2a-af72-e123a4b9fa28	2009-7-28	NA	NA	HORMONE THERAPY	765	FALSE	873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PALLIATIVE	NA	NA	NA
1225	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26196	64f69477-8db0-43cf-9bac-2ae1b6f59698	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	281	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6250	NA
1226	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26208	1cc3aa32-4736-449f-ac47-a04687665f87	2009-7-28	TAXOL	NA	CHEMOTHERAPY	1090	FALSE	1154	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1300	NA
1227	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26201	9b12afd7-4c83-4a87-acfa-6bdb3ac8bc09	2009-7-28	TAXOL	NA	CHEMOTHERAPY	462	FALSE	623	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2600	NA
1228	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26204	522480c7-725f-40d4-86d9-911d47a79860	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	754	FALSE	798	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	45.5	NA
1229	7dcc809b-e33a-4453-b92a-c00786f48cb0	TCGA.24.1557	TCGA-24-1557-D26209	6680f2b7-6970-4e51-a357-8755f0d0e451	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	1090	FALSE	1154	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2315	NA
1230	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26218	63155ebc-160a-4045-a54a-e81db14d275a	2009-7-28	GEMCITABINE	NA	CHEMOTHERAPY	515	FALSE	588	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	11810	NA
1231	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26219	7e540806-6473-46d6-a1ed-008e4c59cd9e	2009-7-28	DOXIL	NA	CHEMOTHERAPY	403	FALSE	487	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	277	NA
1232	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26217	4c049036-fc07-4cb7-aefb-4b246a630259	2009-7-28	TAXOTERE	NA	CHEMOTHERAPY	316	FALSE	382	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT DISEASE TREAMENT	524	NA
1233	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26214	e59ea4e0-2e2c-4f4a-942b-7efb1c0870fe	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	247	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	43.75	NA
1234	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26215	ec054464-9e15-41b0-94b1-a7143163f896	2009-7-28	TAXOL	NA	CHEMOTHERAPY	37	FALSE	247	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
1235	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26213	e3d7f2e6-d2ae-4801-b607-03c8f2c13303	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	37	FALSE	247	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	14.4	NA
1236	ba68f2cf-9271-41fd-9655-1fac7681f588	TCGA.24.1558	TCGA-24-1558-D26216	265b7191-2211-4f94-b21e-ae81322cb380	2009-7-28	GEMCITABINE	NA	CHEMOTHERAPY	316	FALSE	382	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	PERSISTENT DISEASE TREATMENT	3600	NA
1237	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26229	f16bdc03-c3a6-4145-b549-b96b1f1ed982	2009-7-27	GEMZAR	NA	CHEMOTHERAPY	635	FALSE	726	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	15000	NA
1238	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26235	c351ac0b-9b82-4bb8-805d-fa9600249741	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	1216	FALSE	1258	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1640	NA
1239	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26222	b3f798db-b752-4079-b430-8d7d3cea945c	2009-7-27	TAXOL	NA	CHEMOTHERAPY	15	FALSE	117	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1620	NA
1240	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26226	f6f38be5-a3cf-4506-8aff-4ba14246fdc2	2009-7-27	AMITOSTIN	NA	CHEMOTHERAPY	509	FALSE	614	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	7220	NA
1241	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26232	7b14e46a-8a83-4fc5-b3ca-f941f72a255a	2009-7-27	ETOPSIDE	NA	CHEMOTHERAPY	757	FALSE	901	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	OTHER	NA	NA	RECURRENCE	NA	4650	NA
1242	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26227	38a5fbe9-e640-4d56-b32b-034b72d65f5f	2009-7-27	TAXOL	NA	CHEMOTHERAPY	509	FALSE	614	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1730	NA
1243	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26230	a5d8710d-3672-4dda-b17b-f73e9e9c6238	2009-7-27	DOXIL	NA	CHEMOTHERAPY	635	FALSE	726	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	200	NA
1244	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26225	519de3c8-57e8-4eff-b384-e6009fef6629	2009-7-27	TOPOTECAN	NA	CHEMOTHERAPY	398	FALSE	481	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	48	NA
1245	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26228	187361ca-a5d7-4c06-9f76-a4e679d45120	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	509	FALSE	614	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3100	NA
1246	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26231	bfb5f291-5d88-41ff-b188-cd65f7d75f9d	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	757	FALSE	901	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	OTHER	NA	NA	RECURRENCE	NA	2875	NA
1247	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26223	6a13deac-102e-4729-9d5d-1f596ff8ddbd	2009-7-27	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	117	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4620	NA
1248	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26233	eaaa368c-902a-4b74-8d3a-8f1c52f88526	2009-7-27	XELODA	NA	CHEMOTHERAPY	931	FALSE	1015	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	210000	NA
1249	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26234	4cc322ae-a086-4db1-9219-ea8fd592c0b2	2009-7-27	TAXOL	NA	CHEMOTHERAPY	1043	FALSE	1189	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2730	NA
1250	afd92922-b8dc-48bd-a9c0-bc8d95855eb7	TCGA.24.1560	TCGA-24-1560-D26224	c4244ff8-464e-4aca-994a-e9ba64291b6b	2009-7-27	TOPOTECAN	NA	CHEMOTHERAPY	398	FALSE	481	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	48	NA
1251	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26241	983f19e8-c170-4e8c-a957-2fd3136788b3	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	848	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1252	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26242	ee1fa917-d739-42c0-a6a9-ed708dfb432d	2009-5-13	TAXOL	NA	CHEMOTHERAPY	848	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1253	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26246	9953bd31-98a7-4304-9edc-fd8d0a59cea7	2009-5-13	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	1157	NA	NA	NA	NA	10	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1254	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26243	4b34bcc3-f52f-492f-9ba7-1937763104e1	2009-5-13	DOXIL	NA	CHEMOTHERAPY	531	FALSE	642	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	375	NA
1255	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26239	0334ce07-bbcf-45f3-bfca-861ce3612e89	2009-5-13	TAXOL	NA	CHEMOTHERAPY	21	FALSE	152	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1256	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26244	bdfeb5b7-63f2-4a09-ac87-33fa567a3c19	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	677	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1257	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26245	b7064ebb-533d-4713-9120-c9eb84ab6ce2	2009-5-13	TAXOL	NA	CHEMOTHERAPY	677	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1258	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26238	a426f399-4902-40c8-b6d3-f24a234dac4e	2009-5-13	CISPLATIN	NA	CHEMOTHERAPY	21	FALSE	152	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1259	4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e	TCGA.24.1562	TCGA-24-1562-D26240	108a7baa-7cfc-4e5f-b5a3-fd69f3093a19	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	257	FALSE	405	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1260	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26256	0a7b61df-19a5-490f-be5a-3ce579d751d4	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	1183	FALSE	1239	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	24.7	NA
1261	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26257	610a8295-344d-4fd1-9716-df116525edf1	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1402	FALSE	1402	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	459	NA
1262	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26251	dd492ae2-573e-41f7-b671-4cc2cec89e5c	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	408	FALSE	676	NA	NA	NA	NA	14	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	135	NA
1263	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26254	268270d4-d717-41f2-9c43-964163522ded	2009-5-13	DOXIL	NA	CHEMOTHERAPY	812	FALSE	868	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	181	NA
1264	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26252	95408fd7-f755-419a-8146-2263478e1c30	2009-5-13	TAXOL	NA	CHEMOTHERAPY	728	FALSE	805	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1050	NA
1265	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26249	d33a7059-08ca-4bb1-b763-fcaade80c979	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3450	NA
1266	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26255	f65e8c56-e88c-4759-8cb6-66183229fcd6	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	889	FALSE	1061	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3310	NA
1267	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26258	1e096777-3bc5-41f1-94f2-87440512f7e0	2009-5-13	TAMOXIFEN	NA	HORMONE THERAPY	1087	FALSE	1182	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	20	NA
1268	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26253	06e2c625-c9ad-454e-bc58-427688825aeb	2009-5-13	GEMZAR	NA	CHEMOTHERAPY	812	FALSE	868	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2820	NA
1269	52386f66-2877-4c75-894e-5c1dc03e6ef4	TCGA.24.1563	TCGA-24-1563-D26250	bc788a60-417a-421c-8fb6-073e20697b4d	2009-5-13	TAXOL	NA	CHEMOTHERAPY	22	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1910	NA
1270	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26262	4274b50b-6f29-4a5b-8db4-d3a6bf59e040	2009-5-13	TAXOL	NA	CHEMOTHERAPY	8	FALSE	116	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1396	NA
1271	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26265	57fa40c2-e908-4f10-b4a6-d694ac8a1cbd	2009-5-13	AMITOSTINE	NA	CHEMOTHERAPY	248	FALSE	295	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5080	NA
1272	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26267	5ee39715-291f-406e-84f2-8e4b5ba1beab	2009-5-13	DOXIL	NA	CHEMOTHERAPY	435	FALSE	463	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	136	NA
1273	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26271	505397d8-457f-4ff7-8a80-079b34298244	2009-5-13	TAMOXIFEN	NA	HORMONE THERAPY	736	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	20	NA
1274	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26261	f3a01cf8-d968-4223-82cc-bd63aa6e9e04	2009-5-13	CISPLATIN	NA	CHEMOTHERAPY	8	FALSE	116	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	779	NA
1275	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26269	885692fc-e283-4f72-9e5a-3fe4b23f90df	2009-5-13	VP16	NA	CHEMOTHERAPY	589	FALSE	624	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	1500	NA
1276	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26268	2179241a-2d85-45a8-ba4f-489c7af8a09b	2009-5-13	TAXOL	NA	CHEMOTHERAPY	499	FALSE	568	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1496	NA
1277	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26263	51e43b92-611a-4890-9826-27aff4d67584	2009-5-13	TAXOL	NA	CHEMOTHERAPY	248	FALSE	295	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1200	NA
1278	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26264	69a543c6-6550-4db1-a0a8-b9826d22017c	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	248	FALSE	295	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5080	NA
1279	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26270	a5908269-249e-4154-b6c3-3255d80efacf	2009-5-13	GEZMAR	NA	CHEMOTHERAPY	589	FALSE	624	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2462	NA
1280	d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06	TCGA.24.1564	TCGA-24-1564-D26266	550d7621-efda-4cae-917c-292e022877ba	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	333	FALSE	406	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	32.5	NA
1281	cf1e86ec-4bcb-403c-831b-d67bddef14eb	TCGA.24.1565	TCGA-24-1565-D26277	43054d58-b335-4d70-a5db-42959006cfc5	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	178	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1282	cf1e86ec-4bcb-403c-831b-d67bddef14eb	TCGA.24.1565	TCGA-24-1565-D26275	f520e210-c6e9-48c9-bbff-f257cb97ba74	2009-5-13	TAXOL	NA	CHEMOTHERAPY	39	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1389	NA
1283	cf1e86ec-4bcb-403c-831b-d67bddef14eb	TCGA.24.1565	TCGA-24-1565-D26276	00f13539-fd47-4c29-96ff-381d74b856a4	2009-5-13	CISPLATIN	NA	CHEMOTHERAPY	39	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	774	NA
1284	2cb50c2d-e749-4172-b101-d975507435c5	TCGA.24.1567	TCGA-24-1567-D26282	31ebe1d0-b99f-4a7e-8abb-aa91ab2aec48	2009-7-24	TOPECAN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1285	2cb50c2d-e749-4172-b101-d975507435c5	TCGA.24.1567	TCGA-24-1567-D26281	f43d1ffa-d988-4cc3-acfd-7e4947d8ced1	2009-7-24	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	153	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1286	2cb50c2d-e749-4172-b101-d975507435c5	TCGA.24.1567	TCGA-24-1567-D26280	37c78ac7-dfc0-49fd-903a-05a2a8300aef	2009-7-24	TAXOL	NA	CHEMOTHERAPY	41	FALSE	153	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1287	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26295	38ef06ab-1145-47bd-b309-658243311e65	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	2234	FALSE	2448	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1288	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26294	040db0b8-aff7-4a23-91e1-26379fb0e44c	2009-5-13	TAXOL	NA	CHEMOTHERAPY	2022	FALSE	2203	NA	NA	NA	NA	28	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1289	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26287	faecc8ec-f46c-4ea3-a013-3370d0692293	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1107	FALSE	1181	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1290	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26292	087cc90f-f414-4d12-b7a8-7c94798e1b4c	2009-5-13	GEMZAR	NA	CHEMOTHERAPY	1899	FALSE	1991	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1291	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26285	29019868-73c5-442e-93bb-8e83ea1504ae	2009-5-13	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1292	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26290	931b22e6-c6ab-4846-b1a4-4a22273d74c1	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1356	FALSE	1516	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1293	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26288	5d9979f4-99a7-405a-93ed-dabecce5eacd	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1107	FALSE	1181	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1294	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26296	d4130ac0-ad5f-40f4-bc29-77b8a859e40b	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	2568	FALSE	2629	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1295	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26289	6d56fba5-bc5f-4161-b73f-5a4fa8ee9809	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1356	FALSE	1516	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1296	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26291	f52b3576-79f5-4a6e-917a-2e7962393f43	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	1853	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1297	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26286	3dcddc28-0f92-48c0-81ee-683913402b4d	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1298	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26297	8f14e722-33d5-4063-9ffc-83a6ed940314	2009-5-13	TAXOTERE	NA	CHEMOTHERAPY	2629	FALSE	2629	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1299	19427350-619b-4b9c-a3ba-37f667bb2843	TCGA.24.1603	TCGA-24-1603-D26293	8366500b-f54e-499d-98e4-e46780890b36	2009-5-13	DOXIL	NA	CHEMOTHERAPY	1899	FALSE	1991	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1300	65435f50-a35d-49e3-a36e-b95d9e274ca0	TCGA.24.1604	TCGA-24-1604-D26301	bed4ffb4-9a55-4d58-b397-da646f96aa74	2009-5-13	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1301	65435f50-a35d-49e3-a36e-b95d9e274ca0	TCGA.24.1604	TCGA-24-1604-D26302	85fca390-b524-4247-a5db-7f6c3f76196e	2009-5-13	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1302	65435f50-a35d-49e3-a36e-b95d9e274ca0	TCGA.24.1604	TCGA-24-1604-D26303	b92fd08e-07a3-48f6-8490-99db36a1e4ff	2009-5-13	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1303	65435f50-a35d-49e3-a36e-b95d9e274ca0	TCGA.24.1604	TCGA-24-1604-D26300	6f7f507e-ed71-4327-97f9-50366d7aae44	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1304	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26309	c1b63ae7-ab4d-4099-9c0e-258e497592cb	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	644	FALSE	888	NA	NA	NA	NA	11	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1305	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26311	3d68a968-d13b-4ac5-bf8d-30f04aec9604	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	1010	FALSE	1133	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1306	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26307	cfb807b3-6f3b-4d81-ba3b-b873bc99e8de	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	188	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1307	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26310	d4a208fe-06b7-4a31-929e-0f583e7fb3d7	2009-5-13	NAVELBINE	NA	CHEMOTHERAPY	644	FALSE	888	NA	NA	NA	NA	11	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1308	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26312	fa6b707e-13d5-41cc-baf3-af81fce80495	2009-5-13	TAXOL	NA	CHEMOTHERAPY	1010	FALSE	1133	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1309	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26308	182d6037-89ec-4b51-9376-02ae5255ef66	2009-5-13	TAXOL	NA	CHEMOTHERAPY	22	FALSE	188	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1310	d3164236-c14a-4230-b527-ecd1a3992f02	TCGA.24.1614	TCGA-24-1614-D26313	9e5ef115-0bd9-4e75-b594-70ec7010fc98	2009-5-13	DOXIL	NA	CHEMOTHERAPY	1284	FALSE	1443	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1311	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26319	92f77834-4053-4145-a116-5dcec0326efd	2009-5-13	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1312	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26323	b2d785f8-6f1a-4971-8ce9-822f6d1f7270	2009-5-13	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1313	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26318	2346b95a-8b34-41a1-9489-cea42c9c5fd2	2009-5-13	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1314	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26316	0c8429b0-fc35-4b1c-80fb-413423b37379	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	165	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1315	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26317	0800291c-aa44-4757-aa71-a9006dfb1af0	2009-5-13	TAXOL	NA	CHEMOTHERAPY	18	FALSE	165	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1316	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26322	b0f49dab-9394-4ad9-b5f8-091f90596108	2009-5-13	GEMZAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1317	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26321	668a90a6-760c-44f1-b6b0-791749668e43	2009-5-13	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1318	5d7027f5-60a0-47ab-a79d-667c9acc0e54	TCGA.24.1616	TCGA-24-1616-D26320	6e2e7642-c775-4c35-9930-1c443468a918	2009-5-13	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1319	09c77947-a333-4392-b18d-a6c1f08764a1	TCGA.24.1842	TCGA-24-1842-D26328	df6ea24c-564d-43a8-adf8-78174c16894c	2009-8-24	BEVACIZUMIAB/ VERSUS PLACEBO	NA	TARGETED MOLECULAR THERAPY	43	FALSE	253	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	14331	NA
1320	09c77947-a333-4392-b18d-a6c1f08764a1	TCGA.24.1842	TCGA-24-1842-D26327	740a180c-a931-483e-be25-7580f2c5f4e9	2009-8-24	PACLITAXEL	NA	CHEMOTHERAPY	24	FALSE	253	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2043	NA
1321	09c77947-a333-4392-b18d-a6c1f08764a1	TCGA.24.1842	TCGA-24-1842-D26326	7171dab9-2b07-41ce-92ac-dda733de4616	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	253	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4355	NA
1322	9ec86cbd-8c74-4697-90da-529ab91ab835	TCGA.24.1843	TCGA-24-1843-D26331	e6b12e88-599d-4d24-8628-c3d561b959f1	2009-8-24	TAXOL	NA	CHEMOTHERAPY	20	FALSE	134	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	373	NA
1323	9ec86cbd-8c74-4697-90da-529ab91ab835	TCGA.24.1843	TCGA-24-1843-D26333	56bb4b8e-25cd-4200-8444-4be7bf4dbc66	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	134	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2957	NA
1324	9ec86cbd-8c74-4697-90da-529ab91ab835	TCGA.24.1843	TCGA-24-1843-D26332	eb2bc7df-1c3d-4cb5-8759-e3e1f218165b	2009-8-24	TAXOTERE	NA	CHEMOTHERAPY	20	FALSE	134	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	582	NA
1325	a36a4440-15ef-4837-904b-380a964d16f1	TCGA.24.1844	TCGA-24-1844-D26337	0a33fed2-263a-493b-9cdd-9f88ce31ef9b	2009-8-24	PACLITAXEL	NA	CHEMOTHERAPY	24	FALSE	134	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1285	NA
1326	a36a4440-15ef-4837-904b-380a964d16f1	TCGA.24.1844	TCGA-24-1844-D26338	0839f9cf-d618-4e02-b47c-6400449516f1	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	134	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2660	NA
1327	a36a4440-15ef-4837-904b-380a964d16f1	TCGA.24.1844	TCGA-24-1844-D26336	a38574db-890c-452c-abb7-3c28b26d82af	2009-8-24	DOCETAXEL	NA	CHEMOTHERAPY	24	FALSE	134	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	405	NA
1328	a782352e-c4bb-4c3e-ba82-456a47c3689a	TCGA.24.1845	TCGA-24-1845-D26341	648e66f9-bb04-47e6-b0b3-5924e9d57a16	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	72	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1169	NA
1329	a782352e-c4bb-4c3e-ba82-456a47c3689a	TCGA.24.1845	TCGA-24-1845-D26343	83aed886-8165-445f-9927-bd928274d9fe	2009-8-24	CISPLATIN	NA	CHEMOTHERAPY	72	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	469	NA
1330	a782352e-c4bb-4c3e-ba82-456a47c3689a	TCGA.24.1845	TCGA-24-1845-D26344	3eb57026-ad81-47df-b3f8-c4a97364c200	2009-8-24	PACLIATXEL	NA	CHEMOTHERAPY	72	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	118	NA
1331	a782352e-c4bb-4c3e-ba82-456a47c3689a	TCGA.24.1845	TCGA-24-1845-D26342	bd50326e-286b-406c-93da-ac4a34f33bb0	2009-8-24	DOXETAXEL	NA	CHEMOTHERAPY	72	FALSE	123	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	603	NA
1332	67f526f1-def5-43b4-bc89-154baae190fc	TCGA.24.1846	TCGA-24-1846-D26347	b64016e1-72c8-4a3b-8f11-3dc2a09dd64b	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	43	FALSE	175	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3800	NA
1333	67f526f1-def5-43b4-bc89-154baae190fc	TCGA.24.1846	TCGA-24-1846-D26348	f815ee22-1cf2-484f-a4bf-7ee83a32679e	2009-8-24	PACLITAXEL	NA	CHEMOTHERAPY	43	FALSE	175	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1173	NA
1334	21966708-4e66-4211-add0-f1515b09e362	TCGA.24.1847	TCGA-24-1847-D26353	c4a831bf-4848-4384-ba02-f802c9f681c4	2009-7-24	TAXOL	NA	CHEMOTHERAPY	28	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	687	NA
1335	21966708-4e66-4211-add0-f1515b09e362	TCGA.24.1847	TCGA-24-1847-D26351	1b6a9f6f-1592-436b-800f-4e4d1a19ba98	2009-7-24	TAXOTERE	NA	CHEMOTHERAPY	28	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	733	NA
1336	21966708-4e66-4211-add0-f1515b09e362	TCGA.24.1847	TCGA-24-1847-D26352	d01c128c-796e-4aa3-9939-631fc9179bbc	2009-7-24	CIPLASTIN	NA	CHEMOTHERAPY	28	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	862	NA
1337	94efd4f9-69b0-4efa-8a0c-61106e898fdd	TCGA.24.1849	TCGA-24-1849-D26357	400d2f6c-3fea-402d-95b7-44939bd2741c	2009-8-24	DOCETAXEL	NA	CHEMOTHERAPY	36	FALSE	141	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	696	NA
1338	94efd4f9-69b0-4efa-8a0c-61106e898fdd	TCGA.24.1849	TCGA-24-1849-D26356	0521934a-f71f-4439-9f05-99c3eb435b47	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	36	FALSE	141	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3306	NA
1339	b6b607cd-67b8-4c04-a212-a4e8c0743f05	TCGA.24.1850	TCGA-24-1850-D26360	f7c53c2b-1b5d-48ce-9a74-26affe5d69ee	2009-8-24	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	138	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3138	NA
1340	b6b607cd-67b8-4c04-a212-a4e8c0743f05	TCGA.24.1850	TCGA-24-1850-D26361	2be1a502-15f0-4f43-b7ec-c94679b5e0d4	2009-8-24	TAXOTERE	NA	CHEMOTHERAPY	34	FALSE	138	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	706	NA
1341	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26370	e7eb9218-249e-49ad-b914-a39276408ee6	2010-2-26	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	1709	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1342	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26367	df90f7fb-b62b-48db-af5d-7c531637e2c2	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	1071	FALSE	1255	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1343	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26365	55c0ae4e-b446-4d4c-b6f0-4e29ecf218c0	2010-2-26	TAXOL	NA	CHEMOTHERAPY	6	FALSE	128	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1344	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26368	2daf9300-1112-4263-8c24-998de2e397b3	2010-2-26	TAXOL	NA	CHEMOTHERAPY	1071	FALSE	1255	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1345	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26364	4fbaa045-8c1a-4562-8a14-027c36c47dc8	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	128	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1346	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26369	416cb486-e33c-42e3-a36f-a9a39252ecd5	2010-2-26	TAXOTERE	NA	CHEMOTHERAPY	1497	FALSE	1558	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1347	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26366	41abc427-0a0a-417c-bdac-62964cd28fc6	2010-2-26	TOPOTECAN	NA	CHEMOTHERAPY	1010	FALSE	1040	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
1348	d48fff14-9413-40a7-a09c-41f12bbe0aa9	TCGA.24.1852	TCGA-24-1852-D26371	f16113a4-2994-442f-a585-2f7a08d53101	2010-2-26	GEMZAR	NA	CHEMOTHERAPY	NA	FALSE	1709	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1349	97efb80d-4f46-4aef-b95e-20d260de01b2	TCGA.24.1920	TCGA-24-1920-D26376	60e3adc8-609a-4ba5-823a-c75a423ac0b5	2010-2-3	TAXOL	NA	CHEMOTHERAPY	24	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	224	NA
1350	97efb80d-4f46-4aef-b95e-20d260de01b2	TCGA.24.1920	TCGA-24-1920-D26374	d93c627d-3367-4275-af6c-0f3fb99702c6	2010-2-3	TAXOTERE	NA	CHEMOTHERAPY	24	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	540	NA
1351	97efb80d-4f46-4aef-b95e-20d260de01b2	TCGA.24.1920	TCGA-24-1920-D26377	7df933df-bf58-41f3-81b9-772e4f0b5960	2010-2-3	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	593	NA
1352	97efb80d-4f46-4aef-b95e-20d260de01b2	TCGA.24.1920	TCGA-24-1920-D26375	dbe3b69a-5471-42c9-b8e2-7f0a3447efca	2010-2-3	CISPLATIN	NA	CHEMOTHERAPY	24	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	354	NA
1353	8449955f-42d9-46f6-919a-5cc5d59e6284	TCGA.24.1923	TCGA-24-1923-D26383	dd656b25-2f04-4167-937f-f3d8b4434a9c	2010-2-19	TOPOTECAN	NA	CHEMOTHERAPY	383	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1354	8449955f-42d9-46f6-919a-5cc5d59e6284	TCGA.24.1923	TCGA-24-1923-D26381	ea59cc77-d039-49f3-9ebc-8a903228c266	2010-2-19	TAXOL	NA	CHEMOTHERAPY	35	FALSE	233	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1355	8449955f-42d9-46f6-919a-5cc5d59e6284	TCGA.24.1923	TCGA-24-1923-D26380	6472b85a-ce8f-4dd6-b255-8d215538af3f	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	233	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1356	8449955f-42d9-46f6-919a-5cc5d59e6284	TCGA.24.1923	TCGA-24-1923-D26382	8c315697-557b-4e11-9d30-223d743a4782	2010-2-19	DOXIL	NA	CHEMOTHERAPY	35	FALSE	233	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1357	8449955f-42d9-46f6-919a-5cc5d59e6284	TCGA.24.1923	TCGA-24-1923-D26384	aa10be72-fe56-4ef3-9a71-3abf202da29c	2010-6-4	GOG182	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1358	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26393	e36c9e00-fc2f-4c5e-b431-98eba3c2118a	2010-2-26	GEMZAR	NA	CHEMOTHERAPY	597	FALSE	681	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	7914	NA
1359	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26387	c723aeb5-e5fe-484c-99f6-21e20b245735	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2595	NA
1360	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26391	5f75fd73-f687-48f7-9cc1-f4a8ec07679b	2010-2-26	NAVELBINE	NA	CHEMOTHERAPY	553	FALSE	583	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	184	NA
1361	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26392	ad26b9f3-a159-4558-87f5-8659e0f24ca6	2010-2-26	CISPLATIN	NA	CHEMOTHERAPY	597	FALSE	681	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	441	NA
1362	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26388	56f40dff-03e0-4832-bcad-78ced0f5ca2a	2010-2-26	TAXOL	NA	CHEMOTHERAPY	21	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1621	NA
1363	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26390	6afe2675-ab28-4150-b5ab-93fa07fdbd99	2010-2-26	TOPOTECAN	NA	CHEMOTHERAPY	553	FALSE	583	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	18.4	NA
1364	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26394	b0797198-ab1c-487a-8587-9d4b65e76dd1	2010-2-26	HEXALEN	NA	CHEMOTHERAPY	706	FALSE	743	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	12600	NA
1365	26558703-a659-43f2-86cb-0695989bc14e	TCGA.24.1924	TCGA-24-1924-D26389	e22e432e-4877-404e-b67c-452eaeef5a91	2010-2-26	DOXIL	NA	CHEMOTHERAPY	329	FALSE	525	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	576	NA
1366	8c47ae58-91c7-4247-b420-50f31f5eb00d	TCGA.24.1927	TCGA-24-1927-D26397	86eca33e-cb34-4166-9875-5c1d0a83466b	2010-3-1	TAXOL	NA	CHEMOTHERAPY	15	FALSE	132	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1587	NA
1367	8c47ae58-91c7-4247-b420-50f31f5eb00d	TCGA.24.1927	TCGA-24-1927-D26401	ad8c1787-5794-4bc3-95ed-0ed4f4b84efa	2010-3-1	SCH 58500	NA	TARGETED MOLECULAR THERAPY	15	FALSE	132	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	4200	NA
1368	8c47ae58-91c7-4247-b420-50f31f5eb00d	TCGA.24.1927	TCGA-24-1927-D26399	a191ec4f-2b7b-4766-8c5b-1bad03dbc5d3	2010-3-1	GAMINOCAMPTOTHECIN	NA	CHEMOTHERAPY	293	FALSE	328	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3750	NA
1369	8c47ae58-91c7-4247-b420-50f31f5eb00d	TCGA.24.1927	TCGA-24-1927-D26398	d7b1885b-3bef-4eb1-996e-229cbcd78c8d	2010-3-1	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	132	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3947	NA
1370	8c47ae58-91c7-4247-b420-50f31f5eb00d	TCGA.24.1927	TCGA-24-1927-D26400	2ecf64b7-e849-4d43-bf62-b9e2074a9a34	2010-3-1	AMINOPTERIN	NA	CHEMOTHERAPY	372	FALSE	435	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	8100	NA
1371	b45c543a-40d9-423a-a7fa-98e4b325b487	TCGA.24.1928	TCGA-24-1928-D26404	84aa9ced-7dc3-4ffe-88f5-66e7f23074ad	2010-3-15	TAXOL	NA	CHEMOTHERAPY	14	FALSE	126	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1130	NA
1372	b45c543a-40d9-423a-a7fa-98e4b325b487	TCGA.24.1928	TCGA-24-1928-D26406	bd6a4fde-5afb-48cc-a6cd-6538eb9a0726	2010-3-15	TAXOTERE	NA	CHEMOTHERAPY	156	FALSE	226	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	560	NA
1373	b45c543a-40d9-423a-a7fa-98e4b325b487	TCGA.24.1928	TCGA-24-1928-D26408	f968a12b-04f3-4647-a29c-b5af2d7f610a	2010-3-15	ETOPOSIDE	NA	CHEMOTHERAPY	327	FALSE	NA	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	1200	NA
1374	b45c543a-40d9-423a-a7fa-98e4b325b487	TCGA.24.1928	TCGA-24-1928-D26405	e3a4fc7d-f026-495c-ba6e-a47f284cbba8	2010-3-15	CISPLATIN	NA	CHEMOTHERAPY	14	FALSE	126	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	537	NA
1375	b45c543a-40d9-423a-a7fa-98e4b325b487	TCGA.24.1928	TCGA-24-1928-D26407	c759afb6-7464-4e2e-ba2c-560abc41b8d8	2010-3-15	DOXIL	NA	CHEMOTHERAPY	254	FALSE	282	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	138	NA
1376	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26413	42a297e9-ec61-4400-8745-73b1640c5461	2010-4-5	CISPLATIN	NA	CHEMOTHERAPY	14	FALSE	274	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	518	NA
1377	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26418	9086fde0-9ee3-4bd6-b4a4-5d839da5a442	2010-4-5	TAXOL	NA	CHEMOTHERAPY	1112	FALSE	1112	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	305	NA
1378	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26426	49444753-00db-4017-92ca-a382d843fd92	2010-4-5	CISPLATIN	NA	CHEMOTHERAPY	2164	FALSE	2325	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	896	NA
1379	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26420	02605ba7-d542-46e5-bcfe-98776bd33895	2010-4-5	DOXIL	NA	CHEMOTHERAPY	1331	FALSE	1389	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	218	NA
1380	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26417	a301ab51-acb4-43f8-aa33-f545f90b0e05	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	1112	FALSE	1112	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	450	NA
1381	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26412	ca6822ec-a578-4121-b321-ab2c95e1258f	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	274	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4020	NA
1382	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26424	463db060-351c-40c4-879a-df2335f578fb	2010-4-5	NAVELBINE	NA	CHEMOTHERAPY	2052	FALSE	2144	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	448	NA
1383	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26414	e547bd75-7dc8-4f1b-842e-a0194ce97a1a	2010-4-5	AMITOSTIN	NA	CHEMOTHERAPY	14	FALSE	274	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1960	NA
1384	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26421	dc04c370-83b2-43a7-9056-046e157157ab	2010-4-5	GEMCITABINE	NA	CHEMOTHERAPY	1422	FALSE	1475	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	11435	NA
1385	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26415	a9a826f0-b068-4db5-8615-3b2a585578f0	2010-4-5	OVAREX/PLACEBO	NA	CHEMOTHERAPY	547	FALSE	631	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
1386	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26411	cb1b0037-5317-42e9-aa49-71ed0d133007	2010-4-5	TAXOL	NA	CHEMOTHERAPY	14	FALSE	274	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2286	NA
1387	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26416	204bad86-3701-46aa-87bf-b90605370054	2010-4-5	TOPOTECAN	NA	CHEMOTHERAPY	726	FALSE	1083	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	95.4	NA
1388	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26419	1c7de380-a8bf-42e1-bcc3-74884e150e50	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	1135	FALSE	1275	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3170	NA
1389	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26423	95d84403-e2dd-44a7-8788-27ee16d4f0a1	2010-4-5	TOPOTECAN	NA	CHEMOTHERAPY	2052	FALSE	2144	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	44.8	NA
1390	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26425	6363893c-0be6-4cef-8d0f-77cddb3d53fc	2010-4-5	GEMZAR	NA	CHEMOTHERAPY	2164	FALSE	2325	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	23008	NA
1391	62efb5ae-43dc-4a4c-a898-6cd9c6dba027	TCGA.24.1930	TCGA-24-1930-D26422	72bb79de-05db-4399-a015-de42d19cbb55	2010-4-5	HEXAMETHYMELAMINE	NA	CHEMOTHERAPY	1492	FALSE	1684	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	49	NA
1392	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26439	19d878df-30b8-4dd0-8ac9-22b938ca4021	2010-3-1	TAXOL	NA	CHEMOTHERAPY	2235	FALSE	2298	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1225	NA
1393	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26440	940f4776-0977-4739-bfab-c2d2ea68f56f	2010-3-1	CARBOPLATIN	NA	CHEMOTHERAPY	2593	FALSE	2757	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1394	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26436	aa45d459-df46-4429-a1eb-c4b7b073ebfd	2010-3-1	TAXOL	NA	CHEMOTHERAPY	745	FALSE	940	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3024	NA
1395	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26434	7aa60143-74ad-4409-a132-ccd6e17d4473	2010-3-1	CARBOPLATIN	NA	CHEMOTHERAPY	274	FALSE	414	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2013	NA
1396	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26433	329ca615-a2d4-49ba-bb76-8766d1c58663	2010-3-1	TAXOL	NA	CHEMOTHERAPY	274	FALSE	414	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1836	NA
1397	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26432	af49fe20-8feb-40e3-bd7f-02304f1d85f4	2010-3-1	CISPLATIN	NA	CHEMOTHERAPY	44	FALSE	176	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1032	NA
1398	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26437	da54104e-edf3-496d-9bb4-0a3e21627587	2010-3-1	TOPOTECAN	NA	CHEMOTHERAPY	1381	FALSE	1555	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	77	NA
1399	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26438	16ff8ab0-dc3b-4e6e-83fe-68792b53fed2	2010-3-1	DOXIL	NA	CHEMOTHERAPY	1905	FALSE	2085	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	504	NA
1400	e20ea417-7296-4da8-9fdb-71cd1f45153a	TCGA.24.2020	TCGA-24-2020-D26435	4a4c8d77-7b48-4d12-91cd-d84d72ab935a	2010-3-1	CARBOPLATIN	NA	CHEMOTHERAPY	745	FALSE	940	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2496	NA
1401	5201ee13-2aed-4641-9169-4d5ee07a23da	TCGA.24.2023	TCGA-24-2023-D26443	e6e1767b-c704-4c4c-a6fa-108c9024c4a7	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	214	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5775	NA
1402	5201ee13-2aed-4641-9169-4d5ee07a23da	TCGA.24.2023	TCGA-24-2023-D26445	e8d6fbd5-5369-4e58-8efe-8b2f82ce54d6	2010-3-16	CISPLATIN	NA	CHEMOTHERAPY	273	FALSE	502	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	450	NA
1403	5201ee13-2aed-4641-9169-4d5ee07a23da	TCGA.24.2023	TCGA-24-2023-D26447	b78b10cb-7049-4c3c-b560-95defbc79e0a	2010-3-16	TAXOL	NA	CHEMOTHERAPY	1126	FALSE	1245	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2100	NA
1404	5201ee13-2aed-4641-9169-4d5ee07a23da	TCGA.24.2023	TCGA-24-2023-D26444	723fff60-9a4d-4926-9ddc-5c109565804f	2010-3-16	TAXOL	NA	CHEMOTHERAPY	6	FALSE	214	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2151	NA
1405	5201ee13-2aed-4641-9169-4d5ee07a23da	TCGA.24.2023	TCGA-24-2023-D26446	16528892-89f9-4770-a7b5-a9fa9bde5046	2010-3-16	CYTOXAN	NA	CHEMOTHERAPY	273	FALSE	502	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3000	NA
1406	5201ee13-2aed-4641-9169-4d5ee07a23da	TCGA.24.2023	TCGA-24-2023-D26448	6037de33-2474-48a3-bb85-c4f84c3f0f75	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	1126	FALSE	1245	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2740	NA
1407	0a48873a-092a-4b25-822b-b0b3c18c08a8	TCGA.24.2024	TCGA-24-2024-D26453	38b75d0f-1ca9-4064-b1e6-b5137f0d86bf	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	456	FALSE	568	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3533	NA
1408	0a48873a-092a-4b25-822b-b0b3c18c08a8	TCGA.24.2024	TCGA-24-2024-D26454	b6880a72-50bd-41c7-b4b8-360e632eb75c	2010-2-26	TAXOL	NA	CHEMOTHERAPY	456	FALSE	568	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2444	NA
1409	0a48873a-092a-4b25-822b-b0b3c18c08a8	TCGA.24.2024	TCGA-24-2024-D26452	a14ae0bf-eabb-413b-8ff0-8caa2797bc01	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	10	FALSE	120	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3348	NA
1410	0a48873a-092a-4b25-822b-b0b3c18c08a8	TCGA.24.2024	TCGA-24-2024-D26451	0b41e156-a9cb-47a8-9417-eade393e92ee	2010-3-15	TAXOL	NA	CHEMOTHERAPY	10	FALSE	120	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1573	NA
1411	2517ca7a-6057-4c19-b7e1-f6d078e9881a	TCGA.24.2026	TCGA-24-2026-D26458	ea8accae-d7ca-4fd7-ad89-da2f1cc2e415	2010-3-15	CISPLATIN	NA	CHEMOTHERAPY	23	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1412	2517ca7a-6057-4c19-b7e1-f6d078e9881a	TCGA.24.2026	TCGA-24-2026-D26457	f88ee7b6-f4e7-481c-9ef4-5fd54df656e6	2010-3-15	TAXOL	NA	CHEMOTHERAPY	23	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1413	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26467	2d2b4a81-4f1d-47a5-a5b0-372469ed0d16	2010-3-15	TAXOL	NA	CHEMOTHERAPY	2048	FALSE	2216	NA	NA	NA	NA	20	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1747	NA
1414	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26465	54208a6d-19e0-4665-a518-330bd875c85b	2010-3-15	CISPLATIN	NA	CHEMOTHERAPY	624	FALSE	784	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	88	NA
1415	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26468	39b52851-9ea8-4dcb-b413-aa58da9233b1	2010-3-15	DOXIL	NA	CHEMOTHERAPY	2400	FALSE	2540	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	400	NA
1416	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26461	2d43a2fe-8c73-4fc0-b6df-5bdf7e245f96	2010-3-15	TAXOL	NA	CHEMOTHERAPY	6	FALSE	258	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3724	NA
1417	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26472	7a0c196f-7579-4417-8df7-250b3790b44e	2010-3-15	TAXOL	NA	CHEMOTHERAPY	2759	FALSE	2951	NA	NA	NA	NA	18	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1108	NA
1418	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26464	67b0bdd5-4fb4-45ad-9910-b53124852ebb	2010-3-15	TAXOL	NA	CHEMOTHERAPY	624	FALSE	784	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1860	NA
1419	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26462	a3364f64-b01d-4bd7-bc80-7f57e825af8f	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	258	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	9838	NA
1420	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26466	f2bd2c6e-2dcd-4f31-a184-ca1b3b57f630	2010-3-15	TOPOTECAN	NA	CHEMOTHERAPY	1614	FALSE	1985	NA	NA	NA	NA	17	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	151	NA
1421	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26470	4629f733-986c-4921-836a-29f1968e7f2c	2010-3-15	CISPLATIN	NA	CHEMOTHERAPY	2577	FALSE	2591	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	83	NA
1422	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26474	f0bcae84-ea4c-4013-ae03-5fcbde163417	2010-3-15	TAXOL	NA	CHEMOTHERAPY	3168	FALSE	3273	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1052	NA
1423	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26463	e1480191-f1f7-4995-a17e-fda2f9dee553	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	624	FALSE	784	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3411	NA
1424	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26469	4e98ff92-93cd-4216-842d-416ba1559929	2010-3-15	GEMZAR	NA	CHEMOTHERAPY	2577	FALSE	2591	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1992	NA
1425	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26471	10a2545f-f218-4b9f-9b3d-a0efb8844d26	2010-3-15	NAVELBINE	NA	CHEMOTHERAPY	2602	FALSE	2745	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	311	NA
1426	219f54ef-4235-482d-b799-f2fa9930105c	TCGA.24.2027	TCGA-24-2027-D26473	abff2c37-622f-462a-9cfd-3f9b51bf3440	2010-3-15	TOPOTECAN	NA	CHEMOTHERAPY	2982	FALSE	3154	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	67.05	NA
1427	bbbf1184-1e19-479a-b31f-daa692d52e02	TCGA.24.2029	TCGA-24-2029-D26477	541eb0c1-a2d4-464c-bdf3-8324f4bbff54	2010-3-15	TAXOL	NA	CHEMOTHERAPY	8	FALSE	218	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1946	NA
1428	bbbf1184-1e19-479a-b31f-daa692d52e02	TCGA.24.2029	TCGA-24-2029-D26478	52b83717-b8f7-4848-add1-2b37c6de9dcb	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	218	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3773	NA
1429	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26481	86e9993c-2161-4fd6-8e3b-d782e8d7b07c	2010-3-16	TAXOL	NA	CHEMOTHERAPY	13	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1064	NA
1430	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26485	5e971953-a98a-4612-bf01-e5f656e45ff8	2010-3-16	TOPOTECAN	NA	CHEMOTHERAPY	864	FALSE	994	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	48	NA
1431	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26487	983be44f-bafd-4148-897e-f00814c3f649	2010-3-16	TAXOL	NA	CHEMOTHERAPY	1176	FALSE	1253	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1100	NA
1432	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26486	f3d03ec6-706d-44d0-a89b-d662bc0bb9ea	2010-3-16	DOXIL	NA	CHEMOTHERAPY	1028	FALSE	1028	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	50	NA
1433	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26483	70169bdf-9305-4494-a6f9-4d83f54bdc26	2010-3-16	TAXOL	NA	CHEMOTHERAPY	657	FALSE	790	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1380	NA
1434	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26488	b3ffba76-89e3-409b-8ffa-d79a8440d978	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	1274	FALSE	1365	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1420	NA
1435	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26484	d7b6b9ee-28f5-434d-9f33-4f7733e9670b	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	657	FALSE	790	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1778	NA
1436	d2ccefea-c1d6-465f-97b1-e51e29c5f1f8	TCGA.24.2030	TCGA-24-2030-D26482	29f56a89-c0a3-487d-8cde-7998973ac418	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	13	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2334	NA
1437	872d2922-7292-4681-adb7-d3b267eccbe7	TCGA.24.2033	TCGA-24-2033-D26494	c32ae140-edf1-44da-b2ae-3eee3ef19553	2010-3-15	HEXALEN	NA	CHEMOTHERAPY	471	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1438	872d2922-7292-4681-adb7-d3b267eccbe7	TCGA.24.2033	TCGA-24-2033-D26492	cf9d8857-7237-4caf-99e5-a79b8fd29421	2010-3-15	TAXOL	NA	CHEMOTHERAPY	38	FALSE	232	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2940	NA
1439	872d2922-7292-4681-adb7-d3b267eccbe7	TCGA.24.2033	TCGA-24-2033-D26491	ef87003d-e997-422d-84af-6d400d8d9cc9	2010-3-15	CARBOPLATIN 6TH	NA	CHEMOTHERAPY	38	FALSE	232	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3020	NA
1440	872d2922-7292-4681-adb7-d3b267eccbe7	TCGA.24.2033	TCGA-24-2033-D26493	3b90cc85-3ff1-4f51-abf7-8d2c3554bda3	2010-3-15	TOPOTECAN	NA	CHEMOTHERAPY	358	FALSE	400	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1441	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26501	1d759db4-e008-4860-82be-d4e68759c228	2010-3-29	TOPOTECAN	NA	CHEMOTHERAPY	343	FALSE	679	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1442	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26499	8b07cdb1-fd20-4693-a570-d3d9a65a391d	2010-3-29	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1443	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26502	66b642e8-83f9-47bc-871f-e6156f363161	2010-3-29	VP16	NA	CHEMOTHERAPY	688	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1444	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26497	7ec23e69-94f3-444b-b7c0-69dec024718f	2010-3-29	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1445	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26503	9b196005-4792-4e49-a9b9-fd9018c4606a	2010-3-29	IFOSTAMIDE	NA	CHEMOTHERAPY	688	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1446	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26500	ed9654da-c2f1-4280-ac44-e22812dd52ef	2010-3-29	PSC833	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1447	062982f8-9f49-425a-99e9-008af5ed9040	TCGA.24.2035	TCGA-24-2035-D26498	baefbf0e-5174-4efb-90d2-283e5f1c4c4c	2010-3-29	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1448	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26509	bc14658b-86a2-4a1f-870a-341bd741fbb8	2010-2-19	TOPOTECAN	NA	CHEMOTHERAPY	592	FALSE	638	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1449	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26507	ee86ed68-4a7a-4351-91fd-30b88a37e9e1	2010-2-19	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	153	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1450	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26511	14225659-0bd5-4f58-a64d-dc0ea9287d74	2010-2-19	TAXOL	NA	CHEMOTHERAPY	1156	FALSE	NA	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1451	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26512	c4ede41b-9b04-4c0d-a118-e94eb903797c	2010-2-19	DOXIL	NA	CHEMOTHERAPY	1430	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1452	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26513	b4e39ce6-689b-42ed-8318-45fc53d4696b	2010-2-19	MITOMYCIN C	NA	CHEMOTHERAPY	1454	FALSE	NA	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1453	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26510	52ed5c3b-9463-4989-be52-0f43c0a1647d	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	1156	FALSE	NA	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1454	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26506	9ad91411-5ada-42b1-8c1b-3cecf1c8b3b4	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	153	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1455	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26514	c7f4e305-74e3-4c1b-9f9c-c33e1ff66512	2010-2-19	TAXOL	NA	CHEMOTHERAPY	1855	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1456	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26515	0d178a19-0839-48c5-92bb-9d47ac316742	2010-2-19	TAMOXIFEN	NA	HORMONE THERAPY	1064	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1457	c9226204-cb61-40b8-8a94-a7e71c14ea3a	TCGA.24.2036	TCGA-24-2036-D26508	11db3802-3c6e-43cf-9b7f-6b6c52a8fa85	2010-2-19	CISPLATIN	NA	CHEMOTHERAPY	592	FALSE	638	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1458	17181157-c9e2-4bd6-8653-f5dce56f9053	TCGA.24.2038	TCGA-24-2038-D26519	d15be7f1-44d9-45a2-aebb-c743ee12a8fe	2010-2-19	TOPOTECAN	NA	CHEMOTHERAPY	1212	FALSE	1254	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	35.2	NA
1459	17181157-c9e2-4bd6-8653-f5dce56f9053	TCGA.24.2038	TCGA-24-2038-D26521	58c875e5-4f1d-46f3-bc72-100d4df55821	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	1268	FALSE	1352	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2345	NA
1460	17181157-c9e2-4bd6-8653-f5dce56f9053	TCGA.24.2038	TCGA-24-2038-D26520	a072c4d8-69e2-471b-8007-4a211bafee54	2010-2-19	TAXOL	NA	CHEMOTHERAPY	1268	FALSE	1352	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1407	NA
1461	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26530	384a517f-ad06-41c1-80f4-3469584c01cf	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	984	FALSE	1112	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4630	NA
1462	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26528	f2497656-b837-4017-8ab0-97d93059374a	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	615	FALSE	718	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2765	NA
1463	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26526	0362e136-d6c8-4db8-93b0-f02785a3ccee	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	165	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3000	NA
1464	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26529	82cbc27a-6761-4f89-b883-f8421831e315	2010-2-19	GEMZAR	NA	CHEMOTHERAPY	984	FALSE	1112	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	16000	NA
1465	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26524	ef5ca1b9-d193-4a6f-bce0-d480174dd9c7	2010-2-19	TAXOL	NA	CHEMOTHERAPY	17	FALSE	165	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2717	NA
1466	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26527	2bf84b24-19c6-4b84-8e8e-c27da4acf2db	2010-2-19	TAXOTERE	NA	CHEMOTHERAPY	615	FALSE	718	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	780	NA
1467	9af2248a-d86a-4277-93b4-8eba5a39bd3c	TCGA.24.2254	TCGA-24-2254-D26525	a12fb8d1-7f50-472a-800a-53b1adcdb84d	2010-2-19	DOXIL	NA	CHEMOTHERAPY	17	FALSE	165	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	233	NA
1468	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	TCGA.24.2260	TCGA-24-2260-D26536	be9c03cb-0688-422d-bbba-c3b8ad80547d	2010-2-26	CYTOXAN	NA	CHEMOTHERAPY	682	FALSE	849	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5810	NA
1469	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	TCGA.24.2260	TCGA-24-2260-D26534	486ab8c1-e67a-4f02-84fc-9d4463840857	2010-2-26	CISPLATIN	NA	CHEMOTHERAPY	24	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	727	NA
1470	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	TCGA.24.2260	TCGA-24-2260-D26535	e69ef23b-4fcd-426c-9680-aba7c3773664	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	682	FALSE	849	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2905	NA
1471	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	TCGA.24.2260	TCGA-24-2260-D26538	ca2ff536-892b-4233-b660-b424a07d9133	2010-2-26	CHLORAMBUCIL	NA	CHEMOTHERAPY	1011	FALSE	1081	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1472	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	TCGA.24.2260	TCGA-24-2260-D26533	0d57b63c-7817-41f7-ac60-a2bdb86ca7e3	2010-2-26	TAXOL	NA	CHEMOTHERAPY	24	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1110	NA
1473	f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b	TCGA.24.2260	TCGA-24-2260-D26537	68704d25-051a-471c-a28e-460d3f9e5802	2010-2-26	HEXALEN	NA	CHEMOTHERAPY	876	FALSE	1009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1474	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26548	be3d0294-80f9-4963-a9e2-1cb9cd844483	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	580	FALSE	793	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	836	NA
1475	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26553	e6f21e39-f7e8-4d1b-bd85-610ce88ab7e9	2010-3-16	CARBOPLATIN #1	NA	CHEMOTHERAPY	1172	FALSE	1332	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	375	NA
1476	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26549	ee87030e-ab29-41cc-ab1f-578c59409e73	2010-3-16	HEXALEN	NA	CHEMOTHERAPY	827	FALSE	946	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1477	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26545	2f85a28c-7869-4a5d-b332-7968861c41ca	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	219	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5570	NA
1478	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26547	04311818-c59d-4fb2-8a48-9c6e708a25de	2010-3-16	TAXOL	NA	CHEMOTHERAPY	580	FALSE	793	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2524	NA
1479	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26555	a457bccc-0352-40de-8b76-62e657783707	2010-3-16	GEMZAR	NA	CHEMOTHERAPY	1347	FALSE	1381	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4560	NA
1480	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26546	e1443b92-f117-4894-90a5-9dce2d137e05	2010-3-16	CYTOXAN	NA	CHEMOTHERAPY	6	FALSE	219	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	7740	NA
1481	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26552	5ac265d1-a02c-4322-b595-e41e47f869dc	2010-3-16	TAXOL	NA	CHEMOTHERAPY	1172	FALSE	1332	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2302	NA
1482	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26551	ac6e2596-885c-4402-bd72-a60cd1a76c62	2010-3-16	TOPOTECAN	NA	CHEMOTHERAPY	1011	FALSE	1011	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2.4	NA
1483	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26550	299c0ea3-e684-4499-8259-f831fced1a2f	2010-3-16	NAVELBINE	NA	CHEMOTHERAPY	983	FALSE	997	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	145	NA
1484	99a61986-7b23-46b5-99a4-efba6bad3766	TCGA.24.2267	TCGA-24-2267-D26554	6bb395af-f4f7-4d4d-9e89-b91f4208e217	2010-3-16	CISPLATIN #2-7	NA	CHEMOTHERAPY	1172	FALSE	1332	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	375	NA
1485	a8c4a333-6b67-44c8-9000-516f8ccea788	TCGA.24.2271	TCGA-24-2271-D26559	6efd5855-3b58-4628-9e62-c993e2ad5554	2010-6-25	NA	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1486	a8c4a333-6b67-44c8-9000-516f8ccea788	TCGA.24.2271	TCGA-24-2271-D26558	9cc98084-f3e0-467d-aac7-d99952fa1fc1	2010-6-25	NA	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1487	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26567	d4c1aa33-8106-4504-b217-27a2fb6accfc	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	906	FALSE	1025	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2882	NA
1488	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26563	2b16b758-e19d-49e6-9459-6aff9e5f60c5	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	178	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4240	NA
1489	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26566	ea7b837d-bd0d-492e-a86c-465e4bf2be80	2010-4-5	TAXOTERE	NA	CHEMOTHERAPY	906	FALSE	1025	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	599	NA
1490	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26562	9c3be379-ed37-4783-be42-e672ea742981	2010-4-5	TAXOL	NA	CHEMOTHERAPY	17	FALSE	178	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2248	NA
1491	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26568	d053512b-b2e1-474b-8f28-2aca5360d223	2010-4-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	906	FALSE	1025	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	57.5	NA
1492	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26564	56d3c465-44f3-4e81-8160-e949e0ad7d63	2010-4-5	DOXIL	NA	CHEMOTHERAPY	17	FALSE	178	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	192	NA
1493	97ad0360-3be4-401a-a94c-7f2800a1b519	TCGA.24.2280	TCGA-24-2280-D26565	4f041d9d-20ed-4b8c-b24e-f02931809265	2010-4-5	DOXIL	NA	CHEMOTHERAPY	538	FALSE	766	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	478	NA
1494	59b3fbfe-0b7c-41e5-b756-ee7e23730df5	TCGA.24.2281	TCGA-24-2281-D26572	15f30f01-7272-4617-84a1-8e94f86f6372	2010-4-5	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1495	59b3fbfe-0b7c-41e5-b756-ee7e23730df5	TCGA.24.2281	TCGA-24-2281-D26571	c3bc6bfa-aeaf-48c8-9afb-72f424b38730	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1496	28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf	TCGA.24.2288	TCGA-24-2288-D26576	f9e65bb5-d987-4920-ba32-65526fa41a72	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	21	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	600	NA
1497	28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf	TCGA.24.2288	TCGA-24-2288-D26575	a60ba99a-bb6f-4c5d-a38b-cb3218c5aeed	2010-2-19	TAXOL	NA	CHEMOTHERAPY	21	FALSE	21	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	350	NA
1498	b867e933-e3e3-4491-9bb6-b18c48d6f173	TCGA.24.2289	TCGA-24-2289-D26580	586feb5d-42b7-4242-945c-dfdd16f8647e	2010-3-16	CISPLATIN	NA	CHEMOTHERAPY	4	FALSE	183	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	645	NA
1499	b867e933-e3e3-4491-9bb6-b18c48d6f173	TCGA.24.2289	TCGA-24-2289-D26579	e30043ad-c281-46eb-9aa1-a49e87ab0647	2010-3-16	TAXOL	NA	CHEMOTHERAPY	4	FALSE	183	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1735	NA
1500	b867e933-e3e3-4491-9bb6-b18c48d6f173	TCGA.24.2289	TCGA-24-2289-D26581	09917dd3-3ce9-4899-8d93-69466b71bdb0	2010-3-16	TAXOTERE	NA	CHEMOTHERAPY	598	FALSE	708	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	957	NA
1501	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26584	53051e26-96ea-4381-935b-d86d4e464e6e	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	119	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4620	NA
1502	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26587	d5c6eadd-a0ce-4465-b7c7-7e3097a30df4	2010-2-19	CARBOPLATIN	NA	CHEMOTHERAPY	349	FALSE	412	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3000	NA
1503	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26591	7019634d-a409-44df-8bad-84a1aca17ae3	2010-2-19	TAXOL	NA	CHEMOTHERAPY	663	FALSE	705	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	780	NA
1504	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26586	7d77c5da-5552-44b1-8c6c-576ffdeebe86	2010-2-19	TAXOL	NA	CHEMOTHERAPY	349	FALSE	412	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1270	NA
1505	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26588	1a112873-89ab-4529-bc98-8ed1d92e82f2	2010-2-19	TOPOTECAN	NA	CHEMOTHERAPY	439	FALSE	550	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	707	NA
1506	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26589	457c381a-169a-40b2-8c7d-830abe8195e0	2010-2-19	TAXOL	NA	CHEMOTHERAPY	578	FALSE	599	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	600	NA
1507	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26590	6e13ad8f-bd41-4fa0-85b0-746ed6cc06d4	2010-2-19	GEMZAR	NA	CHEMOTHERAPY	607	FALSE	614	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	7060	NA
1508	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26593	9886b603-9d94-4810-9353-3667147b2718	2010-2-19	TOPOTECAN	NA	CHEMOTHERAPY	727	FALSE	823	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	60	NA
1509	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26595	8176d176-b9b6-4830-a395-f70cdbb3a561	2010-2-19	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1510	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26585	76e08919-c8aa-463f-94ef-39dd7a978a2f	2010-2-19	TAXOL	NA	CHEMOTHERAPY	7	FALSE	119	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
1511	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26596	347a3fb1-1fa2-4ba3-963c-15dc7ba75973	2010-2-19	TAMOXIFEN	NA	HORMONE THERAPY	1005	FALSE	1055	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1512	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26592	9820826f-3bc0-4f1d-a77a-c94f988b7243	2010-2-19	CISPLATIN	NA	CHEMOTHERAPY	663	FALSE	705	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	279	NA
1513	2b14123b-8fcd-402c-9399-4e7c47f20252	TCGA.24.2290	TCGA-24-2290-D26594	ee1d8054-d6cb-4ac4-a322-4504c3bdf623	2010-2-19	VAMYDEX	NA	CHEMOTHERAPY	855	FALSE	939	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2250	NA
1514	bdd792e7-d75f-4aa3-b38e-f0708e112075	TCGA.24.2293	TCGA-24-2293-D26602	c370ef42-66a2-4812-a7b2-c1a6cfdf941d	2010-2-26	ETOPOSIDE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1515	bdd792e7-d75f-4aa3-b38e-f0708e112075	TCGA.24.2293	TCGA-24-2293-D26600	478b2750-e834-4ab0-9745-79e4791c52ea	2010-2-26	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1516	bdd792e7-d75f-4aa3-b38e-f0708e112075	TCGA.24.2293	TCGA-24-2293-D26603	a3d3ee41-2df1-443f-afc8-12b8d71bb04f	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1517	bdd792e7-d75f-4aa3-b38e-f0708e112075	TCGA.24.2293	TCGA-24-2293-D26601	8050a129-6bfa-4037-8fe8-a5b254002a76	2010-2-26	MELPHALAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1518	bdd792e7-d75f-4aa3-b38e-f0708e112075	TCGA.24.2293	TCGA-24-2293-D26599	259222b7-aa56-4b27-b5c1-a167efcc5a05	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1519	7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1	TCGA.24.2295	TCGA-24-2295-D26609	fa744431-dc45-47a0-aeef-bfff1ee692fc	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	868	NA	NA	NA	NA	14	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2874	NA
1520	7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1	TCGA.24.2295	TCGA-24-2295-D26606	4b24ec33-656b-4372-8c85-24b7baf3e849	2010-4-5	TAXOL	NA	CHEMOTHERAPY	6	FALSE	133	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1591	NA
1521	7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1	TCGA.24.2295	TCGA-24-2295-D26607	def7542e-56d7-45d4-ab76-bbf9b8045491	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	133	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3737	NA
1522	7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1	TCGA.24.2295	TCGA-24-2295-D26608	f6b1b0fe-2b75-479a-a270-6363001de556	2010-4-5	TAXOTERE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1523	7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1	TCGA.24.2295	TCGA-24-2295-D26610	b5f3da82-9a24-4265-b713-fc348932d319	2010-4-5	VP 16	NA	CHEMOTHERAPY	895	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1524	2ab32e11-80d6-4ed0-a42e-da612219bbdd	TCGA.24.2297	TCGA-24-2297-D26614	bade886c-5107-470b-a559-711bc8169b7c	2010-2-26	CYTOXAN	NA	CHEMOTHERAPY	19	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5530	NA
1525	2ab32e11-80d6-4ed0-a42e-da612219bbdd	TCGA.24.2297	TCGA-24-2297-D26613	e6ac7e27-9cfb-4e5a-9db9-eeac915c3e23	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3981	NA
1526	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26617	4027e5e5-c127-453d-b1cd-fed38de4e230	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	12	FALSE	218	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3605	NA
1527	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26621	0d6bb242-0d31-4085-9602-963c9791488c	2010-3-16	TOPOTECAN	NA	CHEMOTHERAPY	762	FALSE	817	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	27.7	NA
1528	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26624	364cb2f7-17b3-4ba1-9c59-a3d286407790	2010-3-16	DOXIL	NA	CHEMOTHERAPY	1454	FALSE	1568	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	308	NA
1529	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26618	fe77059f-2f22-47c8-9eaa-bf0724926c0f	2010-3-16	CYTOXAN	NA	CHEMOTHERAPY	12	FALSE	218	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5830	NA
1530	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26622	14a42edb-bca3-40f7-aeb5-d55e4146512a	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	986	FALSE	1328	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	424	NA
1531	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26619	213e17eb-ff72-482a-b2f0-1bd215af56c4	2010-3-16	CARBOPLATIN	NA	CHEMOTHERAPY	474	FALSE	726	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2477	NA
1532	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26623	f2aedc57-777a-4a52-a35c-d6cb5de91ee1	2010-3-16	NAVELBINE	NA	CHEMOTHERAPY	986	FALSE	1328	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	731	NA
1533	7e4e7914-ec23-4c55-98d6-3c5eecffa8e4	TCGA.24.2298	TCGA-24-2298-D26620	66801fd9-77b5-4227-aed6-30f08f29ad7f	2010-3-16	TAXOL	NA	CHEMOTHERAPY	474	FALSE	NA	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1984	NA
1534	d73a0a33-e4e8-44bd-9580-2038ab06583a	TCGA.25.1313	TCGA-25-1313-D26631	64b80a98-0e23-47cf-bcb1-77881ca35bf0	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	394	FALSE	547	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1535	d73a0a33-e4e8-44bd-9580-2038ab06583a	TCGA.25.1313	TCGA-25-1313-D26630	4f66c38b-6088-4295-adf1-a6dfc5e09598	2009-3-27	CARBO	NA	CHEMOTHERAPY	29	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1536	d73a0a33-e4e8-44bd-9580-2038ab06583a	TCGA.25.1313	TCGA-25-1313-D26629	9a05fe1c-906f-4d7a-9f6e-1d0ff03b187b	2009-3-27	TAXOL	NA	CHEMOTHERAPY	29	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1537	0b2ea4b7-98bb-4190-b682-2c75b447c90a	TCGA.25.1314	TCGA-25-1314-D26634	2bc86970-b813-419d-8821-e2a618a9af3d	2009-3-27	CARBO	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1538	0b2ea4b7-98bb-4190-b682-2c75b447c90a	TCGA.25.1314	TCGA-25-1314-D26636	579ce73b-269e-4c24-894b-9066edf721fb	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	274	FALSE	425	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1539	0b2ea4b7-98bb-4190-b682-2c75b447c90a	TCGA.25.1314	TCGA-25-1314-D26635	547d8656-df9f-4efe-b7be-f94cd726c8b9	2009-3-27	CISPLATINUM	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1540	0b2ea4b7-98bb-4190-b682-2c75b447c90a	TCGA.25.1314	TCGA-25-1314-D26637	56d387be-95f9-4b53-ae0c-c4b479c8a965	2009-3-27	TAXOL	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1541	635f5335-b008-428e-b005-615776a6643f	TCGA.25.1315	TCGA-25-1315-D26642	d4f35481-a6a4-428f-a818-6234b6ced3c3	2009-3-27	CARBO	NA	CHEMOTHERAPY	153	FALSE	334	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1542	635f5335-b008-428e-b005-615776a6643f	TCGA.25.1315	TCGA-25-1315-D26641	c395c2f1-e27d-4a82-81f6-4762e3f4988d	2009-3-27	TAXOL	NA	CHEMOTHERAPY	153	FALSE	334	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1543	635f5335-b008-428e-b005-615776a6643f	TCGA.25.1315	TCGA-25-1315-D26640	38092d51-5b3f-48c2-a4e2-05502242355f	2009-3-27	CISPLATIN	NA	CHEMOTHERAPY	30	FALSE	153	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1544	635f5335-b008-428e-b005-615776a6643f	TCGA.25.1315	TCGA-25-1315-D26643	b8fab70f-4e15-47c4-8b5e-ab9d6db13556	2009-3-27	TAXOL	NA	CHEMOTHERAPY	143	NA	334	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1545	635f5335-b008-428e-b005-615776a6643f	TCGA.25.1315	TCGA-25-1315-D26644	c50db350-ba19-4e40-b7b1-7487af0619b7	2009-3-27	TAXOL	NA	CHEMOTHERAPY	30	FALSE	153	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1546	58427bce-6b81-4083-aeda-25f59e292bbc	TCGA.25.1316	TCGA-25-1316-D26648	367c6a85-9774-4f94-a158-d267423a02ae	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	276	FALSE	406	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1547	58427bce-6b81-4083-aeda-25f59e292bbc	TCGA.25.1316	TCGA-25-1316-D26647	937633f3-8ac6-4073-b96b-b491f465f7f6	2009-3-27	CARBO	NA	CHEMOTHERAPY	61	FALSE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1548	58427bce-6b81-4083-aeda-25f59e292bbc	TCGA.25.1316	TCGA-25-1316-D26649	8c815216-6c85-454c-b0ae-2f590d0c8aef	2009-3-27	TAXOL	NA	CHEMOTHERAPY	61	FALSE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1549	78777a80-cc6c-46c9-a14a-837ac7943719	TCGA.25.1317	TCGA-25-1317-D26652	4415066a-d41d-4847-b874-98a231029cf3	2009-3-27	TAXOL	NA	CHEMOTHERAPY	0	FALSE	31	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1550	78777a80-cc6c-46c9-a14a-837ac7943719	TCGA.25.1317	TCGA-25-1317-D26653	0b21e1d6-b7d7-4509-84fd-30a3a6f2ba0c	2009-3-27	CARBOPLATIN	NA	CHEMOTHERAPY	0	FALSE	31	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1551	13319c20-02f6-4b5f-b24f-3d8f4084094c	TCGA.25.1318	TCGA-25-1318-D26656	9f44ee55-e19b-4469-a2ca-6ca3de3dea19	2009-3-27	TAXOL	NA	CHEMOTHERAPY	30	FALSE	122	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1552	13319c20-02f6-4b5f-b24f-3d8f4084094c	TCGA.25.1318	TCGA-25-1318-D26658	e9dbb616-a754-4560-91d3-70c2166bff27	2009-3-27	TOPETECAN	NA	CHEMOTHERAPY	212	FALSE	273	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1553	13319c20-02f6-4b5f-b24f-3d8f4084094c	TCGA.25.1318	TCGA-25-1318-D26657	34a3d4ed-3134-4055-807f-d263f12fbe00	2009-3-27	CARBO	NA	CHEMOTHERAPY	30	FALSE	122	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1554	914d8613-3c25-4a10-be50-28b42f4d3a5d	TCGA.25.1319	TCGA-25-1319-D26661	c61612c2-a456-4253-97b0-a3354dfbd96a	2009-3-27	CARBO	NA	CHEMOTHERAPY	61	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1555	914d8613-3c25-4a10-be50-28b42f4d3a5d	TCGA.25.1319	TCGA-25-1319-D26662	994fc650-88ad-49bc-83d0-b2f707ef5859	2009-3-27	TAXOL	NA	CHEMOTHERAPY	61	NA	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1556	46395c3d-5e51-477f-946e-e58b87cc7baa	TCGA.25.1320	TCGA-25-1320-D26667	5c3d0e22-0362-45b8-9daf-27c853cebc0f	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	28	NA	181	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1557	46395c3d-5e51-477f-946e-e58b87cc7baa	TCGA.25.1320	TCGA-25-1320-D26665	ace5ad75-8cc5-441f-80ff-875333731b1c	2009-3-27	TAXOL	NA	CHEMOTHERAPY	28	FALSE	181	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1558	46395c3d-5e51-477f-946e-e58b87cc7baa	TCGA.25.1320	TCGA-25-1320-D26666	32ce5448-ce5a-4626-ae66-c2f43005976b	2009-3-27	CARBO	NA	CHEMOTHERAPY	28	NA	181	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1559	46395c3d-5e51-477f-946e-e58b87cc7baa	TCGA.25.1320	TCGA-25-1320-D26668	4494b225-32ae-457c-add4-f6ee7654acec	2009-3-27	DOXIL	NA	CHEMOTHERAPY	424	FALSE	607	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1560	6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d	TCGA.25.1321	TCGA-25-1321-D26671	b6642ab9-ddb0-47d9-847b-edf5d7ad4a7a	2009-3-27	CARBO	NA	CHEMOTHERAPY	28	FALSE	181	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1561	6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d	TCGA.25.1321	TCGA-25-1321-D26674	0a92e43c-03a4-49b0-8988-d565ab0f53b8	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	454	FALSE	498	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1562	6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d	TCGA.25.1321	TCGA-25-1321-D26672	fbb96ad3-036d-4338-b798-0b952467b432	2009-3-27	GEMZAR	NA	CHEMOTHERAPY	28	FALSE	181	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1563	6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d	TCGA.25.1321	TCGA-25-1321-D26673	00fdffad-a9ac-447b-b494-d4c6acc9a1e4	2009-3-27	TAXOL	NA	CHEMOTHERAPY	28	FALSE	181	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1564	b520aae5-65a6-4b27-bc2a-10b02c7b1aeb	TCGA.25.1322	TCGA-25-1322-D26678	1a388ff5-ebda-4497-83dc-d0d6d3229810	2009-3-27	CARBO	NA	CHEMOTHERAPY	30	NA	91	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1565	b520aae5-65a6-4b27-bc2a-10b02c7b1aeb	TCGA.25.1322	TCGA-25-1322-D26677	739c8ffc-668b-4118-a7a3-5e7bf16ec133	2009-3-27	TAXOL	NA	CHEMOTHERAPY	30	FALSE	91	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1566	2ee36d9d-128b-4761-aa1a-a637da106f3d	TCGA.25.1323	TCGA-25-1323-D26681	5457762b-8086-46df-b0f1-b18019f572b8	2009-3-27	DOXIL	NA	CHEMOTHERAPY	365	NA	365	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1567	2ee36d9d-128b-4761-aa1a-a637da106f3d	TCGA.25.1323	TCGA-25-1323-D26683	8f1e9ed6-2060-4f4b-a9db-76db4190ce6a	2009-3-27	CARBO	NA	CHEMOTHERAPY	30	FALSE	122	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1568	2ee36d9d-128b-4761-aa1a-a637da106f3d	TCGA.25.1323	TCGA-25-1323-D26682	bfd7343e-9a15-493c-9b9d-0895f18fde09	2009-3-27	TAXOL	NA	CHEMOTHERAPY	30	FALSE	122	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1569	c73244fd-d486-439f-a94f-fb0bd4e9ac8f	TCGA.25.1324	TCGA-25-1324-D26687	db95bdbb-40b6-444b-b6c7-f8cfd3d260d7	2009-3-27	CARBO	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1570	c73244fd-d486-439f-a94f-fb0bd4e9ac8f	TCGA.25.1324	TCGA-25-1324-D26686	1f668234-3cb1-44c3-b63d-ddd8accfe042	2009-3-27	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1571	07a859fc-6f78-4905-9035-90e2403dbe8d	TCGA.25.1326	TCGA-25-1326-D26692	135291be-0cf9-4eff-a32f-e251268a5f6b	2009-3-27	TOPETECAN	NA	CHEMOTHERAPY	31	FALSE	153	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1572	07a859fc-6f78-4905-9035-90e2403dbe8d	TCGA.25.1326	TCGA-25-1326-D26696	e9376983-d8c4-4462-94bd-b2bdfe55ab02	2009-3-27	DOXIL	NA	CHEMOTHERAPY	396	NA	518	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1573	07a859fc-6f78-4905-9035-90e2403dbe8d	TCGA.25.1326	TCGA-25-1326-D26694	58e93434-8106-4fde-8237-8f06debfac04	2009-3-27	TAXOL	NA	CHEMOTHERAPY	31	NA	153	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1574	07a859fc-6f78-4905-9035-90e2403dbe8d	TCGA.25.1326	TCGA-25-1326-D26693	793c8970-8384-4df9-a64a-7f0044bb4524	2009-3-27	CARBO	NA	CHEMOTHERAPY	31	NA	153	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1575	07a859fc-6f78-4905-9035-90e2403dbe8d	TCGA.25.1326	TCGA-25-1326-D26695	c162c533-1b7a-47a4-9eef-32d33fbd1c44	2009-3-27	TAXOL	NA	CHEMOTHERAPY	31	NA	153	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1576	79fd602b-3e8e-4353-aa78-4f5f170b607d	TCGA.25.1328	TCGA-25-1328-D26700	7cf22dc8-eab8-40af-919b-502e16d6da2a	2009-3-27	CYTOXAN	NA	CHEMOTHERAPY	275	FALSE	395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1577	79fd602b-3e8e-4353-aa78-4f5f170b607d	TCGA.25.1328	TCGA-25-1328-D26703	2bf527ee-a751-4f97-ae92-5d1509de4d83	2009-3-27	CARBO	NA	CHEMOTHERAPY	30	FALSE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1578	79fd602b-3e8e-4353-aa78-4f5f170b607d	TCGA.25.1328	TCGA-25-1328-D26699	35af06d0-1470-4bcc-b7de-b72f7bf5a4e4	2009-3-27	TOPOTECAN	NA	CHEMOTHERAPY	275	FALSE	395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1579	79fd602b-3e8e-4353-aa78-4f5f170b607d	TCGA.25.1328	TCGA-25-1328-D26702	c713fc4f-e804-4cde-9a55-e2302007534c	2009-3-27	TAXOL	NA	CHEMOTHERAPY	30	FALSE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1580	79fd602b-3e8e-4353-aa78-4f5f170b607d	TCGA.25.1328	TCGA-25-1328-D26701	74b4f735-4e91-4cc1-b586-2b6debf758be	2009-3-27	CARBO	NA	CHEMOTHERAPY	275	NA	395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1581	808eb134-9c7d-43bb-b86c-2f3259193954	TCGA.25.1623	TCGA-25-1623-D26708	d9439bd7-877e-492d-85c7-8c04fff9154d	2009-6-17	A202171 PROTOCOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1582	808eb134-9c7d-43bb-b86c-2f3259193954	TCGA.25.1623	TCGA-25-1623-D26709	8a30a7a1-bdd1-481a-bde2-e96b6f7d9ab0	2009-6-17	TAXOL	NA	CHEMOTHERAPY	16	FALSE	138	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1583	808eb134-9c7d-43bb-b86c-2f3259193954	TCGA.25.1623	TCGA-25-1623-D26710	f38d9a87-50ec-4e63-9295-238f9c127577	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	138	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1584	88d61634-913c-435a-8d25-e019c8dab7da	TCGA.25.1625	TCGA-25-1625-D26714	3eac29d8-a7d5-4c20-be59-87f846c18e02	2009-6-15	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1585	88d61634-913c-435a-8d25-e019c8dab7da	TCGA.25.1625	TCGA-25-1625-D26713	cf67ac82-70f1-4f1e-bff1-f4e1f59f7bc0	2009-6-15	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1586	662d77d1-1a43-427a-813b-e11edd30868e	TCGA.25.1626	TCGA-25-1626-D26718	e35ee48a-e2ed-46c0-bc8d-99b1952ba6c4	2009-6-15	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	208	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1587	662d77d1-1a43-427a-813b-e11edd30868e	TCGA.25.1626	TCGA-25-1626-D26719	be7f9a79-ee48-4e2c-a58a-f9c54237084e	2009-6-15	GEMZAR	NA	CHEMOTHERAPY	21	FALSE	208	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1588	662d77d1-1a43-427a-813b-e11edd30868e	TCGA.25.1626	TCGA-25-1626-D26720	65255dd7-ebe5-4226-aa16-7268117cf88c	2009-6-15	DOXIL	NA	CHEMOTHERAPY	319	FALSE	319	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1589	662d77d1-1a43-427a-813b-e11edd30868e	TCGA.25.1626	TCGA-25-1626-D26717	41ec1a22-9d13-48f6-a366-98d7ba9b6812	2009-6-15	TAXOL	NA	CHEMOTHERAPY	21	FALSE	208	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1590	3f917550-89a6-404b-94df-938c99121411	TCGA.25.1628	TCGA-25-1628-D26727	6b515f85-0f51-40e8-a3c8-80ce274d199e	2009-6-17	GEMCITABINE	NA	CHEMOTHERAPY	299	FALSE	350	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1591	3f917550-89a6-404b-94df-938c99121411	TCGA.25.1628	TCGA-25-1628-D26725	60320a2a-a599-48c4-ba83-457f94d9c083	2009-6-17	TAXOL	NA	CHEMOTHERAPY	35	FALSE	182	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1592	3f917550-89a6-404b-94df-938c99121411	TCGA.25.1628	TCGA-25-1628-D26726	3ec7e384-43ab-4947-a08c-80b115ff8ef0	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	35	FALSE	182	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1593	263e85e2-7b6f-453f-8fd0-e5ea1409fece	TCGA.25.1630	TCGA-25-1630-D26730	94a3ddc3-9d4a-47a5-a36a-de3736298c44	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	33	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1594	263e85e2-7b6f-453f-8fd0-e5ea1409fece	TCGA.25.1630	TCGA-25-1630-D26731	9c32d4f7-8cc1-4b59-b283-5ddc42545296	2009-6-17	TAXOL	NA	CHEMOTHERAPY	33	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1595	c435627c-159d-4a6d-a819-30abac24bf4d	TCGA.25.1632	TCGA-25-1632-D26739	4fe0a3f6-7b53-4115-8a2a-7e3d948ed169	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	566	FALSE	719	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1596	c435627c-159d-4a6d-a819-30abac24bf4d	TCGA.25.1632	TCGA-25-1632-D26740	da7c4e92-7f80-4302-aed3-833dc33e5ee6	2009-6-17	TAXOL	NA	CHEMOTHERAPY	566	FALSE	719	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1597	c435627c-159d-4a6d-a819-30abac24bf4d	TCGA.25.1632	TCGA-25-1632-D26738	c6464d1a-44a2-400e-b1bb-9d4bf8921c3a	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	82	FALSE	200	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1598	c435627c-159d-4a6d-a819-30abac24bf4d	TCGA.25.1632	TCGA-25-1632-D26737	48dd2827-21eb-4711-ac76-adb1caa6884d	2009-6-17	TAXOL	NA	CHEMOTHERAPY	82	FALSE	200	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1599	c435627c-159d-4a6d-a819-30abac24bf4d	TCGA.25.1632	TCGA-25-1632-D26736	434bcedc-1d40-4be8-8da0-4c711ac644db	2009-6-17	DOXIL	NA	CHEMOTHERAPY	82	FALSE	200	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1600	20336269-5a5b-4ba7-8fe8-665a1f9af738	TCGA.25.1633	TCGA-25-1633-D26743	926932a0-85d9-4736-b465-0f4c56b8a5af	2009-6-17	TAXOL	NA	CHEMOTHERAPY	26	FALSE	184	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1601	20336269-5a5b-4ba7-8fe8-665a1f9af738	TCGA.25.1633	TCGA-25-1633-D26747	427c83f1-26f0-4fe8-9a55-0084402a72e5	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	617	FALSE	740	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1602	20336269-5a5b-4ba7-8fe8-665a1f9af738	TCGA.25.1633	TCGA-25-1633-D26744	5d315761-84c9-49cf-8c15-eaa878daade1	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	184	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1603	20336269-5a5b-4ba7-8fe8-665a1f9af738	TCGA.25.1633	TCGA-25-1633-D26745	2974ff47-ecb9-4eb0-9fb1-64a7abe5887b	2009-6-17	GEMZAR	NA	CHEMOTHERAPY	26	FALSE	184	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1604	20336269-5a5b-4ba7-8fe8-665a1f9af738	TCGA.25.1633	TCGA-25-1633-D26746	6fbbf988-5e98-4f81-bf14-b1ab4ee1fe6a	2009-6-17	TAXOL	NA	CHEMOTHERAPY	617	FALSE	740	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1605	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	TCGA.25.1634	TCGA-25-1634-D26750	77f0fa9e-4f0e-4ad7-9b9c-164793954696	2009-6-17	TOPTECAN	NA	CHEMOTHERAPY	29	FALSE	206	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1606	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	TCGA.25.1634	TCGA-25-1634-D26753	8e382f61-b38a-43a3-9947-df69a2c74a5b	2009-6-17	TAMOXIFEN	NA	HORMONE THERAPY	380	FALSE	843	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1607	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	TCGA.25.1634	TCGA-25-1634-D26752	677bee05-2917-4607-845e-3e4a39387f0f	2009-6-17	TAXOL	NA	CHEMOTHERAPY	29	FALSE	206	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1608	15556b28-c6bd-455a-87b6-4b7b3e33d0e4	TCGA.25.1634	TCGA-25-1634-D26751	9a6ce675-728d-4759-b42a-6c3646dcff73	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	206	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1609	bc2591b0-65d7-48c3-a5cc-783f67b65869	TCGA.25.1635	TCGA-25-1635-D26757	f2c02abe-3a05-4bc0-914c-48f367820dfa	2009-6-17	TAXOL	NA	CHEMOTHERAPY	24	FALSE	233	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1610	bc2591b0-65d7-48c3-a5cc-783f67b65869	TCGA.25.1635	TCGA-25-1635-D26758	6c145dd3-1953-43e8-8e9d-9837ebbe110c	2009-6-17	GEMZAR	NA	CHEMOTHERAPY	24	FALSE	233	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1611	bc2591b0-65d7-48c3-a5cc-783f67b65869	TCGA.25.1635	TCGA-25-1635-D26759	cedc0d74-6848-4ad4-b8b1-73046c2b6d83	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	233	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1612	bc2591b0-65d7-48c3-a5cc-783f67b65869	TCGA.25.1635	TCGA-25-1635-D26761	71ad95f2-916c-4bfe-8f65-738b7c70f090	2009-6-17	TAXOL	NA	CHEMOTHERAPY	614	FALSE	741	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1613	bc2591b0-65d7-48c3-a5cc-783f67b65869	TCGA.25.1635	TCGA-25-1635-D26760	c428925d-3fb6-46e7-87a4-90747d2e33b9	2009-6-17	CARBOPLATIN	NA	CHEMOTHERAPY	614	FALSE	741	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1614	15f1a992-0724-4d76-a71a-702ac7753a41	TCGA.25.1870	TCGA-25-1870-D26765	4bc62a25-6c3d-4d78-954d-188ffcb588d9	2009-11-20	CYTOXAN	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1615	15f1a992-0724-4d76-a71a-702ac7753a41	TCGA.25.1870	TCGA-25-1870-D26767	b2a59205-5185-49f2-86a8-2afc4d4ccf2b	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	151	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1616	15f1a992-0724-4d76-a71a-702ac7753a41	TCGA.25.1870	TCGA-25-1870-D26764	0b248d06-5a2e-4a14-9ab0-886deac002cc	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1617	15f1a992-0724-4d76-a71a-702ac7753a41	TCGA.25.1870	TCGA-25-1870-D26766	f889655c-9daa-433c-a1a9-86d2e757677e	2009-11-20	CYTOXAN	NA	CHEMOTHERAPY	151	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1618	ff844242-7559-4b07-b09e-69ea40e5ac6b	TCGA.25.1871	TCGA-25-1871-D26771	924836ed-90a7-4364-a68e-5ab77f2c0e5f	2009-11-20	CISPLATIN	NA	CHEMOTHERAPY	47	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1619	ff844242-7559-4b07-b09e-69ea40e5ac6b	TCGA.25.1871	TCGA-25-1871-D26772	c52ffe62-beb4-4e65-8800-9ad2f5d6ddc3	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	47	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1620	ff844242-7559-4b07-b09e-69ea40e5ac6b	TCGA.25.1871	TCGA-25-1871-D26770	d92a92dd-9124-458e-bc3c-4809ba6811c5	2009-11-20	TAXOL	NA	CHEMOTHERAPY	233	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1621	077079c3-6877-467b-b9cc-5c650aae4f07	TCGA.25.1877	TCGA-25-1877-D26776	cd38b202-c4a0-40bb-87e0-14323d353670	2009-11-20	CYTOXAN	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1622	077079c3-6877-467b-b9cc-5c650aae4f07	TCGA.25.1877	TCGA-25-1877-D26777	aa853d2b-f944-48a8-acdb-816b629fa09c	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1623	077079c3-6877-467b-b9cc-5c650aae4f07	TCGA.25.1877	TCGA-25-1877-D26775	1db2e824-9247-48e7-8fde-e1f15f8e6b2b	2009-11-20	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1624	9bdbaccf-b43b-4ec3-8b9b-dff65215eb00	TCGA.25.1878	TCGA-25-1878-D26783	48a35437-9288-49cd-ae24-3a823d6bcb0f	2009-11-20	CISPLATIN	NA	CHEMOTHERAPY	976	FALSE	NA	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1625	9bdbaccf-b43b-4ec3-8b9b-dff65215eb00	TCGA.25.1878	TCGA-25-1878-D26782	48b9c418-a412-48f8-a53d-e838216fdb8d	2009-11-20	CISPLATIN	NA	CHEMOTHERAPY	61	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1626	9bdbaccf-b43b-4ec3-8b9b-dff65215eb00	TCGA.25.1878	TCGA-25-1878-D26781	0a18dede-dff1-44eb-a51c-a1d4c4e62aee	2009-11-20	CYTOXAN	NA	CHEMOTHERAPY	61	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1627	9bdbaccf-b43b-4ec3-8b9b-dff65215eb00	TCGA.25.1878	TCGA-25-1878-D26780	0ead63ed-b358-4809-b61d-f26d2ce59642	2009-11-20	TAXOL	NA	CHEMOTHERAPY	976	FALSE	NA	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1628	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26790	d2120dac-c367-4e8b-bf47-4defae73d882	2009-11-20	DOXIL	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1629	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26792	3d6dee1b-1b8e-4505-8aeb-21d50754c68c	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1630	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26786	404a7c2b-b98b-4746-8fd4-d6a9b2082d7c	2009-11-20	TAXOL	NA	CHEMOTHERAPY	0	FALSE	123	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1631	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26789	944d91a1-d9d3-42ea-839c-7bfac4d6e1bf	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1632	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26793	5312bdff-a94c-42e6-9730-0eac4f016934	2009-11-20	TOPOTECAN	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1633	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26788	f51efcd0-d4f8-4952-8ded-9510e58c4648	2009-11-20	TAXOL	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1634	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26791	21269f23-6d86-4696-9758-640be84884d1	2009-11-20	GEMZAR	NA	CHEMOTHERAPY	184	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1635	818dc159-aba4-46bc-a4ed-68ee0f8c4461	TCGA.25.2042	TCGA-25-2042-D26787	36818245-ce52-4b65-a391-aaf7cdc2f464	2009-11-20	CARBOPLATIN	NA	CHEMOTHERAPY	0	FALSE	123	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1636	f5033d52-ec36-4e67-88d8-b6d898b81b2f	TCGA.25.2391	TCGA-25-2391-D26798	80def7b0-0486-484f-b014-381d703f1ff1	2010-1-5	TAXOL	NA	CHEMOTHERAPY	31	NA	153	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1637	f5033d52-ec36-4e67-88d8-b6d898b81b2f	TCGA.25.2391	TCGA-25-2391-D26797	416777aa-730e-4ecb-9f3e-193f5095066c	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	153	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1638	f5033d52-ec36-4e67-88d8-b6d898b81b2f	TCGA.25.2391	TCGA-25-2391-D26799	c57fb4b0-6cdc-4067-95a8-0f82c14e07ac	2010-1-5	TAXOTERE	NA	CHEMOTHERAPY	31	FALSE	153	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1639	b4b49027-7815-4813-9769-a3fe3a26a37a	TCGA.25.2393	TCGA-25-2393-D26804	f9f70865-c436-451d-b7cb-66c175893433	2010-1-5	TAXOL	NA	CHEMOTHERAPY	31	FALSE	123	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1640	b4b49027-7815-4813-9769-a3fe3a26a37a	TCGA.25.2393	TCGA-25-2393-D26806	9208f692-32d6-4340-b523-c6d8ae520f26	2010-1-5	DOXIL	NA	CHEMOTHERAPY	305	FALSE	517	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1641	b4b49027-7815-4813-9769-a3fe3a26a37a	TCGA.25.2393	TCGA-25-2393-D26805	74515577-69c9-4221-9daf-8dd8bca545c2	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	123	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1642	fd4740db-76a8-4362-be71-7b609479bb67	TCGA.25.2398	TCGA-25-2398-D26815	3e6a6ff7-6b15-4b7b-b636-374a1ff5b5c4	2010-1-5	TAXOL	NA	CHEMOTHERAPY	608	FALSE	638	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1643	fd4740db-76a8-4362-be71-7b609479bb67	TCGA.25.2398	TCGA-25-2398-D26814	41fdf2d1-c9cc-49c5-83c4-a444f3bb2ce0	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1644	fd4740db-76a8-4362-be71-7b609479bb67	TCGA.25.2398	TCGA-25-2398-D26813	36111e26-366f-4d5d-a6d5-42950816aaaf	2010-1-5	TAXOL	NA	CHEMOTHERAPY	31	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1645	fd4740db-76a8-4362-be71-7b609479bb67	TCGA.25.2398	TCGA-25-2398-D26816	f6a05e71-bcad-4194-9d40-47255dd4cb92	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	603	FALSE	638	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1646	ad2b1a0a-153f-483d-b228-5763eba3f6cc	TCGA.25.2399	TCGA-25-2399-D26821	9ca6cc56-eeb0-4463-8fad-adb07d1f9dae	2010-1-5	DOXIL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1647	ad2b1a0a-153f-483d-b228-5763eba3f6cc	TCGA.25.2399	TCGA-25-2399-D26819	f67bbe0c-7be0-4fd0-9911-bdf622d7f6d3	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	61	FALSE	182	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1648	ad2b1a0a-153f-483d-b228-5763eba3f6cc	TCGA.25.2399	TCGA-25-2399-D26820	2bdcf36c-2cf7-4179-8ba3-4fef5c34ce65	2010-1-5	TAXOL	NA	CHEMOTHERAPY	61	FALSE	182	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1649	5c127332-5ca0-45f1-a5ac-4876ad94e491	TCGA.25.2400	TCGA-25-2400-D26826	b2c304b8-84cc-401b-96cf-efb9ef1818ac	2010-1-5	TAXOL	NA	CHEMOTHERAPY	577	FALSE	669	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1650	5c127332-5ca0-45f1-a5ac-4876ad94e491	TCGA.25.2400	TCGA-25-2400-D26825	ca0c6a83-308f-49c2-8e37-8b1f9a7132ec	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	61	FALSE	182	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1651	5c127332-5ca0-45f1-a5ac-4876ad94e491	TCGA.25.2400	TCGA-25-2400-D26824	6e054b23-144e-4321-9b35-9402bf36de69	2010-1-5	TAXOL	NA	CHEMOTHERAPY	61	FALSE	182	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1652	5c127332-5ca0-45f1-a5ac-4876ad94e491	TCGA.25.2400	TCGA-25-2400-D26827	bbae9713-7efb-4282-ae16-6d2982fdbce5	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	577	FALSE	669	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1653	22178c3c-6b04-46d8-8041-dc83fa195029	TCGA.25.2404	TCGA-25-2404-D26834	4123b5ea-9752-4c53-b3c4-a2caeb17b133	2010-1-5	TAXOL	NA	CHEMOTHERAPY	184	FALSE	306	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1654	22178c3c-6b04-46d8-8041-dc83fa195029	TCGA.25.2404	TCGA-25-2404-D26832	ee45824f-b834-4398-9099-e4d8084dda45	2010-1-5	TAXOL	NA	CHEMOTHERAPY	0	FALSE	122	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1655	22178c3c-6b04-46d8-8041-dc83fa195029	TCGA.25.2404	TCGA-25-2404-D26835	0e941bf3-b016-4c1b-950e-b8376803e7df	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	184	FALSE	306	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1656	22178c3c-6b04-46d8-8041-dc83fa195029	TCGA.25.2404	TCGA-25-2404-D26833	1b5f7082-be2b-44dd-a5b6-9dc5903110fc	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	0	FALSE	122	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1657	fdd4adb8-9295-480a-9352-305b5eb51187	TCGA.25.2408	TCGA-25-2408-D26839	39386c00-8aa3-4ae3-9a10-8f09e244de14	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	61	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1658	fdd4adb8-9295-480a-9352-305b5eb51187	TCGA.25.2408	TCGA-25-2408-D26838	d85bbcd3-e90c-46cb-ac16-f0e6fb8ce699	2010-1-5	TAXOL	NA	CHEMOTHERAPY	61	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1659	dce71741-ccbe-40b7-a0b8-2048d07187a4	TCGA.25.2409	TCGA-25-2409-D26843	f9e622c7-2103-4813-979c-461082e72b52	2010-1-5	TAXOTERE	NA	CHEMOTHERAPY	31	FALSE	182	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1660	dce71741-ccbe-40b7-a0b8-2048d07187a4	TCGA.25.2409	TCGA-25-2409-D26844	e4044ad0-3ce1-44b3-9b0a-9b22bab4fe96	2010-1-5	TAMOXIFEN	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1661	dce71741-ccbe-40b7-a0b8-2048d07187a4	TCGA.25.2409	TCGA-25-2409-D26842	6e085dc2-54ad-4fd4-b583-556c47e0fceb	2010-1-5	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	182	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1662	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27125	7f10efbe-1ac7-4b34-8a8f-d2018c500d2a	2009-12-18	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1663	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27126	f7096fd1-a75b-40ad-908c-dcdb17d5cd01	2009-12-18	CYTOXAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1664	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27133	2ff9881a-ae13-4df7-acf6-5ec75660419f	2010-2-16	ETOPOSIDE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1665	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27135	8b78391e-9f51-426d-91ab-a34a0f7efd4a	2010-2-16	HEXALEN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1666	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27129	82e60918-c339-44fc-a5e8-d2e1ac77bd14	2010-2-16	CARBOPLATIN	NA	CHEMOTHERAPY	743	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1667	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27137	c7d13c51-ca4e-4da5-bf9b-2509804ed7e5	2010-2-16	PACLITAXEL	NA	CHEMOTHERAPY	1900	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	175	NA
1668	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27139	51e458fd-2614-41e5-9f4b-779a7d8ebbee	2010-2-16	CYTOXAN	NA	CHEMOTHERAPY	NA	FALSE	2395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1669	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27138	79bc99cb-f7b0-44ea-9611-2552e156242c	2010-2-16	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	2395	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1670	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27127	553498e9-4fe2-45d7-9580-0ced2aa9ffba	2010-2-16	CISPLATIN	NA	CHEMOTHERAPY	197	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1671	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27131	568adf68-a27f-4f9c-944c-b128bdc775b2	2010-2-16	ORAL ETOPOSIDE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1672	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27134	a72dc90d-76a7-464f-a6b5-1e6e5248cb0e	2010-2-16	TAXOTERE	NA	CHEMOTHERAPY	1719	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1673	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27132	a3c745b9-c5ed-42e9-bac6-15d75ede0e8e	2010-2-16	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1674	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27130	c7147c57-ad18-4e46-91b1-41247eacbe8a	2010-2-16	CYTOXAN	NA	CHEMOTHERAPY	743	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1675	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27136	f168b196-edb1-49f3-9196-eb9e7332f9ab	2010-2-16	CARBOPLATIN	NA	CHEMOTHERAPY	1900	FALSE	NA	NA	NA	NA	NA	NA	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
1676	05019013-7ea5-4905-ac79-901146ba2ee2	TCGA.29.1688	TCGA-29-1688-D27128	62430697-e553-49a9-a8fe-953be4c87a64	2010-2-16	ETOPOSIDE	NA	CHEMOTHERAPY	197	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1677	6b06281b-d3a9-440e-a86c-ee7db003352a	TCGA.29.1690	TCGA-29-1690-D27144	27a85986-1d9f-457a-b3ca-613d2b8873ee	2010-2-16	CYTOXAN	NA	CHEMOTHERAPY	8	FALSE	NA	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	500	NA
1678	6b06281b-d3a9-440e-a86c-ee7db003352a	TCGA.29.1690	TCGA-29-1690-D27143	0d7fdf72-7232-4393-8010-1726ecc18ae0	2010-2-16	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	NA	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	350	NA
1679	6b06281b-d3a9-440e-a86c-ee7db003352a	TCGA.29.1690	TCGA-29-1690-D27146	9ffc6761-7c68-4a4c-ac9d-2cd3fe1748e7	2010-2-16	PACLITAXEL	NA	CHEMOTHERAPY	91	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1680	6b06281b-d3a9-440e-a86c-ee7db003352a	TCGA.29.1690	TCGA-29-1690-D27145	12b9fc4e-5a0b-44cd-98a4-73f1ff3cbff9	2010-2-16	CISPLATIN	NA	CHEMOTHERAPY	91	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
1681	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27150	af52351f-2a65-4bab-8bf4-573d7d8c7298	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	137	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1682	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27149	5981636e-0c5c-47af-832a-7eb7e79b6129	2009-12-18	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	137	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1683	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27153	3cf322bf-45f6-4d30-896a-5a44d2a27e15	2010-2-16	TOPOTECAN	NA	CHEMOTHERAPY	868	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1684	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27152	75e41a0f-d235-4fb2-bf9f-34dc7fff8807	2010-2-16	PACLITAXEL	NA	CHEMOTHERAPY	654	FALSE	868	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	175	NA
1685	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27157	56c9442e-1bb2-4585-8583-da00a67982b0	2010-2-16	MEGACE (ORAL)	NA	HORMONE THERAPY	988	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1686	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27155	877c785c-7487-4730-b800-ec7ca6a067f5	2010-2-16	CYTOXAN	NA	CHEMOTHERAPY	1233	FALSE	1353	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1687	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27151	3c9233cf-e2f4-4c15-835e-c8f00dafb4a7	2010-2-16	CARBOPLATIN	NA	CHEMOTHERAPY	654	FALSE	868	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
1688	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27154	a5cf93f1-4cc5-4e17-bfaf-4fa8c64efbb5	2010-2-16	DOXIL	NA	CHEMOTHERAPY	988	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1689	b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b	TCGA.29.1691	TCGA-29-1691-D27156	af8df55a-1129-4a08-ac99-6b6e6328d6ed	2010-2-16	CARBOPLATIN	NA	CHEMOTHERAPY	1233	FALSE	1353	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1690	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27161	685c255e-2242-435e-b5d3-229453699a04	2010-3-3	CISPLATIN	NA	CHEMOTHERAPY	5	FALSE	NA	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	7	NA
1691	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27164	2917d0e8-ad7f-4643-8b76-7d5a97ff304d	2010-3-3	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	694	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1692	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27162	9c687c7a-133d-404f-917c-d69210cd5624	2010-3-3	CARBOPLATIN	NA	CHEMOTHERAPY	544	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1693	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27166	2438d130-a7cc-471c-8770-e9cab1a2f523	2010-3-3	CARBOPLATIN	NA	CHEMOTHERAPY	2120	FALSE	2247	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1694	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27172	0ab57961-2afb-4492-b67e-51bdc6130ea7	2010-3-3	TAMOXIFEN	NA	HORMONE THERAPY	1793	FALSE	2125	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	20	NA
1695	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27165	6a477a8e-e65c-467e-a25d-caae5486b693	2010-3-3	DOXIL	NA	CHEMOTHERAPY	1548	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1696	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27167	fd9a3712-96c8-4b72-92fe-5432b346c056	2010-3-3	TAXOTERE	NA	CHEMOTHERAPY	2120	FALSE	2247	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1697	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27169	92bc26a1-5bab-4fd2-858c-6f31f45e04e2	2010-3-3	PACLITAXEL	NA	CHEMOTHERAPY	2556	FALSE	2577	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	289	NA
1698	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27160	5949a274-8f5b-4410-89b4-3d629590e929	2010-3-3	TAXOL	NA	CHEMOTHERAPY	5	FALSE	NA	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1699	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27168	f32e96f4-6144-4ed9-be21-ae2a8f6c0b8a	2010-3-3	CYTOXAN	NA	CHEMOTHERAPY	2278	FALSE	2521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1700	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27163	90600159-513c-457a-9f29-036530819aea	2010-3-3	PACLITAXEL	NA	CHEMOTHERAPY	544	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1701	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27171	5190da4a-540d-4dd0-bf50-a58711ff9aea	2010-3-3	CISPLATIN	NA	CHEMOTHERAPY	2616	FALSE	2785	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	45	NA
1702	92960f76-0242-4a1c-bf7d-014c2f720219	TCGA.29.1692	TCGA-29-1692-D27170	642fd6be-d54d-4093-bfe4-f2a4bf2f939c	2010-3-3	GEMCITABINE	NA	CHEMOTHERAPY	2616	FALSE	2785	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1250	NA
1703	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27176	fb8da9b0-00a9-430c-a45e-3800eb539f96	2009-12-11	PACLITAXEL	NA	CHEMOTHERAPY	19	FALSE	191	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2240	NA
1704	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27175	0757d278-2318-4b45-9678-47eb8fcd786e	2009-12-11	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	191	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3430	NA
1705	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27186	2b068aab-26e8-4d5a-a660-39db26909fe9	2010-3-24	PACLITAXEL	NA	CHEMOTHERAPY	2788	FALSE	3018	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1706	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27188	7b31538c-cb7a-49f2-b298-883d0d7265ad	2010-3-24	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	3124	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	600	NA
1707	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27189	edd1f6b0-04b0-4e5e-9c38-9e06e27bd456	2010-3-24	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1668	FALSE	1724	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	740	NA
1708	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27180	09f2c506-a8de-433b-8463-52ecb7d8023b	2010-3-24	CARBOPLATIN	NA	CHEMOTHERAPY	1300	FALSE	NA	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	345	NA
1709	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27183	e4783d5b-4f80-410d-8ebf-7cbc99d4bb3e	2010-3-24	CARBOPLATIN	NA	CHEMOTHERAPY	2027	FALSE	2058	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1710	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27182	0db74b13-ee6a-4798-8578-305ae89eded5	2010-3-24	DOXIL	NA	CHEMOTHERAPY	1780	FALSE	1892	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	70	NA
1711	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27185	7c9b327c-69b8-4fed-86a2-711957766a83	2010-3-24	PACLITAXEL	NA	CHEMOTHERAPY	2627	FALSE	2669	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1712	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27187	c12cf4bd-c639-48b1-805a-bb3f7fd66ebc	2010-3-24	CYTOXAN	NA	CHEMOTHERAPY	3124	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
1713	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27177	911cfe1e-c684-4c8b-a1de-9819fbfb1f3a	2010-3-24	CARBOPLATIN	NA	CHEMOTHERAPY	717	FALSE	814	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
1714	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27184	914a0b3d-a2b8-4daf-878e-bb64c869e520	2010-3-24	PACLITAXEL	NA	CHEMOTHERAPY	2232	FALSE	2239	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1715	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27181	48ad0517-e616-4bc4-a5c8-66eb467f5e18	2010-3-24	GEMZAR	NA	CHEMOTHERAPY	1668	FALSE	1724	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1375	NA
1716	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27178	4489659a-4376-4edb-b06d-0f34644d7822	2010-3-24	PACLITAXEL	NA	CHEMOTHERAPY	717	FALSE	814	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	135	NA
1717	6fb71a0c-bc50-48c8-acfa-db94be1e151a	TCGA.29.1693	TCGA-29-1693-D27179	42a47a83-7947-4c60-bd0b-68bc8f373b71	2010-3-24	XYOTAX	NA	CHEMOTHERAPY	1069	FALSE	1157	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	300	NA
1718	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27200	b5f367a1-a738-4e22-a8a7-2955c3f77f89	2010-4-5	TOPOTECAN	NA	CHEMOTHERAPY	1101	FALSE	1108	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4	NA
1719	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27196	e0acd0c1-67c5-4fec-9a4e-5fa66cabb881	2010-4-5	CT2103 TAXANE ANALOG	NA	CHEMOTHERAPY	658	FALSE	719	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	243	NA
1720	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27195	ade1f387-8cb7-4e4d-8868-333460058f40	2010-4-5	CISPLATIN	NA	CHEMOTHERAPY	241	FALSE	485	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	50	NA
1721	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27199	81ddb67a-43e6-4641-8513-cf5f881a7693	2010-4-5	CISPLATIN	NA	CHEMOTHERAPY	1057	FALSE	1071	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
1722	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27198	07cd68f0-122d-49b4-b143-3c7b65ac8a72	2010-4-5	GEMCITABINE	NA	CHEMOTHERAPY	969	FALSE	1071	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1020	NA
1723	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27201	3808c300-3209-4949-9587-1d31449fa233	2010-4-5	TAMOXIFEN	NA	HORMONE THERAPY	339	FALSE	658	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1724	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27193	537110ed-8116-4d74-99e4-41d8b322fe29	2010-4-5	CARBOPLATIN	NA	CHEMOTHERAPY	43	FALSE	161	NA	NA	NA	NA	NA	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4	NA
1725	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27197	3a3e5828-1122-4499-bc15-0ce8f44feeb3	2010-4-5	DOXORUBICIN HCL LIPOSOMAL	NA	CHEMOTHERAPY	750	FALSE	928	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	56	NA
1726	1db60f09-7f5a-4f21-8003-06a6abc781db	TCGA.29.1694	TCGA-29-1694-D27194	cc3697a1-5e61-408e-bd54-3f001f19f4c8	2010-4-5	PACLITAXEL	NA	CHEMOTHERAPY	43	FALSE	161	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	150	NA
1727	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27207	5a0a45c1-c2b7-49f9-a424-cd55b46658ac	2009-12-11	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	171	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2550	NA
1728	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27208	935ba94e-17b1-42bb-bfcb-777d7af0b574	2009-12-11	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	171	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5472	NA
1729	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27209	9b52668c-3ac3-46d0-824a-5e670e09207e	2010-4-7	DOXORUBICIN HCL	NA	CHEMOTHERAPY	357	FALSE	479	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	70	NA
1730	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27213	a99ed1d2-8b6d-4027-869a-87359a36904f	2010-4-7	CYCLOPHOSPHAMIDE	NA	CHEMOTHERAPY	948	FALSE	997	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1305	NA
1731	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27211	74cef5fc-3be7-47ae-9823-b91fc4246b28	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	598	FALSE	791	NA	NA	NA	NA	10	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6	NA
1732	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27214	2391893d-dd51-43c2-b966-532867973538	2010-4-7	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	633	FALSE	997	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	660	NA
1733	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27212	02efd7a1-75d6-4e57-b6e6-9146747f5cc3	2010-4-7	PACLITAXEL	NA	CHEMOTHERAPY	864	FALSE	934	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	140	NA
1734	8a98a6e6-b763-4824-858b-fd2738e6c9a3	TCGA.29.1696	TCGA-29-1696-D27210	46c5e2a6-3891-4521-9859-437c416d0ad3	2010-4-7	GEMCITABINE	NA	CHEMOTHERAPY	507	FALSE	573	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	8321	NA
1735	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27218	d5003891-7fb6-49cf-a9d9-e8c42ce205f6	2009-12-18	GEMCITABINE	NA	CHEMOTHERAPY	28	FALSE	91	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	11184	NA
1736	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27217	2defdb44-07c7-4c6f-989c-522e938522e5	2009-12-18	CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	182	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4512	NA
1737	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27219	08e36e3c-04d0-4eb9-82d4-db345de17ba7	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	111	FALSE	182	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1246	NA
1738	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27220	cc1a9ed1-7a73-4ac6-af71-62aaef17faab	2010-4-7	DOCETAXEL	NA	CHEMOTHERAPY	510	FALSE	535	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	54	NA
1739	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27221	b1d90209-3eef-4785-bbe2-df492af098b4	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	552	FALSE	664	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	574	NA
1740	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27223	71741cc7-cf5c-4722-83bf-365852338e29	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	878	FALSE	899	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	574	NA
1741	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27224	54c4ffc2-7da7-44bc-b3f3-c4ec287b03d4	2010-4-7	TOPOTECAN HCL	NA	CHEMOTHERAPY	927	FALSE	934	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5.2	NA
1742	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27222	0454b893-307a-4c01-8b81-3973f8a22e54	2010-4-7	DOXORUBICIN	NA	CHEMOTHERAPY	780	FALSE	843	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	70	NA
1743	42ebd30b-175e-4ece-a806-e55cb7e40e96	TCGA.29.1697	TCGA-29-1697-D27225	4bbdb89d-adc9-4248-a03d-a57515745d82	2010-4-7	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	927	FALSE	927	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	650	NA
1744	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27229	b9c29270-ee60-4e30-a093-5f075678c76a	2009-12-11	PACLITAXEL	NA	CHEMOTHERAPY	8	FALSE	237	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2603	NA
1745	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27228	d19d3315-e66f-4c1a-ac23-98bece9f387a	2009-12-11	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	237	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5600	NA
1746	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27239	f5e6d97b-a6dc-4699-8440-cfe1999a7c59	2010-4-9	TAMOXIFEN	NA	HORMONE THERAPY	328	FALSE	1419	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	20	NA
1747	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27235	9c5d0db2-99d5-41ba-b046-73bcf1606509	2010-4-9	DOXIL	NA	CHEMOTHERAPY	1615	FALSE	1783	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	68	NA
1748	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27232	61b62b7a-751e-47c8-952b-ae69e732b57f	2010-4-9	GEMCITABINE HCL	NA	CHEMOTHERAPY	1321	FALSE	1566	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1020	NA
1749	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27236	a7599369-16cc-498d-a785-820ab146b2f3	2010-4-9	PACLITAXEL	NA	CHEMOTHERAPY	1811	FALSE	1972	NA	NA	NA	NA	17	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	100	NA
1750	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27234	9879c952-a90b-4770-80e8-145d5b666e53	2010-4-9	TOPTECAN	NA	CHEMOTHERAPY	1580	FALSE	1587	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
1751	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27237	649ad6e9-fc1e-4d4b-a6f7-c658c687eaf9	2010-4-9	DOCETAXEL	NA	CHEMOTHERAPY	1986	FALSE	2028	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	100	NA
1752	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27238	2ebf8390-c1f5-4b22-ae80-22ec2332c195	2010-4-9	CARBOPLATIN	NA	CHEMOTHERAPY	2051	TRUE	2245	NA	NA	NA	NA	8	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
1753	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27233	4515594c-0c88-4d51-80b8-5b339a8c5f5f	2010-4-9	CARBOPLATIN	NA	CHEMOTHERAPY	1321	FALSE	1349	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	510	NA
1754	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27240	ac7e4095-4661-4ea2-bd92-532cd8fe44c8	2010-4-9	AVASTIN (BEVACIZUMAB)	NA	TARGETED MOLECULAR THERAPY	1524	FALSE	1580	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	600	NA
1755	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27230	6ad63dbf-f942-4b8a-bf8f-e7dd53d68606	2010-4-9	CARBOPLATIN	NA	CHEMOTHERAPY	741	FALSE	909	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	570	NA
1756	18d21132-a795-4551-83ba-66483de423a2	TCGA.29.1698	TCGA-29-1698-D27231	67b7d4d3-f5ae-4f94-854b-bd9759d9535e	2010-4-9	DOCETAXEL	NA	CHEMOTHERAPY	741	FALSE	853	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	53	NA
1757	86b513ba-df09-485d-92d4-fb9e888f7350	TCGA.29.1701	TCGA-29-1701-D27245	8a9dbe36-b51f-41ec-a7f0-2cd48435ff0e	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	160	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4505	NA
1758	86b513ba-df09-485d-92d4-fb9e888f7350	TCGA.29.1701	TCGA-29-1701-D27244	3afc4585-7d77-43be-9d92-ae8b9b0b2bbf	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	31	FALSE	160	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1280	NA
1759	86b513ba-df09-485d-92d4-fb9e888f7350	TCGA.29.1701	TCGA-29-1701-D27246	80f36875-2327-4911-af6e-4d9c45dbafc4	2010-4-21	DOXIL	NA	CHEMOTHERAPY	318	FALSE	381	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	75	NA
1760	86b513ba-df09-485d-92d4-fb9e888f7350	TCGA.29.1701	TCGA-29-1701-D27247	2cc1b601-8961-400e-906f-a8d1ec418ba8	2010-4-21	CARBOPLATIN	NA	CHEMOTHERAPY	409	FALSE	472	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6	NA
1761	0e1598d8-cbe5-4113-95f1-4bcda061239b	TCGA.29.1702	TCGA-29-1702-D27250	9cbffc31-fc40-4166-b1b8-601d6f9fa089	2009-12-18	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	199	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
1762	0e1598d8-cbe5-4113-95f1-4bcda061239b	TCGA.29.1702	TCGA-29-1702-D27251	8929ea04-1247-4be3-aecc-300064ec7a3b	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1763	0e1598d8-cbe5-4113-95f1-4bcda061239b	TCGA.29.1702	TCGA-29-1702-D27252	0722dd17-afea-443f-a0cb-14c6334919b9	2010-4-20	DOXIL	NA	CHEMOTHERAPY	376	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1764	0e1598d8-cbe5-4113-95f1-4bcda061239b	TCGA.29.1702	TCGA-29-1702-D27253	475e241e-06ea-4bd8-a562-92e47214f991	2010-4-20	TOPOTECAN	NA	CHEMOTHERAPY	466	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1765	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27256	14913535-e3ee-4b29-8485-5ef50b7c1123	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	16	FALSE	163	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	1595	NA
1766	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27257	299385fc-3e5b-4fd2-a656-6fdb78daa069	2009-12-18	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	163	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	4081	NA
1767	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27258	8cb8447c-f35a-435e-9fb1-d51d74f152d2	2010-4-26	CARBOPLATIN	NA	CHEMOTHERAPY	478	FALSE	651	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	773	NA
1768	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27263	4d5bfe23-dd0f-43f5-8880-c91953ddc025	2010-4-26	CARBOPLATIN	NA	CHEMOTHERAPY	1720	FALSE	1720	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	390	NA
1769	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27266	5a22c5fc-1192-4db9-86cb-84768e401698	2010-4-26	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	743	FALSE	946	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	800	NA
1770	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27259	7f6adfa1-73ce-46ec-b9ae-fdec4acedd2f	2010-4-26	DOCETAXEL	NA	CHEMOTHERAPY	478	FALSE	651	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	55	NA
1771	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27262	98b7f1cd-615d-4d0f-8e2d-ac2ababfc43d	2010-4-26	GEMCITABINE	NA	CHEMOTHERAPY	1577	FALSE	1667	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1370	NA
1772	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27261	4c4f2cec-35a9-462b-bc94-0fb8506d93aa	2010-4-26	DOXORUBICIN HCL LIPOSOMAL -DOXIL	NA	CHEMOTHERAPY	1317	FALSE	1457	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	70	NA
1773	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27264	53f8a8a1-9b2e-4469-9d98-66f1234ca04d	2010-4-26	PACLITAXEL	NA	CHEMOTHERAPY	1746	FALSE	1753	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
1774	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27260	48f028c2-6e0e-4b9a-a457-ab27cc986d53	2010-4-26	CYTOXAN	NA	CHEMOTHERAPY	743	FALSE	946	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
1775	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27265	7f78908a-4b31-41ff-9268-b209ed2e6c93	2010-4-26	TAMOXIFEN	NA	HORMONE THERAPY	337	FALSE	470	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1776	b3511675-fd68-4745-8020-e290ca0fd115	TCGA.29.1703	TCGA-29-1703-D27267	e56227e6-4d59-43d0-b3a9-8d0ba62a4731	2010-4-26	AMGEN 706	NA	TARGETED MOLECULAR THERAPY	1030	FALSE	1314	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1777	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27275	6e65321e-a2c2-438b-bdff-716ffd3b90ac	2010-3-3	TAXOTERE	NA	CHEMOTHERAPY	1566	TRUE	1587	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	70	NA
1778	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27270	4a020b5d-1ba8-4996-a204-5c0b373e2693	2010-3-3	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	169	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4	NA
1779	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27272	68023b00-a088-44b2-8aed-3c723e70c172	2010-3-3	CARBOPLATIN	NA	CHEMOTHERAPY	642	FALSE	775	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	485	NA
1780	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27273	1225fcb2-265b-417c-9401-e86d350027a4	2010-3-3	PACLITAXEL	NA	CHEMOTHERAPY	642	FALSE	775	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	230	NA
1781	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27276	21531b27-b04c-4716-b054-832e9646f84e	2010-3-3	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1566	TRUE	1587	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	1100	NA
1782	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27271	05c70827-4563-4f78-b419-5a8d88b695fe	2010-3-3	PACLITAXEL	NA	CHEMOTHERAPY	21	FALSE	169	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
1783	8e7f1c74-7cb3-43c0-b07c-bf69b780053f	TCGA.29.1704	TCGA-29-1704-D27274	3a06f6c4-c0c7-4806-a597-21b86570feb4	2010-3-3	DOXIL	NA	CHEMOTHERAPY	1188	FALSE	1300	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	70	NA
1784	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27282	05836639-1a84-47c3-89c5-694b2a5435b3	2009-12-18	DOCETAXEL	NA	CHEMOTHERAPY	76	FALSE	118	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	450	NA
1785	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27281	615621a7-8290-4dca-b679-0976af6b59a0	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	13	FALSE	55	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1050	NA
1786	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27280	12ace512-a8b1-4ed4-816f-77013d68ef1f	2009-12-18	CARBOPLATIN	NA	CHEMOTHERAPY	13	FALSE	167	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4905	NA
1787	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27284	4aeb20a4-d869-46cd-8c57-04ed761d6fb4	2010-3-15	DOXORUBICIN HCL	NA	CHEMOTHERAPY	416	FALSE	489	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
1788	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27283	5ed39f48-80a2-4a76-94a0-313bd99a7df8	2010-3-15	GEMCITABINE	NA	CHEMOTHERAPY	287	FALSE	356	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2000	NA
1789	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27285	539804dc-173d-426d-b2ec-e4a1b4cdb703	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	524	FALSE	524	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	725	NA
1790	f9c835db-2ab6-4bf5-826f-48723493c0ec	TCGA.29.1705	TCGA-29-1705-D27286	eb8131b7-b5ed-4fb3-b08f-f744072602e0	2010-3-15	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	287	FALSE	356	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	990	NA
1791	7fd6ab8a-201e-431d-a886-6ab553b6ca36	TCGA.29.1707	TCGA-29-1707-D27290	fc8868bb-2ed5-4725-a212-cd48bbf7c30f	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	24	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1789	NA
1792	7fd6ab8a-201e-431d-a886-6ab553b6ca36	TCGA.29.1707	TCGA-29-1707-D27289	e28df67d-25f3-4d16-9603-b74cb561c0df	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3840	NA
1793	7fd6ab8a-201e-431d-a886-6ab553b6ca36	TCGA.29.1707	TCGA-29-1707-D27292	708f4379-a553-4e68-bf82-a4c4c10480b1	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	1277	FALSE	1375	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	570	NA
1794	7fd6ab8a-201e-431d-a886-6ab553b6ca36	TCGA.29.1707	TCGA-29-1707-D27291	07440f16-26f4-408f-bed7-79da5f4f959b	2010-3-15	DOXORUBICIN	NA	CHEMOTHERAPY	1277	FALSE	1326	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	50	NA
1795	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27296	cb4c7e37-e52e-4fb8-8fa2-b06c4fbe488f	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	88	FALSE	150	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1200	NA
1796	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27298	1870b77f-b3fb-4d51-96e7-40c68e3af351	2009-12-10	DOCETAXEL	NA	CHEMOTHERAPY	31	FALSE	52	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	260	NA
1797	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27304	84cb2e2e-ce41-4f1d-a1cd-a6d742fb2eab	2009-12-10	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	31	FALSE	52	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	1870	NA
1798	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27295	8d6988ea-2c98-4eee-8af3-1f1b8f6e91dd	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	88	FALSE	150	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2790	NA
1799	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27297	2f49fa88-c076-48ba-94c2-fa4d9a572e80	2009-12-10	OXALIPLATIN	NA	CHEMOTHERAPY	31	FALSE	52	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
1800	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27301	5b6525f0-9d61-446a-83e7-b1a19eff710c	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	556	FALSE	580	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	700	NA
1801	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27302	a00ec514-4300-45f1-801d-4a792374bdf9	2010-3-15	PACLITAXEL	NA	CHEMOTHERAPY	682	FALSE	766	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	310	NA
1802	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27299	6303ae09-5316-4b1f-9a64-00d5aad22cb6	2010-3-15	DOXORUBINCIN HCL	NA	CHEMOTHERAPY	322	FALSE	437	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	70	NA
1803	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27300	c217baa5-64ae-4d44-9f6c-3f18651504b7	2010-3-15	GEMCITABINE HCL	NA	CHEMOTHERAPY	468	FALSE	542	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1410	NA
1804	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27303	d6f9fb02-9165-45de-bb0e-4af029666a8c	2010-3-15	TOPOTECAN	NA	CHEMOTHERAPY	780	FALSE	853	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	7	NA
1805	4261267c-7042-4c6e-83ed-12fb401003fc	TCGA.29.1710	TCGA-29-1710-D27305	e024dbec-28ae-40c1-9e8f-79c02f82ff18	2010-3-15	CEP 11981	NA	TARGETED MOLECULAR THERAPY	619	FALSE	653	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1806	f58e49fc-9641-4b46-be4c-766445ec70a3	TCGA.29.1711	TCGA-29-1711-D27309	c10283d7-f31a-4930-b91d-e81e88307348	2009-11-13	OXALIPLATIN	NA	CHEMOTHERAPY	30	FALSE	136	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	170	NA
1807	f58e49fc-9641-4b46-be4c-766445ec70a3	TCGA.29.1711	TCGA-29-1711-D27310	5006a879-35cd-40f4-959a-d7c4ac2e9da4	2009-11-13	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	30	FALSE	234	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	1863	NA
1808	f58e49fc-9641-4b46-be4c-766445ec70a3	TCGA.29.1711	TCGA-29-1711-D27308	403d3536-f161-4d82-81c6-8c42ccda444c	2009-11-13	DOCETAXEL	NA	CHEMOTHERAPY	30	FALSE	136	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	150	NA
1809	374ea8df-ecc4-44b0-b519-33efa5078018	TCGA.29.1761	TCGA-29-1761-D27313	fe321eac-53ee-44e1-a7b6-8047473fcbf2	2009-11-18	CARBOPLATIN	NA	CHEMOTHERAPY	49	FALSE	202	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1810	374ea8df-ecc4-44b0-b519-33efa5078018	TCGA.29.1761	TCGA-29-1761-D27314	c8045157-0494-4ff3-81f0-5ad85149afb6	2009-11-30	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	202	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1811	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27323	cd162e63-987c-4f2a-ae65-454519e42da0	2009-11-30	DOCETAXEL	NA	CHEMOTHERAPY	2509	FALSE	2555	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	150	NA
1812	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27322	718474fa-5bd1-47e2-b4f3-1e1d8862e5b6	2009-11-30	TOPOTECAN HCL	NA	CHEMOTHERAPY	2439	FALSE	2488	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	60	NA
1813	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27320	0217767c-919b-42cc-9e93-cc15c80a7898	2009-11-30	DOXORUBICIN HCI LIIPOSOMAL	NA	CHEMOTHERAPY	2167	FALSE	2229	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	80	NA
1814	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27319	62ebbf79-daf4-4030-8213-1c06279ced96	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	1387	FALSE	1513	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1815	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27321	70b6d9af-391e-4fec-a670-83101d90add9	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	2255	FALSE	2418	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	400	NA
1816	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27317	41be6bf3-dcfb-4d18-8360-f08247ea6ab4	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	140	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1817	5495b18a-10ec-427b-83b8-03ef4b587b13	TCGA.29.1762	TCGA-29-1762-D27318	fc15c1dd-7e5f-443e-a5a5-e8bd13e582ee	2009-11-30	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	140	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1818	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27327	09bda96f-0f13-49ee-acb6-2d6f13f554c5	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	15	FALSE	100	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1645	NA
1819	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27326	cb9f2119-7302-400b-83e8-3f5ad57235a0	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	100	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3175	NA
1820	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27332	feb62c19-c331-439f-937c-9067cac1f748	2010-4-7	PACLITAXEL	NA	CHEMOTHERAPY	1727	FALSE	1839	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	350	NA
1821	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27328	0edd2650-9330-4381-8830-33e36ca5e4a2	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	450	FALSE	579	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	675	NA
1822	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27334	413c6676-1d15-45d6-9312-3ef011666f04	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	2189	TRUE	2252	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6	NA
1823	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27330	f931a981-978e-4332-8125-5f615bb61706	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	1346	FALSE	1367	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	435	NA
1824	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27335	0fddbda9-cca7-4024-8e3a-f946b424ef6d	2010-4-7	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	2049	FALSE	2161	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	1000	NA
1825	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27333	8b5415a7-cf18-4683-aff5-dab81c1097a6	2010-4-7	DOXIL	NA	CHEMOTHERAPY	2049	FALSE	2126	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
1826	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27331	14e4248a-479b-4a23-9689-768e0c095441	2010-4-7	PACLITAXEL	NA	CHEMOTHERAPY	1346	FALSE	1376	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	350	NA
1827	242da7d0-8c6a-4395-9a0d-aa36e7c25ce6	TCGA.29.1763	TCGA-29-1763-D27329	643648fe-7469-4eba-8a99-020867cbdb1a	2010-4-7	GEMCITABINE HCL	NA	CHEMOTHERAPY	1283	FALSE	1325	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2000	NA
1828	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27340	669fa902-94cd-4761-a34a-ea52ea36e477	2009-12-18	GEMCITABINE	NA	CHEMOTHERAPY	15	FALSE	87	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12000	NA
1829	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27341	83c24fb9-19f6-410f-aaaf-62de9ce57d42	2009-12-18	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	167	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4581	NA
1830	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27339	85cefe8c-1946-4726-86f9-76af29868908	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	111	FALSE	167	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1050	NA
1831	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27343	2ed46035-c347-455e-9929-04ea06ea6a27	2010-4-21	CARBOPLATIN	NA	CHEMOTHERAPY	822	FALSE	968	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	590	NA
1832	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27346	6ec309e5-10b4-426d-b870-50ae85cfacdf	2010-4-21	DOXIL	NA	CHEMOTHERAPY	1785	FALSE	1785	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	80	NA
1833	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27348	3b9a01d6-eba5-46dd-9f01-cca971cfa936	2010-4-21	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1816	FALSE	1973	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	1100	NA
1834	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27342	43f88f80-cf14-4b7a-aeaf-28fc5909aab4	2010-4-21	DOCETAXEL	NA	CHEMOTHERAPY	797	FALSE	818	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	60	NA
1835	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27345	990413d8-d086-4927-80af-1ad44a3a2002	2010-4-21	DOXIL	NA	CHEMOTHERAPY	1366	FALSE	1515	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
1836	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27344	0f5f3466-2df4-4ffd-ace9-bbcf4c0edd98	2010-4-21	CARBOPLATIN	NA	CHEMOTHERAPY	1301	FALSE	1343	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1837	c70228cc-79c0-4c00-8926-6671c1474701	TCGA.29.1764	TCGA-29-1764-D27347	4c572c40-ea4e-48bd-9a55-2181e2a7a827	2010-4-21	TOPOTECAN HCL	NA	CHEMOTHERAPY	1816	FALSE	1973	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	6	NA
1838	01ea6354-137b-47f3-9021-a01a382b1147	TCGA.29.1766	TCGA-29-1766-D27351	ef80a8af-4328-4fe3-8e92-d75f92c1b8f2	2009-12-10	GEMCITABINE	NA	CHEMOTHERAPY	39	FALSE	196	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	19590	NA
1839	01ea6354-137b-47f3-9021-a01a382b1147	TCGA.29.1766	TCGA-29-1766-D27352	85e08cba-87ad-4cd9-a99a-e7e8ebce3b30	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	98	FALSE	189	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1580	NA
1840	01ea6354-137b-47f3-9021-a01a382b1147	TCGA.29.1766	TCGA-29-1766-D27353	28d919af-cf13-4344-82b0-4b3bf6086ddb	2010-4-26	PACLITAXEL	NA	CHEMOTHERAPY	224	FALSE	406	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	320	NA
1841	01ea6354-137b-47f3-9021-a01a382b1147	TCGA.29.1766	TCGA-29-1766-D27356	af7205f0-a192-41e7-b706-5f49b22dc251	2010-4-26	TOPOTECAN	NA	CHEMOTHERAPY	1084	FALSE	1112	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5.4	NA
1842	01ea6354-137b-47f3-9021-a01a382b1147	TCGA.29.1766	TCGA-29-1766-D27355	bbd623cf-b7e5-418b-92c9-bf283a3e5baa	2010-4-26	DOXIL	NA	CHEMOTHERAPY	825	FALSE	909	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	75	NA
1843	01ea6354-137b-47f3-9021-a01a382b1147	TCGA.29.1766	TCGA-29-1766-D27354	0abcc6b0-9996-4a86-8660-099bc0af0f02	2010-4-26	CARBOPLATIN	NA	CHEMOTHERAPY	685	FALSE	727	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6	NA
1844	838693d5-1ae0-4d75-834b-e1b89b96b0ed	TCGA.29.1768	TCGA-29-1768-D27360	2c0ce251-f345-4a8a-aa00-e298dbc2b8c5	2009-11-13	PACILTAXEL	NA	CHEMOTHERAPY	19	FALSE	124	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	348	NA
1845	838693d5-1ae0-4d75-834b-e1b89b96b0ed	TCGA.29.1768	TCGA-29-1768-D27363	ed65a20a-8958-4fff-ba00-02ed6343c835	2009-11-13	DOXORUBICIN	NA	CHEMOTHERAPY	827	FALSE	915	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
1846	838693d5-1ae0-4d75-834b-e1b89b96b0ed	TCGA.29.1768	TCGA-29-1768-D27361	76216199-6c74-4f8b-8259-3693f0df3818	2009-11-13	CARBOPLATIN	NA	CHEMOTHERAPY	551	FALSE	719	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	675	NA
1847	838693d5-1ae0-4d75-834b-e1b89b96b0ed	TCGA.29.1768	TCGA-29-1768-D27364	7b41d12a-5d40-47dc-95e1-2e6fe9230598	2009-11-13	BEVACIZUMAB OR PLACEBO	NA	TARGETED MOLECULAR THERAPY	40	FALSE	252	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	1493	NA
1848	838693d5-1ae0-4d75-834b-e1b89b96b0ed	TCGA.29.1768	TCGA-29-1768-D27359	46ff17c1-0870-4b53-8e92-fcd7ccef6c0e	2009-11-13	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	103	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	816	NA
1849	838693d5-1ae0-4d75-834b-e1b89b96b0ed	TCGA.29.1768	TCGA-29-1768-D27362	b4a10dad-0fcb-4aa0-a4a8-d8eb58d7cc56	2009-11-13	GEMCITABINE	NA	CHEMOTHERAPY	551	FALSE	719	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1200	NA
1850	94769f2c-b6fd-48ec-af34-b41165340b7c	TCGA.29.1769	TCGA-29-1769-D27367	8825618c-518a-4baf-b858-9aab04f99db2	2009-11-2	PACILTAXEL	NA	CHEMOTHERAPY	20	FALSE	20	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	318	NA
1851	94769f2c-b6fd-48ec-af34-b41165340b7c	TCGA.29.1769	TCGA-29-1769-D27368	44526a07-f299-45c9-bcb9-c9ffd10801e6	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	20	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	870	NA
1852	94769f2c-b6fd-48ec-af34-b41165340b7c	TCGA.29.1769	TCGA-29-1769-D27371	2fb6d93d-b53e-4aa6-aff1-90ff331b09d6	2009-11-2	ABAGOVOMAB VS PLACEBO	NA	IMMUNOTHERAPY	206	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2	NA
1853	94769f2c-b6fd-48ec-af34-b41165340b7c	TCGA.29.1769	TCGA-29-1769-D27370	5d098ad8-d2fa-4557-9751-80e53c5f41c5	2009-11-2	CISPLATIN	NA	CHEMOTHERAPY	42	FALSE	150	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	130	NA
1854	94769f2c-b6fd-48ec-af34-b41165340b7c	TCGA.29.1769	TCGA-29-1769-D27369	f005e844-c120-4a8d-9084-4363e2a321d1	2009-11-2	PACILTAXEL	NA	CHEMOTHERAPY	42	FALSE	150	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
1855	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27381	ca385d1c-e8cd-4c8d-b8b6-e3f6342b9b43	2009-11-2	AVASTIN	NA	TARGETED MOLECULAR THERAPY	741	FALSE	762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1856	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27379	4fc81e28-e99d-4465-a5a8-ea8769a382d4	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	384	FALSE	546	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	650	NA
1857	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27376	1d5ec102-18ba-4f80-9f5a-75392abd2a11	2009-11-2	TAXOTERE	NA	CHEMOTHERAPY	741	FALSE	762	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1858	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27378	9f9ea9ab-d749-4426-8eca-5a68cfc3c54c	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	87	FALSE	136	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	690	NA
1859	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27377	68258d53-863a-4fea-910f-39d19e435491	2009-11-2	DOCETAXEL	NA	CHEMOTHERAPY	87	FALSE	136	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
1860	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27375	1e51f5fb-e363-496b-ae43-0a814f064d15	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	68	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	630	NA
1861	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27380	7ad46917-dc48-46d5-9e93-4f4dab7ff79d	2009-11-2	GEMCITABINE	NA	CHEMOTHERAPY	384	FALSE	546	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1370	NA
1862	5abb6d80-fc39-49a4-8db5-3db24543feb6	TCGA.29.1770	TCGA-29-1770-D27374	86b9066d-36b2-4f36-b460-71f470c4e95a	2009-11-2	PACILTAXEL	NA	CHEMOTHERAPY	19	FALSE	68	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
1863	7b042fb2-8f53-4fb1-8a44-40cd2128b279	TCGA.29.1771	TCGA-29-1771-D27387	80543e63-933d-4f44-b5c2-c3062cc2448e	2009-11-18	PACILTAXEL	NA	CHEMOTHERAPY	27	FALSE	140	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	200	NA
1864	7b042fb2-8f53-4fb1-8a44-40cd2128b279	TCGA.29.1771	TCGA-29-1771-D27386	03cb09e7-1cf9-421c-a6b1-1647d5106a8b	2009-11-18	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	140	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	345	NA
1865	7b042fb2-8f53-4fb1-8a44-40cd2128b279	TCGA.29.1771	TCGA-29-1771-D27389	d1e90be4-8811-4a8f-a1c5-b914364b9454	2009-11-18	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	602	FALSE	728	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	695	NA
1866	7b042fb2-8f53-4fb1-8a44-40cd2128b279	TCGA.29.1771	TCGA-29-1771-D27384	359e1584-0379-4f8d-a2a5-25b007e48c08	2009-11-18	CARBOPLATIN	NA	CHEMOTHERAPY	602	FALSE	728	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	319	NA
1867	7b042fb2-8f53-4fb1-8a44-40cd2128b279	TCGA.29.1771	TCGA-29-1771-D27388	16adb117-4d4b-4234-b6bb-d2c6435b6e4d	2009-11-18	ABAGOVOMAG VS PLACEBO	NA	IMMUNOTHERAPY	189	FALSE	595	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	2	NA
1868	7b042fb2-8f53-4fb1-8a44-40cd2128b279	TCGA.29.1771	TCGA-29-1771-D27385	2c7306f8-d949-46b9-93fc-b192664a6e89	2009-11-18	PACILATXEL	NA	CHEMOTHERAPY	602	FALSE	728	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	245	NA
1869	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	TCGA.29.1774	TCGA-29-1774-D27393	8f0d525a-84cc-4376-80b4-468b67a8058f	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	14	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	340	NA
1870	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	TCGA.29.1774	TCGA-29-1774-D27392	c9297a2b-c8a3-47df-a05f-0986a27f2382	2009-10-26	GEMCITABINE	NA	CHEMOTHERAPY	247	FALSE	380	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1425	NA
1871	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	TCGA.29.1774	TCGA-29-1774-D27394	a01ca2d5-3332-453a-b76e-75339728fa1f	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	37	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	410	NA
1872	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	TCGA.29.1774	TCGA-29-1774-D27395	a3f71688-b40d-4551-91df-ad954d163bcc	2009-10-26	GEMCITABINE	NA	CHEMOTHERAPY	86	FALSE	86	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1075	NA
1873	d3dd5e69-9752-4b50-9b1f-814afbc2c3dd	TCGA.29.1774	TCGA-29-1774-D27396	8c33e373-811e-4dbf-8c56-ea8a94342b13	2010-2-9	CARBOPLATIN	NA	CHEMOTHERAPY	65	FALSE	133	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	340	NA
1874	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27401	d81cc8d4-ee3e-44c2-9775-1336cc2c23a5	2009-12-18	BEVACIZUMAB VS PLACEBO	NA	CHEMOTHERAPY	114	FALSE	320	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	11694	NA
1875	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27400	3d88301d-c73c-4314-b25e-8d6c5c85050d	2009-12-18	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	166	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4290	NA
1876	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27399	39863e9b-48dc-497d-bc6f-7ddaf6d74979	2009-12-18	PACLITAXEL	NA	CHEMOTHERAPY	29	FALSE	166	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2040	NA
1877	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27402	ac4fe03f-ca40-4a24-96fe-592c7547f834	2010-5-10	CISPLATIN	NA	CHEMOTHERAPY	355	FALSE	432	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	RECURRENCE	NA	100	NA
1878	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27405	fa8fc828-6c75-47d5-927d-86af2fa3cfb2	2010-5-10	GEMCITABINE HCL	NA	CHEMOTHERAPY	397	FALSE	467	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1600	NA
1879	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27404	4e0514c2-918e-49ce-b00d-fda19f334ef1	2010-5-10	TAXOTERE	NA	CHEMOTHERAPY	377	FALSE	377	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	120	NA
1880	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27407	0754f353-8c2d-477a-aa6c-ebb7d3191088	2010-5-10	TAMOXIFEN	NA	HORMONE THERAPY	530	NA	576	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	20	NA
1881	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27403	a1f3b59c-bbe7-4421-a1b4-a70684037a52	2010-5-10	PACLITAXEL	NA	CHEMOTHERAPY	355	FALSE	355	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1882	a4a3fca9-723a-47f5-a49d-b3acb71c04a7	TCGA.29.1775	TCGA-29-1775-D27406	2eb3063c-17a4-467e-8041-172da15d04d5	2010-5-10	DOXIL	NA	CHEMOTHERAPY	576	TRUE	604	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
1883	7472b3ba-9b15-4d97-8708-a2dd82ca0f45	TCGA.29.1776	TCGA-29-1776-D27413	ab1add4a-31c8-482e-a205-0e9c8a61be8b	2010-4-7	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	522	TRUE	592	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	2184	NA
1884	7472b3ba-9b15-4d97-8708-a2dd82ca0f45	TCGA.29.1776	TCGA-29-1776-D27412	a9e8a531-b7c7-4ded-a8d8-72c12e8cf1b2	2010-4-7	DOCETAXEL	NA	CHEMOTHERAPY	522	TRUE	592	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	88	NA
1885	7472b3ba-9b15-4d97-8708-a2dd82ca0f45	TCGA.29.1776	TCGA-29-1776-D27411	383ee8a0-b591-49b5-91f3-fe0b14dbf094	2010-4-7	PACLITAXEL	NA	CHEMOTHERAPY	32	FALSE	154	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1886	7472b3ba-9b15-4d97-8708-a2dd82ca0f45	TCGA.29.1776	TCGA-29-1776-D27410	dc28acfe-77b0-4f61-b4d1-2cefb76d2598	2010-4-7	CARBOPLATIN	NA	CHEMOTHERAPY	32	FALSE	154	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
1887	5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5	TCGA.29.1777	TCGA-29-1777-D27417	b75caa77-a905-4a32-b84b-da1b1c8917a5	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	325	FALSE	325	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	660	NA
1888	5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5	TCGA.29.1777	TCGA-29-1777-D27416	2d46646d-aff6-454e-b00e-294b99ca71f9	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	87	FALSE	303	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	740	NA
1889	5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5	TCGA.29.1777	TCGA-29-1777-D27418	c821d43b-cc39-4e8d-baef-20905b8795e5	2009-10-26	DOXORUBICIN HCL	NA	CHEMOTHERAPY	346	FALSE	346	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	70	NA
1890	44e840c9-ea54-4dba-9b2a-264ef1f2c304	TCGA.29.1778	TCGA-29-1778-D27423	af76c927-da93-45aa-a1f7-96a6182eaa7a	2009-10-26	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	80	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	325	NA
1891	44e840c9-ea54-4dba-9b2a-264ef1f2c304	TCGA.29.1778	TCGA-29-1778-D27422	7b208018-f74b-4c65-ae60-865ca874ba40	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	101	FALSE	125	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	410	NA
1892	44e840c9-ea54-4dba-9b2a-264ef1f2c304	TCGA.29.1778	TCGA-29-1778-D27425	fef2287b-ade4-4f49-808f-23aac02719c6	2009-10-26	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	80	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	500	NA
1893	44e840c9-ea54-4dba-9b2a-264ef1f2c304	TCGA.29.1778	TCGA-29-1778-D27421	76ba3141-d32e-463c-a900-bae906b194f2	2009-10-26	DOCETAXEL	NA	CHEMOTHERAPY	101	FALSE	125	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
1894	44e840c9-ea54-4dba-9b2a-264ef1f2c304	TCGA.29.1778	TCGA-29-1778-D27424	1622a274-30ac-42b7-b84f-9a475d6681f6	2009-10-26	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	80	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	325	NA
1895	f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6	TCGA.29.1781	TCGA-29-1781-D27429	ca447e99-c2a8-46bb-a4db-19480aae1034	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	52	FALSE	255	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2322	NA
1896	f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6	TCGA.29.1781	TCGA-29-1781-D27428	cf2a312b-1bea-47bb-8927-fec695033234	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	52	FALSE	255	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2970	NA
1897	460616ec-f66f-483b-88c1-757edd86261d	TCGA.29.1783	TCGA-29-1783-D27433	896921c8-ee1c-44b6-93d4-67af63d3a66a	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	30	FALSE	156	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1623	NA
1898	460616ec-f66f-483b-88c1-757edd86261d	TCGA.29.1783	TCGA-29-1783-D27434	282d262f-4bb3-40a5-81c7-dc51c8aa8886	2009-12-10	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	52	FALSE	430	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	9750	NA
1899	460616ec-f66f-483b-88c1-757edd86261d	TCGA.29.1783	TCGA-29-1783-D27432	c784772b-4edc-4349-9d95-598ee3dd7271	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	30	FALSE	156	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4536	NA
1900	23d32627-9fd2-4312-bcda-ee7409e3983f	TCGA.29.1784	TCGA-29-1784-D27437	a7ddfd0e-e8fd-4f46-898d-db041e8123b7	2009-12-10	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	136	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3330	NA
1901	23d32627-9fd2-4312-bcda-ee7409e3983f	TCGA.29.1784	TCGA-29-1784-D27438	14115b3c-a38c-47f2-84e9-b36340c5c238	2009-12-10	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	17	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	270	NA
1902	23d32627-9fd2-4312-bcda-ee7409e3983f	TCGA.29.1784	TCGA-29-1784-D27440	f607cd30-cc09-4356-b447-bf0f45cbb16c	2009-12-10	GEMCITABINE HCI	NA	CHEMOTHERAPY	23	FALSE	24	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2480	NA
1903	23d32627-9fd2-4312-bcda-ee7409e3983f	TCGA.29.1784	TCGA-29-1784-D27439	ca6a7ec0-5ee5-4be8-a942-9b86ff67a8b2	2009-12-10	PACLITAXEL; ALBUMIN-BOUNT	NA	CHEMOTHERAPY	59	FALSE	59	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
1904	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27447	f00119e6-143f-459d-8b3a-d340fd6169a6	2009-11-2	PACILTAXEL	NA	CHEMOTHERAPY	496	FALSE	496	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	330	NA
1905	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27445	331fce9e-ac3e-4a38-99a9-35704d71d5e4	2009-11-2	PACILTAXEL	NA	CHEMOTHERAPY	94	FALSE	156	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
1906	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27448	2004f10c-78e9-4a30-aaeb-be371007890c	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	521	FALSE	612	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	610	NA
1907	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27444	ec9873e2-600a-4805-bc39-ff9d81e7fef3	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	94	FALSE	156	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	610	NA
1908	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27443	698a373b-5699-474a-b8d6-fdd85307ffa6	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	51	FALSE	73	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	610	NA
1909	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27449	8111da34-a2c8-4258-aff6-c9d64b6c2e16	2009-11-2	DOCETAXEL	NA	CHEMOTHERAPY	521	FALSE	612	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	110	NA
1910	1aea3c25-d2bc-4ff5-bc27-32e939944e9d	TCGA.29.1785	TCGA-29-1785-D27446	c431ed1c-ba8d-41fc-b6a4-f5e5a1fbc579	2009-11-2	CARBOPLATIN	NA	CHEMOTHERAPY	496	FALSE	496	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	560	NA
1911	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27452	132a139a-586a-4d1a-af97-fa14a99ca34a	2010-2-9	CARBOPLATIN	NA	CHEMOTHERAPY	2042	FALSE	2151	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
1912	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27453	1bb30d93-19c1-43d9-aff6-31304c0e1cab	2010-2-9	DOXIL	NA	CHEMOTHERAPY	2256	FALSE	2287	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
1913	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27455	625a1bad-817a-495e-bbe8-b1b729a59ddc	2010-2-9	PACLITAXEL	NA	CHEMOTHERAPY	3	FALSE	131	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	20	NA
1914	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27454	d3474bc8-4f86-4d81-95e2-3bc02d4caeaf	2010-2-9	TOPOTECAN	NA	CHEMOTHERAPY	2315	FALSE	2424	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3	NA
1915	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27456	f1b37728-c715-49d5-8f09-f3ccd3f67332	2010-2-9	CISPLATIN	NA	CHEMOTHERAPY	3	FALSE	131	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
1916	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27458	317f4820-8ca1-4a04-914d-ed26beb2ab02	2010-3-10	CARBOPLATIN	NA	CHEMOTHERAPY	996	FALSE	1171	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1917	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27457	b3519929-e195-4d53-a529-432c75296acc	2010-3-10	PACLITAXEL	NA	CHEMOTHERAPY	996	FALSE	1171	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1918	a2319490-b85d-4219-a1b0-fa1ec432d5c8	TCGA.29.2414	TCGA-29-2414-D27459	d4828223-bc26-41cd-87bd-0dc1451bb931	2010-3-12	PACLITAXEL	NA	CHEMOTHERAPY	996	FALSE	1171	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1919	40635bf3-d8ba-4833-b623-547e55e5d07e	TCGA.29.2425	TCGA-29-2425-D27465	bb6485f6-0925-462b-b098-086512a78e90	2010-2-9	CARBOPLATIN	NA	CHEMOTHERAPY	10	FALSE	202	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
1920	40635bf3-d8ba-4833-b623-547e55e5d07e	TCGA.29.2425	TCGA-29-2425-D27467	b173f7f4-e6ed-49dc-bf99-a3d7a213801b	2010-2-9	PACLITAXEL	NA	CHEMOTHERAPY	119	FALSE	202	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1921	40635bf3-d8ba-4833-b623-547e55e5d07e	TCGA.29.2425	TCGA-29-2425-D27468	a11754f7-bc64-44fb-b4ba-049a4f6f9766	2010-2-9	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1584	FALSE	1696	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	PROGRESSION	NA	15	NA
1922	40635bf3-d8ba-4833-b623-547e55e5d07e	TCGA.29.2425	TCGA-29-2425-D27463	68120a6b-d428-4644-a08d-39d0d8635aa4	2010-2-9	PACLITAXEL	NA	CHEMOTHERAPY	1584	FALSE	1696	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	175	NA
1923	40635bf3-d8ba-4833-b623-547e55e5d07e	TCGA.29.2425	TCGA-29-2425-D27466	b1c41005-66fb-4b61-bb72-9a2dde69f06d	2010-2-9	GEMZAR	NA	CHEMOTHERAPY	10	FALSE	97	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1000	NA
1924	40635bf3-d8ba-4833-b623-547e55e5d07e	TCGA.29.2425	TCGA-29-2425-D27464	7db78a21-3be4-499a-a7bc-fff049921c40	2010-2-9	CARBOPLATIN	NA	CHEMOTHERAPY	1584	FALSE	1696	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
1925	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	TCGA.29.2427	TCGA-29-2427-D27471	5f00d7f8-73b2-4db4-ba11-5a41234d2ca1	2010-2-8	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	49	NA	NA	NA	NA	3	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
1926	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	TCGA.29.2427	TCGA-29-2427-D27474	3d7a84c3-cc88-4b27-84a0-697e76c7cbc7	2010-2-8	ABRAXANE	NA	CHEMOTHERAPY	1816	FALSE	1900	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	510	NA
1927	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	TCGA.29.2427	TCGA-29-2427-D27473	ee7023c9-49e0-48c5-8781-e28ef2609827	2010-2-8	CARBOPLATIN	NA	CHEMOTHERAPY	1584	FALSE	1690	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	6	NA
1928	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	TCGA.29.2427	TCGA-29-2427-D27472	47d4b680-8d55-4cf4-868b-ae44e3ae1436	2010-2-8	PACLITAXEL	NA	CHEMOTHERAPY	7	FALSE	49	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	0	NA
1929	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	TCGA.29.2427	TCGA-29-2427-D27476	8b87346f-baaf-46c2-9c7d-07ad0af96ad2	2011-10-20	CYCLOPHOSPHAMIDE	NA	CHEMOTHERAPY	73	FALSE	157	NA	NA	NA	NA	6	NA	MG	MG	940	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5640	NA
1930	6f25001a-f890-4fd0-a994-e62a9ea5c6f3	TCGA.29.2427	TCGA-29-2427-D27475	ee835a1c-74f7-4113-a155-edb8c347a4b2	2011-10-20	CISPLATIN	NA	CHEMOTHERAPY	73	FALSE	157	NA	NA	NA	NA	6	NA	MG	MG	110	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	660	NA
1931	b0585c7a-7205-4dac-9d54-6da89674accb	TCGA.29.2428	TCGA-29-2428-D27479	0f7b6d8e-68b1-42e2-8242-af4bf9964970	2010-2-8	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	141	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	670	NA
1932	b0585c7a-7205-4dac-9d54-6da89674accb	TCGA.29.2428	TCGA-29-2428-D27480	a0dae621-3815-4b2a-8364-e19198be75ac	2010-2-8	PACLITAXEL	NA	CHEMOTHERAPY	18	FALSE	141	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	280	NA
1933	4309ca23-1cf9-40a2-a01c-ccee90f958b2	TCGA.29.2429	TCGA-29-2429-D27483	e4df2fd2-1dc4-424a-b456-c3e415c37ace	2010-6-4	PACLITAXEL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1934	4309ca23-1cf9-40a2-a01c-ccee90f958b2	TCGA.29.2429	TCGA-29-2429-D27482	c75fad2f-73f0-4fa6-8870-e9a28e7ae23a	2010-6-4	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1935	996313ef-11e7-459d-ba5f-ac1a4d0de513	TCGA.29.2431	TCGA-29-2431-D27488	c63c5158-3a3d-4f97-92f7-c6cba8fdb995	2010-6-4	PACLITAXEL	NA	CHEMOTHERAPY	977	FALSE	1145	NA	NA	NA	NA	8	NA	MG	MG	335	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1936	996313ef-11e7-459d-ba5f-ac1a4d0de513	TCGA.29.2431	TCGA-29-2431-D27487	02256292-b3b7-427a-9157-5147ef0ba72c	2010-6-4	OXALIPLATIN	NA	CHEMOTHERAPY	33	FALSE	138	NA	NA	NA	NA	6	NA	MG	MG	160	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1937	996313ef-11e7-459d-ba5f-ac1a4d0de513	TCGA.29.2431	TCGA-29-2431-D27490	4697eff4-cb13-4836-8a81-0e4382d5b5fe	2010-6-4	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	33	FALSE	390	NA	NA	NA	NA	NA	NA	MG	MG	1120	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1938	996313ef-11e7-459d-ba5f-ac1a4d0de513	TCGA.29.2431	TCGA-29-2431-D27489	90ddaf81-71b9-42e3-b499-498c241002c3	2010-6-4	CARBOPLATIN	NA	CHEMOTHERAPY	977	FALSE	1145	NA	NA	NA	NA	8	NA	MG	MG	530	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1939	996313ef-11e7-459d-ba5f-ac1a4d0de513	TCGA.29.2431	TCGA-29-2431-D27486	e8857415-3e93-4361-930e-4ccb6671e0c1	2010-6-4	DOCETAXEL	NA	CHEMOTHERAPY	33	FALSE	138	NA	NA	NA	NA	6	NA	MG	MG	140	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1940	0e6c9433-289c-4744-a0c1-47ec67774047	TCGA.29.2432	TCGA-29-2432-D27493	d5720bb9-fbde-4f8d-a0b5-7bb82df87ce2	2010-6-4	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	157	NA	NA	NA	NA	6	NA	MG	MG	540	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3150	NA
1941	0e6c9433-289c-4744-a0c1-47ec67774047	TCGA.29.2432	TCGA-29-2432-D27495	cebea2c3-9245-4c77-b299-33df263ad6d7	2010-6-4	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	38	FALSE	157	NA	NA	NA	NA	NA	NA	MG	MG	1010	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1942	0e6c9433-289c-4744-a0c1-47ec67774047	TCGA.29.2432	TCGA-29-2432-D27494	ec863682-01e3-4e42-b640-495a71b085bc	2010-6-4	PACLITAXEL	NA	CHEMOTHERAPY	14	FALSE	157	NA	NA	NA	NA	6	NA	MG	MG	303	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1809	NA
1943	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	TCGA.29.2433	TCGA-29-2433-D27501	02db8301-db04-448c-8746-b7444a422db3	2010-6-4	PACLITAXEL	NA	CHEMOTHERAPY	42	FALSE	67	NA	NA	NA	NA	2	NA	MG	MG	175	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	280	NA
1944	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	TCGA.29.2433	TCGA-29-2433-D27499	fd6d33a9-4c41-4913-8419-21223bb1d0fd	2010-6-4	PACLITAXEL	NA	CHEMOTHERAPY	14	FALSE	14	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1945	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	TCGA.29.2433	TCGA-29-2433-D27502	e13efaba-05ce-4654-aeba-b4a2ec4de5f9	2010-6-4	DOCETAXEL	NA	CHEMOTHERAPY	94	FALSE	137	NA	NA	NA	NA	3	NA	MG	MG	100	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	300	NA
1946	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	TCGA.29.2433	TCGA-29-2433-D27498	2e115b5c-8485-45e4-8df9-75e36bafe736	2010-6-4	CISPLATINUM	NA	CHEMOTHERAPY	14	FALSE	14	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
1947	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	TCGA.29.2433	TCGA-29-2433-D27500	6c774a12-0b32-4828-af0e-0361420497ac	2010-6-4	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	67	NA	NA	NA	NA	2	NA	MG	MG	540	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1040	NA
1948	fd806e1d-b5ea-4556-9b12-5254fd9f00a2	TCGA.29.2433	TCGA-29-2433-D27503	d4f86338-7a09-4c77-a277-30cd5198568f	2010-6-11	CARBOPLATIN	NA	CHEMOTHERAPY	94	FALSE	137	NA	NA	NA	NA	3	NA	MG	MG	450	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1350	NA
1949	cb090048-9af1-489d-9ebe-7efaa3dc4e85	TCGA.29.2434	TCGA-29-2434-D27506	269dc635-745c-4959-aef6-d92e348c7080	2010-6-7	PACLITAXEL	NA	CHEMOTHERAPY	28	FALSE	134	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	135	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1950	cb090048-9af1-489d-9ebe-7efaa3dc4e85	TCGA.29.2434	TCGA-29-2434-D27507	052789d2-36ee-41a4-8bc3-b6bfa7a2f87b	2010-6-7	CISPLATIN	NA	CHEMOTHERAPY	28	FALSE	134	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	100	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
1951	cb090048-9af1-489d-9ebe-7efaa3dc4e85	TCGA.29.2434	TCGA-29-2434-D27508	266546a4-d823-480b-9c84-a8b4ae413205	2010-6-7	PACLITAXEL	NA	CHEMOTHERAPY	35	FALSE	140	NA	NA	NA	NA	5	NA	MG	MG	100	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
1952	8fa35df3-f544-4c47-bdd1-e4d6fc6662be	TCGA.29.2435	TCGA-29-2435-D27511	4b060dcb-322a-4357-b030-8cbe7307bc71	2010-6-7	CARBOPLATIN	NA	CHEMOTHERAPY	30	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1953	8fa35df3-f544-4c47-bdd1-e4d6fc6662be	TCGA.29.2435	TCGA-29-2435-D27512	9d87155a-3587-4120-8dd9-6703aa7a39c4	2010-6-7	PACLITAXEL	NA	CHEMOTHERAPY	30	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1954	295231ab-477b-4077-a368-db34f867102c	TCGA.29.2436	TCGA-29-2436-D27515	5061e9ad-2cf6-4dd3-970c-57ce41b37689	2010-6-7	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	191	NA	NA	NA	NA	6	NA	MG	MG	275	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1406	NA
1955	295231ab-477b-4077-a368-db34f867102c	TCGA.29.2436	TCGA-29-2436-D27516	906d31f6-1d9e-4baf-a9b5-2cb038fe599e	2010-6-7	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	191	NA	NA	NA	NA	6	NA	MG	MG	870	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5220	NA
1956	F1CB3D48-1415-408D-89D1-DFDCC5924963	TCGA.29.A5NZ	TCGA-29-A5NZ-D59533	061ED9E3-C6F0-4348-9A32-9FAAD64DC411	2014-5-14	PACLITAXEL	NA	NA	25	FALSE	151	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1957	F1CB3D48-1415-408D-89D1-DFDCC5924963	TCGA.29.A5NZ	TCGA-29-A5NZ-D59534	2ABD0BB8-6960-48F8-B08D-28AB17CF9FE6	2014-5-14	CARBOPLATIN	NA	NA	396	FALSE	543	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1958	F1CB3D48-1415-408D-89D1-DFDCC5924963	TCGA.29.A5NZ	TCGA-29-A5NZ-D59535	55F4F735-7B13-4FA5-8105-4B4D8480A870	2014-5-14	DOXIL	NA	NA	396	FALSE	543	PARTIAL RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1959	F1CB3D48-1415-408D-89D1-DFDCC5924963	TCGA.29.A5NZ	TCGA-29-A5NZ-D59537	F3B64637-8466-489E-AAE7-0CB2CD1E80C6	2014-5-14	PACLITAXEL	NA	NA	893	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1960	F1CB3D48-1415-408D-89D1-DFDCC5924963	TCGA.29.A5NZ	TCGA-29-A5NZ-D59532	B8A9B895-3774-4B7A-8E4E-601BAEEB0C3B	2014-5-14	CARBOPLATIN	NA	NA	25	FALSE	151	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1961	F1CB3D48-1415-408D-89D1-DFDCC5924963	TCGA.29.A5NZ	TCGA-29-A5NZ-D59536	F16C6D42-2092-4457-B4B5-D5F1169B78FD	2014-5-14	GEMZAR	NA	NA	686	FALSE	817	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1962	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27529	484b8f0c-dfc0-4609-8b68-bcb68ba7cfb0	2009-9-23	CARBOPLATIN	NA	CHEMOTHERAPY	1002	FALSE	1075	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	343	NA
1963	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27528	e1b0dbd2-3f76-4035-bd5a-4d21fb2d5ead	2009-9-23	VP 16	NA	CHEMOTHERAPY	973	FALSE	990	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	RECURRENCE	NA	50	NA
1964	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27522	5dcaa7ee-b212-4231-a324-aa6ce4fbc112	2009-9-23	TOPOTECAN	NA	CHEMOTHERAPY	424	FALSE	521	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3	NA
1965	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27527	042e666e-6398-41eb-b4a7-a7c8f827113c	2009-9-23	TAXOTERE	NA	CHEMOTHERAPY	906	FALSE	955	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	30	NA
1966	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27521	cef80948-64c3-4608-b830-fc9ffb5114e7	2009-9-23	DOXIL	NA	CHEMOTHERAPY	314	FALSE	417	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	40	NA
1967	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27524	c9389674-3b88-4809-aa7a-cba33bed3d60	2009-9-23	TAXOL	NA	CHEMOTHERAPY	555	FALSE	700	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	175	NA
1968	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27519	0dfd75da-44eb-4094-886c-ea2ef1f0d39d	2009-9-23	TAXOL	NA	CHEMOTHERAPY	15	FALSE	123	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1969	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27530	994c0e08-62d3-4f19-b713-c74fad7d2a4f	2009-9-23	TAXOL	NA	CHEMOTHERAPY	1002	FALSE	1081	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	135	NA
1970	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27520	3b0d4be7-ecbf-4ea1-ad60-3f6e3b6fccad	2009-9-23	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	123	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
1971	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27525	d02262bf-8e14-4818-a03b-da6d5cc93714	2009-9-23	TAXOL	NA	CHEMOTHERAPY	555	FALSE	700	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	278	NA
1972	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27523	96e20ade-957d-4325-bf8a-52bcf4a52c4a	2009-9-23	CARBOPLATIN	NA	CHEMOTHERAPY	555	FALSE	700	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	343	NA
1973	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27526	229d1033-3c45-40c6-a9ff-3ac9a8dfcd07	2009-9-23	GEMCITABINE	NA	CHEMOTHERAPY	906	FALSE	955	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	700	NA
1974	09820a33-80b1-42d0-8366-a0ddaf94b122	TCGA.30.1714	TCGA-30-1714-D27531	ac3a5434-1fed-435f-8b81-48141e149b33	2009-12-9	ARMIDEX	NA	HORMONE THERAPY	246	FALSE	283	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1975	ad2939e6-b8b8-475a-90e2-6a369c3d3167	TCGA.30.1718	TCGA-30-1718-D27535	05090990-3b2e-4695-8640-d685a8dd5e38	2009-9-23	HEXALIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1976	ad2939e6-b8b8-475a-90e2-6a369c3d3167	TCGA.30.1718	TCGA-30-1718-D27537	ca71da11-843d-4468-988f-8a5f48ffbfb5	2009-9-23	TAXOL	NA	CHEMOTHERAPY	206	FALSE	492	NA	NA	NA	NA	11	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1977	ad2939e6-b8b8-475a-90e2-6a369c3d3167	TCGA.30.1718	TCGA-30-1718-D27536	49cdeed1-76cc-4608-aea3-af439a26c1e5	2009-9-23	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	178	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1978	ad2939e6-b8b8-475a-90e2-6a369c3d3167	TCGA.30.1718	TCGA-30-1718-D27540	abea4d31-e57d-4f0f-b821-23a5d05123ec	2009-9-23	TAMOXIFEN	NA	HORMONE THERAPY	865	FALSE	896	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1979	ad2939e6-b8b8-475a-90e2-6a369c3d3167	TCGA.30.1718	TCGA-30-1718-D27538	c2fa4a73-8690-49e7-a1b7-cc0ec4f5d70e	2009-12-9	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1980	ad2939e6-b8b8-475a-90e2-6a369c3d3167	TCGA.30.1718	TCGA-30-1718-D27539	0a8e0ead-87c1-40cb-a0a2-d7af833547a1	2009-12-9	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1981	5d603bba-62e6-48fb-b8fc-401109abcaee	TCGA.30.1853	TCGA-30-1853-D27548	87eb4360-2370-42e4-9920-32b4be6791ba	2009-12-28	DOXIL	NA	CHEMOTHERAPY	950	FALSE	1011	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
1982	5d603bba-62e6-48fb-b8fc-401109abcaee	TCGA.30.1853	TCGA-30-1853-D27544	02e54e5c-6ffc-4742-92ba-1de798919bf9	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	126	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
1983	5d603bba-62e6-48fb-b8fc-401109abcaee	TCGA.30.1853	TCGA-30-1853-D27546	d1cdcf9f-1d4f-495b-9ca3-3f1820988c17	2009-12-28	TAXOL	NA	CHEMOTHERAPY	669	FALSE	778	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	175	NA
1984	5d603bba-62e6-48fb-b8fc-401109abcaee	TCGA.30.1853	TCGA-30-1853-D27547	aee7c046-3c2e-4a58-80b4-4b642c08a7e9	2009-12-28	TRABECTEDIN	NA	CHEMOTHERAPY	886	FALSE	932	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	580	NA
1985	5d603bba-62e6-48fb-b8fc-401109abcaee	TCGA.30.1853	TCGA-30-1853-D27543	8a8fea1c-af3d-4d12-abe1-1732158991df	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	669	FALSE	778	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
1986	5d603bba-62e6-48fb-b8fc-401109abcaee	TCGA.30.1853	TCGA-30-1853-D27545	23159ed1-9189-4f06-bf1f-100d10cfbf8b	2009-12-28	TAXOL	NA	CHEMOTHERAPY	42	FALSE	126	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1987	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27556	17d3f156-81fa-443c-9bcd-8c5a72174dbb	2009-9-23	ADRIAMYCIN	NA	CHEMOTHERAPY	17	FALSE	195	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1988	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27559	c66732af-f355-40df-a6b3-4993bb55a8f7	2009-9-23	DOXIL	NA	CHEMOTHERAPY	339	FALSE	462	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	30	NA
1989	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27560	c580c4e7-0a42-4ca4-b24f-43a2ca827d00	2009-9-23	NAVELBINE	NA	CHEMOTHERAPY	339	FALSE	462	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	20	NA
1990	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27562	4f34558c-9912-4486-8df5-f0a6fcc95fb1	2009-9-23	TAMOXIFEN	NA	HORMONE THERAPY	230	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	40	NA
1991	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27553	06847472-6031-4f11-a05b-a66e4c119973	2009-9-23	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	195	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
1992	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27557	7f66f918-6c82-4943-a08a-9ce8dee928ec	2009-9-23	TOPOTECAN	NA	CHEMOTHERAPY	17	FALSE	195	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1993	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27555	1df9a4b7-edff-4838-abd5-cb77b22ee5a5	2009-9-23	GEMCITABINE	NA	CHEMOTHERAPY	17	FALSE	195	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1000	NA
1994	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27558	9d9e6ff1-26ab-4620-9423-bc250e900e29	2009-9-23	TAXOTERE	NA	CHEMOTHERAPY	272	FALSE	300	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	30	NA
1995	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27561	76cc12ec-df1b-4744-aea9-228dca5926e0	2009-9-23	CPT 11	NA	CHEMOTHERAPY	339	FALSE	462	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	50	NA
1996	91a6f311-c758-4e40-9abb-cc0f6584b9c9	TCGA.30.1856	TCGA-30-1856-D27554	8b99703a-2b37-485b-9c5b-9fd8cf793f2a	2009-9-23	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	195	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
1997	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27570	1c7d824c-50bd-44c9-8d9b-885a9264aaf6	2009-12-21	ADRIAMYCIN	NA	CHEMOTHERAPY	31	FALSE	199	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	25	NA
1998	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27569	d9e87488-f292-4809-82e9-b9d72576d084	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	31	FALSE	199	NA	NA	NA	NA	9	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
1999	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27572	adb0eafc-52e6-4a08-9a54-550b06ff59ef	2009-12-21	TRABECTEDIN	NA	CHEMOTHERAPY	369	FALSE	593	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	500	NA
2000	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27567	2994f82f-4e05-4b8d-b9ca-755057a83d52	2009-12-21	TAXOL	NA	CHEMOTHERAPY	31	FALSE	199	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2001	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27575	93b2bc44-d1e0-47f3-9e5b-acbef8b3a702	2009-12-21	TAXOL	NA	CHEMOTHERAPY	1214	FALSE	1376	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
2002	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27571	afacbc4a-1d91-481a-9356-4e49172e7a00	2009-12-21	TOPOTECAN	NA	CHEMOTHERAPY	31	FALSE	199	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.25	NA
2003	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27576	bb4f183e-5f3e-46f4-9694-2a4f046344e2	2009-12-21	CYTOXAN	NA	CHEMOTHERAPY	1334	FALSE	1379	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
2004	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27568	39b99982-93f4-4457-a0fe-8336aafbe6dd	2009-12-21	GEMCITABINE	NA	CHEMOTHERAPY	31	FALSE	199	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1000	NA
2005	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27574	2fe73c42-528a-49b7-8ace-300e3463ab5b	2009-12-21	DOXIL	NA	CHEMOTHERAPY	1162	FALSE	1197	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
2006	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27573	c6e94b43-b6ed-43ef-b8bb-65ed70ca8fb9	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	982	FALSE	1103	NA	NA	NA	NA	5	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
2007	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27577	d9868c5b-53d0-4d6b-8ac2-95b76c3a77b4	2009-12-21	ARMIDEX	NA	HORMONE THERAPY	1135	FALSE	1166	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2008	dac8d825-dd47-47ed-a426-0ee75feb76f3	TCGA.30.1859	TCGA-30-1859-D27578	4f6ba9dd-c995-4de2-8e41-6f52823d25d7	2010-1-27	SARGRAMOSTIN	NA	IMMUNOTHERAPY	1104	FALSE	1131	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2009	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27585	2b258497-1982-434d-8908-7f2d70f63de5	2009-12-28	GEMCITABINE	NA	CHEMOTHERAPY	744	FALSE	915	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	750	NA
2010	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27581	3329995b-440d-44b0-bae0-188b798ee53c	2009-12-28	DOXIL	NA	CHEMOTHERAPY	413	FALSE	561	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	40	NA
2011	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27586	3abc00eb-e2d3-4427-8aa4-b023be30b7dd	2009-12-28	TOPOTECAN	NA	CHEMOTHERAPY	915	FALSE	957	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4	NA
2012	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27583	2b1e50e4-2b3e-4287-9fb3-c53cce0cb15f	2009-12-28	TAXOL	NA	CHEMOTHERAPY	22	FALSE	207	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2013	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27584	d3ce4085-ca82-4143-ad0b-ec81ff9f2ea9	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	744	FALSE	915	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
2014	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27587	cf6521d0-a099-4672-b87c-60626cb8ac54	2009-12-28	TAXOL	NA	CHEMOTHERAPY	994	FALSE	1069	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	70	NA
2015	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27588	6f7e67db-f301-47f1-a6f6-e0f3af86bd09	2009-12-28	NAVELBINE	NA	CHEMOTHERAPY	1191	FALSE	1246	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	15	NA
2016	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27582	0f428947-8a45-4e60-a43e-7772159e8841	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	207	NA	NA	NA	NA	7	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
2017	563853a2-9ac2-48be-adf3-1e547ee2b274	TCGA.30.1860	TCGA-30-1860-D27589	078a36dd-f808-4f61-bea3-655803dd03ab	2010-1-8	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1191	FALSE	1246	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
2018	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27597	42b5deb5-1f12-40c6-b3c9-532ec204c50a	2009-12-28	TAXOL	NA	CHEMOTHERAPY	19	FALSE	126	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2019	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27601	e9f71e7a-9032-4e6d-8906-57b4fa5f37b8	2009-12-28	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2020	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27599	c64a880a-85be-42d3-8378-642a1f1dce7f	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2021	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27598	6b21b434-6af0-431c-90dd-0fc0118ede26	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	126	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2022	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27600	41f27513-1242-4061-a85b-c2884f60a85c	2009-12-28	GEMCITABINE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2023	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27602	70f90115-e87d-47e9-bf4f-7456761ae58e	2009-12-28	GEMCITABINE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2024	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27596	898a6998-0b59-4803-ba74-26e008181c0e	2009-12-28	DOXIL	NA	CHEMOTHERAPY	265	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2025	cbc7f427-5f7b-4267-ad56-055d8880a4cc	TCGA.30.1866	TCGA-30-1866-D27603	e1c6ebe7-8c5c-4199-a06f-ab66088a058b	2009-12-28	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2026	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27608	65d2783e-d0d4-43f0-b528-fa7114edf7cd	2009-12-21	TAXOL	NA	CHEMOTHERAPY	22	FALSE	179	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2027	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27609	d9cac678-a898-49d5-b2a4-66e0b4a3f093	2009-12-21	GEMCITABINE	NA	CHEMOTHERAPY	22	FALSE	179	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1000	NA
2028	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27611	2e966536-4070-4988-b610-3209fb63fbd4	2009-12-21	ALIMTA	NA	CHEMOTHERAPY	767	FALSE	943	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	500	NA
2029	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27616	baf2c401-c86f-49bf-a41e-7796a1bdab3e	2009-12-21	TAXOL	NA	CHEMOTHERAPY	1398	FALSE	1489	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	175	NA
2030	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27612	99f53275-3d20-47d8-b7a2-9abc8e23d5ec	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	767	FALSE	943	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	400	NA
2031	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27617	140f7ef0-28fe-4f59-83ca-87f440debd96	2009-12-21	TOPOTECAN	NA	CHEMOTHERAPY	1510	FALSE	1534	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3	NA
2032	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27614	f1585f4b-3343-44d0-a65c-ea6a32f8f8f9	2009-12-21	SNS 595	NA	CHEMOTHERAPY	1279	FALSE	1331	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	48	NA
2033	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27610	3e6d063a-3c03-4260-a94a-c80bf3c5d04a	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	179	NA	NA	NA	NA	9	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
2034	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27613	b19d902f-e78b-4c03-8c6d-10e286a434f3	2009-12-21	DOXIL	NA	CHEMOTHERAPY	1184	FALSE	1211	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
2035	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27615	2a21156d-6a16-4035-bcbe-3876506d6d74	2009-12-21	CARBPLATIN	NA	CHEMOTHERAPY	1398	FALSE	1489	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
2036	84f5876d-82b0-45ff-8f3d-a10653683454	TCGA.30.1869	TCGA-30-1869-D27618	9c9e5af4-0f8a-426b-8a5a-445a5fcbc1d1	2010-1-27	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1132	FALSE	1175	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	30	NA
2037	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27627	85360ccf-2a0a-47ee-83db-5975230aeea8	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	1400	FALSE	1610	NA	NA	NA	NA	9	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
2038	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27622	38844241-56d0-4348-bad6-cea1c8676542	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	46	FALSE	152	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
2039	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27625	cd005c2a-a2f0-4edc-80ae-1a99c144c424	2009-12-28	TAXOL	NA	CHEMOTHERAPY	718	FALSE	823	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	175	NA
2040	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27630	c3c91988-c02c-4a0a-a97d-2a9642af6acd	2009-12-28	NAVELBINE	NA	CHEMOTHERAPY	1660	FALSE	1722	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	20	NA
2041	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27629	13b6227e-71f3-470b-9004-61740ce4ae73	2009-12-28	CBP501	NA	CHEMOTHERAPY	1642	FALSE	1656	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3.6	NA
2042	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27624	4f399194-c399-49e7-8a36-5be1a8c99795	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	718	FALSE	823	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
2043	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27623	9ac2fa30-2499-46b0-a7fb-bcfb674103ca	2009-12-28	TAXOL	NA	CHEMOTHERAPY	46	FALSE	152	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2044	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27626	b598f971-0c3c-459c-bbc9-82ee2b755e69	2009-12-28	GEMCITABINE	NA	CHEMOTHERAPY	1106	FALSE	1228	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	700	NA
2045	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27628	06ef436c-e8d9-4b26-94f4-70f29686f536	2009-12-28	TAXOL	NA	CHEMOTHERAPY	1400	FALSE	1610	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	175	NA
2046	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27621	628b3fcc-ca45-466b-98fc-54ef1c3a8bea	2009-12-28	DOXIL	NA	CHEMOTHERAPY	357	FALSE	497	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	40	NA
2047	bc873b2a-35b7-4365-a2cc-e6a83063556e	TCGA.30.1880	TCGA-30-1880-D27631	8eafb3d9-4869-4af0-9a1f-cf55767563cd	2010-1-8	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1660	FALSE	1722	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
2048	f7e01929-733b-420a-ab2b-051dd4a992e5	TCGA.30.1887	TCGA-30-1887-D27635	18d7a1d8-66b8-4c1c-ad1c-13862bf6263b	2009-12-21	TAXOL	NA	CHEMOTHERAPY	27	FALSE	134	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2049	f7e01929-733b-420a-ab2b-051dd4a992e5	TCGA.30.1887	TCGA-30-1887-D27634	e96002ef-d950-4ede-b623-c6ca3cdff2f2	2009-12-21	GEMCITABINE	NA	CHEMOTHERAPY	328	FALSE	433	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	800	NA
2050	f7e01929-733b-420a-ab2b-051dd4a992e5	TCGA.30.1887	TCGA-30-1887-D27637	867b6ed3-96ff-40dc-a6e7-722a047a5b95	2009-12-21	TOPOTECAN	NA	CHEMOTHERAPY	454	FALSE	482	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3	NA
2051	f7e01929-733b-420a-ab2b-051dd4a992e5	TCGA.30.1887	TCGA-30-1887-D27638	f0f317a4-a2de-4a8f-8fff-54f488ba5642	2009-12-21	TAXOL	NA	CHEMOTHERAPY	503	FALSE	671	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	64	NA
2052	f7e01929-733b-420a-ab2b-051dd4a992e5	TCGA.30.1887	TCGA-30-1887-D27636	d1a4e7ac-6745-47f8-8a98-0b3be8413eca	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	134	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
2053	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27647	ef980ca7-1da5-42fc-85e7-525fe996afd6	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	460	FALSE	526	NA	NA	NA	NA	4	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
2054	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27650	cd524283-81d7-4569-8af9-8bae2aa59655	2009-12-21	TOPOTECAN	NA	CHEMOTHERAPY	701	FALSE	890	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3	NA
2055	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27642	cbedad2d-cf2a-4f75-b280-dfa270d0b918	2009-12-21	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	141	NA	NA	NA	NA	7	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
2056	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27641	99ab0f66-db33-4c20-9813-a34ce14f25d6	2009-12-21	DOXIL	NA	CHEMOTHERAPY	189	FALSE	330	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	40	NA
2057	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27645	fd0a5766-c375-4546-8acd-af9b0cb09e93	2009-12-21	GEMCITABINE	NA	CHEMOTHERAPY	400	FALSE	453	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	700	NA
2058	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27651	c5a7f0b8-9eba-4728-9684-dfe16a36d94a	2009-12-21	NAVELBINE	NA	CHEMOTHERAPY	855	FALSE	890	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	25	NA
2059	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27643	2c926101-6d5b-42b0-8452-bd5074d5c811	2009-12-21	TAXOL	NA	CHEMOTHERAPY	15	FALSE	141	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2060	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27646	d5f3bf0d-8d21-4914-88a2-107de938f057	2009-12-21	GEMCITABINE	NA	CHEMOTHERAPY	460	FALSE	526	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	700	NA
2061	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27649	f3619476-e2c4-4284-9f6a-0ac66cec5f6c	2009-12-21	TAXOL	NA	CHEMOTHERAPY	666	FALSE	694	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	80	NA
2062	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27644	ebea0ddd-3575-40ef-843f-5007f3fde1d6	2009-12-21	CYTOXAN	NA	CHEMOTHERAPY	358	FALSE	386	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
2063	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27648	a2090fb3-e9be-4240-9b2a-17011087a3de	2009-12-21	CISPLATIN	NA	CHEMOTHERAPY	554	FALSE	638	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	75	NA
2064	4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3	TCGA.30.1891	TCGA-30-1891-D27652	9ada3d87-0c7b-450a-8c0e-0577b7ea4a49	2010-1-27	AVASTIN	NA	TARGETED MOLECULAR THERAPY	358	FALSE	386	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
2065	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27655	8613c854-9f6d-47d0-82ed-0e350279b555	2009-12-28	DOXIL	NA	CHEMOTHERAPY	253	FALSE	419	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2066	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27659	4ac6ea86-5442-489f-b149-c59fd9bf4337	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	601	FALSE	754	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2067	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27663	19c74bf7-d4e0-4ed9-bb80-9ae383b30f63	2009-12-28	TAXOL	NA	CHEMOTHERAPY	1197	FALSE	1258	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	70	NA
2068	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27660	a87f93b1-bdb0-4f71-8935-83676e4ed831	2009-12-28	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2069	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27664	7a5870a1-c1e0-40f5-bbd4-40f24bf5b58c	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	1265	FALSE	1384	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5	NA
2070	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27665	ac5780c2-338d-43f3-bba7-da96287273e4	2009-12-28	CATUMAXUMAB	NA	CHEMOTHERAPY	1428	FALSE	1449	NA	NA	NA	NA	4	NA	UG	UG	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	10	NA
2071	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27661	86024c3e-d6d1-4070-b455-2802e60f49cb	2009-12-28	ALTIMA	NA	CHEMOTHERAPY	862	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2072	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27656	2ac4a1ea-4121-4873-8a86-65f2bbcc6841	2009-12-28	TAXOL	NA	CHEMOTHERAPY	10	FALSE	132	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2073	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27657	15b4f156-d559-4a4c-a41e-4f580ece69c1	2009-12-28	CARBOPLATIN	NA	CHEMOTHERAPY	10	FALSE	132	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
2074	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27658	06790c50-25b2-4844-acd8-09bc85d7380d	2009-12-28	GEMCITABINE	NA	CHEMOTHERAPY	428	FALSE	573	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2075	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27662	bca6db49-eba4-482d-b1b7-38025d302b3a	2009-12-28	CYTOXIN	NA	CHEMOTHERAPY	1113	FALSE	1197	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
2076	a09f0626-002a-48fd-8b2d-c66b8285cf23	TCGA.30.1892	TCGA-30-1892-D27666	ef88b090-ede2-43bf-b637-d824c853ef5c	2009-12-28	AVASTIN	NA	IMMUNOTHERAPY	1134	FALSE	1197	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	15	NA
2077	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27676	23580769-8adf-40ec-b355-47fff6d32793	2009-10-19	AZD 2281	NA	CHEMOTHERAPY	1032	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
2078	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27672	fc93f3e4-6ccb-4337-9034-702229893171	2009-10-19	PACILTAXEL	NA	CHEMOTHERAPY	153	FALSE	223	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	835	NA
2079	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27674	1808b6be-23eb-4458-a360-341875a10491	2009-10-19	PACILTAXEL	NA	CHEMOTHERAPY	721	FALSE	841	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1650	NA
2080	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27671	1d97e4b9-be4e-4cee-a355-0b45ddc151f3	2009-10-19	CISPLATIN	NA	CHEMOTHERAPY	153	FALSE	223	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	345	NA
2081	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27677	e2d31a97-b9d2-412e-b26f-0484d481e4c5	2009-10-19	TAMOXIFEN	NA	HORMONE THERAPY	479	FALSE	944	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	RECURRENCE	NA	9140	NA
2082	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27669	fd7a3513-ddff-4504-a30a-3788779f9e79	2009-10-19	CARBOPLATIN	NA	CHEMOTHERAPY	7	FALSE	126	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4200	NA
2083	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27670	9abcadac-29d0-4872-bf15-828eb4d2e730	2009-10-19	PACILTAXEL	NA	CHEMOTHERAPY	7	FALSE	126	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1650	NA
2084	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27675	39eb5ea5-4df1-41c4-b4e9-3369be3f31fd	2009-10-19	MEGACE	NA	CHEMOTHERAPY	944	FALSE	1099	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	OTHER	SWITCHED FROM TAMOZIFEN	NA	NA
2085	6fee41dc-b8a9-4347-8085-b7e05f813ad0	TCGA.31.1944	TCGA-31-1944-D27673	d9a922f5-a0b8-49a9-b586-fd2fcc484996	2009-10-19	CARBOPLATIN	NA	CHEMOTHERAPY	721	FALSE	841	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3300	NA
2086	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27682	56f9a0bb-a46c-40eb-95a8-194c7567a88b	2009-10-20	GEMCITABINE	NA	CHEMOTHERAPY	64	FALSE	148	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	12000	NA
2087	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27685	87e7d1d3-165b-4969-bce1-1a00f13eec10	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	687	FALSE	743	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	180	NA
2088	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27681	1686102f-3307-402f-ba68-dfff1343b060	2009-10-20	PACILTAXEL	NA	CHEMOTHERAPY	22	FALSE	43	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	260	NA
2089	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27680	67422b5d-9481-47cc-850b-68769f0c75d5	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	43	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1400	NA
2090	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27684	67ffe7ae-da38-4393-8271-545d0259f6ff	2009-10-20	LIOSOMAL DOCORUBICIN	NA	CHEMOTHERAPY	687	FALSE	743	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	144	NA
2091	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27683	6a769fec-2edb-4b44-910d-e1d49d42c7ce	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	64	FALSE	148	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2200	NA
2092	da274941-3edd-420b-9262-bbd959923c67	TCGA.31.1946	TCGA-31-1946-D27686	870e5a5d-f290-492a-b282-4171aac9f5d4	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	771	FALSE	828	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	UNABLE TO TOLERATE LIPOSOMAL DOXOROBICIN	1500	NA
2093	4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1	TCGA.31.1950	TCGA-31-1950-D27689	15db6c90-507f-4efe-82aa-9cb243720c1e	2009-10-19	CARBOPLATIN	NA	CHEMOTHERAPY	33	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3300	NA
2094	4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1	TCGA.31.1950	TCGA-31-1950-D27690	4979d025-1341-4190-b965-c7dc0349b252	2009-10-19	PACILTAXEL	NA	CHEMOTHERAPY	431	FALSE	571	NA	NA	NA	NA	18	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1440	NA
2095	b0839f46-8c82-4619-be3d-c857a1759463	TCGA.31.1951	TCGA-31-1951-D27693	c56143b7-c7a5-4bbd-86fc-83ffbd920fc5	2010-1-4	CARBOPLATIN	NA	CHEMOTHERAPY	328	FALSE	482	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3600	NA
2096	b0839f46-8c82-4619-be3d-c857a1759463	TCGA.31.1951	TCGA-31-1951-D27696	bf9312cc-d8a3-4719-b7bf-b516ea90cadd	2010-1-4	PACLITAXEL	NA	CHEMOTHERAPY	41	FALSE	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1260	NA
2097	b0839f46-8c82-4619-be3d-c857a1759463	TCGA.31.1951	TCGA-31-1951-D27694	657dd0b8-f79b-44b4-9847-db5ac8eed2ea	2010-1-4	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	328	FALSE	482	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	240	NA
2098	b0839f46-8c82-4619-be3d-c857a1759463	TCGA.31.1951	TCGA-31-1951-D27695	5334b5e4-7145-488e-a753-00c01b6c049d	2010-1-4	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3600	NA
2099	61feee94-3ac9-42fe-aaa3-dc6a3efe563c	TCGA.31.1953	TCGA-31-1953-D27699	87f2114d-3ed1-418a-b563-c4a1efdd6c0f	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	65	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1350	NA
2100	61feee94-3ac9-42fe-aaa3-dc6a3efe563c	TCGA.31.1953	TCGA-31-1953-D27702	eb1db586-968a-445e-87e4-81609c8cc5e2	2009-10-20	PACILTAXLE	NA	CHEMOTHERAPY	100	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2101	61feee94-3ac9-42fe-aaa3-dc6a3efe563c	TCGA.31.1953	TCGA-31-1953-D27701	c46dae01-314c-4890-b522-e1446a0f2223	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	100	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2102	61feee94-3ac9-42fe-aaa3-dc6a3efe563c	TCGA.31.1953	TCGA-31-1953-D27700	ece15379-890e-4d24-8c23-a9bd4dcd8e46	2009-10-20	PACILTAXEL	NA	CHEMOTHERAPY	23	FALSE	65	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	840	NA
2103	cce34351-1700-405b-818f-a598f63a33e8	TCGA.31.1955	TCGA-31-1955-D27707	757d2b76-c7e5-4149-b65c-a27c6ad1cd5d	2009-10-19	CARBOPLATIN	NA	CHEMOTHERAPY	1189	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2104	cce34351-1700-405b-818f-a598f63a33e8	TCGA.31.1955	TCGA-31-1955-D27706	8a4bfe3d-6d89-4c2c-81c6-56515d7caf3d	2009-10-19	PACILTAXEL	NA	CHEMOTHERAPY	42	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1560	NA
2105	cce34351-1700-405b-818f-a598f63a33e8	TCGA.31.1955	TCGA-31-1955-D27705	a8c5e460-08d8-4949-8b43-c0ef7c599020	2009-10-19	CARBOPLATIN	NA	CHEMOTHERAPY	42	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3600	NA
2106	cce34351-1700-405b-818f-a598f63a33e8	TCGA.31.1955	TCGA-31-1955-D27708	0b6c3e47-9f51-45cd-8472-8b584f993367	2009-10-19	PACILTAXLE	NA	CHEMOTHERAPY	1189	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2107	e1158102-06f2-47bb-9fe0-49b57f070755	TCGA.31.1956	TCGA-31-1956-D27712	d3e74b41-1369-48f8-a1ad-767692bd830f	2009-10-19	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	188	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5150	NA
2108	e1158102-06f2-47bb-9fe0-49b57f070755	TCGA.31.1956	TCGA-31-1956-D27713	5cc90a67-38af-4ca7-a5cf-9c7676f0cb0b	2009-10-19	PACLITAXEL	NA	CHEMOTHERAPY	34	FALSE	188	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1590	NA
2109	186d40cd-624c-4016-a497-b30c892d393c	TCGA.31.1959	TCGA-31-1959-D27717	47c2d5b6-061b-4fb7-be57-74717e442a52	2009-10-20	PACILTAXEL	NA	CHEMOTHERAPY	26	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2110	186d40cd-624c-4016-a497-b30c892d393c	TCGA.31.1959	TCGA-31-1959-D27716	5b3d6d1e-fcaa-435b-b73d-24586385e15c	2009-10-20	CARBOPLATIN	NA	CHEMOTHERAPY	26	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2111	de548bdd-14ca-486b-bd16-a6fbdd5b50d2	TCGA.36.1568	TCGA-36-1568-D27852	9d38e2ae-a6be-479e-9c79-8865a90a7eb5	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	10	FALSE	123	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2610	NA
2112	de548bdd-14ca-486b-bd16-a6fbdd5b50d2	TCGA.36.1568	TCGA-36-1568-D27853	178044bb-7b27-4a53-b3d0-6e8a5a9352c3	2010-1-15	PACLITAXEL	NA	CHEMOTHERAPY	10	FALSE	123	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1257	NA
2113	de548bdd-14ca-486b-bd16-a6fbdd5b50d2	TCGA.36.1568	TCGA-36-1568-D27851	2a3f80b3-6a80-4ee7-9c35-29309d21d631	2010-1-15	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	624	FALSE	737	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	286	NA
2114	0f530b3e-5b6d-4892-9ebd-9138d76fdca7	TCGA.36.1570	TCGA-36-1570-D27859	630cd072-7436-4d96-9eeb-af8fcd0dcd9b	2010-1-15	PACLITAXEL	NA	CHEMOTHERAPY	23	FALSE	133	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1330	NA
2115	0f530b3e-5b6d-4892-9ebd-9138d76fdca7	TCGA.36.1570	TCGA-36-1570-D27858	1ab5a040-88b7-41b1-a6ee-4bbb809a9b42	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	133	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2808	NA
2116	0f530b3e-5b6d-4892-9ebd-9138d76fdca7	TCGA.36.1570	TCGA-36-1570-D27860	90a5225e-1532-4db6-aef6-b5596c72151e	2010-1-15	GEMCITABINE	NA	CHEMOTHERAPY	432	FALSE	432	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1200	NA
2117	12581634-eebb-4841-8498-71dc9d78c546	TCGA.36.1571	TCGA-36-1571-D27864	1478fbc5-996d-422f-b992-85c1bdc1d14d	2010-1-15	PACLITAXEL	NA	CHEMOTHERAPY	32	FALSE	173	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2100	NA
2118	12581634-eebb-4841-8498-71dc9d78c546	TCGA.36.1571	TCGA-36-1571-D27865	6c4703e2-a040-46b1-8900-b41aa4c1e515	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	384	FALSE	531	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4920	NA
2119	12581634-eebb-4841-8498-71dc9d78c546	TCGA.36.1571	TCGA-36-1571-D27863	5e7ee568-9720-4fc7-aa9a-93f967ae30bc	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	32	FALSE	173	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5130	NA
2120	12581634-eebb-4841-8498-71dc9d78c546	TCGA.36.1571	TCGA-36-1571-D27866	6ad7f24d-3255-4eb0-abb2-2de5df56d30e	2010-1-15	GEMCITABINE	NA	CHEMOTHERAPY	384	FALSE	531	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	26752	NA
2121	eeb9d147-608d-4692-8adf-2f601d23a8ff	TCGA.36.1574	TCGA-36-1574-D27870	b60340a0-dad8-46b3-93d0-e6f6518416c5	2010-1-15	PACLITAXEL	NA	CHEMOTHERAPY	15	FALSE	204	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2122	eeb9d147-608d-4692-8adf-2f601d23a8ff	TCGA.36.1574	TCGA-36-1574-D27869	6eb02c37-b4e7-4e56-9f69-931e6671a4bb	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	204	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2123	3445c524-5a37-40b6-8614-956d76eed939	TCGA.36.1576	TCGA-36-1576-D27875	80ba7cc4-fcbf-4b2d-9604-42e785b2d9ec	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	12	FALSE	222	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3648	NA
2124	3445c524-5a37-40b6-8614-956d76eed939	TCGA.36.1576	TCGA-36-1576-D27876	0dad68a9-7536-434e-9a5c-be93632dbd1b	2010-1-15	PACLITAXEL	NA	CHEMOTHERAPY	12	FALSE	222	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2528	NA
2125	e294b940-2828-499c-be24-47ef6c2e9035	TCGA.36.1577	TCGA-36-1577-D27880	1cf4b2f0-97fd-4253-9c7c-3486f0010871	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	28	FALSE	84	NA	NA	NA	NA	3	NA	MG	MG	248	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	744	NA
2126	e294b940-2828-499c-be24-47ef6c2e9035	TCGA.36.1577	TCGA-36-1577-D27879	983593fc-3f1f-42ad-b8ae-4c4868fc29b6	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	84	NA	NA	NA	NA	3	NA	MG	MG	611	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1833	NA
2127	f65f2e78-c001-4ef3-ae88-3e4f83c7aceb	TCGA.36.1578	TCGA-36-1578-D27886	f8bb0861-fe1f-4810-b9ca-bbfb06383418	2010-2-17	PACLITAXEL	NA	CHEMOTHERAPY	15	FALSE	212	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2013	NA
2128	f65f2e78-c001-4ef3-ae88-3e4f83c7aceb	TCGA.36.1578	TCGA-36-1578-D27885	72c7d40a-c4da-405a-8c98-02ff8c7b4036	2010-2-17	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	212	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4830	NA
2129	f65f2e78-c001-4ef3-ae88-3e4f83c7aceb	TCGA.36.1578	TCGA-36-1578-D27887	67ff741a-20f6-473c-93bf-60dc4e5ef139	2010-2-17	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	321	FALSE	345	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	136	NA
2130	533f5ff9-466c-4cdb-9c46-b841c2626775	TCGA.36.1580	TCGA-36-1580-D27891	e781ca54-c93a-4270-99d5-4d97f278b1f6	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	348	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4796	NA
2131	533f5ff9-466c-4cdb-9c46-b841c2626775	TCGA.36.1580	TCGA-36-1580-D27890	9fd38eaf-a33b-4dc5-9d51-7f07a8c2f098	2010-1-15	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	454	FALSE	553	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	222	NA
2132	ef5e85cf-2d82-4d52-a02c-fed5c76e4cec	TCGA.36.1581	TCGA-36-1581-D27895	56016835-05a9-40f2-92ca-42c4583f66c4	2010-1-15	PACLITAXEL	NA	CHEMOTHERAPY	29	FALSE	141	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2313	NA
2133	ef5e85cf-2d82-4d52-a02c-fed5c76e4cec	TCGA.36.1581	TCGA-36-1581-D27894	ea9b943e-fd52-4668-bfd9-333776986799	2010-1-15	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	141	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4639	NA
2134	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27899	f97ac4b2-d650-4e0b-82ef-023ec4a9925c	2010-8-17	PACLITAXEL	NA	CHEMOTHERAPY	17	FALSE	136	NA	NA	NA	NA	6	NA	MG	MG	276	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1656	NA
2135	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27903	eff0b655-1129-4e38-9a79-2aa737b79883	2010-8-17	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	962	FALSE	990	NA	NA	NA	NA	2	NA	MG	MG	64	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	128	NA
2136	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27904	83421639-814a-411d-92dd-307c3db6c2a0	2010-8-17	PACLITAXEL	NA	CHEMOTHERAPY	1026	TRUE	NA	NA	NA	NA	NA	3	NA	MG	MG	238	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	714	NA
2137	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27898	5b9c44a0-5967-43a8-a397-f66f878463e7	2010-8-17	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	136	NA	NA	NA	NA	6	NA	MG	MG	484	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2904	NA
2138	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27901	7982e596-7543-4260-943d-63f1887475e5	2010-8-17	PACLITAXEL	NA	CHEMOTHERAPY	591	FALSE	738	NA	NA	NA	NA	6	NA	MG	MG	296	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1776	NA
2139	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27902	bca15819-c1b5-4032-b2f1-f535ccbcddb3	2010-8-17	CARBOPLATIN	NA	CHEMOTHERAPY	830	FALSE	925	NA	NA	NA	NA	4	NA	MG	MG	465	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1860	NA
2140	20ac688c-04c1-45a6-823a-6b523002ce92	TCGA.36.2529	TCGA-36-2529-D27900	96151d8e-dc0a-4199-ae71-fdf09fd5aaa6	2010-8-17	CARBOPLATIN	NA	CHEMOTHERAPY	591	FALSE	738	NA	NA	NA	NA	6	NA	MG	MG	454	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2724	NA
2141	92a1a8f3-54f2-4983-bb14-dcb73658d897	TCGA.36.2530	TCGA-36-2530-D27910	215057f5-f69e-4580-ae14-b0022e318d6a	2010-8-17	PACLITAXEL	NA	CHEMOTHERAPY	639	FALSE	763	NA	NA	NA	NA	6	NA	MG	MG	179	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1196	NA
2142	92a1a8f3-54f2-4983-bb14-dcb73658d897	TCGA.36.2530	TCGA-36-2530-D27907	1de2a511-cd83-4b35-8503-f3f0dc13bb5b	2010-8-17	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	660	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	3960	NA
2143	92a1a8f3-54f2-4983-bb14-dcb73658d897	TCGA.36.2530	TCGA-36-2530-D27909	4444d108-727d-4d9d-a952-8bbcb1dbb4f9	2010-8-17	CARBOPLATIN	NA	CHEMOTHERAPY	639	FALSE	763	NA	NA	NA	NA	6	NA	MG	MG	560	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3808	NA
2144	92a1a8f3-54f2-4983-bb14-dcb73658d897	TCGA.36.2530	TCGA-36-2530-D27908	4e54a205-21a1-4976-8efb-8bf32ebc5abf	2010-8-17	PACLITAXEL	NA	CHEMOTHERAPY	21	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	78	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	1836	NA
2145	92a1a8f3-54f2-4983-bb14-dcb73658d897	TCGA.36.2530	TCGA-36-2530-D27911	25e8b24b-f738-482a-9dfc-14cda1f2e880	2010-8-17	CEDIRANIB PLACEBO	NA	TARGETED MOLECULAR THERAPY	639	FALSE	982	NA	NA	NA	NA	NA	NA	MG	MG	15	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
2146	04abcf51-c52a-4e74-a5f4-4bc4fb444902	TCGA.36.2532	TCGA-36-2532-D27915	11a22433-ac29-46a9-ad76-efd5fe41bfce	2010-8-17	PACLITAXEL	NA	CHEMOTHERAPY	27	FALSE	140	NA	NA	NA	NA	6	NA	MG	MG	93	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2201.2	NA
2147	04abcf51-c52a-4e74-a5f4-4bc4fb444902	TCGA.36.2532	TCGA-36-2532-D27914	cbd4dd5a-2acc-4498-bc13-dd61c64eaa82	2010-8-17	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	140	NA	NA	NA	NA	6	NA	MG	MG	564	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
2148	e08a619d-8a55-435d-8c41-a77a112ed889	TCGA.36.2534	TCGA-36-2534-D27921	25f3327a-f99f-435e-b0c9-374a05c7adac	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	544	FALSE	685	NA	NA	NA	NA	6	NA	MG	MG	600	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	3720	NA
2149	e08a619d-8a55-435d-8c41-a77a112ed889	TCGA.36.2534	TCGA-36-2534-D27919	13620b52-e2ce-4432-a515-5fa70c731e9f	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	154	NA	NA	NA	NA	7	NA	MG	MG	470	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3735	NA
2150	e08a619d-8a55-435d-8c41-a77a112ed889	TCGA.36.2534	TCGA-36-2534-D27920	6a4a8078-bc7d-4d80-a77b-932a4360fe9a	2010-8-18	DOCETAXEL	NA	CHEMOTHERAPY	27	FALSE	154	NA	NA	NA	NA	7	NA	MG	MG	135	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	949	NA
2151	5075cdc1-1b7c-4e25-98ea-fb568bd35f2d	TCGA.36.2537	TCGA-36-2537-D27924	95758800-a6d0-45e1-8d9a-5752cd7fc5a6	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	893	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5358	NA
2152	5075cdc1-1b7c-4e25-98ea-fb568bd35f2d	TCGA.36.2537	TCGA-36-2537-D27925	c3174758-216c-4fc8-8a98-36a43e572c20	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	20	FALSE	125	NA	NA	NA	NA	6	NA	MG	MG	301	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1806	NA
2153	5075cdc1-1b7c-4e25-98ea-fb568bd35f2d	TCGA.36.2537	TCGA-36-2537-D27926	13bac041-aab1-4e77-b1bf-d66aab5c449c	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	474	FALSE	614	NA	NA	NA	NA	6	NA	MG	MG	850	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5100	NA
2154	5075cdc1-1b7c-4e25-98ea-fb568bd35f2d	TCGA.36.2537	TCGA-36-2537-D27927	f86a3fa0-169d-4c38-b7ae-1895cedf7055	2010-8-18	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	474	FALSE	614	NA	NA	NA	NA	6	NA	MG	MG	55	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	330	NA
2155	5075cdc1-1b7c-4e25-98ea-fb568bd35f2d	TCGA.36.2537	TCGA-36-2537-D27928	ef10bbf8-5e83-430a-ab10-ddebd51a9219	2010-8-18	GEMCITABINE	NA	CHEMOTHERAPY	721	FALSE	763	NA	NA	NA	NA	6	NA	MG	MG	1512	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	9072	NA
2156	3ea880f4-7a78-4cb7-bfe4-54b3c30a812e	TCGA.36.2538	TCGA-36-2538-D27933	705a490a-ccbc-41a1-809c-d3f33a0265f2	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	542	FALSE	682	NA	NA	NA	NA	6	NA	MG	MG	680	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4080	NA
2157	3ea880f4-7a78-4cb7-bfe4-54b3c30a812e	TCGA.36.2538	TCGA-36-2538-D27932	21626185-0374-4efb-867e-ac1a9976bdd6	2010-8-18	PACITAXEL	NA	CHEMOTHERAPY	72	FALSE	212	NA	NA	NA	NA	6	NA	MG	MG	270	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1620	NA
2158	3ea880f4-7a78-4cb7-bfe4-54b3c30a812e	TCGA.36.2538	TCGA-36-2538-D27931	387a8a6f-3cad-4e2f-b5ac-9faf5418cfe4	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	72	FALSE	212	NA	NA	NA	NA	6	NA	MG	MG	690	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4140	NA
2159	3ea880f4-7a78-4cb7-bfe4-54b3c30a812e	TCGA.36.2538	TCGA-36-2538-D27934	5c21d21c-6cbb-45e6-89d4-afdc7839cae1	2010-8-18	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	542	FALSE	682	NA	NA	NA	NA	6	NA	MG	MG	38	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	238	NA
2160	30c7efdd-5a86-4418-a33c-a5d27fe56e42	TCGA.36.2540	TCGA-36-2540-D27938	eb3e8ac7-0199-40aa-b642-d77d932a1478	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	46	FALSE	185	NA	NA	NA	NA	6	NA	MG	MG	370	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2220	NA
2161	30c7efdd-5a86-4418-a33c-a5d27fe56e42	TCGA.36.2540	TCGA-36-2540-D27940	e4be68cd-4638-4590-b0f3-6f83e64f48b0	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	726	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	300	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2162	30c7efdd-5a86-4418-a33c-a5d27fe56e42	TCGA.36.2540	TCGA-36-2540-D27937	ae88c1fa-9bf0-4d92-8b5b-786a2cdb17ca	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	46	FALSE	185	NA	NA	NA	NA	6	NA	MG	MG	1280	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	7680	NA
2163	30c7efdd-5a86-4418-a33c-a5d27fe56e42	TCGA.36.2540	TCGA-36-2540-D27939	d8bff8c2-883d-4027-bb84-1ed49eb546f2	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	726	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	940	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2164	7aadc24b-3de2-478f-b9e5-aca44424f514	TCGA.36.2542	TCGA-36-2542-D27944	fb87fce9-8378-400b-913d-98bf43261971	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	25	FALSE	159	NA	NA	NA	NA	6	NA	MG	MG	77	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1345	NA
2165	7aadc24b-3de2-478f-b9e5-aca44424f514	TCGA.36.2542	TCGA-36-2542-D27943	c15888a5-ada4-4d21-bda0-cac3f969bd25	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	25	FALSE	152	NA	NA	NA	NA	6	NA	MG	MG	540	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3240	NA
2166	da56dfbe-35ae-4bd7-9a11-d9bbb02b1833	TCGA.36.2544	TCGA-36-2544-D27950	f7dd65b4-7325-4b8e-a966-a1d861d1b258	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	23	FALSE	128	NA	NA	NA	NA	6	NA	MG	MG	247	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1542	NA
2167	da56dfbe-35ae-4bd7-9a11-d9bbb02b1833	TCGA.36.2544	TCGA-36-2544-D27949	d7582250-4e83-4f98-9c7e-db0b477604b2	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	128	NA	NA	NA	NA	6	NA	MG	MG	546	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3276	NA
2168	da56dfbe-35ae-4bd7-9a11-d9bbb02b1833	TCGA.36.2544	TCGA-36-2544-D27951	1aab2bea-e290-440c-af43-f14733a32813	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	343	FALSE	343	NA	NA	NA	NA	1	NA	MG	MG	605	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	605	NA
2169	da56dfbe-35ae-4bd7-9a11-d9bbb02b1833	TCGA.36.2544	TCGA-36-2544-D27952	cf3913cd-287d-4a0c-a040-c13ae4ef276f	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	343	FALSE	343	NA	NA	NA	NA	1	NA	MG	MG	260	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	260	NA
2170	f3cd0ca3-8e5d-481b-b28c-619a4123dcd0	TCGA.36.2545	TCGA-36-2545-D27956	f704b1b9-e697-44d8-9ce9-bd83bccb7ab4	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	19	FALSE	152	NA	NA	NA	NA	6	NA	MG	MG	90	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2364	NA
2171	f3cd0ca3-8e5d-481b-b28c-619a4123dcd0	TCGA.36.2545	TCGA-36-2545-D27955	f6ca9e7b-80f0-47bd-9a94-dad045441d16	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	19	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	750	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	5450	NA
2172	5e447cbc-9bc9-4e1a-9b43-06cf619e5aa9	TCGA.36.2547	TCGA-36-2547-D27959	2d0f8024-f78a-4818-b9a7-2f78a52624a2	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
2173	5e447cbc-9bc9-4e1a-9b43-06cf619e5aa9	TCGA.36.2547	TCGA-36-2547-D27960	88a8157c-ca8d-494c-ab8d-de85bb90d7c1	2010-8-18	PACLILTAXEL	NA	CHEMOTHERAPY	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2174	3250e604-d12a-4922-aaca-6f0cae095842	TCGA.36.2548	TCGA-36-2548-D27964	c61c0ee3-7792-4556-a74e-0f4ce2ceb27b	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	58	FALSE	267	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2175	3250e604-d12a-4922-aaca-6f0cae095842	TCGA.36.2548	TCGA-36-2548-D27963	7905da51-efd8-42a9-9ef7-e165f09bb674	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	58	FALSE	267	NA	NA	NA	NA	9	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2176	9815ab87-454d-4dfc-8b3d-4b35af32d764	TCGA.36.2549	TCGA-36-2549-D27968	5a6c332e-d031-47ff-8289-63c802a63356	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	41	FALSE	181	NA	NA	NA	NA	6	NA	MG	MG	309	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1854	NA
2177	9815ab87-454d-4dfc-8b3d-4b35af32d764	TCGA.36.2549	TCGA-36-2549-D27967	45c7c8d0-307f-4398-800e-680320d860a1	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	181	NA	NA	NA	NA	6	NA	MG	MG	710	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4400	NA
2178	9f096022-e3ec-4f63-8c52-03ef24c018f3	TCGA.36.2551	TCGA-36-2551-D27973	c5bf7b9a-ad76-474f-9a4c-47d768c31c8c	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	346	TRUE	NA	NA	NA	NA	NA	6	NA	MG	MG	555	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2179	9f096022-e3ec-4f63-8c52-03ef24c018f3	TCGA.36.2551	TCGA-36-2551-D27974	0ca9fe75-fd2c-420d-9ba2-b0f3b63798df	2010-8-18	LIPOSOMAL DOXORUBICIN	NA	CHEMOTHERAPY	346	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	55	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2180	9f096022-e3ec-4f63-8c52-03ef24c018f3	TCGA.36.2551	TCGA-36-2551-D27972	d1503daa-5943-43ab-bce9-9e6c09b8eab5	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	38	FALSE	163	NA	NA	NA	NA	6	NA	MG	MG	243	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1602	NA
2181	9f096022-e3ec-4f63-8c52-03ef24c018f3	TCGA.36.2551	TCGA-36-2551-D27971	21e402db-38f5-420a-be93-d6c90b1b5f97	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	16	FALSE	198	NA	NA	NA	NA	8	NA	MG	MG	650	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6340	NA
2182	2d8b42fb-b12c-454e-a5a5-22c91913386f	TCGA.36.2552	TCGA-36-2552-D27978	8a05a1cd-08bc-4e8a-b376-7580f51e54b5	2010-8-18	PACLITAXEL	NA	CHEMOTHERAPY	15	FALSE	121	NA	NA	NA	NA	6	NA	MG	MG	241	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1449.5	NA
2183	2d8b42fb-b12c-454e-a5a5-22c91913386f	TCGA.36.2552	TCGA-36-2552-D27977	9d94ac77-895f-4af1-9a46-8a1f6ca3fb17	2010-8-18	CARBOPLATIN	NA	CHEMOTHERAPY	15	FALSE	121	NA	NA	NA	NA	6	NA	MG	MG	454	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2724	NA
2184	E35B2813-427E-4E83-95F6-4F0281F42A59	TCGA.3P.A9WA	TCGA-3P-A9WA-D60123	CBB9DB6A-C8A4-465E-8180-0CE8BB362721	2014-5-29	TAXOL	NA	CHEMOTHERAPY	92	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2185	E35B2813-427E-4E83-95F6-4F0281F42A59	TCGA.3P.A9WA	TCGA-3P-A9WA-D60124	ADC8FFC1-7FE3-4DBB-A041-FC4CD4F35B60	2014-5-29	PARAPLATIN	NA	CHEMOTHERAPY	92	FALSE	212	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2186	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D28028	55f15f39-17c5-4aa3-9a39-bab6794e69f5	2010-6-3	TAXOTERE	NA	CHEMOTHERAPY	57	FALSE	184	NA	NA	NA	NA	6	NA	MG	MG	135	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	945	NA
2187	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D28031	dfdd0a09-cbbb-4dcb-9cc5-cefebd224b34	2010-6-3	TAXOL	NA	CHEMOTHERAPY	36	FALSE	36	NA	NA	NA	NA	1	NA	MG	MG	325	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	325	NA
2188	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D28030	c19b14c4-4aae-4c87-bf43-e31418a4506b	2010-6-3	CISPLATIN	NA	CHEMOTHERAPY	37	FALSE	185	NA	NA	NA	NA	7	NA	MG	MG	180	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	1260	NA
2189	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D28029	cb3e3212-e23f-4b37-9f42-93c5ee99a980	2010-6-3	TAXOL	NA	CHEMOTHERAPY	232	TRUE	NA	NA	NA	NA	NA	7	NA	MG	MG	240	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1440	NA
2190	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D28819	f7f05050-c2e8-4fa4-8768-ce2a34d3835e	2011-5-18	CISPLATIN	NA	CHEMOTHERAPY	640	FALSE	682	NA	NA	NA	NA	3	NA	MG	MG	180	3	INTRA-PERITONEAL	NA	NA	RECURRENCE	NA	540	NA
2191	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D28818	495ec0d8-ca4e-4ef2-af6c-2f5ee7b212fc	2011-5-18	TAXOL	NA	CHEMOTHERAPY	232	FALSE	560	NA	NA	NA	NA	6	NA	MG	MG	242	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	1453	NA
2192	7922df77-f09a-488c-a1be-58646ceb9b3e	TCGA.42.2582	TCGA-42-2582-D31446	44CFCC79-0825-468C-84A0-5E1288307CF4	2012-5-2	TOPOTECAN	NA	CHEMOTHERAPY	800	FALSE	955	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2193	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28037	32127c37-e882-42f0-ab66-04c4714e1a54	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	150	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	515	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	2575	NA
2194	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28035	b35f1439-dc93-4cce-84ce-54954bd7c017	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	94	NA	NA	NA	NA	3	NA	MG	MG	395	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1183	NA
2195	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28034	1e1bb656-c424-468b-bd66-cb465f9f5eae	2010-6-3	TAXOL	NA	CHEMOTHERAPY	17	FALSE	94	NA	NA	NA	NA	3	NA	MG	MG	160	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1018	NA
2196	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28036	ffec8b1d-1d6c-4050-b6c3-f453bbffc47e	2010-6-3	TAXOL	NA	CHEMOTHERAPY	150	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	119	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1507	NA
2197	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28799	6b469b25-b567-4107-b82e-efe85e137b95	2011-8-22	CLINICAL TRIAL	NA	CHEMOTHERAPY	326	FALSE	605	NA	NA	NA	NA	10	NA	MG	MG	267	3	INTRAVENOUS	NA	NA	OTHER	MAINTENANCE	2694	NA
2198	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28798	f8ec148f-6eed-4601-8312-6fe0888b92b3	2011-8-22	CARBOPLATIN	NA	CHEMOTHERAPY	276	FALSE	276	NA	NA	NA	NA	5	NA	NA	NA	NA	2	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
2199	eef62876-7d17-496a-8971-2c7008d77014	TCGA.42.2587	TCGA-42-2587-D28796	61a1c2b5-2d22-4594-b3a4-46f029c4a77c	2011-8-22	TAXOL	NA	CHEMOTHERAPY	283	FALSE	290	NA	NA	NA	NA	1	NA	MG	MG	117	2	INTRAVENOUS	NA	NA	ADJUVANT	NA	234	NA
2200	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28042	b4616f91-0148-4e23-8b9d-ab3fd76760d7	2010-6-3	TAXOL	NA	CHEMOTHERAPY	161	FALSE	258	NA	NA	NA	NA	4	NA	MG	MG	97	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1146	NA
2201	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28043	2c83e6ca-240b-4be5-b796-006d114d3975	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	161	FALSE	258	NA	NA	NA	NA	4	NA	MG	MG	590	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	2360	NA
2202	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28041	ad0e141f-2887-4cee-9a89-8172ebda8ce7	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	90	NA	NA	NA	NA	4	NA	MG	MG	558	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2169	NA
2203	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28040	06643023-c853-4442-ba1b-5cd6259c1b6b	2010-6-3	TAXOL	NA	CHEMOTHERAPY	48	FALSE	104	NA	NA	NA	NA	3	NA	MG	MG	137	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	948	NA
2204	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28834	dedd22e6-28a2-4020-8f6d-c266b1f48fe7	2012-1-26	CARBOPLATIN	NA	CHEMOTHERAPY	744	FALSE	819	NA	NA	NA	NA	4	NA	MG	MG	300	6	INTRAVENOUS	NA	NA	PROGRESSION	NA	1203	NA
2205	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28824	30c139f2-e12d-4ed8-a1b3-31fc9eb5bb59	2012-1-26	AVASTIN	NA	TARGETED MOLECULAR THERAPY	343	FALSE	399	NA	NA	NA	NA	3	NA	MG	MG	747	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	2323	NA
2206	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28822	1d0588af-256c-45d7-b974-d57254093ea4	2012-1-26	DOXIL	NA	CHEMOTHERAPY	315	FALSE	399	NA	NA	NA	NA	4	NA	MG	MG	60	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	248	NA
2207	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28831	b29f6f17-e86e-411b-a740-fec10c2f256b	2012-1-26	FEMARA	NA	HORMONE THERAPY	687	FALSE	784	NA	NA	NA	NA	NA	NA	MG	MG	2.5	5	ORAL	NA	NA	PROGRESSION	NA	245	NA
2208	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28826	c56b5635-c884-4eba-be7b-af5898e3ce77	2012-1-26	CARBOPLATIN	NA	CHEMOTHERAPY	455	FALSE	595	NA	NA	NA	NA	7	NA	MG	MG	266	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	1862	NA
2209	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28937	74BDD96A-B5A2-41A7-926D-5F07411E36B7	2012-1-26	MEGESTROL ACETATE	NA	HORMONE THERAPY	687	FALSE	784	NA	NA	NA	NA	1	NA	MG	MG	400	5	ORAL	NA	NA	PROGRESSION	NA	39200	NA
2210	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28825	800d12e7-9f55-4e4a-80b4-0d6d58cca353	2012-1-26	CISPLATIN	NA	CHEMOTHERAPY	427	FALSE	427	NA	NA	NA	NA	1	NA	MG	MG	72	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	72	NA
2211	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28827	575215c3-b906-40ca-a891-4f6663e92d32	2012-1-26	GEMCITABINE	NA	CHEMOTHERAPY	427	FALSE	602	NA	NA	NA	NA	8	NA	MG	MG	621	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	10302	NA
2212	654d02ab-05b4-4863-99d9-04d087ff91b4	TCGA.42.2588	TCGA-42-2588-D28833	d04a7679-dc92-4c44-8f30-ad96ecf65f2c	2012-1-26	GEMCITABINE	NA	CHEMOTHERAPY	735	FALSE	819	NA	NA	NA	NA	4	NA	MG	MG	675	6	INTRAVENOUS	NA	NA	PROGRESSION	NA	4881	NA
2213	dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb	TCGA.42.2589	TCGA-42-2589-D28046	811bc53a-f05b-4779-a676-128d0da2822a	2010-6-3	TAXOL	NA	CHEMOTHERAPY	21	FALSE	132	NA	NA	NA	NA	6	NA	MG	MG	308	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2046	NA
2214	dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb	TCGA.42.2589	TCGA-42-2589-D28048	6a1466ac-1f06-4617-a34e-604e6945dac0	2010-6-3	CISPLATIN	NA	CHEMOTHERAPY	63	FALSE	126	NA	NA	NA	NA	4	NA	MG	MG	140	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	545	NA
2215	dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb	TCGA.42.2589	TCGA-42-2589-D28047	1a6c0376-6bc1-4d52-ad00-2a5d128b8232	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	41	NA	NA	NA	NA	2	NA	MG	MG	696	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1392	NA
2216	dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb	TCGA.42.2589	TCGA-42-2589-D28802	F4DC11FC-B77B-4047-A7F3-0C9AC3E36A26	2011-5-11	CARBOPLATIN	NA	CHEMOTHERAPY	377	FALSE	504	NA	NA	NA	NA	6	NA	MG	MG	475	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	2375	NA
2217	dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb	TCGA.42.2589	TCGA-42-2589-D28805	180D0212-9DF5-42F7-928C-EB0455BB8FAE	2011-6-9	GEMCITABINE	NA	CHEMOTHERAPY	377	FALSE	644	NA	NA	NA	NA	11	NA	MG	MG	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	21398	NA
2218	2724109f-7d5a-402c-a915-741e43c6f7f9	TCGA.42.2590	TCGA-42-2590-D28051	6706e8b9-0a34-469c-a95f-9bb26531c61e	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	38	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	640	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2470	NA
2219	2724109f-7d5a-402c-a915-741e43c6f7f9	TCGA.42.2590	TCGA-42-2590-D28052	b71ee922-d388-4f5d-b45a-25f2f102aada	2010-6-3	GEMCITABINE	NA	CHEMOTHERAPY	31	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	1600	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12100	NA
2220	2724109f-7d5a-402c-a915-741e43c6f7f9	TCGA.42.2590	TCGA-42-2590-D28811	ab3bd573-dcf1-44c5-8518-8d44a22e4b93	2011-5-18	TAXOTERE	NA	CHEMOTHERAPY	249	FALSE	269	NA	NA	NA	NA	2	NA	MG	MG	110	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	235	NA
2221	0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa	TCGA.42.2591	TCGA-42-2591-D28055	72d60219-e3a7-4bcb-9264-f882a37c8488	2010-6-3	TAXOL	NA	CHEMOTHERAPY	23	FALSE	204	NA	NA	NA	NA	8	NA	MG	MG	120	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2747	NA
2222	0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa	TCGA.42.2591	TCGA-42-2591-D28056	72191190-2d62-46d3-ae53-fc701676bbb8	2010-6-3	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	204	NA	NA	NA	NA	8	NA	MG	MG	715	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	5720	NA
2223	0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa	TCGA.42.2591	TCGA-42-2591-D28794	5782a341-5e6f-45a5-bd62-6a5e998694fc	2011-8-22	TAXOL	NA	CHEMOTHERAPY	253	FALSE	561	NA	NA	NA	NA	12	NA	MG	MG	270	2	INTRAVENOUS	NA	NA	OTHER	MAINTENANCE	3240	NA
2224	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28065	52fe6e4b-e0f3-45ac-a637-1646983fa465	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	597	FALSE	718	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2225	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28062	465a4575-5435-43fd-83d8-e1e1e3f854a2	2009-7-28	PATUPILONE	NA	CHEMOTHERAPY	260	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2226	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28060	4476f55a-92b6-41f6-86a8-d943b07880fc	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	17	FALSE	170	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2227	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28061	6e3807f9-6043-4aec-aa04-b7e7feab6f77	2009-7-28	TAXOTERE	NA	CHEMOTHERAPY	17	FALSE	170	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2228	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28066	64899839-fe30-4966-ad41-a6039e479566	2009-7-28	GEMZAR	NA	CHEMOTHERAPY	597	FALSE	718	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2229	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28063	cf142304-ee75-49b0-9661-d6a7f35b0e5f	2009-7-28	DOXIL	NA	CHEMOTHERAPY	444	FALSE	505	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
2230	4ea50685-3b63-440a-b037-597ef2529e7d	TCGA.57.1582	TCGA-57-1582-D28064	9041086b-05e4-47fa-a97e-8a2434ee502f	2009-7-28	TOPOTECAN	NA	CHEMOTHERAPY	505	FALSE	597	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2231	76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8	TCGA.57.1583	TCGA-57-1583-D28070	434279a5-98f5-4980-865b-49ce6f7f5e16	2009-7-28	TAXOL	NA	CHEMOTHERAPY	37	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2232	76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8	TCGA.57.1583	TCGA-57-1583-D28069	fcaf527f-ac45-49ba-b12e-0898f26aa9fe	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	37	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2233	ed21615c-0de3-421c-9e8d-8996026c4431	TCGA.57.1584	TCGA-57-1584-D28074	ebf8762c-60c4-480c-b622-f381bd0c690b	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	573	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	6	NA
2234	ed21615c-0de3-421c-9e8d-8996026c4431	TCGA.57.1584	TCGA-57-1584-D28073	0c8bcfba-47b8-4021-9897-453225bb8218	2009-7-28	TAXOL	NA	CHEMOTHERAPY	573	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	175	NA
2235	5ed14506-f69a-4da8-9965-72d3270b9f72	TCGA.57.1585	TCGA-57-1585-D28077	81bf2efd-8318-47a1-9950-fbc7a075cf68	2009-7-28	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	53	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2236	5ed14506-f69a-4da8-9965-72d3270b9f72	TCGA.57.1585	TCGA-57-1585-D28078	e291cd52-9ae7-45f5-a0bd-fc522f30f01b	2009-7-28	TAXOL	NA	CHEMOTHERAPY	18	FALSE	53	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2237	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28085	154aa145-3583-4eae-b349-106673305fb4	2009-9-15	DOXIL	NA	CHEMOTHERAPY	323	FALSE	406	NA	NA	NA	NA	3	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2238	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28084	5948359f-b509-4b5a-ba6a-be19c611bbce	2009-9-15	CISPLATIN	NA	CHEMOTHERAPY	259	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2239	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28081	bbf33820-9f76-4cfb-afe0-79a5c0eb3edb	2009-9-15	TAXOL	NA	CHEMOTHERAPY	49	FALSE	163	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2240	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28083	d67969e3-a53c-49a7-9e9d-e199f334de35	2009-9-15	GEMZAR	NA	CHEMOTHERAPY	259	FALSE	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2241	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28086	f5064788-37a0-4453-8e48-7afd74568b5a	2009-9-15	TOPOTECAN	NA	CHEMOTHERAPY	433	FALSE	542	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2242	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28088	c50fed41-30b0-467a-9fce-96067cfa97d2	2009-9-15	TAXOL	NA	CHEMOTHERAPY	553	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2243	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28082	39d706ee-04ea-4d4b-b740-faa6cc534736	2009-9-15	CARBOPLATIN	NA	CHEMOTHERAPY	49	FALSE	163	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2244	48e66676-dbed-48a4-9a7f-a6d247b15c17	TCGA.57.1586	TCGA-57-1586-D28087	ded42d21-aa2e-4520-a82a-0e2c905d3c55	2009-9-15	CARBOPLATIN	NA	CHEMOTHERAPY	553	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2245	15fc17cd-d073-4f81-a4a2-2db3cb9d7069	TCGA.57.1993	TCGA-57-1993-D28093	b07a8455-73a1-4571-bd1b-3e468ec2f2f8	2010-2-9	CARBOPLATIN	NA	CHEMOTHERAPY	62	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2246	15fc17cd-d073-4f81-a4a2-2db3cb9d7069	TCGA.57.1993	TCGA-57-1993-D28094	6953096a-c7ed-4c25-b134-8dca8f12f670	2010-2-9	TAXOL	NA	CHEMOTHERAPY	62	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2247	d7925dfc-18ce-46ab-a47b-9d06eacc96d0	TCGA.59.2354	TCGA-59-2354-D28108	efd422e2-ed42-4926-ac5f-947cb1a6f888	2010-3-31	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2248	d7925dfc-18ce-46ab-a47b-9d06eacc96d0	TCGA.59.2354	TCGA-59-2354-D28109	a31debf1-cc26-497d-8434-113fc8930b99	2010-3-31	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2249	708eec28-2348-4e15-b98c-8c6f9d057b1e	TCGA.59.2355	TCGA-59-2355-D28113	90eccdfc-050e-473d-854a-6bd75e253a13	2010-3-31	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2250	708eec28-2348-4e15-b98c-8c6f9d057b1e	TCGA.59.2355	TCGA-59-2355-D28112	a484b2da-a6d7-403b-b76e-17312504bdbc	2010-3-31	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2251	f4d95c8e-fb84-46ca-acc0-827015cc9d0a	TCGA.59.2363	TCGA-59-2363-D28116	370376ef-e337-4f4a-99e9-1946fb317d53	2010-3-15	CARBOPALTIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2252	f4d95c8e-fb84-46ca-acc0-827015cc9d0a	TCGA.59.2363	TCGA-59-2363-D28117	3947e570-c2af-4b0d-8d63-fb7eb1a976ca	2010-3-15	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2253	5d8abed4-62b3-4e17-a8ce-9f6028e97103	TCGA.59.2372	TCGA-59-2372-D28120	791be596-c56b-401b-8e73-0067dcd7484f	2010-3-15	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2254	5d8abed4-62b3-4e17-a8ce-9f6028e97103	TCGA.59.2372	TCGA-59-2372-D28121	ae86c082-8c04-4078-bd1e-b303705819cd	2010-3-15	TAXOL	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2255	BC84C5C5-1785-4EDD-B732-8987F862063E	TCGA.5X.AA5U	TCGA-5X-AA5U-D68523	BCE4C9F7-2318-4C8B-8545-9F0283051595	2014-11-24	TAXOTERE	NA	CHEMOTHERAPY	66	FALSE	178	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2256	BC84C5C5-1785-4EDD-B732-8987F862063E	TCGA.5X.AA5U	TCGA-5X-AA5U-D69109	22AB155E-AD49-40BF-BE96-92E5512C3A5C	2014-12-29	CISPLATIN	NA	CHEMOTHERAPY	63	FALSE	178	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2257	BC84C5C5-1785-4EDD-B732-8987F862063E	TCGA.5X.AA5U	TCGA-5X-AA5U-D69110	75E7835F-DABB-414B-939A-450620B2352C	2014-12-29	CARBOPLATIN	NA	CHEMOTHERAPY	63	FALSE	178	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2258	1c0318d9-0472-4840-add4-46bb9f914a30	TCGA.61.1721	TCGA-61-1721-D28125	be53f54f-26ff-45ce-8475-53ab28702ead	2009-12-1	TAXOL	NA	CHEMOTHERAPY	2	FALSE	338	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	NEOADJUVANT	1782	NA
2259	1c0318d9-0472-4840-add4-46bb9f914a30	TCGA.61.1721	TCGA-61-1721-D28126	88f75546-60dd-4748-83ef-3e287dfec167	2009-12-1	CARBOPLATIN	NA	CHEMOTHERAPY	2	FALSE	338	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	OTHER	NEOADJUVANT	3960	NA
2260	1c0318d9-0472-4840-add4-46bb9f914a30	TCGA.61.1721	TCGA-61-1721-D28124	0b65dd59-5982-4c6e-bd9a-705298dcb9bd	2009-12-1	OXALIPLATIN	NA	CHEMOTHERAPY	193	FALSE	317	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	528	NA
2261	1c0318d9-0472-4840-add4-46bb9f914a30	TCGA.61.1721	TCGA-61-1721-D28127	d4666102-4b7e-48ee-80ae-e210b59c5590	2009-12-1	TAXOTERE	NA	CHEMOTHERAPY	193	FALSE	317	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	786	NA
2262	47feba88-1ec9-4904-b0e2-3718f294badb	TCGA.61.1722	TCGA-61-1722-D28130	08dcb240-abe5-4cd2-8b81-b865b8e57bf9	2009-12-4	CYTOXAN	NA	CHEMOTHERAPY	103	FALSE	174	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3000	NA
2263	47feba88-1ec9-4904-b0e2-3718f294badb	TCGA.61.1722	TCGA-61-1722-D28132	1ebe6dcf-919d-439f-ad65-eca304b64bc0	2009-12-4	VINCRISTINE	NA	CHEMOTHERAPY	103	FALSE	174	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
2264	47feba88-1ec9-4904-b0e2-3718f294badb	TCGA.61.1722	TCGA-61-1722-D28131	905dc122-807e-446f-80c3-408de2511c9f	2009-12-4	MITOXANTRONE	NA	CHEMOTHERAPY	103	FALSE	171	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	29	NA
2265	47feba88-1ec9-4904-b0e2-3718f294badb	TCGA.61.1722	TCGA-61-1722-D28133	594842d6-0c7e-4151-b277-bf6fbd04c4ab	2010-3-12	DECODRON	NA	HORMONE THERAPY	103	FALSE	174	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	30	NA
2266	2ae65a06-df0f-4de1-a536-537cae0cc260	TCGA.61.1724	TCGA-61-1724-D28139	10ae53d3-cf86-4d27-acc9-b14b417c38e9	2009-12-1	DOXIL	NA	CHEMOTHERAPY	368	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2267	2ae65a06-df0f-4de1-a536-537cae0cc260	TCGA.61.1724	TCGA-61-1724-D28141	01418efe-a192-41b4-b329-40e650144015	2009-12-1	GEMZAR	NA	CHEMOTHERAPY	608	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2268	2ae65a06-df0f-4de1-a536-537cae0cc260	TCGA.61.1724	TCGA-61-1724-D28138	5a48d2d4-f2f1-4169-aa5f-c07f1a4897e3	2009-12-1	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2269	2ae65a06-df0f-4de1-a536-537cae0cc260	TCGA.61.1724	TCGA-61-1724-D28137	17389b1d-4f26-4ea4-9e25-44de0d1f6504	2009-12-1	GEMCITABINE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2270	2ae65a06-df0f-4de1-a536-537cae0cc260	TCGA.61.1724	TCGA-61-1724-D28136	6af00c2d-d0db-4f4b-8bcf-05807748460e	2009-12-1	CISPLATIN	NA	CHEMOTHERAPY	287	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	NA	NA
2271	2ae65a06-df0f-4de1-a536-537cae0cc260	TCGA.61.1724	TCGA-61-1724-D28140	cd8e9c06-c812-47cd-be39-6f65386c41ef	2009-12-1	TAXOTERE	NA	CHEMOTHERAPY	514	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2272	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28148	ae6635ba-24c7-4ef6-9109-fcb345f40100	2009-12-4	AVASTIN	NA	CHEMOTHERAPY	908	TRUE	NA	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	8550	NA
2273	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28147	be9ce53c-8440-43ce-9790-f43f463a4749	2009-12-4	TAXOL	NA	CHEMOTHERAPY	235	FALSE	577	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3204	NA
2274	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28144	ff470391-4fb2-4ee9-b99a-db1ca43e94df	2009-12-4	TAXOL	NA	CHEMOTHERAPY	45	FALSE	158	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1548	NA
2275	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28146	f8dca13c-4cb2-443d-852d-5f8c0ef3f597	2009-12-4	TAXOL	NA	CHEMOTHERAPY	45	FALSE	158	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	456	NA
2276	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28149	e3c3aa0d-b3cf-4832-a3b3-7edb59254a73	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	908	TRUE	NA	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4368	NA
2277	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28145	de6d03ff-d938-406d-934b-3b682ca22abc	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	45	FALSE	158	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	585	NA
2278	a6eb0cd0-fe57-41b0-8593-776208684293	TCGA.61.1725	TCGA-61-1725-D28150	0b003971-e65d-4cad-886b-054a4cb03a53	2009-12-4	GAMZAR	NA	CHEMOTHERAPY	908	TRUE	NA	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2400	NA
2279	99407c1d-40b5-4ded-ba29-1e40dfd65be4	TCGA.61.1727	TCGA-61-1727-D28153	5b0e1651-62e8-40b8-8bd2-0b31b786ad3d	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	62	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	600	NA
2280	99407c1d-40b5-4ded-ba29-1e40dfd65be4	TCGA.61.1727	TCGA-61-1727-D28154	131ac56b-194e-470a-b9b1-98791766dc47	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	62	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2250	NA
2281	07fbdb3c-8337-4319-8255-f2363f8a031e	TCGA.61.1728	TCGA-61-1728-D28158	f040590a-48e8-4891-9aff-f2534f18ff54	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	43	FALSE	204	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5280	NA
2282	07fbdb3c-8337-4319-8255-f2363f8a031e	TCGA.61.1728	TCGA-61-1728-D28157	f38cdfc3-7031-4308-ad4e-4dc2ee43c0d7	2009-11-30	SNS 595	NA	CHEMOTHERAPY	246	FALSE	848	NA	NA	NA	NA	20	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1920	NA
2283	07fbdb3c-8337-4319-8255-f2363f8a031e	TCGA.61.1728	TCGA-61-1728-D28159	c225c5ce-5c01-4ae5-b74f-a6e2034824bf	2009-11-30	TAXOL	NA	CHEMOTHERAPY	43	FALSE	204	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2000	NA
2284	04ecaf38-0232-4dcd-9242-308a22cc1331	TCGA.61.1733	TCGA-61-1733-D28164	c5f1a4ae-9989-4347-8a0a-d1afa03088c0	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3924	NA
2285	04ecaf38-0232-4dcd-9242-308a22cc1331	TCGA.61.1733	TCGA-61-1733-D28167	9cb8b2cf-4118-4be9-bfb9-b27a645a9d44	2009-12-4	TAXOL	NA	CHEMOTHERAPY	484	FALSE	625	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	390	NA
2286	04ecaf38-0232-4dcd-9242-308a22cc1331	TCGA.61.1733	TCGA-61-1733-D28166	3d4bc96f-852a-4613-af54-9a451e00749f	2009-12-4	DOXIL	NA	CHEMOTHERAPY	231	FALSE	372	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	482	NA
2287	04ecaf38-0232-4dcd-9242-308a22cc1331	TCGA.61.1733	TCGA-61-1733-D28169	54936660-8150-4378-bb3a-200680460618	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	484	FALSE	625	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	582	NA
2288	04ecaf38-0232-4dcd-9242-308a22cc1331	TCGA.61.1733	TCGA-61-1733-D28168	62907e81-bc0a-4302-9897-8d0b0a0fa75e	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	484	FALSE	625	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	720	NA
2289	04ecaf38-0232-4dcd-9242-308a22cc1331	TCGA.61.1733	TCGA-61-1733-D28165	b774d231-1124-433a-818f-ba0a853908d0	2009-12-4	DOCETAXEL	NA	CHEMOTHERAPY	22	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	638	NA
2290	b5e64bdb-24f1-400d-aaf7-8fda8ab6fd3c	TCGA.61.1734	TCGA-61-1734-D28172	199c76a7-19fe-4f8a-90f0-0064008b434b	2009-12-8	TAXOL	NA	CHEMOTHERAPY	46	FALSE	158	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2291	b5e64bdb-24f1-400d-aaf7-8fda8ab6fd3c	TCGA.61.1734	TCGA-61-1734-D28173	14804ed4-485f-4cb9-b2be-ce15222dcfc1	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	46	FALSE	158	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2292	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	TCGA.61.1736	TCGA-61-1736-D28177	0dd45cff-9b04-43bc-862b-62ac6b70880a	2009-12-8	TAXOL	NA	CHEMOTHERAPY	34	FALSE	138	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2293	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	TCGA.61.1736	TCGA-61-1736-D28178	57649c27-8fde-4924-bb6a-36f78d3d965e	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	138	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2294	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	TCGA.61.1736	TCGA-61-1736-D28176	f0714214-07d4-4c41-9e61-b6470308eea9	2009-12-8	GEMZAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2295	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	TCGA.61.1736	TCGA-61-1736-D28179	4be9230a-4d81-4cd4-a1ba-3f24ad91f5cc	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2296	0a2d29de-869a-4dc8-ad11-6ee0d0a3a895	TCGA.61.1736	TCGA-61-1736-D28180	6b95b794-0927-46c0-8786-6e66ec7050fc	2009-12-8	DOXIL	NA	CHEMOTHERAPY	946	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2297	0aa020cb-69d2-4235-a609-c279a133d8bb	TCGA.61.1737	TCGA-61-1737-D28184	bde9b500-2bbc-4635-9b62-37438f743031	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	43	FALSE	106	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2600	NA
2298	0aa020cb-69d2-4235-a609-c279a133d8bb	TCGA.61.1737	TCGA-61-1737-D28183	36e353f0-bed3-40a3-affc-66fbe869646f	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	43	FALSE	106	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	480	NA
2299	0aa020cb-69d2-4235-a609-c279a133d8bb	TCGA.61.1737	TCGA-61-1737-D28186	593c4bb6-7022-48d5-a8df-50583f549c87	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	127	FALSE	176	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	372	NA
2300	0aa020cb-69d2-4235-a609-c279a133d8bb	TCGA.61.1737	TCGA-61-1737-D28187	567b59df-038a-4301-84af-f74ac4ccfccd	2009-12-4	PACLITAXEL	NA	CHEMOTHERAPY	127	FALSE	176	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	198	NA
2301	0aa020cb-69d2-4235-a609-c279a133d8bb	TCGA.61.1737	TCGA-61-1737-D28185	9a678242-a8a6-4502-b315-c6433876552a	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	127	FALSE	176	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	270	NA
2302	0aa020cb-69d2-4235-a609-c279a133d8bb	TCGA.61.1737	TCGA-61-1737-D28188	83835e07-7625-4324-9530-b58a5533f592	2009-12-4	TAMOXIFEN	NA	HORMONE THERAPY	582	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	19000	NA
2303	72c40fba-f502-489b-ad87-843f52655894	TCGA.61.1738	TCGA-61-1738-D28195	5cae6b69-090f-47c8-8713-2eaa5c448e60	2009-12-4	TOPTECAN	NA	CHEMOTHERAPY	422	FALSE	658	NA	NA	NA	NA	29	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	191.4	NA
2304	72c40fba-f502-489b-ad87-843f52655894	TCGA.61.1738	TCGA-61-1738-D28196	265b0571-09c1-4944-b6d1-b8f6b8c01b1c	2009-12-4	GEMZAR	NA	CHEMOTHERAPY	709	FALSE	843	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	6200	NA
2305	72c40fba-f502-489b-ad87-843f52655894	TCGA.61.1738	TCGA-61-1738-D28194	0008d328-4bb3-4d4a-b5d0-28d09f97d2c3	2009-12-4	DOXIL	NA	CHEMOTHERAPY	287	FALSE	338	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	210	NA
2306	72c40fba-f502-489b-ad87-843f52655894	TCGA.61.1738	TCGA-61-1738-D28192	f55cc532-8bdd-4cad-ad7b-e462a95f6c05	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	135	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5	NA
2307	72c40fba-f502-489b-ad87-843f52655894	TCGA.61.1738	TCGA-61-1738-D28193	b26e2e7f-9a62-4f34-90d4-d3463baaab74	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	198	FALSE	276	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	364	NA
2308	72c40fba-f502-489b-ad87-843f52655894	TCGA.61.1738	TCGA-61-1738-D28191	b8292746-a108-4445-8ef5-59cea4a9b2b0	2009-12-4	TAXOL	NA	CHEMOTHERAPY	21	FALSE	135	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2376	NA
2309	005a6517-2e5a-4ea3-ab36-531522723607	TCGA.61.1740	TCGA-61-1740-D28199	bc6d55fe-44ed-4ff5-92ae-80281edfcb66	2009-12-4	TAMOXIFEN	NA	HORMONE THERAPY	23	FALSE	74	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	1020	NA
2310	16ced1b8-64d5-4498-82df-4d37bfe5b310	TCGA.61.1741	TCGA-61-1741-D28205	5aea964c-d67f-417c-94a3-3c4307475905	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	522	FALSE	605	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1750	NA
2311	16ced1b8-64d5-4498-82df-4d37bfe5b310	TCGA.61.1741	TCGA-61-1741-D28202	ce5d7a64-d023-4d01-946f-515257c9017a	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	12	FALSE	180	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3799	NA
2312	16ced1b8-64d5-4498-82df-4d37bfe5b310	TCGA.61.1741	TCGA-61-1741-D28204	846166d2-712d-44eb-9155-a202bd1f1136	2009-12-4	TAXOL	NA	CHEMOTHERAPY	522	FALSE	605	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	838	NA
2313	16ced1b8-64d5-4498-82df-4d37bfe5b310	TCGA.61.1741	TCGA-61-1741-D28203	de49cd91-151a-46e9-a204-106b50968a1f	2009-12-4	TAXOL	NA	CHEMOTHERAPY	12	FALSE	180	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2240	NA
2314	16ced1b8-64d5-4498-82df-4d37bfe5b310	TCGA.61.1741	TCGA-61-1741-D28206	286c1a59-9223-4a69-b1f8-b72959043137	2009-12-4	TAMOXIFEN	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
2315	a3e26259-732b-49fb-bc95-2f0ec7a0494e	TCGA.61.1743	TCGA-61-1743-D28210	030502fa-6d42-4a5a-a3af-eedba0383040	2009-11-30	TAXOL	NA	CHEMOTHERAPY	40	FALSE	172	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2316	a3e26259-732b-49fb-bc95-2f0ec7a0494e	TCGA.61.1743	TCGA-61-1743-D28211	90ea70e1-cefe-4bee-b0bb-c04b6269d3a3	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	40	FALSE	172	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2317	0dd95368-0713-45f0-84f4-c91af9cbba74	TCGA.61.1895	TCGA-61-1895-D28214	509215c0-2874-4032-a07f-fe9216ced5a7	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	44	FALSE	156	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3780	NA
2318	0dd95368-0713-45f0-84f4-c91af9cbba74	TCGA.61.1895	TCGA-61-1895-D28215	8ef7db20-0617-45f6-90ae-fe393e156f93	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	44	FALSE	156	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	400	NA
2319	35b1bb47-b32b-4acd-8e5e-fe6bd56c0289	TCGA.61.1899	TCGA-61-1899-D28219	e0d17430-bc63-44d6-894d-4b001467cc7a	2009-12-4	TAXOL	NA	CHEMOTHERAPY	52	FALSE	159	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1104	NA
2320	35b1bb47-b32b-4acd-8e5e-fe6bd56c0289	TCGA.61.1899	TCGA-61-1899-D28218	6194d641-aa69-41e2-8f81-acbf267cc1df	2009-12-4	CARBPLATIN	NA	CHEMOTHERAPY	52	FALSE	159	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2220	NA
2321	ef653772-e5d2-46ec-8610-f81d75d7353c	TCGA.61.1900	TCGA-61-1900-D28224	ee2b9e79-59a9-465a-bef5-7c013a3693c7	2009-12-4	TAXOL	NA	CHEMOTHERAPY	35	FALSE	76	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	75	NA
2322	ef653772-e5d2-46ec-8610-f81d75d7353c	TCGA.61.1900	TCGA-61-1900-D28223	ab4e8e00-7f0c-4de9-96bb-e60b0987d787	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	35	FALSE	76	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	135	NA
2323	ef653772-e5d2-46ec-8610-f81d75d7353c	TCGA.61.1900	TCGA-61-1900-D28222	abc2cd6c-fb56-402d-b274-676c502e0ea5	2009-12-4	TAXOL	NA	CHEMOTHERAPY	35	FALSE	76	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	250	NA
2324	7a75d318-b301-4f77-a97f-4d6784d27216	TCGA.61.1901	TCGA-61-1901-D28228	4b2e65d9-beef-462d-9820-6aa8c06bf8c1	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	294	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3941	NA
2325	7a75d318-b301-4f77-a97f-4d6784d27216	TCGA.61.1901	TCGA-61-1901-D28227	f89a19a1-eb39-4031-9043-3ea9fd7fe6cf	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	28	FALSE	294	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2098	NA
2326	b3df9c0a-420c-4cc2-a3e0-56df1ed7e997	TCGA.61.1903	TCGA-61-1903-D28234	438d748a-9cd1-4c10-8e86-c856d91b1b2b	2009-12-4	TAXOL	NA	CHEMOTHERAPY	32	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	412	NA
2327	b3df9c0a-420c-4cc2-a3e0-56df1ed7e997	TCGA.61.1903	TCGA-61-1903-D28232	a528c65e-1612-4b37-ae33-ae6ecab7b7e1	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	32	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	560	NA
2328	b3df9c0a-420c-4cc2-a3e0-56df1ed7e997	TCGA.61.1903	TCGA-61-1903-D28233	d44ae97c-2ba5-4224-bb8e-a2b0df6b511a	2009-12-4	TAXOL	NA	CHEMOTHERAPY	32	FALSE	147	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	120	NA
2329	2cdd5154-ee5c-4d67-b2eb-947dfaa56be2	TCGA.61.1904	TCGA-61-1904-D28237	849f17c4-a3e6-4980-83f5-dd6cfc965087	2009-12-4	TAXOTERE	NA	CHEMOTHERAPY	42	FALSE	161	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	720	NA
2330	2cdd5154-ee5c-4d67-b2eb-947dfaa56be2	TCGA.61.1904	TCGA-61-1904-D28238	9631e833-0db2-4797-ad8d-eebda0dea026	2009-12-4	CISPLATIN	NA	CHEMOTHERAPY	42	FALSE	161	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2600	NA
2331	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28247	256a66da-facb-406a-b470-479d7de669f4	2009-12-4	TAXOL	NA	CHEMOTHERAPY	489	FALSE	1038	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1500	NA
2332	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28248	08069844-2b07-4cb9-ba89-13dc8ef3efcc	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	489	FALSE	1038	NA	NA	NA	NA	10	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5	NA
2333	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28241	ad137f25-8a5c-497a-a23c-cc32c105dbf9	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	27	FALSE	153	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
2334	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28246	10f0eb71-7ac1-4247-ac2f-0c1943154b96	2009-12-4	AVASTIN	NA	CHEMOTHERAPY	400	FALSE	484	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1000	NA
2335	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28242	3df3ef68-bd63-40f3-8aac-cda81634d52e	2009-12-4	TAXOL	NA	CHEMOTHERAPY	27	FALSE	153	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2076	NA
2336	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28243	bc864245-d830-48e2-b862-7ee8c983f05d	2009-12-4	TOPOTECAN	NA	CHEMOTHERAPY	279	FALSE	321	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	7.8	NA
2337	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28244	f5a0e7fc-c6ea-43b4-89f5-f51891c4f550	2009-12-4	DOXIL	NA	CHEMOTHERAPY	335	FALSE	391	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	234	NA
2338	f553e953-6464-421f-8933-26ca82cb79d3	TCGA.61.1906	TCGA-61-1906-D28245	d096b01e-2201-4d76-8e34-adaf4f8cd7f9	2009-12-4	GEMZAR	NA	CHEMOTHERAPY	400	FALSE	484	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1600	NA
2339	7ab3765f-910a-41c9-86cc-08534d2a4e4b	TCGA.61.1907	TCGA-61-1907-D28252	81f78f66-be55-4b92-8c94-7e94311bbce0	2009-12-4	DOCETAXEL	NA	CHEMOTHERAPY	37	FALSE	163	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	678	NA
2340	7ab3765f-910a-41c9-86cc-08534d2a4e4b	TCGA.61.1907	TCGA-61-1907-D28251	ad0cedb8-9cfe-4c7d-a378-44814f214092	2009-12-4	OXALIPLATIN	NA	CHEMOTHERAPY	37	FALSE	163	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	768	NA
2341	7ab3765f-910a-41c9-86cc-08534d2a4e4b	TCGA.61.1907	TCGA-61-1907-D28254	46b1d80a-bd2f-47c1-b54e-9840ed2f9d2f	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	774	FALSE	927	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2342	7ab3765f-910a-41c9-86cc-08534d2a4e4b	TCGA.61.1907	TCGA-61-1907-D28253	b7771071-32ea-49c0-95ce-797ccca2d8b5	2009-12-4	AVASTIN	NA	CHEMOTHERAPY	37	FALSE	357	NA	NA	NA	NA	17	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	14280	NA
2343	75f2d97a-b96c-403f-8055-5c5c8083e856	TCGA.61.1910	TCGA-61-1910-D28258	4a16e1dc-aba9-48c9-b387-2f5461cbc49b	2009-12-4	TAXOL	NA	CHEMOTHERAPY	56	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	756	NA
2344	75f2d97a-b96c-403f-8055-5c5c8083e856	TCGA.61.1910	TCGA-61-1910-D28257	1156e454-75aa-4807-9098-9c0c7f48c158	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	56	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4550	NA
2345	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28263	0cdd8ba8-eb65-46bb-aed4-903e1f8e4311	2009-12-4	GEMZAR	NA	CHEMOTHERAPY	893	FALSE	998	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	8400	NA
2346	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28265	d1f8adbb-656c-4ba2-897a-f44078508729	2009-12-4	GEMZAR	NA	CHEMOTHERAPY	1306	FALSE	1432	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	9800	NA
2347	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28264	57b42526-f8f9-4174-9f48-ef76fc389e56	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	893	FALSE	998	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3000	NA
2348	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28267	35c6a1ab-a350-42c4-adc4-1f8a13363ab3	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	1306	FALSE	1432	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5700	NA
2349	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28261	07995a31-b89c-4dcf-a2ac-8df6206991d6	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4650	NA
2350	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28266	d66c5aa9-31ea-436a-b0f6-83a2a727862c	2009-12-4	AVASTIN	NA	CHEMOTHERAPY	1306	FALSE	1432	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	500	NA
2351	93095c36-2263-438f-a619-a4a4d6ae13c7	TCGA.61.1911	TCGA-61-1911-D28262	50d13255-fa36-4270-9b48-bf97f80061db	2009-12-4	TAXOL	NA	CHEMOTHERAPY	34	FALSE	144	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1710	NA
2352	8516d4f2-0b98-4847-99c6-4d7269fa4af2	TCGA.61.1913	TCGA-61-1913-D28271	490e164d-620b-44b0-bb79-d767b6bd4d4c	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	21	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3930	NA
2353	8516d4f2-0b98-4847-99c6-4d7269fa4af2	TCGA.61.1913	TCGA-61-1913-D28270	a567da40-6f3c-49d1-b3f8-ce39c43506a2	2009-12-4	DOCETAXEL	NA	CHEMOTHERAPY	21	FALSE	127	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	720	NA
2354	8e1b8811-1eb2-4337-852c-c19eaa0ee418	TCGA.61.1914	TCGA-61-1914-D28275	40a2d81b-7bf7-4f8e-a283-d44999b5d6ce	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	22	FALSE	193	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3360	NA
2355	8e1b8811-1eb2-4337-852c-c19eaa0ee418	TCGA.61.1914	TCGA-61-1914-D28274	6f5663c3-61f6-4e8c-b0d0-f89618d07922	2009-12-4	TAXOL	NA	CHEMOTHERAPY	22	FALSE	193	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2400	NA
2356	8e1b8811-1eb2-4337-852c-c19eaa0ee418	TCGA.61.1914	TCGA-61-1914-D28276	6ffd14a7-cd33-4aa5-af00-b98302635493	2009-12-4	TAXOL	NA	CHEMOTHERAPY	1753	FALSE	1871	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1890	NA
2357	8e1b8811-1eb2-4337-852c-c19eaa0ee418	TCGA.61.1914	TCGA-61-1914-D28278	6d844227-9edb-4c02-bd47-494f8080a17f	2009-12-4	TAMOXIFEN	NA	HORMONE THERAPY	1155	FALSE	1673	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	1030	NA
2358	8e1b8811-1eb2-4337-852c-c19eaa0ee418	TCGA.61.1914	TCGA-61-1914-D28277	b2513645-c71d-4268-bb2e-b6543d55e1b3	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	1753	FALSE	1871	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2580	NA
2359	0adadf17-c4b6-48b0-a326-21450de3e144	TCGA.61.1915	TCGA-61-1915-D28281	4bd27c43-6a47-4962-a865-7fbad514b6d9	2009-12-4	TAXOL	NA	CHEMOTHERAPY	25	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1560	NA
2360	0adadf17-c4b6-48b0-a326-21450de3e144	TCGA.61.1915	TCGA-61-1915-D28282	04be4ceb-917f-4055-b536-a529442dfbcf	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	25	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3300	NA
2361	b25b3379-df8f-4900-9bce-0f8df50f549b	TCGA.61.1916	TCGA-61-1916-D28288	5e8b3d4e-c2e0-42c2-b5e8-a398b22b2443	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	142	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2362	b25b3379-df8f-4900-9bce-0f8df50f549b	TCGA.61.1916	TCGA-61-1916-D28287	598ec300-0689-445d-8bf0-36cb29f5a1b8	2010-2-26	TAXOL	NA	CHEMOTHERAPY	142	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2363	b25b3379-df8f-4900-9bce-0f8df50f549b	TCGA.61.1916	TCGA-61-1916-D28285	24ff60f6-90b7-445c-ad89-3ccb0e5e15ba	2010-2-26	TOPOTECAN	NA	CHEMOTHERAPY	37	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2364	b25b3379-df8f-4900-9bce-0f8df50f549b	TCGA.61.1916	TCGA-61-1916-D28286	e5b625fa-134d-465f-b7c8-424ba5a72067	2010-2-26	CARBOPLATIN	NA	CHEMOTHERAPY	37	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2365	87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4	TCGA.61.1917	TCGA-61-1917-D28291	77081d9f-b721-4405-931e-35b61c21871b	2009-11-30	GEMZAR	NA	CHEMOTHERAPY	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2366	87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4	TCGA.61.1917	TCGA-61-1917-D28292	e7226494-66f0-4f59-8453-395e4e996045	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2367	87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4	TCGA.61.1917	TCGA-61-1917-D28293	8bc7ad9c-d6f6-4863-863b-8d9a79d97ca5	2009-11-30	TAXOL	NA	CHEMOTHERAPY	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2368	3491d67a-4f83-4f67-8085-bbb9fe942be5	TCGA.61.1918	TCGA-61-1918-D28297	a042ee9d-a58b-4d21-9b66-936fdf07b954	2009-11-30	TAXOL	NA	CHEMOTHERAPY	9	FALSE	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2179	NA
2369	3491d67a-4f83-4f67-8085-bbb9fe942be5	TCGA.61.1918	TCGA-61-1918-D28296	c63c99b6-fa3c-4a93-9fd6-6e95ef6aad5c	2009-11-30	CARBOPLATIN	NA	CHEMOTHERAPY	9	TRUE	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4686	NA
2370	3491d67a-4f83-4f67-8085-bbb9fe942be5	TCGA.61.1918	TCGA-61-1918-D28298	9c8afc14-2d7e-4c8e-a376-8e012320308d	2009-11-30	GEMCITIBINE	NA	CHEMOTHERAPY	9	FALSE	146	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	15616	NA
2371	931738a7-4b5b-46dc-b69f-72600862d8af	TCGA.61.1995	TCGA-61-1995-D28303	154a83f9-1655-45ff-9961-44cd5d6992a7	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	67	FALSE	132	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3202	NA
2372	931738a7-4b5b-46dc-b69f-72600862d8af	TCGA.61.1995	TCGA-61-1995-D28304	5b457183-3195-43d4-8c3e-f244c641648d	2009-12-8	TAXOL	NA	CHEMOTHERAPY	67	FALSE	132	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1311	NA
2373	565d06a1-3640-4274-8fb3-8cad7e578876	TCGA.61.1998	TCGA-61-1998-D28309	d1901164-9c69-4aa7-bfc2-bf9a93581e24	2009-12-8	TAXOL	NA	CHEMOTHERAPY	52	TRUE	NA	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	175	NA
2374	565d06a1-3640-4274-8fb3-8cad7e578876	TCGA.61.1998	TCGA-61-1998-D28308	32b34fbe-8dba-4a98-8abb-fdabf73ff607	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	52	TRUE	NA	NA	NA	NA	NA	6	NA	AUC	AUC	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6	NA
2375	565d06a1-3640-4274-8fb3-8cad7e578876	TCGA.61.1998	TCGA-61-1998-D28307	bf3290fb-d43f-40f0-b67f-584975a56c14	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	10	FALSE	77	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	188	NA
2376	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28312	01c66404-139e-49b4-880f-f7fc97c53c34	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	28	FALSE	231	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1905	NA
2377	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28318	b473a7f5-5323-4b38-b6ec-4f105fe01e5c	2009-12-8	AVASTIN	NA	CHEMOTHERAPY	525	FALSE	588	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3780	NA
2378	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28319	c8caf399-a8ff-4dc9-8b74-2708050e41c0	2009-12-8	TAXOL	NA	CHEMOTHERAPY	525	FALSE	588	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	855	NA
2379	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28313	f41bfb1f-715c-488a-8c23-0547b7a39613	2009-12-8	TAXOL	NA	CHEMOTHERAPY	28	FALSE	231	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2130	NA
2380	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28316	f43225b8-2247-4397-90fb-8ac91e6a7806	2009-12-8	DOCETAXEL	NA	CHEMOTHERAPY	420	FALSE	491	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	508	NA
2381	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28314	de3a38db-115b-4578-b4ca-1a70e152bc86	2009-12-8	CCDP	NA	CHEMOTHERAPY	28	FALSE	231	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	720	NA
2382	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28317	a7437859-e26f-4182-a68e-d71bb725f774	2009-12-8	OXALIPLATIN	NA	CHEMOTHERAPY	420	FALSE	491	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	367	NA
2383	29949b65-2913-4c86-bbd7-b85c5df6f15e	TCGA.61.2000	TCGA-61-2000-D28315	d8595da8-5331-4069-8b2c-8ce6f92b1d33	2009-12-8	TAXOL	NA	CHEMOTHERAPY	28	FALSE	231	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	390	NA
2384	85bb4987-51e7-40fe-ad59-2aa56754eca9	TCGA.61.2002	TCGA-61-2002-D28324	eb420498-8627-4216-ab0a-82de0025a5ca	2009-12-8	DOXORUBICIN	NA	CHEMOTHERAPY	157	FALSE	563	NA	NA	NA	NA	14	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	924	NA
2385	85bb4987-51e7-40fe-ad59-2aa56754eca9	TCGA.61.2002	TCGA-61-2002-D28325	258ebe71-34ac-4e7a-8daa-c688b3a646d9	2009-12-8	AVASTIN	NA	CHEMOTHERAPY	400	FALSE	558	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	6600	NA
2386	85bb4987-51e7-40fe-ad59-2aa56754eca9	TCGA.61.2002	TCGA-61-2002-D28322	d6e3f98a-0305-4a2c-8bea-29b7e39775c5	2009-12-8	PACLITAXEL	NA	CHEMOTHERAPY	24	FALSE	129	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1668	NA
2387	85bb4987-51e7-40fe-ad59-2aa56754eca9	TCGA.61.2002	TCGA-61-2002-D28323	400a7f22-69a2-4b72-84ef-540194cb48b8	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	129	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4800	NA
2388	33dc48d8-2e01-482b-944c-ac10da727ec9	TCGA.61.2003	TCGA-61-2003-D28329	1de90898-a17b-4157-9573-4a8049004b10	2009-12-8	TAXOL	NA	CHEMOTHERAPY	52	FALSE	121	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	ADJUVANT	NA	NA	NA
2389	33dc48d8-2e01-482b-944c-ac10da727ec9	TCGA.61.2003	TCGA-61-2003-D28331	c055893d-8966-4aca-8d83-54c687fa097f	2009-12-8	GEMCITABINE	NA	CHEMOTHERAPY	122	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2390	33dc48d8-2e01-482b-944c-ac10da727ec9	TCGA.61.2003	TCGA-61-2003-D28330	08a1b811-658b-474d-8e5c-6b15e313b88e	2009-12-8	TAXOL	NA	CHEMOTHERAPY	52	FALSE	121	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2391	33dc48d8-2e01-482b-944c-ac10da727ec9	TCGA.61.2003	TCGA-61-2003-D28328	548a0b5e-a665-40db-864c-7a990f366c0d	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	52	FALSE	121	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2392	33dc48d8-2e01-482b-944c-ac10da727ec9	TCGA.61.2003	TCGA-61-2003-D28332	682e5459-eee9-47d4-aa3f-b5543a57a9c5	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	122	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2393	3ac45a71-c463-4f0f-b030-58c475a34418	TCGA.61.2008	TCGA-61-2008-D28336	d05da628-44eb-4405-8981-f0723b085b60	2009-12-8	TAXOTERE	NA	CHEMOTHERAPY	29	FALSE	149	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	690	NA
2394	3ac45a71-c463-4f0f-b030-58c475a34418	TCGA.61.2008	TCGA-61-2008-D28339	f5583f7b-a50c-4bf5-a9c9-11a8333d4781	2009-12-8	TAXOL	NA	CHEMOTHERAPY	861	FALSE	979	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	RECURRENCE	NA	372	NA
2395	3ac45a71-c463-4f0f-b030-58c475a34418	TCGA.61.2008	TCGA-61-2008-D28338	5258713d-41d6-476f-9869-3f98a9284455	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	861	FALSE	979	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	702	NA
2396	3ac45a71-c463-4f0f-b030-58c475a34418	TCGA.61.2008	TCGA-61-2008-D28337	e3ffc3a5-5a6b-4053-a5c4-3a61628c98ce	2009-12-8	TAXOL	NA	CHEMOTHERAPY	861	FALSE	979	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1260	NA
2397	3ac45a71-c463-4f0f-b030-58c475a34418	TCGA.61.2008	TCGA-61-2008-D28335	aae34ce1-d57d-4c05-924f-9c8a7cbc4f8f	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	149	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3600	NA
2398	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28342	fd4307f9-d370-43de-9bb1-aa5a096b8295	2009-12-8	TAXOL	NA	CHEMOTHERAPY	41	FALSE	83	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	778	NA
2399	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28343	d23924cf-bfbe-491c-857d-ee0725112933	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	83	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1545	NA
2400	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28346	fb931ec9-877c-411a-b75f-07a07fd3afd4	2009-12-8	TAXOL	NA	CHEMOTHERAPY	120	FALSE	295	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	490	NA
2401	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28348	ef2747cc-31fe-4893-8aab-d084a7b528c2	2009-12-8	DOCETAXEL	NA	CHEMOTHERAPY	839	FALSE	1003	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	658	NA
2402	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28347	a6d772c2-aeae-48ee-9e3e-c9357345c653	2009-12-8	OXALIPLATIN	NA	CHEMOTHERAPY	839	FALSE	1003	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	987	NA
2403	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28350	9d9b6e91-c5ec-4d50-b8fc-c27068ee4470	2009-12-8	TAMOXIFEN	NA	HORMONE THERAPY	658	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2404	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28344	6d2c40c5-e1e8-4083-a77d-24b61b62bef7	2009-12-8	TAXOL	NA	CHEMOTHERAPY	120	FALSE	295	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1200	NA
2405	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28345	3ff0898b-635f-4c55-b7d9-beb06c6248c8	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	120	FALSE	295	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	635	NA
2406	ae914f23-87b9-4169-a7f7-a3483078c902	TCGA.61.2009	TCGA-61-2009-D28349	60906890-5f6c-494d-8601-e9967fafa145	2009-12-8	DOXIL	NA	CHEMOTHERAPY	1100	FALSE	1126	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	304	NA
2407	20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c	TCGA.61.2012	TCGA-61-2012-D28354	03ea578a-6288-48d0-aac8-a043b050c091	2009-12-8	TAXOL	NA	CHEMOTHERAPY	29	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2408	20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c	TCGA.61.2012	TCGA-61-2012-D28353	d10ed0e0-e577-49c9-8ed4-ad2fb0a269bd	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2409	f0ca8205-0754-4bd8-a6a8-31901040c5e7	TCGA.61.2017	TCGA-61-2017-D28363	7c13d883-2763-4805-b918-f5c98710e43d	2009-12-8	TAXOL	NA	CHEMOTHERAPY	1053	FALSE	1186	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	456	NA
2410	f0ca8205-0754-4bd8-a6a8-31901040c5e7	TCGA.61.2017	TCGA-61-2017-D28362	d69aaa81-29d1-4b99-baa8-5b5f7db327bb	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	1053	FALSE	1186	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	618	NA
2411	f0ca8205-0754-4bd8-a6a8-31901040c5e7	TCGA.61.2017	TCGA-61-2017-D28364	d8e6f6d0-11e5-4857-9176-65b9fd0c367b	2009-12-8	TAXOL	NA	CHEMOTHERAPY	1053	FALSE	1186	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1206	NA
2412	f0ca8205-0754-4bd8-a6a8-31901040c5e7	TCGA.61.2017	TCGA-61-2017-D28360	61c43bff-0d72-4d2c-922c-9694670bfceb	2009-12-8	TAXOL	NA	CHEMOTHERAPY	34	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2413	f0ca8205-0754-4bd8-a6a8-31901040c5e7	TCGA.61.2017	TCGA-61-2017-D28361	90f7abab-7512-4fca-acad-6e58dec64576	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2414	13d6c31a-6899-4119-a5c2-90adcb5bd20c	TCGA.61.2018	TCGA-61-2018-D28370	4af20208-1f14-49df-8e50-22ee1f341ab5	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	61	FALSE	139	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1920	NA
2415	13d6c31a-6899-4119-a5c2-90adcb5bd20c	TCGA.61.2018	TCGA-61-2018-D28367	77d725e0-430c-4c12-8d5e-4cae274cdd50	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	18	FALSE	60	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2010	NA
2416	13d6c31a-6899-4119-a5c2-90adcb5bd20c	TCGA.61.2018	TCGA-61-2018-D28369	c38fd237-8010-48ed-8dc4-1bae13e77bb3	2009-12-8	TAXOTERE	NA	CHEMOTHERAPY	61	FALSE	139	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	460	NA
2417	13d6c31a-6899-4119-a5c2-90adcb5bd20c	TCGA.61.2018	TCGA-61-2018-D28368	b98b71fc-711e-4226-b130-12e02b9eb2e1	2009-12-8	TAXOL	NA	CHEMOTHERAPY	18	FALSE	60	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	639	NA
2418	be03bfec-5bb6-4cab-9dd2-bee590bd45f1	TCGA.61.2087	TCGA-61-2087-D28373	ff89b35b-775d-4c23-a18c-aa0cfcd3e92e	2009-12-8	CISPLATIN	NA	CHEMOTHERAPY	1	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2419	be03bfec-5bb6-4cab-9dd2-bee590bd45f1	TCGA.61.2087	TCGA-61-2087-D28374	4ae5fbbf-121c-45a8-8164-fb222d5e5605	2009-12-8	TAXOL	NA	CHEMOTHERAPY	29	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2420	be03bfec-5bb6-4cab-9dd2-bee590bd45f1	TCGA.61.2087	TCGA-61-2087-D28375	e7f46eb7-164e-4af4-821e-a810016df63b	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2421	242943fe-1fa0-4a12-8f7e-9c6c4af1194d	TCGA.61.2088	TCGA-61-2088-D28379	3b8a8370-edc0-494d-8215-80aaae8e9888	2009-12-7	TAXOTERE	NA	CHEMOTHERAPY	34	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	900	NA
2422	242943fe-1fa0-4a12-8f7e-9c6c4af1194d	TCGA.61.2088	TCGA-61-2088-D28378	f85675b8-465d-493f-b708-2e8f9ca175a4	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	34	FALSE	145	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3900	NA
2423	c183d3fb-2eee-44f8-890e-b9bf907141e6	TCGA.61.2092	TCGA-61-2092-D28382	1690eed1-9060-4323-bdef-31b6bfdd2e65	2009-12-8	TAXOL	NA	CHEMOTHERAPY	41	FALSE	160	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2424	c183d3fb-2eee-44f8-890e-b9bf907141e6	TCGA.61.2092	TCGA-61-2092-D28383	310d2d4f-8dad-40ae-b4e9-74aad0299ebd	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	41	FALSE	160	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2425	b31d85cc-d2e2-4bd1-9986-d6bbe30e657f	TCGA.61.2094	TCGA-61-2094-D28387	8ca7bbee-0d63-40d2-b769-73f7e9411a50	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	24	FALSE	166	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2426	b31d85cc-d2e2-4bd1-9986-d6bbe30e657f	TCGA.61.2094	TCGA-61-2094-D28386	384a2e6a-6501-479e-b41c-10713af19c13	2009-12-8	TAXOL	NA	CHEMOTHERAPY	24	FALSE	166	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2427	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28391	954df6b0-eb97-48ef-8420-fc927a9cd581	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	59	FALSE	602	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2428	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28396	e6c07ec3-5875-407b-a937-5379bdc53ed6	2009-12-7	OVAREX MA6 B43.13	NA	IMMUNOTHERAPY	210	FALSE	447	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	12	NA
2429	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28393	579b6224-4d67-44a5-b5fa-72d19bcd0692	2009-12-7	TOPOTECAN	NA	CHEMOTHERAPY	1193	FALSE	1264	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2430	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28390	6a0849e1-a42b-4ac6-a5f9-7a36be83542d	2009-12-7	TAXOL	NA	CHEMOTHERAPY	59	FALSE	602	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2431	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28394	e9c95270-88d0-44f3-972d-75a8bfd8447e	2009-12-7	OXALIPLATIN	NA	CHEMOTHERAPY	1360	FALSE	1389	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	468	NA
2432	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28392	78845da3-7582-496a-a208-b129f7fb4348	2009-12-7	DOXIL	NA	CHEMOTHERAPY	783	FALSE	1188	NA	NA	NA	NA	12	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2433	778ce436-a825-4689-81c1-b7c965404163	TCGA.61.2095	TCGA-61-2095-D28395	40f7e2ed-0250-4c2b-9f7c-bcfa87bce830	2009-12-7	GEMZAR	NA	CHEMOTHERAPY	1474	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2434	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28404	0194e725-95cb-4433-a529-83ed2c8d8982	2009-12-7	TAXOL	NA	CHEMOTHERAPY	1059	FALSE	1156	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1876	NA
2435	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28403	6d4dc7be-241f-4118-bcfc-23669a4aa990	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	916	FALSE	988	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1230	NA
2436	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28406	32b36471-32ff-40be-8198-66ce4f3ce473	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	1191	FALSE	1372	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1430	NA
2437	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28400	747e5765-384f-47e1-b3e6-cb03b2421b71	2009-12-7	TAXOL	NA	CHEMOTHERAPY	29	FALSE	79	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	645	NA
2438	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28399	7d5010dc-37d5-47a1-a188-bb9fc40715d6	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	79	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1440	NA
2439	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28408	4c55795f-5c4d-4e31-8f40-261d3e5b4ebd	2009-12-7	AVASTIN	NA	CHEMOTHERAPY	1723	FALSE	2010	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5320	NA
2440	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28402	9421779f-251f-47b0-b58b-f6a909449e5b	2009-12-7	TAXOL	NA	CHEMOTHERAPY	474	FALSE	544	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1296	NA
2441	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28405	bddc4142-e4c3-4aca-a2af-b3fd121af417	2009-12-7	GEMCITABINE	NA	CHEMOTHERAPY	1191	FALSE	1372	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	9450	NA
2442	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28401	0ce482e8-1b48-4a3b-aba4-5e06a663f25c	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	474	FALSE	544	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2200	NA
2443	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28407	3d15ee97-366f-4c71-9465-e207cf22ffdc	2009-12-7	TOPOTECAN	NA	CHEMOTHERAPY	1723	FALSE	2010	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	43.2	NA
2444	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28410	70f500bc-f3f6-4f06-83c6-f6a96bfed24c	2010-2-9	MELPHALON	NA	CHEMOTHERAPY	NA	FALSE	642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2445	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28411	105b962c-185f-43a2-a308-d39d139bae04	2010-2-9	CYCLOPHOSPHAMIDE	NA	CHEMOTHERAPY	NA	FALSE	642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2446	6beaa1cb-a9f1-4127-898c-7aff2273788e	TCGA.61.2096	TCGA-61-2096-D28409	9e834075-0f48-4e0a-a791-c91c65803a6d	2010-2-9	TOPOTECAN	NA	CHEMOTHERAPY	NA	FALSE	642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2447	47681e4b-01e8-4779-b966-ce57aff4b712	TCGA.61.2097	TCGA-61-2097-D28416	ae9a2672-4912-4212-8eba-36c96d2e1d6f	2009-12-7	INTERFERON GAMMA	NA	IMMUNOTHERAPY	48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2448	47681e4b-01e8-4779-b966-ce57aff4b712	TCGA.61.2097	TCGA-61-2097-D28415	12fc9951-d8e0-437b-8f44-647e2e6662d1	2009-12-7	TAXOL	NA	CHEMOTHERAPY	48	FALSE	167	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1814	NA
2449	47681e4b-01e8-4779-b966-ce57aff4b712	TCGA.61.2097	TCGA-61-2097-D28414	070e6cd1-5dac-4a4d-b01c-582c4b2e1bc9	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	48	FALSE	167	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3060	NA
2450	eb7c3b35-7a5e-4621-b31f-9775c51f9a23	TCGA.61.2098	TCGA-61-2098-D28419	e844b70b-eaae-45a1-98eb-911c6c63e56c	2009-12-8	TAXOL	NA	CHEMOTHERAPY	14	FALSE	145	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2451	eb7c3b35-7a5e-4621-b31f-9775c51f9a23	TCGA.61.2098	TCGA-61-2098-D28420	e06ba706-69b6-4c0a-a1d8-73d71b53a692	2009-12-8	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	145	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2452	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28426	395d5771-ffed-491a-baa5-f715fb8fbd06	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	152	FALSE	221	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3050	NA
2453	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28434	e2b74437-6a3e-4db1-ba77-7c66df176fc0	2009-12-7	IL 12	NA	IMMUNOTHERAPY	1129	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	300	NA
2454	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28430	a0365ba7-19d8-4ea4-9b7a-ce9c9cf90d23	2009-12-7	HEXALEN	NA	CHEMOTHERAPY	1159	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2455	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28428	22a24cee-77c5-423e-b0fa-2fadedc64e6d	2009-12-7	HEXALIN	NA	CHEMOTHERAPY	733	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	800	NA
2456	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28432	bb3e3e24-b6db-4a5c-ae01-b27ab1c1628c	2009-12-7	DOXIL	NA	CHEMOTHERAPY	1220	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2457	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28429	f557ab9d-8841-415f-a81a-2986f12eb545	2009-12-7	DOXIL	NA	CHEMOTHERAPY	1103	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2458	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28433	b3ae2276-2ab9-4b82-bc5e-83f7143af1ea	2009-12-7	VP 16	NA	CHEMOTHERAPY	1251	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2459	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28423	48ba6dc6-f632-4dce-b86d-ff727f1251b3	2009-12-7	TAXOL	NA	CHEMOTHERAPY	2	FALSE	117	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1800	NA
2460	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28425	a9ae8b0a-2427-4bb0-82c6-ee9668363f5f	2009-12-7	TAXOL	NA	CHEMOTHERAPY	152	FALSE	221	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1200	NA
2461	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28431	ad0029f1-24b5-490c-b5e2-56e03495b8a3	2009-12-7	GEMZAR	NA	CHEMOTHERAPY	1190	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
2462	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28424	a17b6920-5a05-4657-a3ee-1dafc0f723e7	2009-12-7	CISPLATIN	NA	CHEMOTHERAPY	2	FALSE	117	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	762	NA
2463	5d1a54fe-e0df-4c17-b623-b649a136dc82	TCGA.61.2101	TCGA-61-2101-D28427	119e9ed1-a261-483a-a7bf-34bcece33123	2009-12-7	GEMCITABINE	NA	CHEMOTHERAPY	733	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	1420	NA
2464	7a08efd0-f984-430e-a8eb-1881047214b6	TCGA.61.2102	TCGA-61-2102-D28439	43d7605a-1774-4181-a4da-677d897ac471	2009-12-7	TAXOL	NA	CHEMOTHERAPY	14	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2465	7a08efd0-f984-430e-a8eb-1881047214b6	TCGA.61.2102	TCGA-61-2102-D28440	9c357105-fe4d-4ec2-93e3-529f563fd5d8	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2466	05263959-c4f5-4540-b6d2-d8c8a128861f	TCGA.61.2104	TCGA-61-2104-D28445	bc697473-6eba-4dfb-8a1c-4a4b60daa0d1	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	1197	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2467	05263959-c4f5-4540-b6d2-d8c8a128861f	TCGA.61.2104	TCGA-61-2104-D28447	172b7324-19f1-4c6a-9b48-f25584cfe417	2009-12-7	CISPLATIN	NA	CHEMOTHERAPY	1680	FALSE	1681	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRA-PERITONEAL	NA	NA	RECURRENCE	NA	200	NA
2468	05263959-c4f5-4540-b6d2-d8c8a128861f	TCGA.61.2104	TCGA-61-2104-D28444	6d9216c8-daf8-4211-927c-874a245d8a96	2009-12-7	TAXOL	NA	CHEMOTHERAPY	6	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2469	05263959-c4f5-4540-b6d2-d8c8a128861f	TCGA.61.2104	TCGA-61-2104-D28448	a1b6da11-0c8e-4f50-bdd0-5590dcf6b817	2009-12-7	TAXANE	NA	CHEMOTHERAPY	1838	FALSE	2338	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2470	05263959-c4f5-4540-b6d2-d8c8a128861f	TCGA.61.2104	TCGA-61-2104-D28446	32cf4d72-b8d4-4a25-99aa-7918878ab0d8	2009-12-7	TAXOL	NA	CHEMOTHERAPY	1197	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2471	05263959-c4f5-4540-b6d2-d8c8a128861f	TCGA.61.2104	TCGA-61-2104-D28443	16e277f4-06cf-4d80-8c70-a07667591497	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	6	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2472	dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5	TCGA.61.2109	TCGA-61-2109-D28453	2ea9b28a-6af9-4fcd-aa66-d49a600f60ac	2009-12-7	GEMZAR	NA	CHEMOTHERAPY	486	FALSE	601	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	9060	NA
2473	dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5	TCGA.61.2109	TCGA-61-2109-D28454	fd722d54-c930-4c8a-b35d-106c76576754	2009-12-7	CISPLATIN	NA	CHEMOTHERAPY	486	FALSE	601	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	325	NA
2474	dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5	TCGA.61.2109	TCGA-61-2109-D28452	8e1688ad-53a1-4989-98a4-ba00ccbb8717	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	14	FALSE	253	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	8910	NA
2475	dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5	TCGA.61.2109	TCGA-61-2109-D28451	c0bde517-fee3-47fb-8d5f-e06a0012720c	2009-12-7	TAXOL	NA	CHEMOTHERAPY	14	FALSE	253	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3125	NA
2476	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28459	cf284d67-59f2-44d4-ac77-0aaaa1a593e9	2009-12-4	TOPOTECAN	NA	CHEMOTHERAPY	661	FALSE	770	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	28	NA
2477	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28458	2b91b2c6-dd7b-4b55-a31e-a5d0b54914e4	2009-12-4	TAXOL	NA	CHEMOTHERAPY	20	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1620	NA
2478	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28457	e104ed61-6ac7-4c6c-ad84-389d00289ed8	2009-12-4	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	161	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2970	NA
2479	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28462	83713042-6ff6-4fb5-af9f-d052de0e9ef4	2009-12-4	GEMZAR	NA	CHEMOTHERAPY	1089	FALSE	1239	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	12640	NA
2480	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28460	b7c2bc59-6246-44da-afb4-445792bf317e	2009-12-4	CARBPLATIN	NA	CHEMOTHERAPY	774	FALSE	930	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3900	NA
2481	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28461	106ff996-b75a-4830-a231-a7812b2ba5bc	2009-12-4	DOXIL	NA	CHEMOTHERAPY	979	FALSE	1089	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	315	NA
2482	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28464	22c34e90-e390-42af-afe8-975c0b18cac9	2009-12-4	IL 2	NA	IMMUNOTHERAPY	244	FALSE	356	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRA-PERITONEAL	NA	NA	PROGRESSION	NA	16	NA
2483	88180134-710f-46ea-9b06-5e5d860d6d9f	TCGA.61.2110	TCGA-61-2110-D28463	59347194-a069-4b01-830f-b2a17362f69d	2009-12-4	TAMOXIFEN	NA	HORMONE THERAPY	459	FALSE	1354	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
2484	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28471	92211853-fa2a-4218-a96b-db3d1db39268	2009-12-7	TAXOL	NA	CHEMOTHERAPY	2268	FALSE	2373	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2485	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28470	ab138666-d4a6-45cd-bb67-a74d0a8c97dd	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	2268	FALSE	2373	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2486	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28468	5cf77f39-17b0-4d14-8ea3-ea290c63b199	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	133	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3400	NA
2487	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28473	6cda5c22-d228-450b-8486-fb10316b9cf7	2009-12-7	CYTOXAN	NA	CHEMOTHERAPY	3079	FALSE	3165	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4000	NA
2488	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28476	a363d2df-0d8e-45e5-8faa-c9bbfb618a20	2009-12-7	MEGACE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
2489	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28469	acfa69b3-3faa-4a7d-9a8d-b719408b3bf9	2009-12-7	TAXOL	NA	CHEMOTHERAPY	29	FALSE	133	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1500	NA
2490	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28474	15db7502-ada4-472f-9061-ef9ea6087a00	2009-12-7	CYTOXAN	NA	CHEMOTHERAPY	3808	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2491	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28472	1f0c6548-7a9f-44a1-ac71-91c393f297a4	2009-12-7	CISPLATIN	NA	CHEMOTHERAPY	3079	FALSE	3165	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	512	NA
2492	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28475	bb037fb1-3dfc-476d-a329-f46e33afc260	2009-12-7	AVASTIN	NA	CHEMOTHERAPY	3808	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/M2/WK	MG/M2/WK	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2493	91a17d40-c8cb-4cce-b306-966382a8fe4a	TCGA.61.2111	TCGA-61-2111-D28477	82428555-0922-4f7b-a9ca-780dd852553d	2009-12-7	PROVERA	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
2494	71faa2c1-0d5b-4dcc-bdf9-f2405f29907c	TCGA.61.2113	TCGA-61-2113-D28482	235aa36e-7dcb-4f30-bc39-310e5bca1a66	2009-12-7	DOXIL	NA	CHEMOTHERAPY	336	FALSE	392	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	418	NA
2495	71faa2c1-0d5b-4dcc-bdf9-f2405f29907c	TCGA.61.2113	TCGA-61-2113-D28480	d22d635b-1e7e-4114-9e2d-0d2b6db38ded	2009-12-7	TAXOL	NA	CHEMOTHERAPY	49	FALSE	143	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1480	NA
2496	71faa2c1-0d5b-4dcc-bdf9-f2405f29907c	TCGA.61.2113	TCGA-61-2113-D28481	d4d534c2-01be-4eff-bfb2-369ee917dcf2	2009-12-7	CARBOPLATIN	NA	CHEMOTHERAPY	49	FALSE	143	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4026	NA
2497	1098441d-fb10-4590-a302-0a7cc2332798	TCGA.61.2610	TCGA-61-2610-D28488	efec5670-4d2b-42da-9e6f-aff946b9e90c	2010-9-7	DOXIL	NA	CHEMOTHERAPY	591	FALSE	1130	NA	NA	NA	NA	12	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2498	1098441d-fb10-4590-a302-0a7cc2332798	TCGA.61.2610	TCGA-61-2610-D28487	4974f4a7-8f86-480b-a922-48a07a10417c	2010-9-7	TAXOL	NA	CHEMOTHERAPY	29	FALSE	357	NA	NA	NA	NA	12	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2499	1098441d-fb10-4590-a302-0a7cc2332798	TCGA.61.2610	TCGA-61-2610-D28486	741fb562-5cf2-415d-a54f-11bcb861ea9a	2010-9-7	CARBOPLATIN	NA	CHEMOTHERAPY	29	FALSE	357	NA	NA	NA	NA	12	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2500	1098441d-fb10-4590-a302-0a7cc2332798	TCGA.61.2610	TCGA-61-2610-D28485	d0b1651f-f3cd-4ccb-b9f5-cd3b5e34a0b5	2010-9-7	TOPTECAN	NA	CHEMOTHERAPY	439	FALSE	530	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2501	499645bd-e33e-4f89-8526-50460e8bb884	TCGA.61.2611	TCGA-61-2611-D28494	b44534f8-de06-4bb5-9592-2d22bb4537a9	2010-9-7	TAXOL	NA	CHEMOTHERAPY	66	FALSE	316	NA	NA	NA	NA	6	NA	MG	MG	265	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2502	499645bd-e33e-4f89-8526-50460e8bb884	TCGA.61.2611	TCGA-61-2611-D28492	34666b3b-f332-478f-9e6c-b0f883bb1244	2010-9-7	DOXORUBICIN HCI LIPSOME	NA	CHEMOTHERAPY	402	FALSE	402	NA	NA	NA	NA	1	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2503	499645bd-e33e-4f89-8526-50460e8bb884	TCGA.61.2611	TCGA-61-2611-D28493	7bd1c9d0-0ad8-486c-9554-76f86e0b5519	2010-9-7	CARBOPLATIN	NA	CHEMOTHERAPY	66	FALSE	316	NA	NA	NA	NA	6	NA	MG	MG	800	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2504	c040df8a-9d6d-43bd-911a-17a7b4e1ec74	TCGA.61.2612	TCGA-61-2612-D28498	ac6ec127-0170-49d5-9779-1f00c29d2825	2010-9-7	CARBOPLATIN	NA	CHEMOTHERAPY	20	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2505	c040df8a-9d6d-43bd-911a-17a7b4e1ec74	TCGA.61.2612	TCGA-61-2612-D28497	e6638335-cf6e-49bd-bf75-5b476c5ad5d5	2010-9-7	TAXOL	NA	CHEMOTHERAPY	20	FALSE	151	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2506	c88502e9-0bc6-47c3-adc4-d98b63c7797b	TCGA.61.2613	TCGA-61-2613-D28503	65037e9d-ec78-4979-b499-010777f95ff1	2010-9-7	CARBOPLATIN	NA	CHEMOTHERAPY	86	FALSE	NA	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
2507	c88502e9-0bc6-47c3-adc4-d98b63c7797b	TCGA.61.2613	TCGA-61-2613-D28501	98cb83b6-f0a2-4cb6-8613-c44af0665952	2010-9-7	TAXOL	NA	CHEMOTHERAPY	384	FALSE	489	NA	NA	NA	NA	5	NA	MG	MG	235	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2508	c88502e9-0bc6-47c3-adc4-d98b63c7797b	TCGA.61.2613	TCGA-61-2613-D28502	17da5326-4465-4984-b2f9-5ce7c262d9ca	2010-9-7	CARBOPLATIN	NA	CHEMOTHERAPY	384	FALSE	489	NA	NA	NA	NA	5	NA	MG	MG	265	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
2509	260723BF-9620-450D-BF31-F3A45543F9DB	TCGA.OY.A56P	TCGA-OY-A56P-D40751	4C69AC4B-5520-421E-ADEF-0F12EB0C0911	2013-2-27	TAXOTERE	NA	CHEMOTHERAPY	26	FALSE	160	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2510	260723BF-9620-450D-BF31-F3A45543F9DB	TCGA.OY.A56P	TCGA-OY-A56P-D40752	002D674C-302E-4EEE-9324-3C912254F7DC	2013-2-27	CARBOPLATIN	NA	CHEMOTHERAPY	26	FALSE	160	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2511	C7CF6755-8856-435B-A443-174B22A25B07	TCGA.OY.A56Q	TCGA-OY-A56Q-D40756	E86F10BA-0449-406C-ABBE-AF17416539F6	2013-2-27	TAXOL	NA	CHEMOTHERAPY	23	FALSE	128	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2512	C7CF6755-8856-435B-A443-174B22A25B07	TCGA.OY.A56Q	TCGA-OY-A56Q-D40757	4E265E98-8861-485E-A5C5-21CEDE8B7F99	2013-2-27	CARBOPLATIN	NA	CHEMOTHERAPY	23	FALSE	128	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2513	8628F1B2-3763-4BA9-A375-083874BB18F2	TCGA.VG.A8LO	TCGA-VG-A8LO-D60809	FC9C6E78-2625-4BFD-879D-1E1FFFD56E85	2014-6-26	PACLITAXEL	NA	CHEMOTHERAPY	8	FALSE	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2514	8628F1B2-3763-4BA9-A375-083874BB18F2	TCGA.VG.A8LO	TCGA-VG-A8LO-D60817	036051C3-A9BB-4A8E-B1F9-DC9174E397E2	2014-6-26	CARBOPLATIN	NA	CHEMOTHERAPY	8	FALSE	8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2515	B8023162-5E82-40E6-AD8C-8ACF81821F01	TCGA.WR.A838	TCGA-WR-A838-D57160	392FF296-622C-4E06-8938-686004A62D8D	2014-10-3	CARBOPLATIN	NA	CHEMOTHERAPY	30	FALSE	92	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
2516	B8023162-5E82-40E6-AD8C-8ACF81821F01	TCGA.WR.A838	TCGA-WR-A838-D66186	CCE11CBD-98D9-43FB-99E6-8770D1782337	2014-10-3	TAXOL	NA	CHEMOTHERAPY	30	FALSE	92	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
